{
  "Complex Reasoning": {
    "average_scores": {
      "rouge_score": 0.3087007907350145,
      "answer_correctness": 0.710011882877113
    },
    "detailed": [
      {
        "id": "Medical-41b1601a",
        "question": "Which two main biomarkers are tested to confirm a diagnosis of CML, and how are they related?",
        "ground_truth": "BCR::ABL1 fusion gene and Philadelphia chromosome are tested, both resulting from the same chromosomal translocation.",
        "generated_answer": "The two main biomarkers tested to confirm a diagnosis of CML are the Philadelphia chromosome and BCR-ABL fusion gene. They are related as the presence of these biomarkers indicates the genetic abnormalities associated with Chronic Myeloid Leukemia.",
        "contexts": "AML has effect biomarker, biomarker has effect AML, AML has cause biomarker, Testing for AML facet of AML | biomarker has effect AML, AML has effect biomarker, spread facet of cancer, Testing for AML facet of AML | Tests used to diagnose CML part of Guide | CML subclass of cancer | blast phase CML subclass of CML, BP-CML subclass of CML, CML has effect CML, CML has cause CML | biomarkers facet of cervical cancer | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | Tumor markers facet of Breast cancer | Bone marrow test facet of Leukemia | in remission facet of AML | Chronic myeloid leukemia subclass of blood cancer | prognosis facet of CLL | immunophenotyping facet of immune system | biopsy facet of cancer",
        "metrics": {
          "rouge_score": 0.18518518518518517,
          "answer_correctness": 0.6639893727616859
        }
      },
      {
        "id": "Medical-904e0a11",
        "question": "How does the anatomical structure of the bile duct relate to the spread of cancer to the liver?",
        "ground_truth": "The bile duct is composed of several layers, and cancer can invade through these layers into the liver.",
        "generated_answer": "The bile duct is part of the hepatobiliary system and connects with the liver, making it a potential pathway for cancer to spread from the bile duct to the liver. Cancer can invade the bile duct and subsequently metastasize to the liver due to their anatomical proximity and shared blood supply.",
        "contexts": "digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | bile part of liver | hepatobiliary system has part liver, hepatobiliary system has part bile duct, bile duct part of hepatobiliary system, liver part of hepatobiliary system, hepatobiliary system has part gallbladder, gallbladder part of hepatobiliary system | bile part of liver, liver subclass of organ | liver part of digestive system, small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | organs has part liver | liver part of organs | liver has part lymph nodes | bile duct connects with gallbladder, gallbladder connects with bile duct | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | liver part of tissues and organs | left instance of hepatic duct | lymph nodes part of liver | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | liver connects with gallbladder, gallbladder connects with liver",
        "metrics": {
          "rouge_score": 0.31884057971014496,
          "answer_correctness": 0.7393450469797795
        }
      },
      {
        "id": "Medical-63b4b70c",
        "question": "Which subtypes of cutaneous B-cell lymphoma should be considered when a biopsy confirms B-cell origin in a patient with skin papules?",
        "ground_truth": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
        "generated_answer": "Primary cutaneous follicle center lymphoma, Primary cutaneous B-cell lymphoma, Primary cutaneous marginal zone lymphoma, Primary cutaneous diffuse large B-cell lymphoma, leg type.",
        "contexts": "Cutaneous T-cell lymphoma subclass of Lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma, papule subclass of nodule, Primary cutaneous marginal zone lymphoma subclass of Primary cutaneous B-cell lymphoma, B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | Non-Hodgkin lymphoma subclass of Lymphoma | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | melanoma subclass of skin cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Hodgkin lymphoma subclass of Lymphoma | Basal cell skin cancer subclass of Skin lesion | mantle cell lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Squamous cell subclass of skin cancer | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.6382978723404256,
          "answer_correctness": 0.8908287825074862
        }
      },
      {
        "id": "Medical-4ff142d9",
        "question": "How does the starting location of renal cell carcinoma compare to that of renal sarcoma within the kidney?",
        "ground_truth": "RCC starts in the renal tubules, while renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
        "generated_answer": "Renal cell carcinoma is a subclass of kidney cancer, while renal sarcoma is a different type of tumor that originates from the connective tissues of the kidney.",
        "contexts": "Osteosarcoma different from Osteosarcoma | cancer different from tumors, tumors different from cancer | Sarcomatoid renal cancer subclass of kidney cancer, Unclassified RCC subclass of Cancer cells, Renal medullary carcinoma subclass of Renal cell carcinoma | Renal cell carcinoma subclass of kidney cancer, Clear cell RCC subclass of sarcomatoid, RCC subclass of kidney cancer | cancer type different from cancer, cancer different from cancer type | lung cancer different from lung cancer | prostate cancer different from prostate cancer | tumor different from Tumor | Cancer cells different from Cancer cell differ from normal cells, Cancer cell differ from normal cells different from Cancer cells | Wilms tumor (nephroblastoma) subclass of Renal sarcoma, kidney cancer subclass of cancer | Clear cell RCC instance of cancer subtype, Papillary RCC subclass of nccRCC, Renal cell carcinoma subclass of kidney cancer | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer | melanoma different from nonmelanoma skin cancer | carcinoma subclass of carcinoma, Kidney cancer subclass of carcinoma",
        "metrics": {
          "rouge_score": 0.425531914893617,
          "answer_correctness": 0.239151383772206
        }
      },
      {
        "id": "Medical-83ff7511",
        "question": "If liver cancer is found to have both hepatocellular and cholangiocarcinoma components, what is the tumor called and what does this imply about its classification?",
        "ground_truth": "Such a tumor is called a mixed-type tumor, implying it contains both HCC and cholangiocarcinoma features.",
        "generated_answer": "The tumor is called \"biliary tract cancer\" or \"mixed hepatocellular-cholangiocarcinoma,\" which implies it has characteristics of both hepatocellular carcinoma and cholangiocarcinoma, affecting its classification as a primary liver cancer.",
        "contexts": "intrahepatic cholangiocarcinoma subclass of Liver cancer, hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma, primary liver cancer subclass of Liver cancer | HCC subclass of Liver cancer, hepatocellular carcinoma subclass of Secondary liver cancer | primary liver cancer subclass of cancer | pancreatic subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Ductal carcinoma subclass of Breast cancer | Adenocarcinoma subclass of colorectal cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer, Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | Adenocarcinoma subclass of colon cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | Adrenocortical carcinoma subclass of Adrenal cancer | lung cancer subclass of carcinoma | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma",
        "metrics": {
          "rouge_score": 0.3829787234042553,
          "answer_correctness": 0.9924014687477767
        }
      },
      {
        "id": "Medical-0e2be889",
        "question": "How does the AJCC TNM system contribute to the staging of nasopharyngeal carcinoma, and what aspects does it assess?",
        "ground_truth": "The AJCC TNM system stages NPC by assessing tumor size (T), lymph node involvement (N), and distant metastasis (M).",
        "generated_answer": "The AJCC TNM system contributes to the staging of nasopharyngeal carcinoma by assessing tumor size (T), lymph node involvement (N), and the presence of metastasis (M). It provides a standardized method to classify the extent of cancer, which is crucial for treatment planning and prognosis.",
        "contexts": "Throat cancer staging How throat cancer is staged instance of cancer staging | T2 tumor instance of staging | How mouth cancer is staged instance of cancer staging, staging facet of cancer | Staging facet of cancer | breast cancer is staged instance of cancer stage | Staging The cancer stage facet of cancer | Nasopharyngeal cancer instance of rare cancer | Clinical staging of lymph nodes subclass of staging | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Stage 1 instance of Cancer stage, stage 0 instance of Cancer stage | Clinical subclass of cancer staging | staging part of grading | stage 1 tumor instance of cancer type | Stage III instance of cancer stage, stage IV instance of cancer stage, Stage 1 instance of cancer stage, stage II instance of cancer stage | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | cancer staging facet of tumor | Cancer stages 1, 2, and 3 A cancer stage instance of cancer stage | ovarian cancer instance of cancer stage, staging system facet of ovarian cancer",
        "metrics": {
          "rouge_score": 0.53125,
          "answer_correctness": 0.7884795650416554
        }
      },
      {
        "id": "Medical-9a34e14c",
        "question": "In a patient with primary CNS lymphoma and concurrent HIV infection, why is additional laboratory testing necessary?",
        "ground_truth": "HIV blood test is needed because immunodeficiency is a risk factor for primary CNS lymphoma and may influence management.",
        "generated_answer": "Additional laboratory testing is necessary to assess the patient's immune system status and to guide treatment decisions, as HIV infection can impair immune function and affect lymphoma management.",
        "contexts": "primary CNS lymphoma has cause impaired immune system | primary CNS lymphoma instance of disease, CNS lymphoma has part primary CNS lymphoma | What causes primary CNS lymphoma? facet of cancer | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma | CNS lymphoma has cause reduced immune system, reduced immune system has effect CNS lymphoma | primary CNS lymphoma has cause Enrolling in a clinical trial | primary CNS lymphoma location central nervous system | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of brain tumor | primary CNS lymphoma instance of Treatment | primary CNS lymphoma subclass of Lymphoma | brain has effect CNS lymphoma | primary CNS lymphoma subclass of brain lymphoma | HIV has cause human immunodeficiency virus | central nervous system has effect CNS lymphoma | primary CNS lymphoma drug used for treatment new therapy | primary CNS lymphoma drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.16666666666666666,
          "answer_correctness": 0.8366942641319043
        }
      },
      {
        "id": "Medical-5c6a1008",
        "question": "Which combination of therapies might be considered for a patient with metastatic prostate cancer and a BRCA2 mutation?",
        "ground_truth": "Androgen deprivation therapy, chemotherapy, and targeted therapy may be considered for metastatic prostate cancer with BRCA2 mutation.",
        "generated_answer": "Combination therapies for a patient with metastatic prostate cancer and a BRCA2 mutation may include PARP inhibitors, androgen receptor-targeted therapies, and chemotherapy.",
        "contexts": "metastatic subclass of prostate cancer, regional subclass of prostate cancer, localized subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic prostate cancer subclass of prostate cancer | metastatic subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | prostate subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | prostate cancer subclass of cancer | advanced subclass of prostate cancer | Metastatic cancer subclass of Metastasis Cancer | metastasized subclass of cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | de novo subclass of Metastatic cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastatic subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.35,
          "answer_correctness": 0.43027595795219686
        }
      },
      {
        "id": "Medical-6a90b47e",
        "question": "What methods are used to assess both nutritional status and speech/swallowing function in nasopharyngeal carcinoma patients?",
        "ground_truth": "Nutrition assessment and speech and swallowing assessment are used in NPC patients.",
        "generated_answer": "Methods to assess nutritional status and speech/swallowing function in nasopharyngeal carcinoma patients include clinical evaluations, dietary assessments, and standardized questionnaires. Additionally, instrumental assessments such as videofluoroscopic swallowing studies may be utilized.",
        "contexts": "trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx | Oropharynx has part Tonsils, Oropharynx connects with Nasopharynx, nose connects with mouth, Oropharynx has part soft palate, larynx connects with esophagus, pharynx connects with esophagus, Nasopharynx connects with Oropharynx, larynx connects with pharynx, Oropharynx has part tongue, esophagus connects with larynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx | Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | Nasopharyngeal cancer different from laryngeal cancer, Nasopharyngeal cancer different from esophageal cancer, laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer subclass of cancer | throat has part Mouth, Mouth part of throat, throat has part Hypopharynx, Hypopharynx part of throat, oral has part mouth, Nasopharynx part of throat, throat connects with nasal, nasal connects with nose, nasal connects with throat, throat has part Oropharynx, Oropharynx part of throat, throat has part Nasopharynx, throat has part Voice box (larynx), Voice box (larynx) part of throat, pharynx connects with throat | squamous cell carcinoma has effect Throat cancer | Nasopharyngeal cancer has cause EBV | smoking has effect Head and neck cancer | mouth has part Lips, mouth has part Parts of the mouth, maxilla part of jaw, mouth part of digestive, digestive has part respiratory, respiratory part of digestive, Parts of the mouth part of mouth, roof of the mouth has part Hard palate, tongue part of respiratory, digestive has part mouth, tongue part of mouth, Oral mucosa instance of mucous membranes, swallow part of eat, mandible part of jaw, respiratory has part mouth, Lips part of mouth, mouth part of respiratory, eat has part swallow | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | squamous cell carcinoma subclass of Nasopharyngeal cancer | speech uses swallow | Tobacco and alcohol use history Tobacco has effect Head and neck cancer | Epstein-Barr virus has effect mononucleosis, Nasopharyngeal cancer has cause EBV",
        "metrics": {
          "rouge_score": 0.2727272727272727,
          "answer_correctness": 0.23667055843105334
        }
      },
      {
        "id": "Medical-2be4d7f3",
        "question": "Which stages of pancreatic ductal adenocarcinoma are eligible for surgery, and what is the criterion for eligibility at Stage III?",
        "ground_truth": "Stages I, II, and selected cases of Stage III pancreatic ductal adenocarcinoma are eligible for surgery, with eligibility at Stage III depending on tumor spread to major arteries or lymph nodes.",
        "generated_answer": "Stages eligible for surgery are Stage 0, Stage I, Stage II, and Stage III pancreatic ductal adenocarcinoma. At Stage III, eligibility for surgery is determined by the absence of metastasis and the ability to remove the tumor completely.",
        "contexts": "Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Stage III subclass of cancer | Stage 3B subclass of cancer | pancreatic subclass of cancer | Stage III subclass of disease | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Stage III subclass of Anal cancer | Stage 3B subclass of cervical cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | inflamed pancreas subclass of Pancreatic cancer | colon subclass of cancer, pancreatic subclass of cancer | stage II subclass of cancer | Stage 4B subclass of bladder cancer | Pancreatic cancer subclass of cancer | early-stage prostate cancer followed by advanced-stage prostate cancer, Advanced stage subclass of prostate cancer, Advanced stage subclass of prostate cancer | Ductal carcinoma subclass of Breast cancer | Adenocarcinoma subclass of NSCLC | advanced-stage prostate cancer subclass of prostate cancer, early-stage subclass of prostate cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer",
        "metrics": {
          "rouge_score": 0.3768115942028986,
          "answer_correctness": 0.6193915064963474
        }
      },
      {
        "id": "Medical-819d9c6c",
        "question": "What distinguishes intrahepatic cholangiocarcinoma from other primary liver cancer subtypes in terms of anatomical origin?",
        "ground_truth": "Intrahepatic cholangiocarcinoma arises from the bile ducts within the liver, unlike HCC or mixed-type tumors.",
        "generated_answer": "Intrahepatic cholangiocarcinoma originates from the bile ducts within the liver, distinguishing it from other primary liver cancer subtypes like hepatocellular carcinoma, which arises from liver parenchymal cells.",
        "contexts": "intrahepatic cholangiocarcinoma subclass of Liver cancer, hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma, primary liver cancer subclass of Liver cancer | primary liver cancer subclass of cancer | HCC subclass of Liver cancer, hepatocellular carcinoma subclass of Secondary liver cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Carcinosarcoma subclass of carcinoma, primary peritoneal cancer subclass of fallopian tube cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Adrenocortical carcinoma subclass of Adrenal cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | High-grade serous carcinoma subclass of ovarian cancer, High-grade endometrioid carcinoma subclass of ovarian cancer | Invasive ductal carcinoma subclass of Invasive ductal carcinoma, Ductal carcinoma subclass of Breast cancer | Adrenocortical carcinoma subclass of adrenal tumor | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | bladder cancer subclass of Cancer of the upper urinary tract",
        "metrics": {
          "rouge_score": 0.4186046511627907,
          "answer_correctness": 0.6739920192038106
        }
      },
      {
        "id": "Medical-ab708cf8",
        "question": "What anatomical sites are included under oropharyngeal cancer, and how does this relate to the diagnosis of throat cancer?",
        "ground_truth": "Oropharyngeal cancer includes the soft palate, tonsils, base of tongue, and side and back walls of the throat, which are common sites where throat cancer arises.",
        "generated_answer": "Oropharyngeal cancer includes the oropharynx, which is part of the throat. It is diagnosed as throat cancer due to its location and the types of cells involved, primarily squamous cells.",
        "contexts": "Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Head and neck cancer subclass of cancer | Squamous cell carcinoma of the head and neck subclass of Head and neck cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer | Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer | Nasopharyngeal cancer subclass of cancer of the nasopharynx | squamous cell carcinoma subclass of Nasopharyngeal cancer | abnormal tissue growth subclass of cancer, Nasopharyngeal cancer subclass of Throat cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | squamous cell carcinoma subclass of Mouth cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Head and neck cancer subclass of Head and neck cancer, extracapsular subclass of Lymph nodes with cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | squamous cell carcinoma subclass of cervical cancer | Oropharynx part of Throat cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.32142857142857145,
          "answer_correctness": 0.70813914282575
        }
      },
      {
        "id": "Medical-68ea8206",
        "question": "What is the relationship between Pap smear screening and the detection of cervical dysplasia and cancer?",
        "ground_truth": "Pap smear is used for cervical cancer screening and can detect cervical dysplasia, which may progress to cancer if untreated.",
        "generated_answer": "Pap smear screening is used to detect cervical dysplasia and cervical cancer.",
        "contexts": "cervical cancer drug used for treatment Pap testing, Pap testing medical condition treated cervical cancer | cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | cervical biopsy medical condition treated cervical cancer | cervical cancer has cause cervical dysplasia, cervical dysplasia subclass of cervical intraepithelial neoplasia | Chemoradiation medical condition treated cervical cancer, cervical cancer drug used for treatment Chemoradiation EBRT, cervical cancer drug used for treatment Chemoradiation | treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Removing only a portion of the cervix medical condition treated cervical cancer | cancer drug used for treatment Treatment | cancer drug used for treatment treatments | Treatment medical condition treated cancer | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | cervical cancer drug used for treatment intensitymodulated radiation therapy | NSCLC drug used for treatment Treatment for NSCLC, Treatment for NSCLC medical condition treated NSCLC | cancer drug used for treatment cancer | cancer drug used for treatment Cancer treatment",
        "metrics": {
          "rouge_score": 0.5,
          "answer_correctness": 0.8461347446412159
        }
      },
      {
        "id": "Medical-17015c75",
        "question": "Which subtypes of pancreatic cancer are described, and which is most common?",
        "ground_truth": "Pancreatic ductal adenocarcinoma is the most common subtype, while pancreatic neuroendocrine tumor is less common.",
        "generated_answer": "The subtypes of pancreatic cancer described include Stage 0, Stage 1, Stage II, Stage III, Stage 4, and Metastatic pancreatic cancer. The most common subtype is pancreatic adenocarcinoma, which is typically classified as Stage 1 or higher.",
        "contexts": "subtype facet of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | What is pancreatic cancer? facet of Pancreatic cancer, What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer subclass of cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments | Treatment facet of Pancreatic cancer | inflamed pancreas subclass of Pancreatic cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Multidisciplinary consult facet of Pancreatic cancer | Pancreatic cancer subclass of Pancreatic cancer | neuroendocrine tumor subclass of Pancreatic cancer, tumor has part Pancreatic cancer cell, Pancreatic cancer cell part of tumor, Pancreas Sounds like PAN-kree-us main subject Pancreatic cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Types facet of adrenal tumor | staging system facet of cancer | cancer stage facet of cancer | Cancer grade facet of cancer | grade facet of cancer, staging facet of cancer | main categories facet of stomach cancer",
        "metrics": {
          "rouge_score": 0.2692307692307693,
          "answer_correctness": 0.48498110435243563
        }
      },
      {
        "id": "Medical-8779d729",
        "question": "What are the main differences in cell type and disease progression risk between classic Hodgkin lymphoma and NLPHL?",
        "ground_truth": "Classic Hodgkin lymphoma has Reed-Sternberg cells and is the most common subtype, while NLPHL has popcorn-shaped cells and can transform into DLBCL.",
        "generated_answer": "Classic Hodgkin lymphoma typically involves Reed-Sternberg cells and has a more aggressive disease progression risk compared to NLPHL, which is characterized by a predominance of small B-cells and generally has a better prognosis.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | diffuse large B-cell lymphoma subclass of classic FL, classic FL subclass of Follicular lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma, SLL different from CLL, CLL different from SLL | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Hodgkin lymphoma subclass of Lymphoma | Nasopharyngeal cancer different from laryngeal cancer, laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer | Non-Hodgkin lymphoma subclass of cancer | Hodgkin lymphoma instance of rare | Lymphoblast different from myeloblast | Locally advanced cancer different from metastatic | Non-Hodgkin lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.3389830508474576,
          "answer_correctness": 0.5757074950179993
        }
      },
      {
        "id": "Medical-bce86fcf",
        "question": "How are germline mutations relevant to bone cancer risk, and what testing modality is used to identify them?",
        "ground_truth": "Germline mutations are risk factors for bone cancer and can be identified by genetic cancer risk testing.",
        "generated_answer": "Germline mutations can increase the risk of developing bone cancer. Germline testing is used to identify these mutations.",
        "contexts": "genetic mutations has effect cancer | hereditary mutation has effect cancer | genetic mutations has effect Inherited cancer risk, Inherited cancer risk has cause genetic mutations | genetic changes has effect Cancer cells, Cancer cells has effect genetic changes | genetic errors has effect Bladder cancer, Bladder cancer has cause genetic errors | Germline testing facet of cancer | pass these genes on has effect cancer, hereditary has effect Breast cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | mutations can put you at risk for more than one type of cancer has effect more than one type of cancer | BRCA mutation has effect ovarian cancer, ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor | genetic mutations has effect hereditary | cancer has effect spread to your bones | mutations has effect gene, gene has cause mutations | genetic changes has effect Leukemia",
        "metrics": {
          "rouge_score": 0.34285714285714286,
          "answer_correctness": 0.9968942961207726
        }
      },
      {
        "id": "Medical-3c536762",
        "question": "Why is tumor size and extent of spread important in staging bile duct cancer?",
        "ground_truth": "Because bile duct cancer staging is based on tumor size and how far it has spread beyond the original location.",
        "generated_answer": "Tumor size and extent of spread are crucial in staging bile duct cancer as they help determine the cancer stage, which influences treatment decisions and prognosis. Accurate staging is essential for assessing how far the cancer has progressed and planning appropriate interventions.",
        "contexts": "cancer staging facet of tumor | Staging facet of cancer | staging facet of cancer | Staging The cancer stage facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | stage facet of tumor | grade facet of cancer, staging facet of cancer | staging system facet of cancer | stage facet of cancer | centimeters facet of tumors | stage the cancer facet of cancer | staging facet of Treatment decisions | cancer staging facet of prognosis | cancer stage facet of cancer | How far and how fast? facet of cancer, stage facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | TNM staging information facet of squamous cell carcinoma | Surgical staging facet of ovarian cancer | Cancer grade facet of tumor | depth of invasion facet of tumor",
        "metrics": {
          "rouge_score": 0.25806451612903225,
          "answer_correctness": 0.6706042551960216
        }
      },
      {
        "id": "Medical-33af9785",
        "question": "What is the relationship between H. pylori infection, precancerous mucosal changes, and stomach cancer development?",
        "ground_truth": "H. pylori infection is a risk factor that can lead to precancerous mucosal changes, which may progress to stomach cancer.",
        "generated_answer": "H. pylori infection has a cause-and-effect relationship with precancerous mucosal changes, which can lead to the development of stomach cancer.",
        "contexts": "stomach cancer has cause abdominal wall, abdominal wall has effect stomach cancer | cancer has effect cancer, cancer has cause cancer | H. pylori instance of bacteria | cancer has cause health problems, health problems has effect cancer | cancer has cause Cancer cells | cancer has cause cell changes | cancer has effect side effects, side effects has cause cancer | HPV infection has cause human papillomavirus, cervical cancer has cause human papillomavirus | cancer type has effect cancer, cancer has cause cancer type | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | cervical cancer has cause human papillomavirus, human papillomavirus has effect cervical cancer | HPV-related cancer has cause HPV infection | cancer has cause risk factors | cancer has cause tumor | cancer has cause cell damage",
        "metrics": {
          "rouge_score": 0.5238095238095238,
          "answer_correctness": 0.8468667770580712
        }
      },
      {
        "id": "Medical-bb361e83",
        "question": "How does the presence of sarcomatoid features influence treatment considerations for RCC?",
        "ground_truth": "Sarcomatoid features indicate more aggressive disease, which is a treatment factor for RCC.",
        "generated_answer": "The presence of sarcomatoid features in RCC indicates that the cancer is treated differently due to its aggressive nature and distinct characteristics. This may lead to more intensive treatment approaches compared to other subtypes of renal cell carcinoma.",
        "contexts": "Non-clear cell RCC subclass of sarcomatoid, Clear cell RCC subclass of sarcomatoid, RCC subclass of kidney cancer | Sarcomatoid renal cancer subclass of kidney cancer, Sarcomatoid features facet of sarcomatoid | treated differently different from RCC, RCC different from treated differently | kidney cancer has cause kidney | tumor has effect cancer, cancer has cause tumor | cancer has cause cell damage | cancer has cause cell changes, cell changes has effect cancer | Gerota\u2019s fascia has effect Kidney cancer | Cancer cells has effect tumor, tumor has cause Cancer cells | tumor has cause Cancer cells, Cancer cells has effect tumor | Clear cell RCC instance of cancer subtype, Papillary RCC subclass of nccRCC, Renal cell carcinoma subclass of kidney cancer | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | tumors has cause Cancer cells | primary tumor has effect metastasized, metastasized has cause primary tumor | Cancer cells has effect tumors, tumors has cause Cancer cells",
        "metrics": {
          "rouge_score": 0.196078431372549,
          "answer_correctness": 0.9109711156085516
        }
      },
      {
        "id": "Medical-7b4429ac",
        "question": "What findings on risk assessment would classify a local CSCC as high-risk, and how does this affect treatment choices?",
        "ground_truth": "Features such as perineural invasion, lymphovascular invasion, or high tumor grade classify local CSCC as high-risk, requiring Mohs surgery or systemic therapy if surgery/radiation is not possible.",
        "generated_answer": "Findings that classify a local CSCC as high-risk include factors such as genetic risk, aggressive characteristics, and the presence of life-threatening side effects. This classification influences treatment choices by necessitating a multidisciplinary team approach and potentially more aggressive treatment options.",
        "contexts": "life-threatening subclass of risk | risk level subclass of factors, Risk assessment facet of skin cancer | Risk assessment studies problem, problem studied by Risk assessment, assessment of their risks facet of Treatment | highest risk subclass of patients | very high risk instance of risk group | Genetic risk testing subclass of Genetic and biomarker testing | high-intensity subclass of physical activity | life-threatening subclass of side effects | multidisciplinary team subclass of Treatment decisions | higher risk opposite of lower risk | Other risks and side effects subclass of side effects | low risk followed by intermediate risk | Aggressive subclass of Treatment | vomiting subclass of side effects, risk subclass of side effects | low risk opposite of high risk | highrisk different from high-risk or very high-risk CSCC, high-risk or very high-risk CSCC different from highrisk | risk factors subclass of risk factors | genetic cancer risk testing subclass of Testing for breast cancer",
        "metrics": {
          "rouge_score": 0.16901408450704225,
          "answer_correctness": 0.2360839690258611
        }
      },
      {
        "id": "Medical-55898188",
        "question": "Which diagnostic procedures are necessary for a patient with suspected regional CSCC presenting with lymph node involvement?",
        "ground_truth": "Lymph node exam, imaging (CT, PET/CT), and lymph node biopsy are required for regional CSCC with lymph node involvement.",
        "generated_answer": "Diagnostic procedures necessary for a patient with suspected regional CSCC presenting with lymph node involvement include pelvic lymph node evaluation, lymph node dissection, and sentinel lymph node biopsy.",
        "contexts": "Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | lymph nodes subclass of cancer, inguinal subclass of lymph nodes | regional subclass of lymph nodes, local subclass of lymph nodes | lymph node dissection subclass of surgery | lymphadenectomy subclass of lymph node dissection, lymph nodes subclass of glands | sentinel lymph node subclass of lymph nodes, signs of cancer subclass of nodes, sentinel node subclass of lymph nodes | Clinical staging of lymph nodes subclass of staging | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | extranodal extension subclass of Lymph nodes with cancer, Head and neck cancer subclass of Head and neck cancer, extracapsular subclass of Lymph nodes with cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | sentinel node subclass of lymph nodes | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | armpit subclass of lymph nodes | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | lymph nodes subclass of tissues | lymph nodes subclass of cells | small lymphocytic lymphoma subclass of lymph nodes, lymphocyte subclass of white blood cell",
        "metrics": {
          "rouge_score": 0.2916666666666667,
          "answer_correctness": 0.6921139014866436
        }
      },
      {
        "id": "Medical-015f2cf7",
        "question": "How would you distinguish between a functional adenoma and a pheochromocytoma in a patient with an adrenal mass and high blood pressure?",
        "ground_truth": "A pheochromocytoma arises from the adrenal medulla and causes high blood pressure, while functional adenoma does not typically present with high blood pressure.",
        "generated_answer": "A functional adenoma typically secretes hormones leading to symptoms like Cushing's syndrome or hyperaldosteronism, while a pheochromocytoma primarily secretes catecholamines, causing episodes of high blood pressure and other adrenergic symptoms. Imaging and biochemical tests can help differentiate between the two conditions.",
        "contexts": "tumors different from cancer, cancer different from tumors | tumor different from Tumor | prostate cancer different from prostate cancer | Benign (not cancer) adrenal tumor subclass of adrenal tumor | BPH different from prostate cancer, prostate cancer different from BPH | follicular tumor different from Papillary | benign different from cancerous, Pheochromocytoma has effect high blood pressure, cancerous different from benign, noncancerous subclass of tumor, cure different from Treatment | Papillary different from follicular tumor, papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | cancer type different from cancer, cancer different from cancer type | lung cancer different from lung cancer | Osteosarcoma different from Osteosarcoma | Imaging different from cancer | diffuse large B-cell lymphoma different from Burkitt lymphoma | adrenal tumor subclass of tumor | prostate cancer subclass of cancerous, prostate cancer different from prostate cancer",
        "metrics": {
          "rouge_score": 0.2153846153846154,
          "answer_correctness": 0.8852394902177637
        }
      },
      {
        "id": "Medical-57f0c93d",
        "question": "Which combination of therapies may be considered for an AML patient with CD33-positive blasts and why?",
        "ground_truth": "Chemotherapy plus gemtuzumab ozogamicin (GO), a targeted therapy for CD33-positive AML, may be used.",
        "generated_answer": "A combination of therapies such as daunorubicin and cytarabine may be considered for an AML patient with CD33-positive blasts due to their effectiveness in treating acute myeloid leukemia. Additionally, FLT3 inhibitors like gilteritinib or sorafenib could be used based on specific mutations.",
        "contexts": "daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, AML drug used for treatment daunorubicin, AML drug used for treatment Cytarabine, AML drug used for treatment FLT3 Gilteritinib, AML drug used for treatment Sorafenib | daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, CD33 instance of Proteins, AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin | Methotrexate medical condition treated AML, Cytarabine medical condition treated AML, AML drug used for treatment Methotrexate, AML drug used for treatment Cytarabine | CD33 instance of Proteins, CD33 instance of Proteins | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia | in remission facet of AML | Treatment medical condition treated cancer | AML has effect biomarker, biomarker has effect AML | biomarker has effect AML",
        "metrics": {
          "rouge_score": 0.24137931034482765,
          "answer_correctness": 0.23548037755635837
        }
      },
      {
        "id": "Medical-70db1204",
        "question": "How is the stage of mouth cancer determined using both tumor characteristics and lymph node involvement?",
        "ground_truth": "Stage is determined by the TNM system, which includes tumor size and depth, lymph node involvement, and distant metastasis.",
        "generated_answer": "The stage of mouth cancer is determined by assessing the size and characteristics of the tumor, along with the involvement of lymph nodes. This includes evaluating whether lymph nodes are affected and the extent of any metastasis.",
        "contexts": "lymph nodes part of tumor | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | lymph nodes part of cancer | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | lymph part of lymph nodes | lymph nodes part of lymph | lymph nodes part of lymphatic | sentinel lymph node part of breast tumor | lymph nodes part of lymph nodes, lymph nodes has part lymph nodes | lymph nodes part of lymph tissue | lymph nodes part of body | lymph nodes part of tissues, tissues part of tumor, organs has part tissues, tumor has part tissues, tissues part of organs | white blood cell has part lymphocyte, white blood cell has part lymphatic fluid, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymph nodes part of lymphatic fluid | body has part lymph nodes, lymph nodes part of body | lymph nodes part of breast | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | lymphatic vessel part of lymph nodes, lymph nodes has part lymphatic vessel, Lymph part of lymphatic vessel | colon wall has part lymph nodes, lymph nodes part of cancer | lymph nodes part of organs | tumor part of cancer",
        "metrics": {
          "rouge_score": 0.39285714285714285,
          "answer_correctness": 0.6843228539488275
        }
      },
      {
        "id": "Medical-1024ca84",
        "question": "How does the treatment strategy for T-ALL differ from BCR::ABL1-positive B-ALL, and what evidence supports this distinction?",
        "ground_truth": "T-ALL is treated with chemotherapy and clinical trials, while BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
        "generated_answer": "The treatment strategy for T-ALL differs from BCR::ABL1-positive B-ALL primarily in the types of chemotherapy and targeted therapies used. Evidence supporting this distinction includes the classification of T-ALL as a different cancer type and the specific inhibitors utilized for BCR::ABL1-positive cases.",
        "contexts": "T-ALL different from B-ALL, B-ALL different from T-ALL | SLL different from CLL, CLL different from SLL | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | Moderately differentiated different from Poorly differentiated, Poorly differentiated different Moderately differentiated, Well differentiated different from Poorly differentiated, Well differentiated different from Moderately differentiated, Moderately differentiated different from Well differentiated | Inhibitors different from Inhibitors | Chemotherapy different from Chemotherapy | cycle different from cycle | tumor different from Tumor | speak different from see | metastasize often different from metastasis | Lymphoblast different from myeloblast | tumors different from cancer | Treatment different from Treatment | intermediate-grade different from high-grade | cancer type different from cancer",
        "metrics": {
          "rouge_score": 0.2777777777777778,
          "answer_correctness": 0.8048778800588227
        }
      },
      {
        "id": "Medical-c41cab28",
        "question": "How does the identification of Barrett esophagus change the risk profile and surveillance strategy for esophageal cancer?",
        "ground_truth": "Barrett esophagus increases adenocarcinoma risk, so surveillance includes biomarker and genetic risk testing.",
        "generated_answer": "The identification of Barrett esophagus increases the risk profile for esophageal cancer, necessitating more frequent surveillance strategies such as endoscopies to monitor for dysplasia or cancer development. This proactive approach aims to detect any malignant changes early, improving patient outcomes.",
        "contexts": "metastatic esophageal cancer subclass of esophageal cancer, Locoregional subclass of esophageal cancer | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | early-stage prostate cancer subclass of esophageal cancer, Esophageal cancer subclass of cancer | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | Adenocarcinoma subclass of colon cancer | Adenocarcinoma subclass of colorectal cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | colon subclass of cancer, pancreatic subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Ductal carcinoma subclass of Breast cancer | prostate cancer subclass of cancer, colorectal subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | pancreatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.18867924528301888,
          "answer_correctness": 0.8132733594521575
        }
      },
      {
        "id": "Medical-cf2fbd21",
        "question": "How do risk factors for oropharyngeal squamous cell carcinoma differ from those for head and neck cancers in general?",
        "ground_truth": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma, while tobacco and alcohol use are risk factors for head and neck cancers in general.",
        "generated_answer": "Risk factors for oropharyngeal squamous cell carcinoma primarily include HPV infection and smoking, while head and neck cancers in general may also involve alcohol consumption and exposure to certain chemicals. The specific risk factors can vary significantly between these cancer types.",
        "contexts": "Squamous cell carcinoma of the head and neck subclass of Head and neck cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | head and neck subclass of cancer | Head and neck cancer subclass of cancer | squamous cell carcinoma subclass of Nasopharyngeal cancer | Mouth cancer subclass of Head and neck cancer | squamous cell carcinoma subclass of Mouth cancer | Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | squamous cell carcinoma subclass of cervical cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | p16- (HPV) cancer subclass of Head and neck cancer | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | Nasopharyngeal cancer subclass of cancer of the nasopharynx | Head and neck cancer subclass of Head and neck cancer, extracapsular subclass of Lymph nodes with cancer | squamous cell carcinoma subclass of squaymous | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | head and neck subclass of cancer, smoking has effect Head and neck cancer, lung subclass of cancer",
        "metrics": {
          "rouge_score": 0.4000000000000001,
          "answer_correctness": 0.9963232958280706
        }
      },
      {
        "id": "Medical-4e39d9d5",
        "question": "What steps are necessary to diagnose and fully characterize an AML case with suspected extramedullary involvement?",
        "ground_truth": "Diagnosis requires blood tests, bone marrow evaluation, flow cytometry, molecular/cytogenetic testing, and imaging (CT, MRI, PET/CT) for extramedullary disease.",
        "generated_answer": "Diagnosis of AML with suspected extramedullary involvement requires a comprehensive evaluation including blood tests, bone marrow biopsy, imaging studies to assess extramedullary sites, and immunophenotyping to characterize the specific subtype of AML. Additionally, cytogenetic and molecular studies may be necessary to identify genetic abnormalities associated with the disease.",
        "contexts": "AML subclass of blood cancer | AML subclass of blood cancer, Subtypes of AML subclass of Subtypes of AML | Subtypes of AML subclass of AML, Subtypes of AML subclass of Subtypes of AML | Acute myeloid leukemia subclass of blood cancer, blasts subclass of AML | rare subtype of AML subclass of AML | myelodysplastic syndrome subclass of Acute myeloid leukemia | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | chronic myeloid leukemia subclass of blood cancer | Blastic plasmacytoid dendritic cell neoplasm subclass of AML | Acute lymphoblastic leukemia subclass of blood cancer | CML subclass of cancer | blast phase CML subclass of CML, BP-CML subclass of CML | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell",
        "metrics": {
          "rouge_score": 0.26086956521739124,
          "answer_correctness": 0.9889795432340583
        }
      },
      {
        "id": "Medical-e99acf57",
        "question": "For a patient presenting with redness, swelling, and peau d\u2019orange of the breast, what subtype and stage of breast cancer should be suspected and which diagnostic methods are indicated?",
        "ground_truth": "Inflammatory breast cancer (IBC), typically stage III or IV, should be suspected and diagnosis should include physical exam, medical photographs, imaging, and biopsy.",
        "generated_answer": "Inflammatory breast cancer should be suspected, typically at an advanced stage. Diagnostic methods indicated include breast exams, biopsy, and tumor markers.",
        "contexts": "spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor, tumor, node, metastasis (TNM) system facet of Breast cancer | Breast cancer found earlier facet of Breast cancer, Breast cancer screening facet of Breast cancer | PS 5 facet of Breast cancer, PS 4 facet of Breast cancer | Breast cancer screening facet of Breast cancer | breast exams facet of Breast cancer | Clinical stage facet of Breast cancer, prognosis facet of cancer, breast cancer is staged facet of Breast cancer | biopsy facet of cancer | Tumor markers facet of Breast cancer | Breast cancer basics The breast facet of breast | spread facet of cancer | test facet of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | How far and how fast? facet of cancer, stage facet of cancer | Breast cancer has part breast, carcinoma has effect Breast cancer, Ductal carcinoma subclass of Breast cancer | Surveillance facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | stage facet of cancer",
        "metrics": {
          "rouge_score": 0.4090909090909091,
          "answer_correctness": 0.6912033757576548
        }
      },
      {
        "id": "Medical-b77d8e3d",
        "question": "How do follow-up strategies change after initial treatment for NSCLC?",
        "ground_truth": "After initial treatment, follow-up care and surveillance are implemented to monitor for recurrence.",
        "generated_answer": "Follow-up strategies after initial treatment for NSCLC typically involve regular imaging and assessments to monitor for recurrence, adjusting treatment plans based on patient response, and considering participation in clinical trials for additional options.",
        "contexts": "early in the course of treatment facet of cancer, Treatment decisions facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | Cancer treatment facet of cancer | Treatment planning facet of cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | radiation therapy facet of cancer | Phase 1 trial facet of Treatment trial | plan treatment facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | more treatment facet of cancer | Stage 1 Chemotherapy facet of cancer | Treatment facet of ovarian cancer | more than one treatment option facet of cancer | Treatment facet of stomach cancer | Treatment facet of Pancreatic cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | best treatment plan facet of cancer",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.5348538570898393
        }
      },
      {
        "id": "Medical-33494794",
        "question": "What cellular changes would you expect to find in a patient with CML, and which test would confirm these findings?",
        "ground_truth": "Increased white blood cells (granulocytes) and abnormal platelet counts, confirmed by blood tests.",
        "generated_answer": "In a patient with CML, you would expect to find abnormal cellular changes such as increased white blood cells, particularly granulocytes. A bone marrow biopsy or blood test showing the Philadelphia chromosome would confirm these findings.",
        "contexts": "CML subclass of cancer | blast phase CML subclass of CML, BP-CML subclass of CML, CML has effect CML, CML has cause CML | Chronic myeloid leukemia subclass of blood cancer | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | AML subclass of blood cancer | Chronic lymphocytic leukemia subclass of white blood cell | AML subclass of blood cancer, Subtypes of AML subclass of Subtypes of AML | cancer subclass of cells | Chronic lymphocytic leukemia subclass of blood cancer | Acute myeloid leukemia subclass of blood cancer | abnormal subclass of Cancer cells | leukemia cells subclass of cells | Acute lymphoblastic leukemia subclass of blood cancer | myelodysplastic syndrome subclass of Acute myeloid leukemia | cell changes has effect cancer",
        "metrics": {
          "rouge_score": 0.28571428571428575,
          "answer_correctness": 0.7342443589887924
        }
      },
      {
        "id": "Medical-ef8fe744",
        "question": "Which diagnostic tests are necessary to confirm and further characterize invasive ductal carcinoma presenting with a breast lump?",
        "ground_truth": "Mammogram, ultrasound, MRI, biopsy, and blood tests are necessary to confirm and characterize invasive ductal carcinoma with a breast lump.",
        "generated_answer": "Diagnostic tests necessary to confirm and further characterize invasive ductal carcinoma include mammography, ultrasound, and biopsy.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Invasive breast cancer subclass of cancer | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer, noninvasive subclass of cancer | Invasive breast cancer subclass of Breast cancer | metastasized subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | carcinoma subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | malignant subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | metastatic subclass of cancer | metastasis subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | tumor subclass of cancer | Tumor subclass of cancer | benign subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor",
        "metrics": {
          "rouge_score": 0.5,
          "answer_correctness": 0.8682502293145563
        }
      },
      {
        "id": "Medical-8307a348",
        "question": "Which surgical procedures are available for early-stage cervical cancer, and how do they relate to fertility preservation?",
        "ground_truth": "Cone biopsy and trachelectomy are surgical options for early-stage disease, with trachelectomy serving as a fertility-sparing procedure.",
        "generated_answer": "Surgical procedures for early-stage cervical cancer include trachelectomy, radical hysterectomy, and extrafascial hysterectomy with lymph node evaluation. Trachelectomy is a fertility-sparing option that allows women to preserve their ability to have children after treatment, while radical hysterectomy typically results in infertility.",
        "contexts": "abdominal surgery subclass of Fertility-sparing surgery | in vitro fertilization subclass of assisted reproductive approaches | fertility preservation options subclass of having children after treatment, inability to produce children subclass of infertility, fertility preservation options facet of fertilityrelated risks | Sperm banking subclass of semen cryopreservation | Trachelectomy subclass of Fertility-sparing surgery | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | fertility preservation options subclass of keeping your options open | Fertility-sparing surgery subclass of difficult for those wishing to get pregnant in the future | shortand long-term symptoms and risks of surgical menopause subclass of symptoms of menopause, Ovary preservation subclass of hysterectomy, Radical hysterectomy subclass of hysterectomy | surgery subclass of Treatment | minimally invasive procedure subclass of surgery | treatment with surgery subclass of surgery, surgery subclass of Treatment | resection subclass of surgical procedure | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | surgery subclass of operation | surgery to remove cancer from the body subclass of surgery | hysterectomy subclass of surgery | systemic therapy subclass of surgery, Chemoradiation subclass of surgery",
        "metrics": {
          "rouge_score": 0.2903225806451613,
          "answer_correctness": 0.9044582371419831
        }
      },
      {
        "id": "Medical-99cbd976",
        "question": "What distinguishes mature B-cell ALL (Burkitt leukemia) from typical B-ALL in terms of classification and treatment?",
        "ground_truth": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL and is treated differently than typical B-ALL.",
        "generated_answer": "Mature B-cell ALL (Burkitt leukemia) is classified as a distinct subtype of acute lymphoblastic leukemia characterized by a more aggressive clinical course and specific genetic abnormalities. Treatment often involves more intensive chemotherapy regimens compared to typical B-ALL, which may have different therapeutic approaches based on its classification.",
        "contexts": "BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | Burkitt lymphoma subclass of non-Hodgkin lymphoma, B cell subclass of lymphocyte, B cell subclass of lymphocyte | Acute lymphoblastic leukemia subclass of blood cancer | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Chronic lymphocytic leukemia subclass of white blood cell | Chronic lymphocytic leukemia subclass of blood cancer | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | diffuse large B-cell lymphoma subclass of classic FL | non-Hodgkin PMBL subclass of Hodgkin lymphoma | B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | diffuse large B-cell lymphoma subclass of Lymphoma | Acute myeloid leukemia subclass of blood cancer | Non-Hodgkin lymphoma subclass of cancer | AML subclass of blood cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.9117535466268942
        }
      },
      {
        "id": "Medical-c76b58b2",
        "question": "How is the transformation of follicular lymphoma into a more aggressive disease identified and classified?",
        "ground_truth": "Transformation is identified by the development of DLBCL from FL, which is classified as transformed FL.",
        "generated_answer": "The transformation of follicular lymphoma into a more aggressive disease is identified and classified as \"FL grade 3B,\" which is a subclass of follicular large B cell lymphoma.",
        "contexts": "primary CNS lymphoma instance of disease | Follicular lymphoma subclass of Lymphoma | Acute lymphoblastic leukemia instance of cancer | cancer instance of diseases, stroke instance of diseases | Follicular lymphoma subclass of non-Hodgkin lymphoma | bladder cancer instance of disease | Treatment for CLL instance of Treatment | enlarged spleen has effect Follicular lymphoma | classic FL subclass of Follicular lymphoma | prostate cancer instance of cancer | Hodgkin lymphoma instance of rare | minimal residual disease instance of condition | chemotherapy instance of Treatment, radiation therapy instance of Treatment | FL grade 3B subclass of follicular large B cell lymphoma | uterine cancer instance of cancer, colorectal cancer instance of cancer | Germinal centers Follicular lymphoma subclass of Lymphoma | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Lymphoma has effect lymph nodes",
        "metrics": {
          "rouge_score": 0.2727272727272727,
          "answer_correctness": 0.2295562168311741
        }
      },
      {
        "id": "Medical-15b033b6",
        "question": "How does the origin of ACC differ from that of pheochromocytoma, and how does this affect their typical symptoms?",
        "ground_truth": "ACC arises from the adrenal cortex and can cause a range of hormone-related symptoms, while pheochromocytoma arises from the adrenal medulla and typically causes high blood pressure, headache, rapid heartbeat, and sweating.",
        "generated_answer": "ACC originates from the adrenal cortex, while pheochromocytoma arises from adrenal medulla chromaffin cells. This difference in origin leads to distinct symptoms, with ACC often causing hormonal imbalances and pheochromocytoma primarily resulting in episodes of hypertension.",
        "contexts": "tumors different from cancer, cancer different from tumors | cancer type different from cancer, cancer different from cancer type | tumor different from Tumor | BPH different from prostate cancer, prostate cancer different from BPH | prostate cancer different from prostate cancer | lung cancer different from lung cancer | Pheochromocytoma has effect high blood pressure, Neuroblastoma subclass of adrenal tumor | Imaging different from cancer | Benign (not cancer) adrenal tumor subclass of adrenal tumor | follicular tumor different from Papillary | Osteosarcoma different from Osteosarcoma | Papillary different from follicular tumor | Chemotherapy different from Chemotherapy | metastasize often different from metastasis | adrenal tumor has cause conditions listed below | Locally advanced cancer different from metastatic | Cancer cells different from Cancer cell differ from normal cells",
        "metrics": {
          "rouge_score": 0.37681159420289856,
          "answer_correctness": 0.8216953293503388
        }
      },
      {
        "id": "Medical-29a8ae2e",
        "question": "Why might a pregnancy test and fertility preservation be considered in the management of CLL?",
        "ground_truth": "They are considered before starting treatment to address potential impacts of therapy on fertility and pregnancy.",
        "generated_answer": "A pregnancy test is relevant in assessing fertility status, while fertility preservation options are important for individuals with CLL who may face infertility due to treatment. Both are crucial for managing reproductive health in the context of cancer treatment.",
        "contexts": "fertility preservation options facet of fertility | fertility preservation options subclass of keeping your options open | fertility preservation options is a list of fertility preservation options | Pregnancy test facet of pregnant | IVF uses embryo, embryo use IVF | fertility studied by family planning, family planning studies fertility | pregnancy has cause fertility, fertility has effect pregnancy | fertility studied by family planning, preserving (keeping) fertility subclass of fertilityrelated risks | natural pregnancy uses hormone | testing uses urine sample | fertility preservation options subclass of having children after treatment, inability to produce children subclass of infertility, fertility preservation options facet of fertilityrelated risks, sperm has effect infertility, eggs has effect infertility | Blood test uses sample | imaging test facet of pregnancy | Pregnancy test subclass of Pregnancy test | TSH test uses thyroid-stimulating hormone | lab use Testing | cervix use pregnancy",
        "metrics": {
          "rouge_score": 0.1090909090909091,
          "answer_correctness": 0.9761444629193461
        }
      },
      {
        "id": "Medical-889e2c6a",
        "question": "What factors contribute to a poorer prognosis in glioma patients, and how are these factors determined?",
        "ground_truth": "High-grade glioma and glioblastoma contribute to poorer prognosis, determined by histology and grade from biopsy.",
        "generated_answer": "Factors contributing to a poorer prognosis in glioma patients include cancer staging, risk factors, and the presence of specific symptoms. These factors are determined through diagnosis, treatment decisions, and the overall course of the disease.",
        "contexts": "prognosis facet of disease | prognosis facet of course the cancer will take, prognosis facet of more than one treatment option | cancer staging facet of prognosis | Treatment facet of disease | risk factors facet of disease | prognosis facet of cancer, breast cancer is staged facet of Breast cancer | prognosis facet of CLL, CLL has effect prognosis, prognosis facet of Cancer treatment | symptom facet of disease | medical conditions facet of health | Treatment facet of cancer, Cancer treatment facet of cancer | Signs and symptoms facet of disease | supportive care facet of cancer, end of life facet of disease, quality of life facet of cancer | Treatment decisions facet of cancer | Treatment facet of cancer | Treatment facet of Treatment | Cancer treatment facet of cancer | progression to cancer facet of cancer | diagnosis facet of cancer",
        "metrics": {
          "rouge_score": 0.23529411764705876,
          "answer_correctness": 0.23380113404010605
        }
      },
      {
        "id": "Medical-32b9ef93",
        "question": "If a patient presents with seizures and cognitive changes, what diagnostic methods should be prioritized and why?",
        "ground_truth": "A neurological exam and MRI should be prioritized because these symptoms are common in glioma and MRI is the best imaging test.",
        "generated_answer": "Brain MRI and CT imaging tests should be prioritized to identify potential abnormalities such as brain tumors, which could be causing the seizures and cognitive changes. These imaging techniques provide critical insights into the structural issues within the brain.",
        "contexts": "seizures subclass of Symptoms | seizures subclass of symptom, seizures subclass of headache, fatigue subclass of symptom, Headaches subclass of symptom | memory loss subclass of Problems with thinking and speech, confusion subclass of Problems with thinking and speech, blurred vision subclass of vision problems, tingling subclass of Sensory disturbances, speech difficulties subclass of Problems with thinking and speech, numbness subclass of Sensory disturbances | long-term problems with cognition subclass of nervous system damage | memory loss subclass of slower thinking | seizures subclass of neurological symptoms, headaches subclass of neurological symptoms, symptom subclass of sign | emotional subclass of cognitive | blurred vision subclass of Changes in eyesight, double vision subclass of Changes in eyesight | mental subclass of emotional | anxiety subclass of mental health conditions, depression subclass of mental health conditions | Brain MRI subclass of Magnetic resonance imaging, CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | Glioblastoma subclass of brain tumor | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | fatigue subclass of symptom",
        "metrics": {
          "rouge_score": 0.19672131147540986,
          "answer_correctness": 0.7347718898837169
        }
      },
      {
        "id": "Medical-03451b65",
        "question": "What is the recommended management for a small, noninvasive papillary thyroid carcinoma found to be less than 1 cm with no lymph node involvement?",
        "ground_truth": "Active surveillance or lobectomy are recommended management options.",
        "generated_answer": "Active surveillance is recommended for small, noninvasive papillary thyroid carcinoma less than 1 cm with no lymph node involvement.",
        "contexts": "lymph nodes has effect cancer, cancer has cause lymph nodes | Lymphoma has effect lymph nodes | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer, Head and neck cancer has cause lymph nodes | lymph nodes has effect metastases, metastases location lymph nodes | squamous cell carcinoma has effect Throat cancer | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Papillary subclass of thyroid cancer | Total thyroidectomy medical condition treated papillary cancer | lymph nodes part of cancer | lymph nodes has effect lymph node removed, bone marrow connects with lymph nodes | thyroid cancer has cause iodine | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | prostate gland has effect prostate cancer",
        "metrics": {
          "rouge_score": 0.22222222222222218,
          "answer_correctness": 0.8737653797785627
        }
      },
      {
        "id": "Medical-40446029",
        "question": "Why are clinical trials particularly preferred for BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes?",
        "ground_truth": "Because these subtypes may have poorer prognosis or lack targeted therapies, making clinical trials a preferred option.",
        "generated_answer": "Clinical trials are preferred for BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes due to the need for targeted therapies and the exploration of novel treatment options specific to these subtypes.",
        "contexts": "BCR::ABL1-negative subclass of B-ALL, BCR::ABL1-like B-ALL subclass of B-ALL | BCR::ABL1 instance of gene, Chronic myeloid leukemia subclass of blood cancer | Acute lymphoblastic leukemia subclass of blood cancer | CML subclass of cancer | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Chronic lymphocytic leukemia subclass of blood cancer | AML subclass of blood cancer | blast phase CML subclass of CML, BP-CML subclass of CML | diffuse large B-cell lymphoma subclass of classic FL | Acute myeloid leukemia subclass of blood cancer, blasts subclass of AML | AML subclass of blood cancer, Subtypes of AML subclass of Subtypes of AML | centroblast subclass of B cell | ALL subclass of Lymphoblast | PML::RARA subclass of gene rearrangements | Chronic lymphocytic leukemia subclass of white blood cell | Non-Hodgkin lymphoma subclass of cancer | myelodysplastic syndrome subclass of Acute myeloid leukemia",
        "metrics": {
          "rouge_score": 0.16,
          "answer_correctness": 0.8376784828286024
        }
      },
      {
        "id": "Medical-ce635798",
        "question": "Which genetic alterations are characteristic of Ewing sarcoma, and by which diagnostic methods can these be detected?",
        "ground_truth": "Ewing sarcoma is characterized by EWSR1-FLI1 and EWSR1-ERG fusions, detectable via biomarker testing such as PCR or next-generation sequencing.",
        "generated_answer": "Characteristic genetic alterations of Ewing sarcoma include gene fusion and genetic mutations. Diagnostic methods for detecting these alterations typically involve genetic testing and molecular analysis.",
        "contexts": "genetic changes has effect Cancer cells, Cancer cells has effect genetic changes, Cancer cells has cause genetic changes | genetic mutations has effect cancer | Ewing sarcoma has cause gene fusion | genetic changes has effect Leukemia | genetic mutations has effect Inherited cancer risk, Inherited cancer risk has cause genetic mutations | hereditary mutation has effect cancer | pass these genes on has effect cancer | genetic errors has effect Bladder cancer, Bladder cancer has cause genetic errors | cell changes has effect cancer, cancer has cause cell changes | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | mutations has effect gene | systemic therapy medical condition treated Ewing sarcoma | tumor has effect cancer | mutations can put you at risk for more than one type of cancer has effect more than one type of cancer | mutations has effect Proteins",
        "metrics": {
          "rouge_score": 0.21276595744680854,
          "answer_correctness": 0.6862396189863198
        }
      },
      {
        "id": "Medical-9b9b7f4a",
        "question": "Which diagnostic and molecular tests are used to guide treatment decisions in high-risk localized prostate cancer?",
        "ground_truth": "PSA test, biopsy, MRI, and molecular biomarker testing are used to guide treatment decisions.",
        "generated_answer": "Molecular tumor testing and biomarker testing are used to guide treatment decisions in high-risk localized prostate cancer.",
        "contexts": "biomarker testing subclass of Molecular | genetic testing subclass of diagnostic test | molecular tumor testing subclass of biomarker testing | molecular subclass of biomarker | genetic testing subclass of test | molecular test use diagnosis | biomarker test subclass of biomarker | Diagnosis by blood test subclass of blood test | Blood test subclass of Blood test | Blood test subclass of test | biomarker test subclass of test | biopsy subclass of testing | molecular subclass of genetic | biopsy subclass of blood test | biomarker testing subclass of biopsy, biopsy subclass of test results | urine subclass of testing, Blood subclass of testing | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | biomarker subclass of genetic testing | testing Biopsy subclass of biopsy",
        "metrics": {
          "rouge_score": 0.6250000000000001,
          "answer_correctness": 0.6699698103031175
        }
      },
      {
        "id": "Medical-5a6b98a7",
        "question": "Why might symptoms of nasopharyngeal carcinoma be absent until advanced stages, and how does this affect the diagnostic process?",
        "ground_truth": "Symptoms may be absent until advanced stage, making imaging and biopsy essential for early diagnosis.",
        "generated_answer": "Symptoms of nasopharyngeal carcinoma may be absent until advanced stages due to the tumor's location and slow growth, which can delay detection. This affects the diagnostic process by potentially leading to a later diagnosis when the disease is more advanced and possibly less treatable.",
        "contexts": "Symptoms used by diagnosis, Symptoms has cause medical problem, medical problem has effect Symptoms | initial diagnosis part of Clinical | Pathologic stage part of initial diagnosis | Symptoms has cause Symptoms, Symptoms has effect Symptoms | Symptoms has cause illness, illness has effect Symptoms | illness has effect Symptoms, Symptoms has cause illness | signs different from Symptoms, Symptoms different from signs | Symptoms has cause Treatment | Symptoms different from Symptoms | Symptoms different from symptom | Signs and symptoms facet of disease | Symptoms subclass of health conditions or concerns | diagnosis uses test, test used by diagnosis | Symptoms subclass of Symptoms | symptom facet of disease | Treatment has cause diagnosis | plan treatment has cause diagnosis",
        "metrics": {
          "rouge_score": 0.3,
          "answer_correctness": 0.8881708868330844
        }
      },
      {
        "id": "Medical-f5089b0a",
        "question": "What symptoms, if present together, should prompt diagnostic testing for rectal cancer using imaging and endoscopic methods?",
        "ground_truth": "Changes in bowel habits, rectal bleeding, and abdominal pain should prompt MRI, EUS, and colonoscopy for diagnosis.",
        "generated_answer": "Symptoms that should prompt diagnostic testing for rectal cancer include rectal bleeding, unexplained weight loss, changes in bowel habits, and abdominal pain.",
        "contexts": "Imaging subclass of test results | imaging test subclass of testing | Imaging subclass of test | Ultrasound subclass of imaging test | imaging test subclass of Imaging | imaging scan subclass of tests | radiology subclass of Imaging | Imaging subclass of blood test | CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | imaging test subclass of test | Ultrasound subclass of imaging test, mammogram subclass of imaging test | Magnetic resonance imaging subclass of imaging test | Biopsy subclass of Imaging | biopsy subclass of Imaging | Brain MRI subclass of Magnetic resonance imaging, CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | MRIs subclass of imaging test | CT scan subclass of Imaging | computed tomography subclass of Imaging | contrast subclass of Imaging | Imaging subclass of biopsy",
        "metrics": {
          "rouge_score": 0.358974358974359,
          "answer_correctness": 0.9002178664845264
        }
      },
      {
        "id": "Medical-bea3adf4",
        "question": "How does the presence of Barrett esophagus influence both risk and diagnostic approach for esophageal adenocarcinoma?",
        "ground_truth": "Barrett esophagus increases risk for esophageal adenocarcinoma and necessitates biomarker and genetic risk testing during diagnosis.",
        "generated_answer": "Barrett esophagus increases the risk of developing esophageal adenocarcinoma and necessitates a more vigilant diagnostic approach, often involving regular surveillance endoscopies to detect dysplasia or early cancer.",
        "contexts": "Barrett esophagus part of esophagus, Barrett esophagus has effect adenocarcinoma of the esophagus, Treatment facet of esophageal cancer, stomach connects with esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach | Treatment medical condition treated cancer | treatments medical condition treated cancer | Chemoradiation medical condition treated cancer | diagnostic colonoscopy medical condition treated colon cancer | radical trachelectomy medical condition treated cancer | surgery medical condition treated cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated ovarian cancer | ovarian cancer medical condition treated ovary, ovary medical condition treated ovarian cancer | its treatment medical condition treated prostate cancer | cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | Chemoradiation medical condition treated lung cancer | basal cell skin cancer treated medical condition treated Basal cell skin cancer | Pap testing medical condition treated cervical cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | Cancer treatment medical condition treated bladder cancer | Methotrexate medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.37209302325581395,
          "answer_correctness": 0.6156632899185789
        }
      },
      {
        "id": "Medical-e54f3250",
        "question": "What are the roles of immunotherapy agents in systemic therapy for advanced bladder cancer?",
        "ground_truth": "Immunotherapy agents like pembrolizumab, nivolumab, avelumab, and atezolizumab are used as systemic therapy for advanced bladder cancer.",
        "generated_answer": "Immunotherapy agents play a crucial role in systemic therapy for advanced bladder cancer by enhancing the immune system's ability to recognize and attack cancer cells. They are often used in conjunction with other treatments, such as chemotherapy and targeted therapy, to improve patient outcomes.",
        "contexts": "Immunotherapy subclass of systemic therapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | Immunotherapy Immunotherapy subclass of systemic therapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | Immunotherapy Immunotherapy subclass of systemic therapy, CTLAImmunotherapy subclass of Immunotherapy | checkpoint inhibitor subclass of Immunotherapy, Immunotherapy subclass of Treatment | targeted therapy subclass of Immunotherapy | Immunotherapy subclass of targeted therapy | targeted therapy subclass of systemic therapy | Targeted therapy and immunotherapy subclass of systemic therapy, chemotherapy subclass of Treatment | Immunotherapy part of systemic therapy | systemic therapy subclass of radiation therapy | Immunotherapy facet of immune system, Immunotherapy subclass of systemic therapy | Cancer Systemic therapy subclass of drug therapy | EBRT subclass of systemic therapy, Immunotherapy subclass of targeted therapy | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | systemic therapy subclass of therapies | systemic therapy subclass of Chemotherapy | induction treatment subclass of Immunotherapy",
        "metrics": {
          "rouge_score": 0.25806451612903225,
          "answer_correctness": 0.908735446761922
        }
      },
      {
        "id": "Medical-b94e5d8e",
        "question": "If a thyroid cancer patient develops brain and bone metastases, which treatment options should be considered?",
        "ground_truth": "External beam radiation therapy, targeted therapy, and clinical trial participation should be considered.",
        "generated_answer": "Treatment options for a thyroid cancer patient with brain and bone metastases may include targeted therapy, radioactive iodine therapy, external beam radiation therapy, and systemic chemotherapy. Palliative care should also be considered to manage symptoms and improve quality of life.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic subclass of cancer | metastasized subclass of cancer | metastasis subclass of cancer | metastasized subclass of metastasis | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | metastases subclass of Cancer cells | local metastasis subclass of cancer, metastasized subclass of Breast cancer | Metastatic cancer subclass of Metastasis Cancer | metastatic subclass of prostate cancer | metastasis subclass of metastasized | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastasis subclass of spread of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | de novo subclass of Metastatic cancer | metastatic subclass of spread",
        "metrics": {
          "rouge_score": 0.30188679245283023,
          "answer_correctness": 0.5618955430326187
        }
      },
      {
        "id": "Medical-23e6b6df",
        "question": "What are the two main phases of primary CNS lymphoma treatment, and which therapies are typically administered in each?",
        "ground_truth": "Induction phase uses high-dose methotrexate and rituximab, while consolidation phase uses whole-brain radiation therapy or stem cell rescue.",
        "generated_answer": "The two main phases of primary CNS lymphoma treatment are induction therapy and consolidation therapy. Induction therapy typically involves high-dose methotrexate and rituximab, while consolidation therapy may include additional chemotherapy or targeted therapy.",
        "contexts": "primary CNS lymphoma instance of Treatment | primary CNS lymphoma drug used for treatment Treatment, Treatment medical condition treated primary CNS lymphoma | primary CNS lymphoma subclass of Treatment | primary CNS lymphoma drug used for treatment new therapy, new therapy medical condition treated primary CNS lymphoma | more than one treatment option facet of primary CNS lymphoma | primary CNS lymphoma instance of disease | plan treatment facet of primary CNS lymphoma, more than one treatment option facet of CNS lymphoma | primary CNS lymphoma drug used for treatment targeted therapy, chemotherapy medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment chemotherapy, targeted therapy medical condition treated primary CNS lymphoma | primary CNS lymphoma drug used for treatment rituximab, rituximab medical condition treated primary CNS lymphoma | Treatment facet of CNS lymphoma | primary CNS lymphoma drug used for treatment Methotrexate | Methotrexate medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment Methotrexate | Can primary CNS lymphoma be cured? medical condition treated CNS lymphoma | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma",
        "metrics": {
          "rouge_score": 0.37037037037037035,
          "answer_correctness": 0.7366510167996383
        }
      },
      {
        "id": "Medical-4124f00f",
        "question": "If a patient with primary CNS lymphoma relapses in the spinal cord, which diagnostic and treatment strategies should be considered?",
        "ground_truth": "Imaging (MRI), lumbar puncture, and possible intrathecal chemotherapy should be considered for spinal cord relapse.",
        "generated_answer": "Diagnostic strategies should include testing the cerebrospinal fluid (CSF) for lymphoma cells. Treatment options may involve chemotherapy, radiation therapy, or targeted therapies specific to CNS lymphoma.",
        "contexts": "CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of Treatment | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | lymphoma in the eyes subclass of CNS lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | testing the CSF facet of CNS lymphoma | central nervous system has effect CNS lymphoma | primary CNS lymphoma location central nervous system | CNS lymphoma has part primary CNS lymphoma | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | CNS lymphoma has cause reduced immune system | Burkitt lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.0975609756097561,
          "answer_correctness": 0.22813988068812358
        }
      },
      {
        "id": "Medical-fa092b30",
        "question": "What is the significance of imaging in the management of pancreatic cancer, and for which purposes is it used?",
        "ground_truth": "Imaging is used for staging, determining surgical eligibility, and as a diagnostic method in pancreatic cancer.",
        "generated_answer": "Imaging is crucial in the management of pancreatic cancer for diagnosing the disease, determining its stage, and planning treatment. It is used for detecting tumors, assessing metastasis, and monitoring treatment response.",
        "contexts": "cancer studied by imaging test, imaging test studies cancer | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | imaging test studies tumor | Imaging facet of cancer | Imaging Imaging facet of cancer | Pancreatic cancer studied by pancreatic cancer is complex, pancreatic cancer is complex studies Pancreatic cancer | Imaging different from cancer | Imaging part of pathology, Imaging facet of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | pancreas has effect Pancreatic cancer | brain tumor studied by Magnetic resonance imaging | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments | Imaging facet of cancer, Imaging subclass of test results | prostate studied by Magnetic resonance imaging, Magnetic resonance imaging studies prostate | computed tomography main subject colon cancer, Imaging Imaging facet of cancer | neuroendocrine tumor subclass of Pancreatic cancer, tumor has part Pancreatic cancer cell, Pancreatic cancer cell part of tumor, Pancreas Sounds like PAN-kree-us main subject Pancreatic cancer | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | neuroendocrine tumor has effect Pancreatic cancer, Pancreatic cancer has cause Cancer cells",
        "metrics": {
          "rouge_score": 0.2127659574468085,
          "answer_correctness": 0.6522010294496746
        }
      },
      {
        "id": "Medical-aacc98ed",
        "question": "What histological layers must a tumor penetrate to reach the serosa from the epithelium in the bile duct?",
        "ground_truth": "A tumor must penetrate the lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa from the epithelium.",
        "generated_answer": "The tumor must penetrate the epithelium, submucosa, muscularis mucosa, and the serosa.",
        "contexts": "Cancer cells studied by histology, histology studies Cancer cells | tumor histology studies cancer | tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | tissues studied by pathologist, pathologist studies tissues | tissues studied by pathologist, pathologist studies tissues | biopsy studies lesion | Epithelium part of tissues, cancer studied by pathologist | pathologist studies tissue sample, tissue sample studied by pathologist | histology uses microscope | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | biopsy studied by pathologist | Biopsy studied by pathologist | pathologic examination studies tumor, Pathologic examination studied by pathologist | Epithelium subclass of tissues | disease studied by Pathologist, Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist | cancer studied by pathologist, pathologist studies cancer",
        "metrics": {
          "rouge_score": 0.5161290322580646,
          "answer_correctness": 0.4577019604831374
        }
      },
      {
        "id": "Medical-032223d5",
        "question": "Why might a patient with a stomach mass and positive family history undergo genetic risk testing in addition to biopsy?",
        "ground_truth": "Because family history is a genetic risk factor and diagnosis requires both tissue confirmation and risk assessment.",
        "generated_answer": "A patient with a stomach mass and positive family history might undergo genetic risk testing to identify any hereditary cancer syndromes or genetic predispositions that could inform treatment options and surveillance strategies, in addition to the biopsy for diagnosis.",
        "contexts": "genetic cancer risk testing subclass of Biopsy | Genetic risk testing subclass of Genetic and biomarker testing | biopsy subclass of testing | biomarker testing subclass of biopsy, biopsy subclass of test results | genetic cancer risk testing subclass of Testing for breast cancer | Biopsy subclass of test | biopsy subclass of test | testing Biopsy subclass of biopsy | genetic testing subclass of test | biopsy subclass of test results | biomarker subclass of genetic testing | genetic testing subclass of diagnostic test | Biopsy subclass of biopsy | biopsy subclass of blood test | tumor testing subclass of genetic testing | biopsy subclass of procedure | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | genetic cancer risk testing subclass of genetic testing | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy",
        "metrics": {
          "rouge_score": 0.21428571428571433,
          "answer_correctness": 0.9845649415491156
        }
      },
      {
        "id": "Medical-45847608",
        "question": "Which hereditary syndromes increase the risk for ovarian cancer and how does this affect patient management?",
        "ground_truth": "BRCA1, BRCA2 mutations, and Lynch syndrome increase risk and prompt genetic testing and consideration of targeted therapies.",
        "generated_answer": "Hereditary syndromes that increase the risk for ovarian cancer include Lynch syndrome and BRCA mutations. This affects patient management by necessitating genetic testing, increased surveillance, and potential preventive measures such as prophylactic surgeries.",
        "contexts": "Lynch syndrome has effect hereditary ovarian cancer | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer, hereditary ovarian cancer subclass of ovarian cancer, Lynch syndrome has effect hereditary colon and uterine cancers, Lynch syndrome subclass of BRCA mutation, ovarian cancer subclass of cancer | hereditary mutation has effect cancer | BRCA mutation has effect ovarian cancer, ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor | hereditary has effect Breast cancer, Breast cancer has cause hereditary, pass these genes on has effect cancer | ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | genetic mutations has effect cancer | Pancreatic cancer has cause factors that increase the chance of developing, genes has effect hereditary pancreatic cancer | Lynch syndrome has effect colorectal, Lynch syndrome subclass of Rectal cancer, microsatellite stable subclass of Tumor | genetic mutations has effect hereditary | genetic errors has effect Bladder cancer | ovarian cancer subclass of less common",
        "metrics": {
          "rouge_score": 0.27999999999999997,
          "answer_correctness": 0.8131662347213892
        }
      },
      {
        "id": "Medical-27281f31",
        "question": "If a patient develops lymph node recurrence after initial treatment for anal cancer, what are the recommended interventions?",
        "ground_truth": "Groin dissection, chemotherapy, and radiation (if not previously given) are recommended for lymph node recurrence.",
        "generated_answer": "Recommended interventions for lymph node recurrence after initial treatment for anal cancer include chemoradiation, radiation therapy, and possibly abdominoperineal resection (APR surgery).",
        "contexts": "Treatment facet of Anal cancer | Stage I anal cancer followed by Stage II anal cancer, Stage II anal cancer follows Stage I anal cancer | Anal cancer has effect anal dysplasia | Chemoradiation facet of Anal cancer | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | longer to respond to treatment than others facet of Anal cancer | metastatic subclass of Anal cancer, radiation therapy medical condition treated Anal cancer, Anal cancer drug used for treatment radiation therapy | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer, Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer | Anal cancer drug used for treatment radiation treatment | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | anal dysplasia has effect Anal cancer | abdominoperineal resection medical condition treated Anal cancer | Abdominoperineal resection medical condition treated Anal cancer | Anal cancer basics main subject Anal cancer | Chemoradiation medical condition treated anal canal cancer, metastatic anal cancer opposite of nonmetastatic, nonmetastatic opposite of metastatic anal cancer, linear accelerator medical condition treated Anal canal cancer | prostate cancer has effect recurrence",
        "metrics": {
          "rouge_score": 0.27027027027027023,
          "answer_correctness": 0.7347868683692109
        }
      },
      {
        "id": "Medical-d2458aa7",
        "question": "If a patient has multiple tumors in both kidneys, how should these be classified and why?",
        "ground_truth": "They should be treated as separate primary tumors, not metastasis.",
        "generated_answer": "The tumors in both kidneys should be classified as kidney cancer, specifically as renal cell carcinoma (RCC), due to their presence in both organs indicating a systemic issue rather than localized tumors. This classification is important for determining the appropriate treatment and management strategy.",
        "contexts": "kidney cancer subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Locoregional subclass of tumor | tumor subclass of cancer | Tumor subclass of cancer | Clear cell RCC subclass of sarcomatoid, RCC subclass of kidney cancer | benign subclass of tumor | tumor subclass of abnormal areas | cancer subclass of Tumor, aggressive type subclass of cancer | adrenal tumor subclass of tumor | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | prostate subclass of cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | benign subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Squamous cell subclass of Tumor, Recurrent tumor subclass of cancer, recurrence subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.14814814814814814,
          "answer_correctness": 0.7266894420248037
        }
      },
      {
        "id": "Medical-6624a28a",
        "question": "How is clinical stage of throat cancer determined prior to treatment?",
        "ground_truth": "Clinical stage is determined by physical exam, imaging, and biopsy before treatment.",
        "generated_answer": "The clinical stage of throat cancer is determined through a combination of physical examinations, imaging tests, and biopsies to assess the extent of the disease and its spread.",
        "contexts": "Clinical stage facet of Breast cancer | stage part of Treatment, Treatment has part stage | Treatment facet of Treatment, more than one treatment option facet of Treatment | Treatment facet of disease | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | staging facet of Treatment decisions | surgical stage facet of surgery | Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Phase 1 trial facet of Treatment trial | Clinical stage instance of rating | cancer stage facet of cancer | plan treatment facet of Treatment, plan treatment facet of disease | plan treatment facet of Treatment | Goals of systemic therapy facet of Treatment | Cancer treatment facet of cancer | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.9224707740801915
        }
      },
      {
        "id": "Medical-2e2c9c8e",
        "question": "If a rectal cancer patient has dMMR or MSI-H, what does this indicate regarding their tumor, and what testing is required?",
        "ground_truth": "It indicates a biomarker status relevant for management, and all rectal tumors should be tested for dMMR or MSI-H.",
        "generated_answer": "dMMR or MSI-H indicates that the tumor has a deficiency in mismatch repair, which may affect treatment options and prognosis. Testing for microsatellite instability (MSI) or immunohistochemistry (IHC) for MMR proteins is required to confirm this status.",
        "contexts": "Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer, Anal cancer drug used for treatment Mitomycin, 5-FU medical condition treated Anal cancer, Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer | Treatment medical condition treated cancer | rituximab medical condition treated colon cancer, Lenalidomide medical condition treated colon cancer | capecitabine Mitomycin medical condition treated Anal cancer, Anal cancer drug used for treatment Mitomycin, 5-FU 5-FU and cisplatin medical condition treated Anal cancer, Mitomycin medical condition treated Anal cancer | oxaliplatin medical condition treated Rectal cancer | treatments medical condition treated cancer | surgery medical condition treated cancer | its treatment medical condition treated prostate cancer | Methotrexate medical condition treated cancer | Abdominoperineal resection medical condition treated Anal cancer | abdominoperineal resection medical condition treated Anal cancer | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | prostate cancer drug used for treatment flutamide, nilutamide medical condition treated prostate cancer, prostate cancer drug used for treatment hormone replacement therapy, triptorelin subject has role <triplet>nilutamide Anti-androgen, leuprolide subject has role Anti-androgen, triptorelin subject has role Anti-androgen, Hormone therapies for prostate cancer has part LHRH antagonists, hormone replacement therapy medical condition treated prostate cancer, bicalutamide subject has role Anti-androgen, flutamide subject has role Anti-androgen, goserelin subject has role Anti-androgen | Chemoradiation medical condition treated cancer | systemic therapy medical condition treated Skin cancer",
        "metrics": {
          "rouge_score": 0.20689655172413793,
          "answer_correctness": 0.9873894717914188
        }
      },
      {
        "id": "Medical-a0cd1d28",
        "question": "Which genetic alteration is most associated with inherited medullary thyroid cancer and what implication does this have for family members?",
        "ground_truth": "RET gene fusion is most associated, indicating the need for family genetic screening for inherited syndromes.",
        "generated_answer": "The genetic alteration most associated with inherited medullary thyroid cancer is a hereditary mutation. This implies that family members may have an increased risk of developing this condition.",
        "contexts": "hereditary mutation subclass of passed down in families, mutations subclass of genetic abnormality | acquired subclass of mutations | somatic mutation subclass of inherited or germline mutation, abnormal change subclass of mutations | Lynch syndrome subclass of inherited condition | somatic subclass of mutations | Mutation testing subclass of abnormalities | molecular subclass of genetic | genetic mutations has effect hereditary, hereditary has cause genetic mutations | mismatch repair genes subclass of inherited mutations, deficient mismatch repair subclass of microsatellite instability-high | xeroderma pigmentosum subclass of genetic conditions | genetic testing subclass of test | Mismatch repair subclass of gene | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | germline mutations subclass of genetic testing, DNA subclass of genetic information | biomarker subclass of genetic | somatic subclass of tumor mutations | genetic cancer risk testing subclass of genetic testing, Mutation testing subclass of abnormalities, genetic code has effect mutations",
        "metrics": {
          "rouge_score": 0.13636363636363635,
          "answer_correctness": 0.22784141258319582
        }
      },
      {
        "id": "Medical-a660735d",
        "question": "Why might a patient with pediatric-type follicular lymphoma present differently from an adult with classic FL?",
        "ground_truth": "PTFL usually presents with a single enlarged lymph node and minimal symptoms, unlike classic FL which may have widespread lymphadenopathy and B symptoms.",
        "generated_answer": "A patient with pediatric-type follicular lymphoma may present differently from an adult with classic FL due to differences in tumor biology, age-related immune responses, and the distinct characteristics of pediatric lymphomas compared to adult forms. These factors can influence the clinical presentation, progression, and response to treatment.",
        "contexts": "classic FL subclass of Follicular lymphoma, diffuse large B-cell lymphoma subclass of classic FL | Follicular lymphoma subclass of non-Hodgkin lymphoma, extranodal (outside of the lymph node) disease subclass of FL | FL grade 3B subclass of follicular large B cell lymphoma, Pediatric-type FL subclass of classic FL, classic FL instance of ICC classification system | Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma | Follicular lymphoma subclass of Lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma | Non-Hodgkin lymphoma subclass of cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Germinal centers Follicular lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma different from Burkitt lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | follicular tumor different from Papillary",
        "metrics": {
          "rouge_score": 0.1388888888888889,
          "answer_correctness": 0.6971863751851574
        }
      },
      {
        "id": "Medical-bfe2b31f",
        "question": "Which imaging and biopsy methods are used together to confirm a diagnosis of primary CNS lymphoma localized to the brain?",
        "ground_truth": "MRI with gadolinium contrast and stereotactic biopsy are used together for diagnosis.",
        "generated_answer": "Imaging methods such as MRI and biopsy are used together to confirm a diagnosis of primary CNS lymphoma localized to the brain.",
        "contexts": "CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of Treatment | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | lymphoma in the eyes subclass of CNS lymphoma | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | Non-Hodgkin lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | oligodendroglioma subclass of Glioblastoma | Glioblastoma subclass of brain tumor | brain has effect CNS lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | testing the CSF facet of CNS lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.4117647058823529,
          "answer_correctness": 0.9857224257262294
        }
      },
      {
        "id": "Medical-727f425f",
        "question": "What follow-up strategies are recommended for a patient on active surveillance for localized prostate cancer?",
        "ground_truth": "Regular PSA testing, repeat biopsy, and imaging as indicated are recommended for active surveillance.",
        "generated_answer": "Recommended follow-up strategies for a patient on active surveillance for localized prostate cancer include regular PSA testing, imaging studies, and periodic biopsies to monitor for any changes in the cancer's status.",
        "contexts": "Surveillance facet of cancer | Surveillance Follow-up testing facet of cancer, surveillance testing facet of cancer survivors | Early detection and treatment facet of prostate cancer | active surveillance subclass of biopsy | detection methods facet of prostate cancer | aggressive facet of prostate cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | tests and scans facet of prostate cancer | active surveillance subclass of Treatment | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Early vs. advanced prostate cancer facet of prostate cancer | new tests and treatments facet of prostate cancer, detection methods and treatments medical condition treated prostate cancer, treatment choices now than they had before facet of prostate cancer, prostate cancer has cause prostate gland, prostate cancer drug used for treatment detection methods and treatments | higher risk facet of prostate cancer | PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Imaging facet of cancer | PSA test facet of prostate cancer | PSA in the blood has cause prostate cancer, prostate cancer location prostate, PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | Imaging Imaging facet of cancer",
        "metrics": {
          "rouge_score": 0.21276595744680848,
          "answer_correctness": 0.9896937603320319
        }
      },
      {
        "id": "Medical-7c1c087a",
        "question": "How does the presence of serosa impact the potential for cancer to spread outside the gallbladder or bile duct?",
        "ground_truth": "The serosa acts as the last anatomical barrier before cancer can spread to structures outside the organ.",
        "generated_answer": "The presence of serosa can limit the potential for cancer to spread outside the gallbladder or bile duct, as it acts as a protective layer. If cancer penetrates the serosa, it may increase the likelihood of metastasis to surrounding tissues.",
        "contexts": "bile duct connects with gallbladder, gallbladder connects with bile duct | common bile duct connects with cystic duct, gallbladder connects with cystic duct, cystic duct connects with common bile duct, stomach connects with small intestine, small intestine connects with stomach, portal vein connects with hepatic artery, hepatic artery connects with portal vein, heart connects with inferior vena cava, right instance of hepatic duct, cystic duct connects with gallbladder | liver connects with gallbladder, gallbladder connects with liver | gallbladder connects with liver, liver connects with gallbladder | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | renal pelvis connects with ureter, kidney has part renal pelvis, ureter connects with renal pelvis, full, healthy lives with only one kidney subclass of less than one complete kidney, vena cava connects with renal vein, ureter connects with bladder, renal pelvis part of kidney, bladder connects with urethra, kidney connects with renal pelvis, renal vein connects with vena cava, bladder connects with ureter, urethra connects with bladder, renal pelvis connects with kidney, kidney has part renal tubules, renal tubules part of kidney | liver connects with abdomen, abdomen connects with liver | intestines connects with abdomen, abdomen connects with intestines | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | urethra connects with ureter, bladder connects with ureter, urethra connects with bladder, ureter connects with urethra, ureter connects with bladder, bladder connects with urethra | urethra connects with ureter | neobladder connects with urethra",
        "metrics": {
          "rouge_score": 0.2456140350877193,
          "answer_correctness": 0.8367964586046766
        }
      },
      {
        "id": "Medical-2d14639d",
        "question": "How does the grade of follicular lymphoma influence its classification and treatment approach?",
        "ground_truth": "Grades 1 and 2 are classified as classic FL and treated accordingly, while grade 3B is classified and treated as DLBCL.",
        "generated_answer": "The grade of follicular lymphoma, such as FL grade 3B, influences its classification as a subclass of follicular large B cell lymphoma and affects the treatment approach, as higher grades may require more aggressive treatment options compared to lower grades.",
        "contexts": "Removing or reducing facet of Lymphoma | Treatment facet of CNS lymphoma | classic FL subclass of Follicular lymphoma, centroblast facet of Lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | Follicular lymphoma subclass of Lymphoma | more than one treatment option facet of CNS lymphoma | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | Cancer treatment facet of cancer | induction phase facet of Lymphoma, more than one treatment option facet of primary CNS lymphoma | FL grade 3B subclass of follicular large B cell lymphoma | Treatment facet of disease | Treatment facet of ovarian cancer | diagnosis facet of cancer | lymph nodes facet of cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Immunotherapy facet of cancer | follicular subclass of lesions, follicular subclass of differentiated thyroid cancers, follicular carcinoma subclass of thyroid cancer",
        "metrics": {
          "rouge_score": 0.22950819672131145,
          "answer_correctness": 0.5685999360438979
        }
      },
      {
        "id": "Medical-18fc35e5",
        "question": "What are the recommended initial treatments for most stages of epithelial ovarian cancer?",
        "ground_truth": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) followed by chemotherapy (typically paclitaxel and carboplatin) is recommended.",
        "generated_answer": "The recommended initial treatments for most stages of epithelial ovarian cancer typically include initial surgery followed by chemotherapy.",
        "contexts": "Treatment facet of ovarian cancer, initial surgery medical condition treated ovarian cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | early in the course of treatment facet of cancer, Treatment decisions facet of cancer | Cancer treatment facet of cancer | Treatment planning facet of cancer | Treatment facet of urothelial cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | Treatment facet of colon cancer | more treatment facet of cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | more than one treatment option facet of cancer | Treatment facet of Pancreatic cancer | plan treatment facet of cancer | Treatment facet of bladder cancer | Treatment facet of stomach cancer | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility",
        "metrics": {
          "rouge_score": 0.2424242424242424,
          "answer_correctness": 0.7333088791649112
        }
      },
      {
        "id": "Medical-24373ebe",
        "question": "How does the disease phase of CML affect the types of blood cells present?",
        "ground_truth": "Blast phase CML is characterized by increased blasts and progenitor cells, while chronic phase has increased mature granulocytes.",
        "generated_answer": "The disease phase of CML leads to an increase in abnormal myeloblasts and affects the normal differentiation of blood cells, resulting in an imbalance of various blood cell types. This can cause elevated levels of white blood cells, particularly immature forms, while reducing healthy red blood cells and platelets.",
        "contexts": "Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, platelet follows Red blood cell | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell | white blood cell part of Blood, Blood part of immune system, plasma part of Blood, plasma has part water, platelet part of Blood, blood stem cell part of Blood, Red blood cell part of Blood | cells part of Blood | Red blood cell has part Red blood cell, white blood cell has part Granulocyte, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet | Blood has part white blood cell, white blood cell part of Blood, Red blood cell part of Blood | white blood cell part of Blood, Blood part of immune system, plasma part of Blood, plasma has part water, platelet part of Blood | Blood has part Red blood cell, platelet part of white blood cell, white blood cell has part platelet, Red blood cell part of Blood | Blood has part Red blood cell, platelet follows white blood cell, Red blood cell part of Blood, Red blood cell followed by white blood cell, white blood cell follows Red blood cell | white blood cell part of Blood, Blood has part Red blood cell, platelet part of Blood, Red blood cell part of Blood",
        "metrics": {
          "rouge_score": 0.17910447761194032,
          "answer_correctness": 0.983933588555254
        }
      },
      {
        "id": "Medical-402f416c",
        "question": "Which chemotherapy regimens are recommended as part of chemoradiation for a patient with Stage II anal squamous cell carcinoma?",
        "ground_truth": "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended regimens.",
        "generated_answer": "Platinum-based chemotherapy regimens are recommended as part of chemoradiation for a patient with Stage II anal squamous cell carcinoma.",
        "contexts": "Chemoradiation subclass of chemotherapy | Chemoradiation subclass of chemotherapy, Chemoradiation part of Chemotherapy | radiation therapy subclass of Chemotherapy | radiation therapy subclass of chemotherapy | Chemoradiation subclass of platinum chemotherapy | Chemoradiation Chemotherapy subclass of radiation therapy, radiation subclass of combination of three treatments, TURBT subclass of combination of three treatments, Trimodal therapy subclass of combination of three treatments, Chemoradiation instance of Cancer treatment, chemoradiotherapy said to be the same as Chemoradiation | Chemoradiation subclass of chemotherapy, Chemotherapy different from Chemoradiation, Chemoradiation followed by chemotherapy | chemotherapy subclass of therapy, radiation subclass of therapy | neoadjuvant therapy subclass of Chemotherapy, Chemotherapy subclass of systemic therapy | chemotherapy subclass of Treatment | chemotherapy subclass of Cancer treatment | Chemoradiation subclass of first-line therapy | Chemotherapy Chemotherapy subclass of systemic therapy | Immunotherapy subclass of Chemotherapy, combined subclass of Therapeutic, Steroids subclass of Chemotherapy, chemotherapy subclass of Therapeutic | targeted therapy subclass of chemotherapy | Chemotherapy subclass of systemic therapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | chemotherapy subclass of treating cancer | immune checkpoint inhibitor therapy subclass of chemotherapy | Chemotherapy subclass of drug treatment",
        "metrics": {
          "rouge_score": 0.1142857142857143,
          "answer_correctness": 0.22672368651121166
        }
      },
      {
        "id": "Medical-ee49f3e8",
        "question": "Why is surgery not typically a treatment option for Stage 4 NSCLC?",
        "ground_truth": "Because Stage 4 NSCLC is metastatic at diagnosis, making local treatments like surgery ineffective.",
        "generated_answer": "Surgery is not typically a treatment option for Stage 4 NSCLC because the cancer has usually spread beyond the lungs to other parts of the body, making it unresectable. At this stage, systemic therapies like chemotherapy and immunotherapy are preferred for managing the disease.",
        "contexts": "surgery subclass of Treatment | treatment with surgery subclass of surgery, surgery subclass of Treatment | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | surgery subclass of Treatment, chemotherapy subclass of Treatment | treatment after surgery subclass of surgery | surgery subclass of operation | radiation therapy subclass of Treatment, surgery subclass of treated | Treatment subclass of procedure | radiation therapy subclass of surgery, systemic therapy subclass of surgery, Intravesical therapy subclass of surgery | minor surgery subclass of Treatment | surgery subclass of Treatment, systemic therapy subclass of Treatment | systemic therapy subclass of surgery, Chemoradiation subclass of surgery | radiation therapy subclass of surgery, Tumors on other areas of the body Surgery subclass of surgery | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery | surgery to remove cancer from the body subclass of surgery | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | Postoperative subclass of surgery, pre-surgery subclass of surgery",
        "metrics": {
          "rouge_score": 0.17241379310344826,
          "answer_correctness": 0.9887956814139932
        }
      },
      {
        "id": "Medical-f078c897",
        "question": "Why is the lamina propria not included in the definition of carcinoma in situ for intrahepatic bile duct cancer?",
        "ground_truth": "Because carcinoma in situ is restricted to the epithelium, and the lamina propria is a connective tissue beneath it.",
        "generated_answer": "The lamina propria is not included in the definition of carcinoma in situ for intrahepatic bile duct cancer because carcinoma in situ refers specifically to cancerous cells that are confined to the epithelium and have not invaded deeper tissues, such as the lamina propria.",
        "contexts": "intrahepatic cholangiocarcinoma subclass of Liver cancer, hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma, primary liver cancer subclass of Liver cancer | noninvasive cancer subclass of in situ | Noninvasive breast cancer subclass of carcinoma in situ | carcinoma in situ subclass of cancerous cells | HCC subclass of Liver cancer, hepatocellular carcinoma subclass of Secondary liver cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | primary liver cancer subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer, noninvasive subclass of cancer | Stage 1 subclass of Stage I anal cancer, carcinoma in situ subclass of cancer | Nasopharynx subclass of cancer, carcinoma in situ subclass of tumor | Ductal carcinoma subclass of Breast cancer, Invasive ductal carcinoma subclass of Invasive ductal carcinoma | inflamed pancreas subclass of Pancreatic cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | stage II subclass of bladder cancer, stage 0 facet of carcinoma in situ, carcinoma in situ subclass of aggressive",
        "metrics": {
          "rouge_score": 0.3492063492063492,
          "answer_correctness": 0.7397275465896759
        }
      },
      {
        "id": "Medical-b200a90c",
        "question": "Which bladder cancer subtypes are less common and how does this affect the overall classification of the disease?",
        "ground_truth": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes, with urothelial carcinoma being the most common.",
        "generated_answer": "Less common bladder cancer subtypes include small cell carcinoma, squamous cell carcinoma, and adenocarcinoma. Their rarity influences the overall classification by creating distinct categories within bladder cancer, highlighting the diversity of the disease.",
        "contexts": "0 subclass of bladder cancer, 3 subclass of bladder cancer, 2 subclass of bladder cancer, metastasized subclass of cancer, Stage 0 Stage 0 subclass of bladder cancer, 1 subclass of bladder cancer | bladder cancer subclass of cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, squamous cell carcinoma subclass of bladder cancer, Adenocarcinoma subclass of bladder cancer | bladder cancer subclass of Cancer of the upper urinary tract | bladder cancer subclass of transitional call cancer | non\u2013 muscle-invasive subclass of bladder cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Stage 4B subclass of bladder cancer | Metastatic bladder cancer subclass of bladder cancer, Metastatic bladder cancer subclass of cancer, High-grade cancer opposite of Low grade bladder cancer | cancer type subclass of cancer | bladder cancer instance of disease | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | bladder cancer commonly comes back again subclass of Bladder cancer | invaded the muscle layer subclass of bladder cancer",
        "metrics": {
          "rouge_score": 0.19230769230769232,
          "answer_correctness": 0.7437931368930364
        }
      },
      {
        "id": "Medical-732c4e13",
        "question": "How does performance status influence treatment eligibility for glioma patients, and how is it assessed?",
        "ground_truth": "Performance status is assessed clinically and determines eligibility for glioma treatments.",
        "generated_answer": "Performance status significantly influences treatment eligibility for glioma patients, as it helps determine their ability to tolerate various therapies. It is typically assessed using standardized scales like the Karnofsky Performance Status or Eastern Cooperative Oncology Group (ECOG) scale.",
        "contexts": "treated facet of Glioblastoma | different options for treating gliomas facet of Glioblastoma | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | Treatment planning facet of cancer | eligibility criteria facet of Clinical trial, Treatment facet of disease | Cancer treatment facet of cancer | Treatment decisions facet of cancer | targeted therapy facet of Glioblastoma | Imaging facet of cancer, Treatment planning facet of cancer | treatment is improving facet of Glioblastoma | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | radiation therapy facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | situation facet of brain tumor | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Treatment facet of ovarian cancer | more treatment facet of cancer | plan treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.2040816326530612,
          "answer_correctness": 0.6670697068052514
        }
      },
      {
        "id": "Medical-d256aef2",
        "question": "If a patient with nasopharyngeal carcinoma presents with enlarged lymph nodes, what does this indicate about possible disease spread and staging?",
        "ground_truth": "Enlarged lymph nodes suggest lymph node metastasis, which is included in the TNM staging system for NPC.",
        "generated_answer": "Enlarged lymph nodes in a patient with nasopharyngeal carcinoma indicate possible regional lymph node metastasis, which is crucial for cancer staging and assessing the extent of disease spread.",
        "contexts": "Clinical staging of lymph nodes subclass of staging | The spread to nearby lymph nodes (N) subclass of spread, Clinical subclass of cancer staging, pathologic subclass of cancer staging | regional subclass of lymph nodes, local subclass of lymph nodes | metastatic subclass of spread | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | lymph nodes subclass of cancer, inguinal subclass of lymph nodes | metastasis subclass of spread | extranodal extension subclass of Lymph nodes with cancer | sentinel lymph node subclass of lymph nodes, signs of cancer subclass of nodes, sentinel node subclass of lymph nodes | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | spread subclass of cancer | metastasis subclass of spreading | staging subclass of Imaging | metastasis subclass of spread of cancer | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | sentinel node subclass of lymph nodes | lymphadenectomy subclass of lymph node dissection, lymph nodes subclass of glands",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.9898665629540622
        }
      },
      {
        "id": "Medical-1a7ab06f",
        "question": "What combination of symptoms and test results would suggest an aldosteronoma rather than a cortisol-producing adenoma?",
        "ground_truth": "Excess aldosterone on biochemical testing without Cushing syndrome symptoms suggests aldosteronoma.",
        "generated_answer": "Symptoms of hypertension and hypokalemia, along with elevated plasma aldosterone levels and suppressed plasma renin activity, would suggest an aldosteronoma rather than a cortisol-producing adenoma.",
        "contexts": "prostate cancer different from prostate cancer, prostate cancer different from prostate cancer, risk factors has effect prostate cancer | tumor different from Tumor | tumors different from cancer, cancer different from tumors | BPH different from prostate cancer, prostate cancer different from BPH | benign different from cancerous, cancerous different from benign, noncancerous subclass of tumor, cure different from Treatment | cancer different from cancer type, cancer type different from cancer | Benign (not cancer) adrenal tumor subclass of adrenal tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Imaging different from cancer | lung cancer different from lung cancer | Osteosarcoma different from Osteosarcoma | follicular tumor different from Papillary | prostate cancer subclass of cancerous, prostate cancer different from prostate cancer | Papillary different from follicular tumor | resection different from polypectomy, polypectomy different from resection, polypectomy part of colonoscopy | adrenal tumor subclass of tumor",
        "metrics": {
          "rouge_score": 0.16216216216216214,
          "answer_correctness": 0.8339944994547341
        }
      },
      {
        "id": "Medical-618ab93c",
        "question": "If a patient is diagnosed with a slow-growing primary cutaneous lymphoma of B-cell origin, which subtypes are likely?",
        "ground_truth": "Primary cutaneous marginal zone lymphoma and primary cutaneous follicle center lymphoma are likely, as most CBCLs are indolent.",
        "generated_answer": "Primary cutaneous diffuse large B-cell lymphoma, leg type and Primary cutaneous B-cell lymphoma.",
        "contexts": "diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | B cell subclass of lymphocyte, B cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma, T-cell subclass of lymphocyte, B cell subclass of lymphocyte | Hodgkin lymphoma subclass of Lymphoma | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma, B lymphocyte subclass of lymphocyte | mantle cell lymphoma subclass of Lymphoma | B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | classic FL subclass of Follicular lymphoma",
        "metrics": {
          "rouge_score": 0.42424242424242425,
          "answer_correctness": 0.2290469859701905
        }
      },
      {
        "id": "Medical-2b2dd1fb",
        "question": "What combination of symptoms and diagnostic methods would most likely lead to an ALL diagnosis involving the central nervous system?",
        "ground_truth": "Symptoms like organ involvement combined with lumbar puncture and imaging tests would indicate CNS involvement in ALL.",
        "generated_answer": "Symptoms such as neurological deficits or seizures combined with diagnostic methods like magnetic resonance imaging (MRI) would most likely lead to an ALL diagnosis involving the central nervous system.",
        "contexts": "central nervous system part of body, body has part central nervous system | central nervous system has part brain, central nervous system has part spinal cord, brain part of central nervous system | central nervous system has part brain, brain part of central nervous system, spinal cord part of central nervous system, central nervous system has part spinal cord | central nervous system has part brain, brain part of central nervous system, spinal cord part of central nervous system, central nervous system has part spinal cord, CNS lymphoma has part primary CNS lymphoma | Magnetic resonance imaging location central nervous system, brain part of CNS | brain has part central part, central part part of brain | brain connects with spinal cord, brain has part central part, central part part of brain, spinal cord connects with brain | brain connects with spinal cord, brain has part normal parts of the brain, central nervous system has part spinal cord, spinal cord connects with brain, nerve cell part of neuron, central nervous system has part brain, brain part of central nervous system | central nervous system has part tumor | CNS has part spine, spine part of CNS | brain part of CNS, body has part brain, brain part of body, spinal cord connects with brain, brain connects with skull, skull connects with vertebrae | central nervous system has effect CNS lymphoma | diagnosis studies brain tumor, brain tumor studied by diagnosis",
        "metrics": {
          "rouge_score": 0.2608695652173913,
          "answer_correctness": 0.7337546642489143
        }
      },
      {
        "id": "Medical-0d237b40",
        "question": "Which metastatic sites are most common in nasopharyngeal carcinoma and how is this reflected in the ontology?",
        "ground_truth": "Lymph node and lung are the most common metastatic sites for NPC, as indicated in the ontology.",
        "generated_answer": "The most common metastatic sites in nasopharyngeal carcinoma include the lymph nodes, lungs, and liver. This is reflected in the ontology through the relationships and entities associated with metastasis and cancer spread.",
        "contexts": "Metastatic cancer has cause Cancer stages and metastasis, Cancer stages and metastasis has effect Metastatic cancer | primary tumor has effect metastasized, metastasized has cause primary tumor | metastasis has effect spread | tumor has effect cancer, cancer has cause tumor | cancer has effect cancer, cancer has cause cancer | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | Cancer cells has effect tumor, tumor has cause Cancer cells | tumor has cause Cancer cells, Cancer cells has effect tumor | cancer has effect Cancer treatment | metastatic different from Locally advanced cancer | Cancer cells has effect tumors, tumors has cause Cancer cells | breast has effect Breast cancer, Breast cancer has cause breast | cancer type has effect cancer, cancer has cause cancer type | metastatic subclass of cancer | tumors has cause Cancer cells | cancer has effect return",
        "metrics": {
          "rouge_score": 0.32653061224489793,
          "answer_correctness": 0.6695762483835361
        }
      },
      {
        "id": "Medical-55f0c0e2",
        "question": "Why is actinic keratosis considered a risk factor for CSCC, and how is it managed to prevent progression?",
        "ground_truth": "Actinic keratosis is a precancerous lesion that can progress to CSCC and is managed with photodynamic therapy, cryotherapy, or topical treatments.",
        "generated_answer": "Actinic keratosis is considered a risk factor for cutaneous squamous cell carcinoma (CSCC) because it involves abnormal skin cell changes due to UV exposure, which can progress to cancer. Management includes treatments like topical 5-fluorouracil and cryotherapy to remove or destroy the abnormal cells and prevent progression to CSCC.",
        "contexts": "CSCC different from squamous cell skin cancer, Squamous cell has effect Skin cancer, squamous cell skin cancer different from CSCC, Skin cancer has cause Squamous cell | develops has effect skin cancer, skin cancer has cause develops | Skin cancer has cause Skin cell, Skin cell has effect Skin cancer | Skin cell has effect skin cancer, genetic risk of skin cancer studied by cancer genetics, skin cancer has cause Skin cell | skin cancer has cause melanin, skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer | CSCC studied by Radiation oncologist | squamous cell carcinoma has cause Squamous cell | radiation therapy has effect Skin cancer | 5-fluorouracil medical condition treated CSCC, CSCC drug used for treatment 5-fluorouracil, 5-fluorouracil medical condition treated Actinic keratoses, Actinic keratoses subclass of abnormal cells, Actinic keratoses drug used for treatment 5-fluorouracil | squamous cell carcinoma has cause arsenic, arsenic has effect squamous cell carcinoma | Throat cancer has cause squamous cell carcinoma | Metastatic CSCC subclass of squamous cell skin cancer, Squamous cell subclass of skin cancer | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of inherited syndromes",
        "metrics": {
          "rouge_score": 0.2816901408450704,
          "answer_correctness": 0.840725134178252
        }
      },
      {
        "id": "Medical-9528082d",
        "question": "Why is detecting either the Philadelphia chromosome or BCR::ABL1 gene sufficient for diagnosing CML?",
        "ground_truth": "Because both result from the same chromosomal translocation specific to CML and serve as key biomarkers.",
        "generated_answer": "Detecting either the Philadelphia chromosome or BCR::ABL1 gene is sufficient for diagnosing CML because these markers are indicative of the disease's presence and are key to its molecular characterization.",
        "contexts": "BCR::ABL1 instance of gene | BRCA1 instance of gene, ATM instance of gene | CHEK2 instance of mutations in certain genes, BRCA1 instance of mutations in certain genes, BRCA1 instance of gene, BRCA2 instance of gene, ATM instance of mutations in certain genes | BRCA1 instance of gene, BRCA2 instance of gene | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | BRCA instance of gene | BRCA1 instance of gene, BRCA2 instance of gene, FANCA instance of gene, DNA instance of molecular | BRCA instance of genes | p16 instance of gene | BRCA2 instance of gene | TP53 instance of genes, IGHV instance of genes | HER2 instance of gene | ERBB instance of gene | IDH instance of gene | BCL2 instance of Proteins | MLH1 instance of gene",
        "metrics": {
          "rouge_score": 0.2127659574468085,
          "answer_correctness": 0.8332669430876252
        }
      },
      {
        "id": "Medical-80912696",
        "question": "Why should fertility counseling be considered for patients undergoing treatment for nasopharyngeal carcinoma?",
        "ground_truth": "Fertility counseling should be considered because NPC treatment can affect fertility.",
        "generated_answer": "Fertility counseling should be considered for patients undergoing treatment for nasopharyngeal carcinoma due to potential changes in fertility caused by the treatment. It is important for patients to understand their options and make informed decisions regarding their reproductive health.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment facet of ovarian cancer | Treatment facet of Pancreatic cancer | Treatment facet of stomach cancer | Treatment facet of colon cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment facet of urothelial cancer | Treatment facet of disease | Treatment facet of Treatment, more than one treatment option facet of Treatment | Treatment facet of bladder cancer | treated facet of Glioblastoma | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | Treatment facet of CNS lymphoma | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility | Treatment facet of Anal cancer | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.28,
          "answer_correctness": 0.7365851780423559
        }
      },
      {
        "id": "Medical-f4972c91",
        "question": "Which treatments are used for metastatic differentiated thyroid cancer that is iodine-avid and which are considered if the disease is not iodine-avid?",
        "ground_truth": "RAI therapy is used for iodine-avid disease, while targeted therapy and external beam radiation therapy are used if the disease is not iodine-avid.",
        "generated_answer": "For iodine-avid metastatic differentiated thyroid cancer, treatments include targeted therapy and immunotherapy. If the disease is not iodine-avid, surgery may be considered along with other treatment options.",
        "contexts": "metastasized subclass of thyroid cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | follicular subclass of thyroid cancer | nodule subclass of thyroid cancer | Papillary subclass of thyroid cancer, oncocytic subclass of thyroid cancer, targeted therapy subclass of Immunotherapy, Metastatic cancer subclass of thyroid cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer, Papillary, follicular, and oncocytic carcinoma subclass of differentiated thyroid cancers | differentiated thyroid cancers subclass of thyroid cancer | follicular subclass of lesions, follicular subclass of differentiated thyroid cancers, follicular carcinoma subclass of thyroid cancer, oncocytic carcinoma subclass of differentiated thyroid cancers, oncocytic tumor subclass of lesions, papillary cancer subclass of thyroid cancer, Papillary subclass of differentiated thyroid cancers | Anaplastic thyroid cancer subclass of medullary, thyroid cancer has cause iodine | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer | Anaplastic thyroid cancer subclass of thyroid cancer | de novo subclass of Metastatic cancer",
        "metrics": {
          "rouge_score": 0.48148148148148145,
          "answer_correctness": 0.5378615069719688
        }
      },
      {
        "id": "Medical-f79d978d",
        "question": "How does the presence of a lung nodule on imaging affect the diagnostic workflow for lung cancer?",
        "ground_truth": "A lung nodule detected by imaging prompts further assessment, including biopsy, to confirm or exclude cancer.",
        "generated_answer": "The presence of a lung nodule on imaging prompts further evaluation to determine if it is benign or malignant, influencing the diagnostic workflow for lung cancer. This may include additional imaging, biopsy, or monitoring, depending on the nodule's characteristics and risk factors.",
        "contexts": "lung cancer subclass of carcinoma, NSCLC subclass of lung cancer | lung subclass of cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer, Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma, Adenosquamous carcinoma subclass of lung cancer | non-small cell lung cancer subclass of lung cancer | non-small cell lung cancer subclass of cancer, lung cancer subclass of cancer | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer, small cell lung cancer subclass of lung cancer | Early detection of lung cancer subclass of Treatment, carcinoma subclass of lung cancer | nodule subclass of thyroid cancer | Large cell (undifferentiated) carcinoma subclass of NSCLC, squamous cell carcinoma subclass of lung cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Tumor subclass of cancer | tumor subclass of cancer | stomach cancer subclass of lung cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | carcinoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.30508474576271183,
          "answer_correctness": 0.7412131590599064
        }
      },
      {
        "id": "Medical-82f4c628",
        "question": "How does the disease site differ between B-cell lymphoblastic lymphoma and T-cell lymphoblastic lymphoma, and what does this imply for clinical presentation?",
        "ground_truth": "B-cell lymphoblastic lymphoma mainly affects lymph nodes, while T-cell lymphoblastic lymphoma primarily involves the thymus, affecting clinical symptoms.",
        "generated_answer": "B-cell lymphoblastic lymphoma typically arises in the bone marrow or peripheral blood, while T-cell lymphoblastic lymphoma often originates in the thymus or mediastinal region. This difference in disease site can lead to variations in clinical presentation, such as the presence of mediastinal masses in T-cell lymphoblastic lymphoma.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | T lymphocyte has effect B-cell lymphoblastic lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Lymphoblast different from myeloblast | Acute lymphoblastic leukemia subclass of blood cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma | Cutaneous T-cell lymphoma subclass of Lymphoma | T-ALL different from B-ALL, B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Osteosarcoma different from Osteosarcoma | diffuse large B-cell lymphoma subclass of classic FL | Immunotherapy different from chemotherapy | Non-Hodgkin lymphoma subclass of cancer | Chronic lymphocytic leukemia subclass of blood cancer",
        "metrics": {
          "rouge_score": 0.34285714285714286,
          "answer_correctness": 0.7406294599438946
        }
      },
      {
        "id": "Medical-39012a36",
        "question": "Which treatments may be considered for a glioma patient after surgical resection and how is this decision guided?",
        "ground_truth": "Radiation therapy, chemotherapy, or clinical trials may be considered after surgery, guided by grade and performance status.",
        "generated_answer": "Treatments for a glioma patient after surgical resection may include chemoradiation and further surgery. The decision is guided by the tumor type, extent of resection, and overall patient health.",
        "contexts": "surgery medical condition treated tumor | biopsy medical condition treated Glioblastoma | surgery medical condition treated cancer | Stereotactic biopsy medical condition treated brain tumor | Magnetic resonance imaging medical condition treated Glioblastoma | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor, treated facet of Glioblastoma | transurethral resection of bladder tumor medical condition treated tumor | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer | Treatment medical condition treated cancer | surgery medical condition treated Skin cancer | bladder cancer surgery medical condition treated bladder cancer | surgery medical condition treated cancer, cancer drug used for treatment surgery | treatments medical condition treated cancer | Chemoradiation medical condition treated cancer | surgery medical condition treated Local disease | Total thyroidectomy medical condition treated thyroid cancer | local excision medical condition treated cancer | Treatment medical condition treated CNS lymphoma",
        "metrics": {
          "rouge_score": 0.2173913043478261,
          "answer_correctness": 0.6609732153352281
        }
      },
      {
        "id": "Medical-193a4b7f",
        "question": "What chromosomal abnormality must be present for a diagnosis of chronic myeloid leukemia (CML)?",
        "ground_truth": "The Philadelphia chromosome (Ph), resulting from a translocation between chromosome 9 and chromosome 22, must be present.",
        "generated_answer": "Philadelphia chromosome",
        "contexts": "chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, chromosome 9 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 22, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9 | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | genetic mutations has effect abnormal chromosome | genetic changes has effect Leukemia, family history of leukemia subclass of predisposition condition, Leukemia has cause genetic changes, Leukemia predisposition syndrome has cause Leukemia | CML has cause CML, CML has effect CML | Chronic myeloid leukemia subclass of blood cancer | Leukemia has cause genetic changes, family history of leukemia subclass of predisposition condition | AML has cause biomarker, AML has effect biomarker, biomarker has effect AML | biomarker has effect AML, AML has effect biomarker | genetic mutations has effect cancer | Glioblastoma has cause abnormality | CLL has cause bone marrow",
        "metrics": {
          "rouge_score": 0.21052631578947367,
          "answer_correctness": 0.7363453190581197
        }
      },
      {
        "id": "Medical-648df362",
        "question": "What distinguishes Wilms tumor from other kidney cancer subtypes in terms of patient population and classification?",
        "ground_truth": "Wilms tumor is a distinct kidney cancer type that usually occurs in young children, unlike other subtypes.",
        "generated_answer": "Wilms tumor primarily affects children, distinguishing it from other kidney cancer subtypes that are more common in adults. It is classified as a nephroblastoma, which is specific to pediatric patients.",
        "contexts": "Wilms tumor (nephroblastoma) subclass of Renal sarcoma, kidney cancer subclass of cancer | Renal cell carcinoma subclass of kidney cancer, Clear cell RCC subclass of sarcomatoid, RCC subclass of kidney cancer | carcinoma subclass of carcinoma, Kidney cancer subclass of carcinoma | Clear cell RCC instance of cancer subtype, Papillary RCC subclass of nccRCC, Renal cell carcinoma subclass of kidney cancer | Sarcomatoid renal cancer subclass of kidney cancer, Unclassified RCC subclass of Cancer cells, Renal medullary carcinoma subclass of Renal cell carcinoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | bladder cancer subclass of Cancer of the upper urinary tract | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma, squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | Metastatic cancer subclass of bone cancer, Ewing sarcoma subclass of bone cancer, Bone sarcomas subclass of Sarcomas, Soft tissue sarcomas subclass of Sarcomas, malignant subclass of cancerous | Gerota\u2019s fascia subclass of kidney cancer | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | non-small cell lung cancer subclass of lung cancer | Adrenocortical carcinoma subclass of Adrenal cancer",
        "metrics": {
          "rouge_score": 0.25531914893617025,
          "answer_correctness": 0.8845918395001975
        }
      },
      {
        "id": "Medical-aba4e30c",
        "question": "Which stages of pancreatic ductal adenocarcinoma may involve lymph node spread, and how does this affect staging?",
        "ground_truth": "Stage II involves spread to 1-3 lymph nodes, while Stage III involves spread to 4 or more lymph nodes.",
        "generated_answer": "Stages II, III, and IV of pancreatic ductal adenocarcinoma may involve lymph node spread, which is a critical factor in determining the cancer's stage and prognosis.",
        "contexts": "spread facet of cancer | lymph nodes facet of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | How liver cancer spreads facet of Liver cancer | The spread to nearby lymph nodes (N) subclass of spread | sentinel lymph node biopsy facet of lymph nodes | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | What is pancreatic cancer? facet of Pancreatic cancer, What are the stages of pancreatic cancer facet of Pancreatic cancer | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | sentinel lymph node biopsy facet of sentinel lymph node | sentinel lymph node biopsy facet of lymph node(s) | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments | Treatment facet of Pancreatic cancer | lymph node removed facet of lymph nodes | Lymph node exam facet of lymph nodes | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | tumor, node, metastasis facet of colon cancer | spread facet of cancer, Testing for AML facet of AML | lymphovascular invasion facet of lymphovascular",
        "metrics": {
          "rouge_score": 0.25531914893617025,
          "answer_correctness": 0.6136828338773856
        }
      },
      {
        "id": "Medical-95283550",
        "question": "Which metastatic anal cancer patients are eligible for immunotherapy, and which drugs are recommended in this setting?",
        "ground_truth": "Patients with metastatic anal cancer that progresses after chemotherapy are eligible for immunotherapy with nivolumab or pembrolizumab.",
        "generated_answer": "Metastatic anal cancer patients eligible for immunotherapy typically have tumors expressing PD-L1 or those with mismatch repair deficiency (dMMR). Recommended drugs include immune checkpoint inhibitors such as pembrolizumab and nivolumab.",
        "contexts": "immune checkpoint inhibitor therapy subclass of Treatment | Immunotherapy subclass of chemotherapy | Immunotherapy subclass of Chemotherapy | checkpoint inhibitor subclass of Immunotherapy, Immunotherapy subclass of Treatment | systemic therapy subclass of Treatment | Immunotherapy subclass of systemic therapy | Immunotherapy subclass of targeted therapy | targeted therapy subclass of chemotherapy, Immunotherapy subclass of Therapeutic, Immunotherapy subclass of Chemotherapy, combined subclass of Therapeutic, Steroids subclass of Chemotherapy, chemotherapy subclass of Therapeutic | Immunotherapy Immunotherapy subclass of systemic therapy, checkpoint inhibitor subclass of Immunotherapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Immunotherapy Immunotherapy subclass of systemic therapy, CTLAImmunotherapy subclass of Immunotherapy | targeted therapy subclass of Immunotherapy | Chemotherapy Chemotherapy subclass of systemic therapy | targeted therapy subclass of Treatment | systemic therapy subclass of therapies | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | immune checkpoint inhibitor therapy subclass of chemotherapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.6174331755999006
        }
      },
      {
        "id": "Medical-a5d38351",
        "question": "How does the presence of distant metastasis affect treatment planning for esophageal cancer?",
        "ground_truth": "Distant metastasis classifies the cancer as metastatic, which alters treatment planning based on stage.",
        "generated_answer": "The presence of distant metastasis significantly complicates treatment planning for esophageal cancer, often leading to a focus on palliative care rather than curative approaches. Treatment may include systemic therapies like chemotherapy and targeted therapies, rather than localized treatments such as surgery or radiation.",
        "contexts": "metastasis has effect spread | cancer has effect Cancer treatment | Cancer stages and metastasis has effect Metastatic cancer, Metastatic cancer has cause Cancer stages and metastasis | Treatment has effect Symptoms | metastasize often different from metastasis, metastasis different from metastasize often | cancer has effect Cancer treatment, Cancer treatment subclass of Treatment | Treatment has cause diagnosis, diagnosis has effect Treatment | diagnosis has effect Treatment, Treatment has cause diagnosis | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | diagnosis has effect Treatment, Treatment has cause diagnosis | Treatment different from cure | side effects has cause Treatment, heart disease subclass of side effects, Treatment has effect side effects | radiation therapy part of Treatment, Treatment has part chemotherapy, Treatment has part radiation therapy | Treatment medical condition treated cancer | side effects has effect Treatment | lymph nodes has effect metastases, metastases location lymph nodes | spread subclass of cancer, spread has cause cancer, Treatment subclass of cancer staging, cancer has effect spread",
        "metrics": {
          "rouge_score": 0.1754385964912281,
          "answer_correctness": 0.6099157148080647
        }
      },
      {
        "id": "Medical-daeae948",
        "question": "What are the most common and less common subtypes of RCC, and how are they organized?",
        "ground_truth": "Clear cell RCC is the most common subtype, while non-clear cell RCC includes papillary, chromophobe, collecting duct RCC, and renal medullary carcinoma.",
        "generated_answer": "The most common subtypes of renal cell carcinoma (RCC) include clear cell carcinoma, papillary carcinoma, and chromophobe carcinoma. Less common subtypes are collecting duct carcinoma and medullary carcinoma. These subtypes are organized based on their histological characteristics and cellular origin.",
        "contexts": "Nested subtype instance of subtype, subtype facet of cancer | tumor has part tumor(s), tumor(s) part of tumor | Subtypes of AML subclass of Subtypes of AML | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | treatment type(s) has part treatment length | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | genes part of families | stomach part of digestive system, stomach gland has part submucosa, mucus has part Epithelium, connective tissue part of muscle, connective tissue part of submucosa, submucosa has part connective tissue, stomach gland has part mucosa, mucosa part of stomach gland, submucosa part of stomach gland, digestive system has part stomach, Surface epithelium part of stomach lining, Mucosa part of stomach, stomach lining has part Surface epithelium, muscle part of submucosa, stomach has part serosa | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | cells part of organs | genetic part of biological | DNA part of genes, genes has part DNA | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test",
        "metrics": {
          "rouge_score": 0.4444444444444444,
          "answer_correctness": 0.8890027226128523
        }
      },
      {
        "id": "Medical-705f9e89",
        "question": "If a patient aged 25 presents with swollen lymph nodes in the upper body, what cancer type should be highly suspected and why?",
        "ground_truth": "Hodgkin lymphoma should be suspected because it usually starts in upper body lymph nodes and is common between ages 15 to 30.",
        "generated_answer": "Hodgkin lymphoma should be highly suspected due to the presentation of swollen lymph nodes in a young adult.",
        "contexts": "lymph nodes part of body | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | body has part lymph nodes, lymph nodes part of body | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | lymph nodes part of skin | lymph part of lymph nodes | lymph nodes part of neck | lymph nodes part of organs | lymph nodes part of lymph | lymph nodes part of internal organ | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | body has part lymph nodes, lymph nodes part of body, pharynx part of throat | lymph nodes part of lymphatic | lymph nodes part of lymph tissue | trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx | lymph nodes part of throat | lymph nodes part of abdomen | lymph nodes part of lymph nodes, lymph nodes has part lymph nodes | lymph nodes part of Lymphatic system | lymph part of Lymphatic system, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes",
        "metrics": {
          "rouge_score": 0.35000000000000003,
          "answer_correctness": 0.6686127850690987
        }
      },
      {
        "id": "Medical-fbc9e7ec",
        "question": "What supportive care measures are recommended at any stage for primary CNS lymphoma patients experiencing severe side effects from treatment?",
        "ground_truth": "Symptom management, palliative care, and quality of life interventions are recommended at any disease stage.",
        "generated_answer": "Supportive care measures for primary CNS lymphoma patients experiencing severe side effects from treatment include palliative care, hospice care, symptom management, and follow-up and surveillance.",
        "contexts": "supportive care subclass of Treatment | supportive care subclass of health care | Symptoms subclass of supportive care | Palliative care subclass of supportive care, Hospice subclass of supportive care | Clinical trial subclass of health research, supportive care subclass of Treatment | cancer care subclass of Treatment | Standard of care subclass of treatment regimen | Treatment subclass of Treatment | Standard of care subclass of treated | Clinical trial subclass of Treatment | If or when someone needs treatment subclass of Treatment | supportive care subclass of supportive care | remission subclass of Treatment | aggressive treatment subclass of Treatment | Follow-up and surveillance subclass of Treatment | Aggressive subclass of Treatment | Cancer treatment subclass of Treatment | Treatment subclass of procedure | initial treatment subclass of Treatment",
        "metrics": {
          "rouge_score": 0.14634146341463417,
          "answer_correctness": 0.7279224345232085
        }
      },
      {
        "id": "Medical-787b9c0b",
        "question": "If a tumor in the bile duct is only found in the muscularis layer, how does this affect its staging compared to a tumor confined to the epithelium?",
        "ground_truth": "A tumor in the muscularis is a more advanced stage than one confined to the epithelium (Tis).",
        "generated_answer": "A tumor in the bile duct confined to the muscularis layer is typically staged higher than one confined to the epithelium, as it indicates deeper invasion and a more advanced disease state.",
        "contexts": "Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | stomach part of digestive system, stomach gland has part submucosa, mucus has part Epithelium, connective tissue part of muscle, connective tissue part of submucosa, submucosa has part connective tissue, stomach gland has part mucosa, mucosa part of stomach gland, submucosa part of stomach gland, digestive system has part stomach, Surface epithelium part of stomach lining, Mucosa part of stomach, stomach lining has part Surface epithelium, muscle part of submucosa, stomach has part serosa | skin has part Epidermis, skin has part Epidermis, Epidermis part of skin, barrier part of skin, Squamous cell part of Epidermis, Skin basics facet of skin, dermis has part connective tissue, Hypodermis has part connective tissue, Epidermis part of skin | Epithelium part of tissues | Epidermis has part Hypodermis, basal cell layer part of Epidermis | muscle layer part of bladder, body has part urinary tract, bladder has part urothelial cells, urothelial layer part of bladder, bladder has part muscle layer, urinary tract part of body | bladder has part urothelial layer, urothelial layer part of bladder | bladder wall has part muscle layer, muscle layer part of bladder wall | Epithelium instance of layer | muscle layer part of bladder | bladder has part muscle layer, urothelial layer part of inner lining | Epidermis different from dermis, Epidermis has part other cells, arms part of body, face part of body, other cells part of Epidermis, legs part of body, Epidermis has part basal cell | Epidermis has part Melanocyte | female reproductive system has part cervix, female reproductive system has part vagina, uterus has part fallopian tubes, uterus connects with cervix, ectocervix part of cervix, female reproductive system has part ovaries, fallopian tubes connects with ovaries, fallopian tubes part of uterus, vagina part of female reproductive system, cervix part of vagina, sexual reproduction has part reproductive system, cervix connects with uterus, ovaries part of female reproductive system, cervix part of female reproductive system, vagina has part cervix, vagina connects with ovaries, female reproductive system has part uterus, fallopian tubes part of female reproductive system, ovaries connects with vagina, uterus part of female reproductive system, ovaries connects with fallopian tubes, cervix has part endocervix, ectocervix part of cervical lining, vagina has part os, Squamous cell part of ectocervix, endocervix part of cervix, cervix connects with uterus, uterus connects with vagina, os part of vagina, ectocervix connects with endocervix, uterus connects with cervix, vagina connects with uterus, endocervix connects with ectocervix, pelvis connects with uterus, cervical lining has part ectocervix, uterus connects with pelvis, endocervix connects with cervix, cervix connects with endocervix, uterus has part cervix | bladder has part muscle layer | fallopian tubes connects with ovary, ovaries has part Epithelium, Epithelium part of ovaries",
        "metrics": {
          "rouge_score": 0.5306122448979592,
          "answer_correctness": 0.8807199173426942
        }
      },
      {
        "id": "Medical-a0699e9e",
        "question": "Which side effects might a patient experience after radical cystectomy and urinary diversion for bladder cancer?",
        "ground_truth": "Patients may experience urinary incontinence, sexual dysfunction, infection, and fatigue after radical cystectomy and urinary diversion.",
        "generated_answer": "Patients may experience side effects such as changes in urinary function, incontinence, urinary tract infections, and potential sexual dysfunction after radical cystectomy and urinary diversion for bladder cancer.",
        "contexts": "bladder cancer drug used for treatment Cancer treatment, Cancer treatment medical condition treated bladder cancer | bladder cancer drug used for treatment Treatment | radical cystectomy medical condition treated bladder cancer, Partial cystectomy medical condition treated bladder cancer | bladder cancer surgery medical condition treated bladder cancer | bladder cancer drug used for treatment surgery, surgery medical condition treated bladder cancer, Treatment facet of cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Intravesical therapy medical condition treated bladder cancer, bladder cancer drug used for treatment Intravesical therapy | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | bladder cancer drug used for treatment chemotherapy, chemotherapy medical condition treated bladder cancer, Intravesical BCG therapy uses Intravesical BCG therapy, bladder cancer drug used for treatment bacillus CalmetteGu\u00e9rin | Chemotherapy alone medical condition treated bladder cancer, bladder cancer drug used for treatment Chemotherapy, Chemotherapy medical condition treated bladder cancer, Intravesical chemotherapy different from Intravesical chemotherapy, Chemotherapy facet of cancer, Chemotherapy subclass of Treatment, bladder cancer drug used for treatment Chemotherapy alone, Intravesical chemotherapy different from Intravesical chemotherapy, Cisplatin medical condition treated bladder cancer, bladder cancer drug used for treatment vinblastine | surgery medical condition treated cancer, cancer drug used for treatment surgery | bladder cancer drug used for treatment dose-dense methotrexate, vinblastine medical condition treated bladder cancer, doxorubicin medical condition treated bladder cancer, bladder cancer drug used for treatment platinum-based chemotherapy, bladder cancer drug used for treatment Cisplatin, dose-dense methotrexate medical condition treated bladder cancer, bladder cancer drug used for treatment doxorubicin | Tumor removal medical condition treated bladder cancer, Tumor removal subclass of surgery | Intravesical BCG therapy start time 6 weeks, Intravesical BCG therapy medical condition treated bladder cancer, bladder cancer drug used for treatment chemotherapy, Intravesical BCG therapy uses Intravesical BCG therapy, chemotherapy medical condition treated bladder cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments",
        "metrics": {
          "rouge_score": 0.5909090909090908,
          "answer_correctness": 0.7893543954282978
        }
      },
      {
        "id": "Medical-18263083",
        "question": "Which risk factors should be considered when assessing a patient's likelihood of developing bladder cancer?",
        "ground_truth": "Smoking, secondhand smoke, age, family history, Lynch syndrome, and chemical exposure should be considered.",
        "generated_answer": "Risk factors for bladder cancer include smoking, secondhand smoke, family history, cancer in the urinary tract, mutations in certain genes, and chemical exposure.",
        "contexts": "bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | risk factors facet of cancer | Risk factors for lung cancer facet of lung cancer | risk factors facet of disease | Smoking has effect bladder cancer, Treatment facet of Bladder cancer, Tests for bladder cancer facet of bladder cancer, Bladder cancer subclass of abnormal cells | risk factors has effect cancer, cancer has cause risk factors | bladder cancer common? facet of bladder cancer | Treatment facet of bladder cancer | risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | stage facet of bladder cancer | tested facet of bladder cancer, Cancer cells has effect bladder cancer | Treatment for bladder cancer facet of bladder cancer | Chemical exposure has effect bladder cancer, bladder cancer has cause Chemical exposure, How advanced is my bladder cancer? facet of bladder cancer | different treatment options for bladder cancer facet of bladder cancer | risk level facet of skin cancer | Smoking has effect bladder cancer | bladder cancer commonly comes back again facet of bladder cancer",
        "metrics": {
          "rouge_score": 0.4324324324324324,
          "answer_correctness": 0.7321951746688011
        }
      },
      {
        "id": "Medical-2529e505",
        "question": "What distinguishes cutaneous B-cell lymphoma from cutaneous T-cell lymphoma in terms of cell of origin and cancer subtype?",
        "ground_truth": "CBCL originates from B lymphocytes and includes subtypes like PCMZL, PCFCL, and PC-DLBCL leg type, while CTCL originates from T lymphocytes.",
        "generated_answer": "Cutaneous B-cell lymphoma originates from B-lymphocytes, while cutaneous T-cell lymphoma originates from T-lymphocytes. They are distinct cancer subtypes based on their cellular origin.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | Cutaneous T-cell lymphoma subclass of Lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell, Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | melanoma different from nonmelanoma skin cancer, squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma | tumors different from cancer, cancer different from tumors | squamous cell skin cancer different from CSCC | Osteosarcoma different from Osteosarcoma | Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma | Immunotherapy different from chemotherapy | cancer type different from cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.36734693877551017,
          "answer_correctness": 0.9002245506009908
        }
      },
      {
        "id": "Medical-60acb9ee",
        "question": "Which patients with throat cancer should undergo dental health assessment and why?",
        "ground_truth": "All patients should have dental health assessment before treatment as dental health impacts treatment planning and outcomes.",
        "generated_answer": "Patients with throat cancer should undergo dental health assessment due to the potential effects of treatments like radiation and chemotherapy on oral health, as well as the association between oral health and overall cancer outcomes.",
        "contexts": "tumor, node, metastasis facet of Throat cancer | HPV testing facet of throat (oropharyngeal) cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | squamous cell carcinoma has effect Throat cancer, Throat cancer has cause squamous cell carcinoma | Oropharynx part of Throat cancer | tumor, node, metastasis (TNM) system facet of Mouth cancer | PS 5 facet of Head and neck cancer | HPV has effect Throat cancer, Throat cancer has cause HPV | Risk assessment facet of skin cancer | Throat cancer staging How throat cancer is staged facet of Throat cancer | How mouth cancer is staged facet of Mouth cancer | Surveillance facet of cancer | test facet of cancer | cancer care facet of cancer | Surveillance Follow-up testing facet of cancer | diagnosis facet of cancer | breast exams facet of Breast cancer | supportive care facet of cancer, end of life facet of disease, quality of life facet of cancer | biopsy facet of cancer",
        "metrics": {
          "rouge_score": 0.3846153846153846,
          "answer_correctness": 0.8377397739855913
        }
      },
      {
        "id": "Medical-213bbcca",
        "question": "What are the main histological subtypes of cervical cancer and how do their frequencies compare?",
        "ground_truth": "Squamous cell carcinoma is the most common, while adenocarcinoma, adenosquamous carcinoma, and NECC are less common or rare.",
        "generated_answer": "The main histological subtypes of cervical cancer include squamous cell carcinoma and adenosquamous carcinoma. Squamous cell carcinoma is the most common subtype, while adenosquamous carcinoma occurs less frequently.",
        "contexts": "cervical biopsy facet of cervical cancer | subtype facet of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | biomarkers facet of cervical cancer | squamous cell carcinoma subclass of cervical cancer | recurrence subclass of cervical cancer | metastatic subclass of cervical cancer | locally advanced cancer subclass of cervical cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer, types (strains) facet of HPV | cervical cancer subclass of cancer | Stage 3B subclass of cervical cancer | Metastatic cancer subclass of cervical cancer | Adenosquamous carcinoma subclass of cervical cancer | lymph nodes facet of cancer | neuroendocrine carcinoma of the cervix subclass of cervical cancer, cervical intraepithelial neoplasia subclass of cervical dysplasia | biopsy facet of cancer | FIGO system facet of cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | neuroendocrine carcinoma of the cervix subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.4782608695652174,
          "answer_correctness": 0.7977817329678601
        }
      },
      {
        "id": "Medical-32861246",
        "question": "Which combination of diagnostic methods is necessary to confirm and stage anal cancer after a patient presents with rectal bleeding and an anal lump?",
        "ground_truth": "Digital rectal exam (DRE), anoscopy or high-resolution anoscopy (HRA), biopsy, and imaging (CT, MRI, PET) are necessary to confirm and stage anal cancer.",
        "generated_answer": "A combination of physical examination, imaging studies (such as MRI or CT scans), and biopsy is necessary to confirm and stage anal cancer after a patient presents with rectal bleeding and an anal lump.",
        "contexts": "rectal bleeding subclass of bleeding from the anus | squamous cell carcinoma subclass of Anal cancer, anal melanoma subclass of Anal squamous cell carcinoma | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | Anal cancer subclass of cancer | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Stage III subclass of Anal cancer, stage II subclass of Anal cancer, Anal tumor subclass of stage IIA | Rectal cancer subclass of lesion | rectal wall subclass of cancer | Anal cancer subclass of cervical cancer | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | intermediate-grade subclass of perianal cancer | Rectal cancer subclass of syndromes | Adenocarcinoma subclass of rectal tumor | Rectal cancer subclass of Cancer cells | Rectal cancer subclass of surgery | Metastatic anal cancer subclass of Anal cancer",
        "metrics": {
          "rouge_score": 0.31034482758620696,
          "answer_correctness": 0.689979754245661
        }
      },
      {
        "id": "Medical-30e7caf0",
        "question": "Which diagnostic methods are required to confirm throat cancer and determine its biomarkers?",
        "ground_truth": "Imaging studies and biopsy are required for diagnosis, and biopsy enables biomarker testing.",
        "generated_answer": "Biopsy, molecular tumor testing, and tumor profiling are required diagnostic methods to confirm throat cancer and determine its biomarkers.",
        "contexts": "biomarker subclass of biomarker | Biomarkers subclass of biomarker | biomarker subclass of test, biomarker test subclass of biomarker | biomarker test subclass of test | molecular subclass of biomarker | biomarker testing subclass of Molecular | biomarker subclass of genetic testing | biomarker subclass of genetic | following biomarkers subclass of biomarker | detection methods subclass of diagnosis | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | Diagnosis by blood test subclass of blood test | molecular tumor testing subclass of biomarker testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor mutation testing subclass of biomarker",
        "metrics": {
          "rouge_score": 0.3125,
          "answer_correctness": 0.6620369024914455
        }
      },
      {
        "id": "Medical-09eac393",
        "question": "Why is radioactive iodine therapy not used for medullary thyroid cancer after total thyroidectomy, and what alternative therapies are recommended?",
        "ground_truth": "RAI therapy is ineffective for medullary thyroid cancer, so targeted therapy and thyroid hormone replacement are recommended alternatives.",
        "generated_answer": "Radioactive iodine therapy is not effective for medullary thyroid cancer because this type of cancer does not absorb iodine. Alternative therapies recommended include surgery, hormone replacement therapy, and external beam radiation therapy.",
        "contexts": "Total thyroidectomy medical condition treated thyroid cancer | Total thyroidectomy medical condition treated papillary cancer | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer, thyroid cancer drug used for treatment Surgery Surgery | Total thyroidectomy medical condition treated thyroid cancer, Total thyroidectomy different from RAI therapy | Levothyroxine medical condition treated thyroid cancer | External beam radiation therapy medical condition treated thyroid cancer, thyroid cancer drug used for treatment External beam radiation therapy, radiation therapy medical condition treated Anaplastic thyroid cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | surgery medical condition treated cancer | Treatment medical condition treated cancer | Ultrasound Ultrasound medical condition treated thyroid cancer | surgery medical condition treated tumor | Neck ultrasound medical condition treated thyroid cancer | treatments medical condition treated cancer | Chemoradiation medical condition treated cancer | hormone replacement therapy medical condition treated TSH | radical trachelectomy medical condition treated cancer | surgery medical condition treated cancer, cancer drug used for treatment surgery | surgery medical condition treated Skin cancer",
        "metrics": {
          "rouge_score": 0.36,
          "answer_correctness": 0.6145846964963244
        }
      },
      {
        "id": "Medical-a7fb4f11",
        "question": "How does the management plan for CLL change if a patient develops Richter transformation?",
        "ground_truth": "Richter transformation requires a shift to therapies targeting aggressive lymphomas such as DLBCL or Hodgkin lymphoma.",
        "generated_answer": "The management plan for CLL changes to address the more aggressive nature of Richter transformation, often requiring more intensive treatment options such as chemotherapy or targeted therapies, rather than standard CLL treatments. This shift is due to the transformation into a more aggressive lymphoma, necessitating a reevaluation of the treatment strategy.",
        "contexts": "Richter transformation instance of condition | Richter transformation instance of plan treatment | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | BCR::ABL1-like B-ALL subclass of B-ALL | Chronic lymphocytic leukemia subclass of blood cancer | SLL different from CLL, CLL different from SLL | Richter transformation instance of rare complication | PCMZL (PCMZ lymphoproliferative disorder) subclass of CBCLs | Chronic lymphocytic leukemia subclass of white blood cell | blast phase CML subclass of CML, BP-CML subclass of CML | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Granulocyte has part Eosinophil, Granulocyte subclass of white blood cell, white blood cell <subj>granulocyte subclass of white blood cell, Neutrophil subclass of Granulocyte, white blood cell has part Granulocyte, Granulocyte has part Basophil, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell | diffuse large B-cell lymphoma subclass of classic FL | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Acute lymphoblastic leukemia subclass of blood cancer | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system",
        "metrics": {
          "rouge_score": 0.20895522388059706,
          "answer_correctness": 0.610740424554298
        }
      },
      {
        "id": "Medical-56f4cb0b",
        "question": "How does the involvement of blood vessels or liver affect the classification of bile duct cancer compared to a tumor confined to the epithelium?",
        "ground_truth": "Involvement of blood vessels or liver indicates a higher stage than a tumor confined to the epithelium (Tis).",
        "generated_answer": "The involvement of blood vessels or liver in bile duct cancer indicates a more advanced stage of the disease, suggesting it has spread beyond the epithelium. This progression typically leads to a more aggressive classification compared to tumors that are confined solely to the epithelium.",
        "contexts": "liver connects with abdomen, abdomen connects with liver | liver connects with stomach, stomach connects with liver | liver connects with spleen | liver connects with lungs, lungs connects with liver | liver connects with kidney | spleen connects with liver | liver connects with rectum, rectum connects with liver | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | liver connects with gallbladder, gallbladder connects with liver | kidney connects with liver | liver connects with gallbladder, gallbladder connects with liver | stomach connects with small intestine, small intestine connects with stomach, portal vein connects with hepatic artery, hepatic artery connects with portal vein, heart connects with inferior vena cava, right instance of hepatic duct, cystic duct connects with gallbladder | lung connects with liver | intestines connects with Blood | arteries connects with veins",
        "metrics": {
          "rouge_score": 0.47619047619047616,
          "answer_correctness": 0.8830409553912464
        }
      },
      {
        "id": "Medical-0a90f1f2",
        "question": "How does the management of recurrent basal cell carcinoma differ from initial treatment, and what factors influence this?",
        "ground_truth": "Management of recurrence depends on risk and recurrence site, with treatment options tailored accordingly.",
        "generated_answer": "The management of recurrent basal cell carcinoma typically involves more aggressive treatment options compared to initial treatment, which may include surgical excision, Mohs micrographic surgery, or radiation therapy. Factors influencing this include the size, location, and histological characteristics of the tumor, as well as the patient's overall health and previous treatment responses.",
        "contexts": "initial treatment subclass of Treatment | Treatment subclass of Treatment | Treatment subclass of procedure | plan treatment subclass of diagnosis | Standard of care subclass of treatment regimen | initial evaluation followed by Treatment, Standard of care subclass of treated | Treatment subclass of monitoring | Clinical trial subclass of Treatment | Aggressive subclass of Treatment | plan treatment subclass of course of action | treatment cycles are needed subclass of Treatment | remission subclass of Treatment | cycle subclass of Treatment | Follow-up and surveillance subclass of Treatment | investigational treatments subclass of Clinical trial, Clinical trial subclass of plan treatment | simulation subclass of Treatment | If or when someone needs treatment subclass of Treatment | transplant subclass of Treatment | supportive care subclass of Treatment",
        "metrics": {
          "rouge_score": 0.1492537313432836,
          "answer_correctness": 0.48316342984307553
        }
      },
      {
        "id": "Medical-86e095c3",
        "question": "How does smoking status influence both the risk and treatment outcomes of cervical cancer?",
        "ground_truth": "Smoking increases the risk of cervical cancer, and smoking cessation improves treatment outcomes.",
        "generated_answer": "Smoking status increases the risk of cervical cancer and negatively impacts treatment outcomes. Tobacco use is associated with more severe disease progression and poorer response to therapies.",
        "contexts": "lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | smoking has effect Head and neck cancer | smoking cigarettes has effect lung cancer, lung cancer has cause smoking cigarettes | risk factors has effect cervical cancer, cervical cancer has cause risk factors | smoking has effect lung cancer, lung cancer has cause smoking | Smoking has effect prostate cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | smoking has effect lung cancer, smoking has effect SCLC, secondhand smoke has effect lung cancer | Smoking has effect bladder cancer, secondhand smoke has effect bladder cancer | ectocervix has effect cervical cancer, Other risk factors facet of cervical cancer | cervical cancer has cause Cervical changes Cervical cancer, cervical cancer has cause ectocervix, ectocervix has effect cervical cancer | tobacco has effect smoking | Tobacco and alcohol use history Tobacco has effect Head and neck cancer | bladder cancer has cause Smoking | human papillomavirus has effect cervical cancer",
        "metrics": {
          "rouge_score": 0.5,
          "answer_correctness": 0.6710535412082022
        }
      },
      {
        "id": "Medical-4e5d3831",
        "question": "What role does imaging play in the diagnosis and surveillance of ovarian cancer?",
        "ground_truth": "Imaging is used for initial diagnosis (ultrasound, CT, MRI, PET) and for surveillance as indicated after treatment.",
        "generated_answer": "Imaging plays a crucial role in the diagnosis and surveillance of ovarian cancer by providing detailed visual information through tests such as MRI, CT scans, and X-rays. These imaging methods help detect the presence of tumors, assess their size, and monitor treatment effectiveness.",
        "contexts": "imaging test use Imaging | test use diagnosis | Magnetic resonance imaging studied by radiologist, Imaging studied by radiologist, Imaging has cause scan, radiologist studies Magnetic resonance imaging, Magnetic resonance imaging uses scanning machine, Magnetic resonance imaging subclass of MRI test, CT scan studied by radiologist, CT scan uses X-ray, scanning machine use Magnetic resonance imaging, radiologist studies CT scan, CT subclass of computed tomography, Magnetic resonance imaging uses magnetic field | imaging test use imaging test | Imaging used by doctor | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | imaging test uses imaging test | radiologist studies Imaging, Imaging studied by radiologist | imaging test used by doctor | Imaging practiced by radiologist | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | Magnetic resonance imaging uses Magnetic resonance imaging | Imaging part of pathology, Imaging facet of cancer | biomarker testing use diagnosis | imaging test practiced by radiologist | scan has effect Imaging | Magnetic resonance imaging use Magnetic resonance imaging | cancer studied by imaging test | imaging scan subclass of tests",
        "metrics": {
          "rouge_score": 0.19672131147540983,
          "answer_correctness": 0.9857665292243212
        }
      },
      {
        "id": "Medical-321f2f6d",
        "question": "What staging system is used for throat cancer, and which parameters does it incorporate?",
        "ground_truth": "The AJCC TNM system is used, incorporating tumor size (T), lymph node involvement (N), and metastasis (M).",
        "generated_answer": "The staging system used for throat cancer is the tumor, node, metastasis (TNM) system. It incorporates parameters such as the size of the tumor, the involvement of lymph nodes, and the presence of metastasis.",
        "contexts": "Throat cancer staging How throat cancer is staged facet of Throat cancer | tumor, node, metastasis facet of Throat cancer | staging system facet of cancer | staging facet of cancer, How mouth cancer is staged facet of Mouth cancer | Staging facet of cancer | cancer staging facet of tumor | Staging The cancer stage facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | grade facet of cancer, staging facet of cancer | stage facet of cancer | cancer stage facet of cancer | TNM staging information facet of squamous cell carcinoma | cancer staging facet of prognosis | stage the cancer facet of cancer | stage facet of tumor | lymph nodes facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | staging facet of Treatment decisions | Surgical staging facet of ovarian cancer",
        "metrics": {
          "rouge_score": 0.35294117647058826,
          "answer_correctness": 0.9010098296103163
        }
      },
      {
        "id": "Medical-8435c9f6",
        "question": "How would the treatment approach change for a primary CNS lymphoma patient with both brain and eye involvement?",
        "ground_truth": "The patient would receive standard CNS-directed therapy plus intraocular chemotherapy or radiation for eye involvement.",
        "generated_answer": "The treatment approach for a primary CNS lymphoma patient with both brain and eye involvement would likely involve a combination of therapies targeting both the central nervous system and the vitreoretinal lymphoma, potentially including chemotherapy, radiation, and targeted therapies. Coordination between oncologists and ophthalmologists would be essential to address both sites of disease effectively.",
        "contexts": "brain has effect CNS lymphoma | central nervous system has effect CNS lymphoma | CNS lymphoma has part primary CNS lymphoma, primary CNS lymphoma instance of disease | primary CNS lymphoma location central nervous system | testing the CSF facet of CNS lymphoma | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma, central nervous system has part spinal cord, CNS lymphoma has part primary CNS lymphoma | Treatment facet of CNS lymphoma | brain part of CNS | primary CNS lymphoma subclass of brain lymphoma | CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of Lymphoma | CNS lymphoma has cause reduced immune system, reduced immune system has effect CNS lymphoma | Cancer cells part of brain tissue, brain tissue has part Cancer cells | more than one treatment option facet of CNS lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma",
        "metrics": {
          "rouge_score": 0.17142857142857143,
          "answer_correctness": 0.6981136592427826
        }
      },
      {
        "id": "Medical-01abc791",
        "question": "Why is intestinal type adenocarcinoma more likely to benefit from targeted therapy compared to diffuse type?",
        "ground_truth": "Because intestinal type more often has mutations treatable with targeted therapy, while diffuse type is less common and lacks these features.",
        "generated_answer": "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy due to its distinct molecular characteristics and specific genetic alterations that can be effectively targeted, unlike diffuse type adenocarcinoma which often lacks these features.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Adenocarcinoma subclass of NSCLC | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | Adenocarcinoma subclass of colon cancer | Adenocarcinoma subclass of colorectal cancer | Adenocarcinoma subclass of adenoma | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | Adenocarcinoma subclass of rectal tumor | cancer subclass of Tumor, aggressive type subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer | Adenosquamous carcinoma subclass of cancer, squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | noninvasive subclass of cancer | metastasized subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | NSCLC subclass of lung cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer",
        "metrics": {
          "rouge_score": 0.3571428571428571,
          "answer_correctness": 0.8033014338987426
        }
      },
      {
        "id": "Medical-ec4712e3",
        "question": "Why is a panoramic dental x-ray (Panorex) included in diagnostic evaluation for mouth cancer?",
        "ground_truth": "A Panorex is used to assess dental health, which is affected by mouth cancer and its treatment.",
        "generated_answer": "A panoramic dental x-ray (Panorex) is included in the diagnostic evaluation for mouth cancer because it provides a comprehensive view of the oral structures, helping to identify any irregularities or tumors.",
        "contexts": "X-ray subclass of Imaging | diagnostic CT subclass of X-ray | X-ray subclass of radiation | Bone scan subclass of X-ray | CT scan uses X-ray, X-ray subclass of Imaging | X-ray subclass of Image, Brain CT scan subclass of CT | radiology subclass of Imaging | CT subclass of Imaging | computed tomography subclass of Imaging | Chest x-ray subclass of chest -ray, PET/CT subclass of positron emission tomography, CT scan subclass of -ray | radiologist studies Magnetic resonance imaging, Magnetic resonance imaging uses scanning machine, Magnetic resonance imaging subclass of MRI test, CT scan studied by radiologist, CT scan uses X-ray, scanning machine use Magnetic resonance imaging, radiologist studies CT scan, CT subclass of computed tomography, Magnetic resonance imaging uses magnetic field | X-ray subclass of beam | Intravenous (IV) contrast subclass of X-ray, Intravenous (IV) contrast subclass of contrast material, CT scan subclass of computed tomography | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | CT scan subclass of computed tomography | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | Imaging subclass of test results | Bone x-ray subclass of X-ray",
        "metrics": {
          "rouge_score": 0.20408163265306123,
          "answer_correctness": 0.2417962415227944
        }
      },
      {
        "id": "Medical-50fe4cfa",
        "question": "Why should all rectal tumors be tested for mismatch repair deficiency or microsatellite instability-high, especially in patients with Lynch syndrome?",
        "ground_truth": "Because dMMR/MSI-H are biomarkers for rectal cancer and Lynch syndrome is a genetic risk factor, making testing essential for management.",
        "generated_answer": "All rectal tumors should be tested for mismatch repair deficiency or microsatellite instability-high because these conditions are associated with Lynch syndrome, which increases the risk of colorectal and other cancers. Identifying these deficiencies can guide treatment decisions and surveillance strategies for affected patients.",
        "contexts": "Lynch syndrome subclass of inherited condition, deficient mismatch repair subclass of microsatellite instability-high | Lynch syndrome subclass of inherited cancer syndromes | Lynch subclass of inherited syndromes | Mismatch repair subclass of cancer, mismatch repair deficiency subclass of microsatellite instability, microsatellite stable subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes | Lynch syndrome subclass of Familial adenomatous polyposis | Mismatch repair subclass of gene | Lynch syndrome subclass of Inherited syndromes related to colon cancer | mismatch repair deficiency subclass of colon cancer, microsatellite instability-high subclass of colon cancer | mismatch repair genes subclass of inherited mutations, deficient mismatch repair subclass of microsatellite instability-high, Lynch syndrome has effect colorectal, Lynch syndrome subclass of Rectal cancer, microsatellite stable subclass of Tumor, rectum subclass of cancer, Mismatch repair subclass of Tumor | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer, Lynch syndrome has effect hereditary colon and uterine cancers, Lynch syndrome subclass of BRCA mutation, ovarian cancer subclass of cancer | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes, colon cancer subclass of cancer | xeroderma pigmentosum subclass of genetic conditions | recurrent subclass of ovarian cancer, BRCA mutation subclass of homologous recombination deficiency",
        "metrics": {
          "rouge_score": 0.1818181818181818,
          "answer_correctness": 0.9026317070701815
        }
      },
      {
        "id": "Medical-ec0be6f4",
        "question": "How is the treatment approach different for a patient with Stage III anal cancer compared to one with Stage IV disease?",
        "ground_truth": "Stage III is treated with chemoradiation while Stage IV requires systemic chemotherapy and possibly immunotherapy.",
        "generated_answer": "The treatment approach for Stage III anal cancer typically involves a combination of chemotherapy and radiation, while Stage IV disease may require more aggressive treatments, including systemic therapy and possibly palliative care, due to the advanced nature of the cancer.",
        "contexts": "Stage III followed by 4 disease, advanced disease said to be the same as Stage 4A, Stage III subclass of disease, 4 disease follows Stage III, Stage 4A said to be the same as advanced disease, 4 subclass of disease | Stage III followed by Stage III, Stage III follows stage II, Stage III follows Stage III, stage IIIA facet of cancer | Stage 1 followed by stage II, Stage III followed by stage IV, stage II followed by Stage III | Stage III instance of cancer stage, stage IV instance of cancer stage, Stage 1 instance of cancer stage | stage IV instance of stage, Stage III instance of stage | Stage III subclass of cancer | more advanced cancers opposite of early-stage prostate cancer, early-stage prostate cancer opposite of more advanced cancers | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer, Cancer grade different from stage, stage different from Cancer grade | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | Stage 4 cancer said to be the same as Stage 4A, Stage 3A1 facet of cancer, Stage 4A said to be the same as Stage 4 cancer",
        "metrics": {
          "rouge_score": 0.3272727272727273,
          "answer_correctness": 0.5711710909645525
        }
      },
      {
        "id": "Medical-ac502742",
        "question": "How can PD-L1 expression influence the treatment of throat cancer?",
        "ground_truth": "PD-L1 expression may guide immunotherapy treatment decisions in throat cancer.",
        "generated_answer": "PD-L1 expression can influence the treatment of throat cancer by serving as a biomarker for the effectiveness of immunotherapies, such as Pembrolizumab and Nivolumab. Higher PD-L1 levels may indicate a better response to these treatments, guiding therapeutic decisions.",
        "contexts": "squamous cell carcinoma has effect Throat cancer, Throat cancer has cause squamous cell carcinoma | Pembrolizumab medical condition treated Breast cancer, Breast cancer drug used for treatment Pembrolizumab | metastatic anal cancer drug used for treatment Pembrolizumab, Nivolumab medical condition treated metastatic anal cancer | cancer drug used for treatment treatments, treatments medical condition treated cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | PD-L1 instance of biomarker | radical trachelectomy medical condition treated cancer | cancer drug used for treatment Treatment | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | cancer drug used for treatment cancer | HPV has effect Throat cancer, Throat cancer has cause HPV | PD-L1 instance of Proteins | Neck ultrasound medical condition treated thyroid cancer | cancer drug used for treatment Cancer treatment | PD-L1-positive has part PD-L1 | Methotrexate medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.2352941176470588,
          "answer_correctness": 0.909088483512854
        }
      },
      {
        "id": "Medical-647b438f",
        "question": "Which biomarkers must be tested to guide targeted therapy decisions in invasive ductal carcinoma, and why?",
        "ground_truth": "Estrogen receptor, progesterone receptor, HER2, BRCA1/2, PIK3CA, MSI-H/dMMR, and PD-L1 must be tested to guide targeted therapy in invasive ductal carcinoma.",
        "generated_answer": "The specific biomarkers for guiding targeted therapy decisions in invasive ductal carcinoma are not provided in the given context.",
        "contexts": "targeted therapy facet of Glioblastoma | targeted therapy facet of genetic mutations | bevacizumab instance of targeted therapy | systemic therapy facet of cancer | Immunotherapy facet of cancer | lenvatinib instance of targeted therapy, targeted therapy subclass of radiation therapy, Sorafenib instance of targeted therapy | targeted therapy subclass of chemoimmunotherapy | invasive test facet of cancer | Side effects of targeted therapy facet of targeted therapy | mirvetuximab soravtansine-gynx instance of targeted therapy | Invasive ductal carcinoma subclass of Invasive ductal carcinoma | Tumor markers facet of Breast cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of Pancreatic cancer | Treatment facet of cancer | targeted therapy subclass of chemotherapy | targeted therapy subclass of Immunotherapy | Gemtuzumab ozogamicin instance of targeted therapy | targeted therapy opposite of chemotherapy | radiation therapy facet of cancer",
        "metrics": {
          "rouge_score": 0.3181818181818182,
          "answer_correctness": 0.23445823859294146
        }
      },
      {
        "id": "Medical-a5435dbc",
        "question": "Why is colonoscopy recommended after rectal cancer surgery, and what risk factor may increase its importance?",
        "ground_truth": "Colonoscopy is recommended for surveillance after surgery, especially important in patients with familial adenomatous polyposis (FAP) due to high polyp risk.",
        "generated_answer": "Colonoscopy is recommended after rectal cancer surgery to monitor for recurrence and detect new polyps or cancers. A significant risk factor that may increase its importance is the presence of inflammatory polyps.",
        "contexts": "Treatment facet of colon cancer | tumor, node, metastasis facet of colon cancer | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | biopsy facet of cancer | surgical margin facet of surgery | polypectomy part of colonoscopy | Imaging facet of cancer, Treatment planning facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Rectal cancer subclass of surgery | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | surgical stage facet of surgery | radiation therapy facet of cancer | Imaging facet of cancer | Imaging Imaging facet of cancer | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | Cancer treatment facet of cancer | computed tomography main subject colon cancer, Imaging Imaging facet of cancer | sentinel lymph node biopsy facet of sentinel lymph node | sentinel lymph node biopsy facet of lymph nodes",
        "metrics": {
          "rouge_score": 0.3018867924528302,
          "answer_correctness": 0.7421541687227288
        }
      },
      {
        "id": "Medical-2a61ebd2",
        "question": "How does the identification of the PML::RARA fusion gene influence both the classification and treatment of AML?",
        "ground_truth": "Detection of PML::RARA classifies the AML as acute promyelocytic leukemia (APL), which is treated with chemotherapy and targeted therapy.",
        "generated_answer": "The identification of the PML::RARA fusion gene aids in classifying acute myeloid leukemia (AML) and informs targeted treatment strategies, enhancing treatment efficacy and patient outcomes.",
        "contexts": "AML drug used for treatment Methotrexate, Methotrexate medical condition treated AML, AML drug used for treatment Cytarabine, Cytarabine medical condition treated AML | AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin, daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML | daunorubicin medical condition treated AML, AML drug used for treatment daunorubicin, AML drug used for treatment Sorafenib, AML drug used for treatment Cytarabine, AML drug used for treatment FLT3 Gilteritinib, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML | cancer drug used for treatment treatments | plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia | cancer drug used for treatment Treatment | treatments medical condition treated cancer, cancer drug used for treatment treatments | cancer drug used for treatment Methotrexate | cancer drug used for treatment Cancer treatment | cancer drug used for treatment cancer | Treatment medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.34782608695652173,
          "answer_correctness": 0.7394003449546049
        }
      },
      {
        "id": "Medical-79d13dd8",
        "question": "What follow-up and surveillance methods are recommended after initial treatment of non\u2013muscle-invasive bladder cancer?",
        "ground_truth": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are recommended for follow-up after non\u2013muscle-invasive bladder cancer treatment.",
        "generated_answer": "Follow-up and surveillance methods for non\u2013muscle-invasive bladder cancer typically include regular cystoscopy examinations, urine cytology tests, and monitoring for any signs of recurrence or progression.",
        "contexts": "non\u2013 muscle-invasive subclass of bladder cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, squamous cell carcinoma subclass of bladder cancer, Adenocarcinoma subclass of bladder cancer | 0 subclass of bladder cancer, 3 subclass of bladder cancer, 2 subclass of bladder cancer, metastasized subclass of cancer, Stage 0 Stage 0 subclass of bladder cancer, 1 subclass of bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | invaded the muscle layer subclass of bladder cancer | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer | noninvasive subclass of cancer | bladder cancer subclass of transitional call cancer | Stage 4B subclass of bladder cancer | bladder cancer subclass of Cancer of the upper urinary tract | bladder cancer subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Metastatic bladder cancer subclass of cancer, High-grade cancer opposite of Low grade bladder cancer | Metastatic bladder cancer subclass of spread outside the bladder | nonmetastatic subclass of cancer, metastatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.8070531078907385
        }
      },
      {
        "id": "Medical-ee644399",
        "question": "Why is lobectomy preferred over total thyroidectomy for some small, low-risk differentiated thyroid cancers?",
        "ground_truth": "Lobectomy is preferred because it is sufficient for small, noninvasive tumors and avoids the need for lifelong thyroid hormone replacement.",
        "generated_answer": "Lobectomy is preferred for small, low-risk differentiated thyroid cancers because it is less invasive, preserves more thyroid function, and reduces the risk of complications compared to total thyroidectomy.",
        "contexts": "Lobectomy different from Thyroidectomy, Thyroidectomy different from Lobectomy, Thyroidectomy subclass of remove any nearby lymph nodes known to have cancer | Thyroidectomy different from Lobectomy | Thyroidectomy different from Lobectomy, Lobectomy instance of Treatment, Lobectomy subclass of surgery, Lobectomy different from Thyroidectomy, Total thyroidectomy medical condition treated papillary cancer | Thyroid hormone replacement therapy different from Lobectomy, Total thyroidectomy subclass of Thyroidectomy, Lobectomy subclass of Thyroidectomy, Papillary thyroid cancer subclass of thyroid cancer | Total thyroidectomy medical condition treated thyroid cancer, Total thyroidectomy different from RAI therapy, Total thyroidectomy followed by After total thyroidectomy, RAI therapy different from Total thyroidectomy, After total thyroidectomy follows Total thyroidectomy | Lobectomy subclass of Thyroidectomy | Total thyroidectomy instance of surgery | thyroid has part lobe, lobe part of thyroid, Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer, Total thyroidectomy subclass of Total thyroidectomy | surgery different from chemotherapy | surgery different from Treatment | Lobectomy followed by After lobectomy | Total thyroidectomy medical condition treated thyroid cancer",
        "metrics": {
          "rouge_score": 0.32653061224489793,
          "answer_correctness": 0.8412187433510178
        }
      },
      {
        "id": "Medical-31580ac0",
        "question": "Which liver cancer subtype is most likely to be found in younger patients, and what are the main risk factors for its parent cancer type?",
        "ground_truth": "Fibrolamellar hepatocellular carcinoma (FLHC) is found in younger patients, and its parent type, HCC, is mainly associated with cirrhosis, hepatitis B, and hepatitis C.",
        "generated_answer": "The liver cancer subtype most likely to be found in younger patients is hepatocellular carcinoma. The main risk factors for liver cancer include chronic hepatitis B and C infections, cirrhosis, and excessive alcohol consumption.",
        "contexts": "cancer type subclass of cancer | tumor subclass of cancer | Tumor subclass of cancer | carcinoma subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | cancer subclass of disease | cancer subclass of diseases | breast subclass of cancer, skin subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | cancer subclass of cells | malignant subclass of cancer | lung subclass of cancer | ovarian subclass of cancer, breast subclass of cancer | breast subclass of cancer, spread subclass of cancer, colon subclass of cancer, pancreatic subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | prostate cancer subclass of cancer, colorectal subclass of cancer | colorectal subclass of cancer",
        "metrics": {
          "rouge_score": 0.31034482758620696,
          "answer_correctness": 0.8590277013863321
        }
      },
      {
        "id": "Medical-e9ac42f1",
        "question": "How does the BCR::ABL1 fusion gene relate to both the diagnosis and treatment of CML?",
        "ground_truth": "The BCR::ABL1 fusion gene is required for diagnosis and is also the target of CML treatment.",
        "generated_answer": "The BCR::ABL1 fusion gene is a key diagnostic marker for chronic myeloid leukemia (CML) and is targeted in treatment with tyrosine kinase inhibitors, which specifically inhibit the activity of the BCR::ABL1 protein.",
        "contexts": "BCR::ABL1 instance of gene | BRCA1 instance of gene, ATM instance of gene | BRCA1 instance of gene, BRCA2 instance of gene | BRCA instance of gene | BRCA instance of genes | CHEK2 instance of mutations in certain genes, BRCA1 instance of mutations in certain genes, BRCA1 instance of gene, BRCA2 instance of gene, ATM instance of mutations in certain genes | BRCA1 instance of gene, BRCA2 instance of gene, FANCA instance of gene, DNA instance of molecular, PALB2 instance of gene, ATM instance of gene | BRCA2 instance of gene | p16 instance of gene | TP53 instance of genes, IGHV instance of genes | HER2 instance of gene | IDH instance of gene | ERBB instance of gene, FGFR3 instance of gene | PALB2 instance of gene, ATM instance of gene, MSH2 instance of gene, MLH1 instance of gene",
        "metrics": {
          "rouge_score": 0.4313725490196078,
          "answer_correctness": 0.9921229627680037
        }
      },
      {
        "id": "Medical-fd4cca6e",
        "question": "When is local excision considered as a treatment option in anal cancer, and what are the tumor characteristics that support this choice?",
        "ground_truth": "Local excision is considered for early-stage, low-grade perianal cancers.",
        "generated_answer": "Local excision is considered for perianal cancer stages I \u2013 III, particularly when the tumors are low grade and nonmetastatic. This approach is suitable for localized tumors that can be completely removed without extensive surgery.",
        "contexts": "Perianal cancer (stages I \u2013 III) facet of perianal cancer, local excision medical condition treated perianal cancer, metastatic anal cancer subclass of nonmetastatic, perianal cancer drug used for treatment local excision | local excision medical condition treated cancer, low grade subclass of perianal cancer, Chemoradiation medical condition treated perianal cancer, perianal cancer drug used for treatment Chemoradiation | Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer, APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer, Anal cancer drug used for treatment Mitomycin, 5-FU medical condition treated Anal cancer, Anal cancer drug used for treatment Cisplatin | Anal cancer drug used for treatment radiation treatment | Abdominoperineal resection medical condition treated Anal cancer | abdominoperineal resection medical condition treated Anal cancer | Anal cancer drug used for treatment radiation therapy | Surgery to remove the anus medical condition treated Anal cancer | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | Treatment facet of Anal cancer | Anal cancer drug used for treatment Mitomycin, 5-FU 5-FU and cisplatin medical condition treated Anal cancer, Mitomycin medical condition treated Anal cancer, capecitabine Mitomycin medical condition treated Anal cancer | Chemoradiation medical condition treated anal canal cancer | High-resolution anoscopy medical condition treated Anal cancer | metastatic anal cancer drug used for treatment Pembrolizumab, Nivolumab medical condition treated metastatic anal cancer | platinum-based chemotherapy medical condition treated Metastatic anal cancer",
        "metrics": {
          "rouge_score": 0.3555555555555555,
          "answer_correctness": 0.6729654871991972
        }
      },
      {
        "id": "Medical-9b3c8ac0",
        "question": "Why should fertility preservation be discussed before starting treatment for bone cancer in young patients?",
        "ground_truth": "Some treatments for bone cancer can affect fertility, so fertility preservation should be discussed prior to treatment.",
        "generated_answer": "Fertility preservation should be discussed before starting treatment for bone cancer in young patients because cancer treatments can affect fertility. Addressing this concern allows for planning and options to preserve reproductive capabilities.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment facet of ovarian cancer | Treatment facet of colon cancer | more treatment facet of cancer | Treatment facet of Pancreatic cancer | Treatment facet of bladder cancer | Treatment facet of urothelial cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment facet of Anal cancer | Treatment facet of stomach cancer | treated facet of Glioblastoma | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer | Treatment facet of disease | cancer drug used for treatment Treatment, best treatment facet of cancer | Treatment facet of Treatment | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial",
        "metrics": {
          "rouge_score": 0.32653061224489793,
          "answer_correctness": 0.7447904180193412
        }
      },
      {
        "id": "Medical-0e57f27f",
        "question": "When should a clinical trial be considered for a thyroid cancer patient, and what disease characteristics warrant this recommendation?",
        "ground_truth": "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer, especially when standard treatments are ineffective.",
        "generated_answer": "A clinical trial should be considered for thyroid cancer patients, particularly those with differentiated thyroid cancers, small low-risk cancers, or metastatic disease. Patients may also consider trials when standard treatments are not effective or when exploring new treatment options.",
        "contexts": "papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | standard treatments subclass of Clinical trial, voluntary subclass of Clinical trial, study subclass of Clinical trial, New clinical trial subclass of Clinical trial | Treatment trial subclass of cancer clinical trial, standard treatments subclass of treatment options available for their type of cancer, systemic therapy subclass of Cancer treatment, Clinical trial subclass of medical research | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | New clinical trial subclass of Clinical trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Clinical trial subclass of studied | standard treatments subclass of treatment options available for their type of cancer, Clinical trial subclass of studied in people, Clinical trial subclass of medical research, Clinical trial studies drug | Clinical trial subclass of research | Clinical trial subclass of research study | Clinical trial subclass of Treatment | Clinical trial subclass of medical research | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | nodule subclass of thyroid cancer | follicular subclass of thyroid cancer | Lifelong thyroid hormone replacement therapy subclass of Cancer treatment | metastasized subclass of thyroid cancer | thyroid cancer subclass of cancer | Papillary subclass of thyroid cancer",
        "metrics": {
          "rouge_score": 0.3793103448275862,
          "answer_correctness": 0.8035853578857036
        }
      },
      {
        "id": "Medical-6d335c18",
        "question": "What histological subtypes are found under RCC and how are they organized in the classification?",
        "ground_truth": "Clear cell RCC, non-clear cell RCC (with papillary, chromophobe, collecting duct, renal medullary carcinoma, clear cell papillary, fumarate hydratase-deficient, ELOC-mutated), and sarcomatoid RCC are all histological subtypes under RCC.",
        "generated_answer": "The histological subtypes of renal cell carcinoma (RCC) include clear cell carcinoma, papillary carcinoma, chromophobe carcinoma, and collecting duct carcinoma. They are organized based on their distinct cellular characteristics and growth patterns.",
        "contexts": "tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | pathologic subclass of Clinical | Immunohistochemistry subclass of staining | Cancer cells studied by histology, histology studies Cancer cells | tissues studied by pathologist | tumor histology studies cancer | tissues studied by pathologist, pathologist studies tissues | subtype facet of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | pathology has part histology, histology part of pathology | stomach part of digestive system, stomach gland has part submucosa, mucus has part Epithelium, connective tissue part of muscle, connective tissue part of submucosa, submucosa has part connective tissue, stomach gland has part mucosa, mucosa part of stomach gland, submucosa part of stomach gland, digestive system has part stomach, Surface epithelium part of stomach lining, Mucosa part of stomach, stomach lining has part Surface epithelium, muscle part of submucosa, stomach has part serosa | HER2-positive subclass of Breast cancer, Immunohistochemistry subclass of staining, estrogen subclass of receptor | pathologist studies tissue sample, tissue sample studied by pathologist | biopsy studied by pathologist | Biopsy studied by pathologist | pathologic subclass of cancer staging | histology uses microscope",
        "metrics": {
          "rouge_score": 0.3125,
          "answer_correctness": 0.6175571888784283
        }
      },
      {
        "id": "Medical-38fe5331",
        "question": "How does the detection of increased blasts in blood or bone marrow influence the classification of CML phase?",
        "ground_truth": "Increased blasts indicate progression to blast phase CML (BP-CML), an advanced disease stage.",
        "generated_answer": "The detection of increased blasts in blood or bone marrow indicates a progression to a more advanced phase of Chronic Myeloid Leukemia (CML), typically signifying a transition from the chronic phase to the accelerated or blast phase. This classification is crucial for determining treatment strategies and prognosis.",
        "contexts": "Blood has part bone marrow, bone marrow part of Blood | Blood has part bone marrow, bone marrow part of Blood | Blood has part bone marrow, bone marrow has part Blood, cells part of tissues | Blood has part bone marrow, bone marrow has part Blood, cells part of tissues, white blood cell has part myeloblast, bone marrow part of Blood, myeloblast subclass of white blood cell, tissues has parts of the class cells, Blood part of bone marrow | hematopoietic stem cell subclass of Red blood cell, stem cell part of bone marrow, stem cell part of bone marrow, bone marrow has part stem cell, Blood has part bone marrow | Blood has part bone marrow, blood stem cell has part abnormal myeloblasts, white blood cell has part platelet, Blood has part Red blood cell | Red blood cell has part stem cell, bone marrow part of Blood | Red blood cell followed by white blood cell, Blood has part bone marrow, blood stem cell has part abnormal myeloblasts, white blood cell has part platelet, Red blood cell subclass of Red blood cell, platelet subclass of Red blood cell, white blood cell follows Red blood cell | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | bone marrow has part bone marrow | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | bone has part bone marrow, bone marrow part of bone | bone has part bone marrow, bone marrow part of bone | bone marrow part of bone, bone has part bone marrow, Bone tissue has part blood vessel | blood stem cell subclass of stem cell, blood cell counts subclass of blood test, stem cell rescue subclass of Treatment, Red blood cell part of bone marrow, bone marrow has part Red blood cell, stem cell part of bone marrow | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell",
        "metrics": {
          "rouge_score": 0.22950819672131148,
          "answer_correctness": 0.7427137463180145
        }
      },
      {
        "id": "Medical-3aa8a2c6",
        "question": "How does the site of disease involvement influence the presentation of follicular lymphoma symptoms?",
        "ground_truth": "Involvement of lymph nodes, spleen, and bone marrow leads to symptoms such as swollen lymph nodes, enlarged spleen, and B symptoms.",
        "generated_answer": "The site of disease involvement in follicular lymphoma can influence symptom presentation by affecting nearby organs, leading to specific symptoms such as abdominal bloating or fever, depending on the location of the lymphoma. Different sites may also result in varying signs and symptoms due to the unique interactions with surrounding tissues.",
        "contexts": "Symptoms used by diagnosis, Symptoms has cause medical problem, medical problem has effect Symptoms | Symptoms has cause Symptoms, Symptoms has effect Symptoms | Signs and symptoms facet of disease | illness has effect Symptoms, Symptoms has cause illness | signs different from Symptoms, Symptoms different from signs | Symptoms has cause illness, illness has effect Symptoms | Symptoms different from symptom, symptom different from Symptoms | Symptoms subclass of Symptoms | Symptoms different from Symptoms | Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms | initial diagnosis part of Clinical | symptom facet of disease | Symptoms subclass of health conditions or concerns | Symptoms has cause Treatment | pressing on nearby organs subclass of Symptoms",
        "metrics": {
          "rouge_score": 0.2222222222222222,
          "answer_correctness": 0.5058391394908873
        }
      },
      {
        "id": "Medical-25c17c3d",
        "question": "What treatments are recommended for advanced or metastatic pancreatic ductal adenocarcinoma?",
        "ground_truth": "Drug treatment, clinical trials, and supportive care are recommended for advanced or metastatic pancreatic ductal adenocarcinoma.",
        "generated_answer": "Recommended treatments for advanced or metastatic pancreatic ductal adenocarcinoma include chemotherapy, targeted therapy, immunotherapy, and palliative care.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastasized subclass of cancer | de novo subclass of Metastatic cancer | metastatic subclass of prostate cancer | metastatic disease subclass of cancer | metastasized subclass of metastasis | advanced subclass of prostate cancer | metastatic subclass of spread | nonmetastatic subclass of cancer, metastatic subclass of cancer | very advanced disease subclass of disease, metastatic subclass of cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of Breast cancer, distant metastasis subclass of cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastasis subclass of metastasized | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastasis subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer",
        "metrics": {
          "rouge_score": 0.48484848484848486,
          "answer_correctness": 0.9486280227708848
        }
      },
      {
        "id": "Medical-833304f8",
        "question": "How does the anatomical location of a tumor help distinguish between esophageal squamous cell carcinoma and adenocarcinoma?",
        "ground_truth": "Squamous cell carcinoma is more common in the upper/middle esophagus, while adenocarcinoma is more common in the lower/middle esophagus.",
        "generated_answer": "The anatomical location of a tumor is crucial as esophageal squamous cell carcinoma typically arises in the upper and middle sections of the esophagus, while adenocarcinoma usually occurs in the lower esophagus, often associated with gastroesophageal reflux disease. This distinction aids in diagnosis and treatment planning.",
        "contexts": "squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer, Adenosquamous carcinoma subclass of cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | Adenocarcinoma subclass of NSCLC, squamous cell carcinoma subclass of squaymous | squamous cell carcinoma subclass of cervical cancer | Adenocarcinoma subclass of adenoma | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Adenocarcinoma subclass of colorectal cancer | Squamous cell carcinoma of the head and neck subclass of Head and neck cancer | Adenocarcinoma subclass of colon cancer | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | Squamous cell subclass of skin cancer | Adenocarcinoma subclass of rectal tumor | squamous cell carcinoma subclass of Nasopharyngeal cancer | squamous cell carcinoma subclass of Mouth cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Adenocarcinoma subclass of bladder cancer",
        "metrics": {
          "rouge_score": 0.41791044776119407,
          "answer_correctness": 0.8440258759533725
        }
      },
      {
        "id": "Medical-ce7076ea",
        "question": "Why is a comprehensive metabolic panel and assessment of performance status important before starting CLL treatment?",
        "ground_truth": "These assessments help guide treatment planning and ensure patient suitability for specific therapies.",
        "generated_answer": "A comprehensive metabolic panel and assessment of performance status are important before starting CLL treatment to evaluate the patient's overall health and organ function, ensuring they can tolerate the treatment and to identify any potential complications.",
        "contexts": "SLL drug used for treatment Treatment of CLL and SLL, Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL | Chronic lymphocytic leukemia drug used for treatment Treatment, Treatment medical condition treated Chronic lymphocytic leukemia, How is CLL confirmed? facet of Chronic lymphocytic leukemia | Treatment for CLL instance of Treatment | effective treatment medical condition treated CLL | cancer drug used for treatment Treatment | cancer drug used for treatment treatments | cancer drug used for treatment Cancer treatment | Lymphoma drug used for treatment Methotrexate | NSCLC drug used for treatment Treatment for NSCLC, Treatment for NSCLC medical condition treated NSCLC | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | CNS lymphoma drug used for treatment standard treatments | Treatment may not be needed for years facet of CLL | bladder cancer drug used for treatment Treatment | cancer drug used for treatment Treatment, best treatment facet of cancer | primary CNS lymphoma drug used for treatment Treatment | ovarian cancer drug used for treatment Treatment | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.16,
          "answer_correctness": 0.9762702008300468
        }
      },
      {
        "id": "Medical-48cb097c",
        "question": "Which anatomical locations are most associated with esophageal squamous cell carcinoma and esophageal adenocarcinoma, and how does this affect treatment planning?",
        "ground_truth": "Squamous cell carcinoma often occurs in the upper/middle esophagus, adenocarcinoma in the lower/middle, and treatment planning considers these locations.",
        "generated_answer": "The anatomical locations most associated with esophageal squamous cell carcinoma and esophageal adenocarcinoma are the esophagus, particularly the upper and middle esophagus. This localization influences treatment planning by determining surgical approaches and the need for targeted therapies based on tumor location.",
        "contexts": "laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | lung cancer different from lung cancer, lung cancer different from lung cancer, Early and locally advanced lung cancers subclass of NSCLC | cancer type different from cancer, cancer different from cancer type | prostate cancer different from prostate cancer | cancer different from tumors, tumors different from cancer | ovarian cancer different from cervical cancer, cervical cancer different from ovarian cancer | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | Osteosarcoma different from Osteosarcoma | squamous cell skin cancer different from CSCC | Adenocarcinoma follows squamous cell carcinoma, squamous cell carcinoma followed by Adenocarcinoma | melanoma different from nonmelanoma skin cancer | Cancer cells different from Cancer cell differ from normal cells | Esophageal cancer subclass of cancer",
        "metrics": {
          "rouge_score": 0.3225806451612903,
          "answer_correctness": 0.7425324834003306
        }
      },
      {
        "id": "Medical-322bb52d",
        "question": "How do medical and family history contribute to the diagnostic process for BCC in a patient with a suspicious skin lesion?",
        "ground_truth": "Both are part of the diagnostic workup to assess risk and guide further testing like biopsy.",
        "generated_answer": "Medical and family history provide essential context for assessing risk factors associated with basal cell carcinoma (BCC), guiding the diagnostic process. They help identify hereditary patterns and previous health issues that could influence the likelihood of malignancy in a suspicious skin lesion.",
        "contexts": "medical has part family history, family history part of medical | health history has part family history, family history part of health history | physical exam part of Medical history | health care provider field of work family history, family has part ancestry, ancestry part of family | family health history has part risk factors | family's ancestry has part ancestors, aunts and uncles part of niece and nephews, ancestors part of family's ancestry | family health history facet of colon cancer | Family history subclass of health history, family history facet of care team | family history subclass of health history | Family history facet of family | family history practiced by genetic counselor, genetic counselor field of this occupation family history | screened has cause family history, family history has effect screened | health history subclass of Medical history, Family history subclass of health history | genes part of families",
        "metrics": {
          "rouge_score": 0.10344827586206898,
          "answer_correctness": 0.6559244045053974
        }
      },
      {
        "id": "Medical-8e0c15db",
        "question": "What combination of findings would indicate the need for genetic testing in a patient with an adrenal tumor?",
        "ground_truth": "If there is a family history or features of hereditary syndromes in a patient with an adrenal tumor, genetic testing should be performed.",
        "generated_answer": "A combination of findings such as a family history of adrenal tumors, early onset of adrenal tumors, or the presence of specific genetic syndromes would indicate the need for genetic testing in a patient with an adrenal tumor.",
        "contexts": "genetic testing subclass of testing | genetic testing subclass of genetic testing | biomarker testing subclass of testing | hereditary gene testing subclass of genetic testing | genetic cancer risk testing subclass of genetic testing | Germline testing subclass of genetic testing, hereditary gene testing subclass of genetic testing, tumor testing subclass of genetic testing | genetic testing subclass of test | Germline testing subclass of genetic testing | Pregnancy test subclass of Pregnancy test | biomarker testing subclass of biomarker testing | genetic testing subclass of diagnostic test | Heart test subclass of test | prostate cancer screening test subclass of test | Genetic risk testing subclass of Genetic and biomarker testing | over the counter subclass of genetic testing | biomarker subclass of genetic testing | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | comprehensive genomic profiling subclass of genomic testing | genetic cancer risk testing subclass of Biopsy",
        "metrics": {
          "rouge_score": 0.4262295081967213,
          "answer_correctness": 0.7443888828102592
        }
      },
      {
        "id": "Medical-c22fc609",
        "question": "Why must both performance status and nutritional assessment be included in the diagnostic workup for esophageal cancer?",
        "ground_truth": "Both are required to assess patient suitability for treatment and are listed as diagnostic methods.",
        "generated_answer": "Both performance status and nutritional assessment are crucial in the diagnostic workup for esophageal cancer as they help determine the patient's overall health and ability to tolerate treatment, which can significantly impact treatment planning and outcomes.",
        "contexts": "diagnosis facet of cancer | test facet of cancer | test facet of Liver cancer | biopsy facet of cancer | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Barrett esophagus part of esophagus, Barrett esophagus has effect adenocarcinoma of the esophagus, Treatment facet of esophageal cancer, stomach connects with esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach | Imaging facet of cancer | breast exams facet of Breast cancer | tests and scans facet of prostate cancer | invasive test facet of cancer | Surveillance Follow-up testing facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Surveillance facet of cancer | grade facet of cancer, staging facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | staging facet of cancer | Staging facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.1923076923076923,
          "answer_correctness": 0.8271489189199168
        }
      },
      {
        "id": "Medical-e2ac8ec4",
        "question": "How does the addition of bevacizumab to chemotherapy alter the management of metastatic cervical cancer?",
        "ground_truth": "Bevacizumab may be added to chemotherapy to improve outcomes in metastatic cervical cancer.",
        "generated_answer": "The addition of bevacizumab to chemotherapy enhances the treatment efficacy for metastatic cervical cancer, potentially improving patient outcomes by targeting tumor vasculature and reducing tumor growth. This combination allows for a more comprehensive management approach to the disease.",
        "contexts": "cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | Chemoradiation medical condition treated cervical cancer, cervical cancer drug used for treatment Chemoradiation EBRT, cervical cancer drug used for treatment Chemoradiation, Chemoradiation EBRT medical condition treated cervical cancer | cervical biopsy medical condition treated cervical cancer | metastatic anal cancer drug used for treatment Pembrolizumab, Nivolumab medical condition treated metastatic anal cancer | cervical cancer drug used for treatment Pap testing, Metastatic cancer subclass of cervical cancer, Pap testing medical condition treated cervical cancer | Non-platinum chemotherapy drug used for treatment bevacizumab, Treatment medical condition treated ovarian cancer | metastatic subclass of cervical cancer | cervical cancer drug used for treatment intensitymodulated radiation therapy, intensitymodulated radiation therapy medical condition treated cervical cancer | Metastatic cervical cancer subclass of metastatic disease | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | platinum-based chemotherapy medical condition treated Metastatic anal cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment Cancer treatment",
        "metrics": {
          "rouge_score": 0.23529411764705882,
          "answer_correctness": 0.4954592345504766
        }
      },
      {
        "id": "Medical-bd7c7e1a",
        "question": "Which patients with recurrent or metastatic cervical cancer are eligible for immunotherapy, and what biomarker guides this decision?",
        "ground_truth": "Patients with recurrent or metastatic cervical cancer who are PD-L1 positive are eligible for immunotherapy such as pembrolizumab.",
        "generated_answer": "Patients with recurrent or metastatic cervical cancer who are eligible for immunotherapy typically have tumors that express the biomarker PD-L1.",
        "contexts": "metastatic subclass of cervical cancer | Metastatic cancer subclass of cervical cancer | Metastatic cervical cancer subclass of metastatic disease | metastatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | metastatic subclass of prostate cancer | metastatic disease subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | locally advanced cancer subclass of cervical cancer | recurrence subclass of cervical cancer | squamous cell carcinoma subclass of cervical cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | cervical cancer subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | Metastatic cancer subclass of Breast cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | de novo subclass of Metastatic cancer | metastasized subclass of cancer",
        "metrics": {
          "rouge_score": 0.6,
          "answer_correctness": 0.6216165634747094
        }
      },
      {
        "id": "Medical-0125ebb1",
        "question": "How do Gleason score and Grade Group contribute to the management of prostate cancer?",
        "ground_truth": "They estimate cancer aggressiveness and help assign risk groups that guide prognosis and treatment decisions.",
        "generated_answer": "Gleason score and Grade Group are critical in assessing the aggressiveness of prostate cancer, guiding treatment decisions and management strategies. They help determine the cancer stage and influence the choice of therapies, impacting patient outcomes.",
        "contexts": "Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | PSA test facet of prostate cancer | PSA facet of prostate cancer, Gleason score instance of PSA density, more than one treatment option facet of prostate cancer | Cancer grade facet of cancer | aggressive facet of prostate cancer | PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | detection methods facet of prostate cancer | Early vs. advanced prostate cancer facet of prostate cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | grade facet of cancer, staging facet of cancer | PSA in the blood has cause prostate cancer, prostate cancer location prostate, PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | tests and scans facet of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Early detection and treatment facet of prostate cancer | higher risk facet of prostate cancer, lower risk facet of prostate cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | biopsy facet of cancer | staging system facet of cancer | Gleason pattern instance of pattern, 1 instance of Gleason pattern, Gleason score part of Gleason pattern, 2 instance of Gleason pattern, Grade Groups part of Gleason pattern, Gleason score instance of pattern number, Gleason pattern has part Gleason score, Gleason pattern has part 1",
        "metrics": {
          "rouge_score": 0.2,
          "answer_correctness": 0.6050236937689397
        }
      },
      {
        "id": "Medical-e9ef7d6f",
        "question": "What distinguishes secondary liver cancer from primary liver cancer in terms of origin and anatomical structure involved?",
        "ground_truth": "Primary liver cancer originates in the liver, while secondary liver cancer spreads to the liver from other organs.",
        "generated_answer": "Secondary liver cancer originates from metastasis of cancer from other organs, while primary liver cancer arises directly in the liver tissue itself.",
        "contexts": "hepatocellular carcinoma subclass of Secondary liver cancer, HCC subclass of Liver cancer | primary liver cancer subclass of cancer | primary liver cancer subclass of Liver cancer | Liver cancer has cause liver | cancer different from cancer type, cancer type different from cancer | cancer different from tumors, tumors different from cancer | lung cancer different from lung cancer | prostate cancer different from prostate cancer | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | Liver cancer has cause increased risk, increased risk has effect Liver cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | primary tumor opposite of metastasis | Locally advanced cancer different from metastatic",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.9968727131176138
        }
      },
      {
        "id": "Medical-34a70628",
        "question": "Which population is most at risk for developing mediastinal gray zone lymphoma based on epidemiology?",
        "ground_truth": "Individuals aged 20 to 40 years assigned male at birth are most at risk for MGZL.",
        "generated_answer": "The population most at risk for developing mediastinal gray zone lymphoma includes young adults, particularly those in their 20s and 30s, and individuals with a history of other lymphomas or immunodeficiency conditions.",
        "contexts": "Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal, MGZL subclass of Primary mediastinal B-cell lymphoma | Non-Hodgkin lymphoma subclass of cancer | Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | regional subclass of lymph nodes | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | lymph nodes subclass of cancer, inguinal subclass of lymph nodes | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Follicular lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.16666666666666666,
          "answer_correctness": 0.6552328321136067
        }
      },
      {
        "id": "Medical-56e2a338",
        "question": "If a stomach cancer is found to be confined to the mucosa and there is no lymph node involvement, what is the stage and which stomach wall layer is affected?",
        "ground_truth": "It is early-stage stomach cancer, affecting only the mucosa.",
        "generated_answer": "Stage 1, mucosa.",
        "contexts": "stage facet of cancer | cancer stage facet of cancer | stage facet of tumor | main categories facet of stomach cancer | stage the cancer facet of cancer | Treatment facet of stomach cancer | How far and how fast? facet of cancer, stage facet of cancer | Staging The cancer stage facet of cancer | stage facet of bladder cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | staging facet of cancer | Staging facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | grade facet of cancer, staging facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Clinical stage facet of Breast cancer | Stage 1 Chemotherapy facet of cancer | staging system facet of cancer, FIGO stages of ovarian cancer facet of ovarian cancer",
        "metrics": {
          "rouge_score": 0.30769230769230765,
          "answer_correctness": 0.9814298350838366
        }
      },
      {
        "id": "Medical-ad0cc053",
        "question": "If a nasopharyngeal carcinoma patient has both high EBV DNA levels and poor performance status, what does this indicate about their prognosis?",
        "ground_truth": "High EBV DNA levels and poor performance status are both poor prognostic factors in NPC.",
        "generated_answer": "This indicates a poor prognosis for the nasopharyngeal carcinoma patient. High EBV DNA levels combined with poor performance status are associated with worse outcomes.",
        "contexts": "Nasopharyngeal cancer has cause EBV | Epstein-Barr virus has effect mononucleosis, Nasopharyngeal cancer has cause EBV | EBV-related cancer has cause Epstein-Barr virus, Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | mononucleosis has cause Epstein-Barr virus, Epstein-Barr virus has effect mononucleosis | Head and neck cancer has cause lymph nodes | Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer subclass of cancer, Nasopharyngeal cancer different from laryngeal cancer | colorectal cancer has cause circulating tumor DNA | Epstein-Barr virus has effect TNM, TNM has cause Epstein-Barr virus | squamous cell carcinoma subclass of Nasopharyngeal cancer | Throat cancer has cause squamous cell carcinoma | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | cancer has cause lymph nodes | cN2 subclass of Nasopharyngeal cancer | cervical cancer has cause human papillomavirus | Cancer cells has cause genetic changes",
        "metrics": {
          "rouge_score": 0.4102564102564102,
          "answer_correctness": 0.9914193223591566
        }
      },
      {
        "id": "Medical-91c35427",
        "question": "What is the standard surgical procedure for muscle-invasive bladder cancer, and what urinary diversion options may follow?",
        "ground_truth": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer, followed by urinary diversion procedures such as ileal conduit, neobladder, or continent cutaneous pouch.",
        "generated_answer": "The standard surgical procedure for muscle-invasive bladder cancer is radical cystectomy. Urinary diversion options that may follow include ileal conduit, continent urinary reservoir, and neobladder.",
        "contexts": "Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | bladder cancer surgery medical condition treated bladder cancer, incontinence has cause urinary diversion | radical cystectomy medical condition treated bladder cancer, Partial cystectomy medical condition treated bladder cancer, urinary diversion uses bladder | Cancer treatment medical condition treated bladder cancer, bladder cancer drug used for treatment Cancer treatment | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Chemotherapy medical condition treated bladder cancer, Intravesical chemotherapy different from Intravesical chemotherapy, Chemotherapy facet of cancer, Chemotherapy subclass of Treatment, bladder cancer drug used for treatment Chemotherapy alone, Intravesical chemotherapy different from Intravesical chemotherapy, Cisplatin medical condition treated bladder cancer, bladder cancer drug used for treatment vinblastine | bladder cancer drug used for treatment dose-dense methotrexate, vinblastine medical condition treated bladder cancer, doxorubicin medical condition treated bladder cancer, bladder cancer drug used for treatment platinum-based chemotherapy, bladder cancer drug used for treatment Cisplatin | Intravesical BCG therapy start time 6 weeks, Intravesical BCG therapy medical condition treated bladder cancer, bladder cancer drug used for treatment chemotherapy, Intravesical BCG therapy uses Intravesical BCG therapy, chemotherapy medical condition treated bladder cancer | bladder cancer drug used for treatment surgery, surgery medical condition treated bladder cancer, Treatment facet of cancer | surgery medical condition treated cancer | Intravesical therapy medical condition treated bladder cancer, bladder cancer drug used for treatment Intravesical therapy | Treatment medical condition treated cancer | treatments medical condition treated cancer | radical trachelectomy medical condition treated cancer | Tumor removal medical condition treated bladder cancer, Tumor removal subclass of surgery | bladder cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.47058823529411764,
          "answer_correctness": 0.8888851668262123
        }
      },
      {
        "id": "Medical-99dd217e",
        "question": "What distinguishes early-stage esophageal cancer from locoregional and metastatic disease in terms of anatomical spread and diagnostic requirements?",
        "ground_truth": "Early-stage is limited to the esophagus without lymph node involvement, while locoregional and metastatic involve spread to nodes or distant organs, requiring imaging and biopsy for staging.",
        "generated_answer": "Early-stage esophageal cancer is typically localized and has not spread beyond the esophagus, while locoregional disease may involve nearby tissues or lymph nodes, and metastatic disease indicates spread to distant organs. Diagnostic requirements for early-stage cancer often involve imaging focused on the esophagus, whereas locoregional and metastatic disease require more extensive imaging to assess the extent of spread.",
        "contexts": "metastatic different from Locally advanced cancer, Locally advanced cancer different from metastatic | metastasize often different from metastasis, metastasis different from metastasize often | tumors different from cancer, cancer different from tumors | Locoregional subclass of tumor | Imaging different from cancer | Locoregional subclass of tumor, metastatic subclass of spread through the blood | cancer type different from cancer, cancer different from cancer type | prostate cancer different from prostate cancer | tumor different from Tumor | numbered stages different from bone cancer, bone cancer different from numbered stages | metastatic subclass of cancer | metastatic disease subclass of cancer | Progressive disease different from Complete remission, Complete remission different from Progressive disease, Persistent disease different from Progressive disease, Progressive disease different from Persistent disease, Persistent disease different from Complete remission, Complete remission different from Persistent disease | surgery different from systemic therapy, systemic therapy different from surgery",
        "metrics": {
          "rouge_score": 0.36363636363636365,
          "answer_correctness": 0.8227511608659726
        }
      },
      {
        "id": "Medical-ee302181",
        "question": "Why is it important to perform both flow cytometry and molecular testing in newly diagnosed AML?",
        "ground_truth": "Both tests are essential to identify cell surface markers and genetic alterations for accurate classification and treatment guidance.",
        "generated_answer": "Performing both flow cytometry and molecular testing in newly diagnosed AML is crucial for accurate diagnosis and classification of the disease, as well as for identifying specific genetic mutations and biomarkers that can guide treatment decisions. This comprehensive approach enhances the understanding of the disease's biology and improves patient management.",
        "contexts": "Flow cytometry subclass of blood test | blood smear subclass of Flow cytometry | biomarker testing subclass of Molecular | molecular tumor testing subclass of biomarker testing | molecular subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | biomarker subclass of genetic testing | biomarker subclass of test, biomarker test subclass of biomarker | comprehensive genomic profiling subclass of genomic testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | testing Biopsy subclass of biopsy | liquid biopsy subclass of blood sample | biomarker test subclass of test | Flow cytometry uses dye | biomarker testing subclass of biopsy, biopsy subclass of test results | tumor mutation testing subclass of biomarker | genetic testing subclass of test",
        "metrics": {
          "rouge_score": 0.2028985507246377,
          "answer_correctness": 0.9808824532218625
        }
      },
      {
        "id": "Medical-96bb3762",
        "question": "How does the treatment approach differ between Stage 1 and Stage 2 NSCLC?",
        "ground_truth": "Stage 1 NSCLC is treated with surgery and possibly radiation therapy, while Stage 2 NSCLC may require surgery and chemoradiation.",
        "generated_answer": "The treatment approach for Stage 1 NSCLC typically involves surgery, such as lobectomy or wedge resection, while Stage 2 NSCLC may require a combination of surgery, chemotherapy, and possibly radiation therapy due to the more advanced nature of the disease.",
        "contexts": "Cancer grade different from stage, stage different from Cancer grade | numbered stages different from bone cancer, bone cancer different from numbered stages | stage II instance of cancer stage | Stage 1A1 cancers has part Stage 1 | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | stage II subclass of cancer | Stage 1 followed by Stage 2A, Stage 2A follows Stage 1 | Stage 1 Chemotherapy different from colectomy | stage II followed by Stage III, Stage 1 followed by stage II, Stage III followed by stage IV | stage 1 tumor instance of cancer type | Stage 1 instance of Cancer stage, stage 0 instance of Cancer stage | lung cancer different from lung cancer, Cancer stages 1, 2, and 3 A cancer stage instance of cancer stage | cancer type has effect stage, stage has cause cancer type | Stage II anal cancer follows Stage I anal cancer, Stage I anal cancer followed by Stage II anal cancer",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.7458779849063326
        }
      },
      {
        "id": "Medical-c8dd3e29",
        "question": "How do immune suppression and prior radiation therapy interact to affect BCC risk and management?",
        "ground_truth": "Both are risk factors that increase BCC risk and may necessitate more aggressive management.",
        "generated_answer": "Immune suppression can increase the risk of basal cell carcinoma (BCC) by reducing the body's ability to detect and eliminate cancerous cells. Prior radiation therapy may further elevate this risk, complicating management and necessitating careful monitoring and treatment strategies.",
        "contexts": "radiation therapy different from chemotherapy | Immunotherapy different from chemotherapy | Immunotherapy different from surgery | systemic therapy different from radiation therapy, systemic therapy subclass of radiation therapy, systemic therapy opposite of radiation therapy, radiation therapy different from systemic therapy | radiation different from chemotherapy, chemotherapy different from radiation | chemotherapy different from Immunotherapy | Chemoradiation different from chemotherapy, chemotherapy different from Chemoradiation | radiation therapy opposite of chemotherapy, chemotherapy opposite of radiation therapy | immune checkpoint inhibitor therapy by itself different from immune checkpoint inhibitor therapy, immune checkpoint inhibitor therapy different from immune checkpoint inhibitor therapy by itself | systemic therapy opposite of radiation therapy | Chemoradiation different from local excision | radiation therapy has effect Skin cancer | radiation therapy uses high-energy radiation | systemic therapy opposite of radiation therapy, systemic therapy subclass of radiation therapy | radiation has effect cancer | surgery different from systemic therapy, systemic therapy different from surgery | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer",
        "metrics": {
          "rouge_score": 0.18518518518518517,
          "answer_correctness": 0.9805902149492782
        }
      },
      {
        "id": "Medical-02d254bc",
        "question": "For which stages of cervical cancer is surgery the primary treatment, and when is chemoradiation preferred?",
        "ground_truth": "Surgery is primary for early-stage cervical cancer, while chemoradiation is preferred for locally advanced stages.",
        "generated_answer": "Surgery is the primary treatment for Stage 1A2 and 1B1 cervical cancer. Chemoradiation is preferred for Stage 1B3 cervical cancer.",
        "contexts": "systemic therapy subclass of surgery, Chemoradiation subclass of surgery, External beam radiation therapy subclass of surgery, brachytherapy subclass of surgery | radiation therapy subclass of surgery | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery | Chemoradiation subclass of chemotherapy | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | Chemoradiation subclass of first-line therapy | Adenocarcinoma subclass of cervical cancer, Chemoradiation subclass of surgery | radiation therapy subclass of Treatment | radiation therapy subclass of surgery, Tumors on other areas of the body Surgery subclass of surgery | Chemoradiation subclass of platinum chemotherapy | radiation therapy subclass of Treatment, systemic therapy subclass of radiation therapy | Chemoradiation Chemotherapy subclass of radiation therapy, radiation subclass of combination of three treatments, TURBT subclass of combination of three treatments, Trimodal therapy subclass of combination of three treatments, Chemoradiation instance of Cancer treatment, chemoradiotherapy said to be the same as Chemoradiation, Chemoradiation subclass of combination of three treatments | radiation therapy subclass of chemotherapy | radiation therapy subclass of Chemotherapy | radiation therapy subclass of Treatment, surgery subclass of treated | radiation therapy subclass of treated | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | surgery subclass of Treatment",
        "metrics": {
          "rouge_score": 0.6666666666666665,
          "answer_correctness": 0.8423616141097099
        }
      },
      {
        "id": "Medical-a0c1c9cd",
        "question": "Why is the anatomical knowledge of layers like lamina propria and muscularis important for understanding tumor invasion in bile duct cancer?",
        "ground_truth": "Because the depth of tumor invasion into these layers determines the cancer stage and treatment approach.",
        "generated_answer": "Understanding the anatomical layers such as lamina propria and muscularis is crucial for assessing how tumors invade surrounding tissues in bile duct cancer. This knowledge helps in determining the extent of cancer spread and informs treatment strategies.",
        "contexts": "Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | muscularis propria followed by serosa, serosa follows muscularis propria, colon wall has part mucosa, muscularis propria follows submucosa, colon wall part of colon, colon wall has part fourth layer, colon has part colon wall, submucosa part of colon wall, abdomen connects with colon, colon connects with abdomen, submucosa followed by muscularis propria | Lamina propria instance of layer | female reproductive system has part cervix, female reproductive system has part vagina, uterus has part fallopian tubes, uterus connects with cervix, ectocervix part of cervix, female reproductive system has part ovaries, fallopian tubes connects with ovaries, fallopian tubes part of uterus, vagina part of female reproductive system, cervix part of vagina, sexual reproduction has part reproductive system, cervix connects with uterus, ovaries part of female reproductive system, cervix part of female reproductive system, vagina has part cervix, vagina connects with ovaries, female reproductive system has part uterus, fallopian tubes part of female reproductive system, ovaries connects with vagina, uterus part of female reproductive system, ovaries connects with fallopian tubes, cervix has part endocervix, ectocervix part of cervical lining, vagina has part os, Squamous cell part of ectocervix, endocervix part of cervix, cervix connects with uterus, uterus connects with vagina, os part of vagina, ectocervix connects with endocervix, uterus connects with cervix, vagina connects with uterus, endocervix connects with ectocervix, pelvis connects with uterus, cervical lining has part ectocervix, uterus connects with pelvis, endocervix connects with cervix, cervix connects with endocervix, uterus has part cervix | trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx | small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | intestines connects with abdomen, abdomen connects with intestines | esophagus connects with esophagogastric junction | windpipe connects with throat, bronchioli connects with bronchi, stomach connects with small intestine, esophagus has part inner lining, small intestine connects with stomach, stomach connects with esophagus, inner lining part of esophagus, digestive system has part esophagus, esophagus connects with stomach | lung tissue connects with airway, airway connects with lung tissue | Antrum part of stomach, stomach part of digestive system, diaphragm connects with stomach, chest connects with abdomen, digestive system has part stomach, heart connects with lungs, small intestine has part <triplet>duodenum stomach, chest connects with heart, heart connects with chest, submucosa has part muscle | bronchi connects with bronchioles, bronchioles connects with bronchi, Airways of the lungs has part alveoli, alveoli connects with bronchioles | small intestine part of small intestine, stomach part of intestines, Body part of stomach, intestines has part stomach, esophagus connects with pylorus, small intestine has part <triplet>duodenum stomach, esophagus connects with stomach, digestive system has part The digestive system, stomach connects with small intestine, small intestine connects with stomach, stomach connects with diaphragm | cervix connects with cervical | bronchi connects with trachea, trachea connects with trachea",
        "metrics": {
          "rouge_score": 0.2641509433962264,
          "answer_correctness": 0.9809468871413995
        }
      },
      {
        "id": "Medical-a56d528c",
        "question": "How does the origin of RCC differ from that of urothelial carcinoma within the kidney?",
        "ground_truth": "RCC starts in the cells lining the renal tubules, while urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
        "generated_answer": "RCC originates from renal tubular cells, while urothelial carcinoma arises from the urothelial cells lining the urinary tract, including the renal pelvis.",
        "contexts": "bladder cancer location urinary tract | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | kidney cancer has cause kidney | renal pelvis connects with ureter, kidney has part renal pelvis, ureter connects with renal pelvis, full, healthy lives with only one kidney subclass of less than one complete kidney, vena cava connects with renal vein, ureter connects with bladder, renal pelvis part of kidney, bladder connects with urethra, kidney connects with renal pelvis, renal vein connects with vena cava, bladder connects with ureter, urethra connects with bladder, renal pelvis connects with kidney, kidney has part renal tubules, renal tubules part of kidney | Further testing facet of kidney cancer | kidney connects with lymph nodes, lymph nodes connects with kidney, kidney connects with Blood, renal vein connects with renal artery, kidney has part renal vein, renal artery connects with renal vein, renal vein part of kidney | cancer location prostate | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | inner kidney part of urinary tract, urinary tract has part inner kidney | muscle layer part of bladder, body has part urinary tract, bladder has part urothelial cells, urothelial layer part of bladder, bladder has part muscle layer, urinary tract part of body | kidney connects with bladder, kidney connects with ureter | kidney part of organs | vena cava part of kidney, kidney has part renal tubules, renal tubules part of kidney, Renal cell carcinoma subclass of kidney cancer | kidney connects with ureter, ureter connects with kidney | kidney connects with ureter | kidneys has part Creatinine, kidneys part of Blood, Blood has part kidneys, Creatinine part of kidneys | vena cava part of kidney | Red blood cell part of Blood, Creatinine part of kidneys, kidneys has part Creatinine, kidneys part of Blood, Blood has part kidneys, Blood has part platelet",
        "metrics": {
          "rouge_score": 0.5,
          "answer_correctness": 0.8462953882383781
        }
      },
      {
        "id": "Medical-1852bc75",
        "question": "What is the rationale for using both oral medications and IV infusions in the treatment of CLL?",
        "ground_truth": "Combination therapy using oral and IV drugs may be required for optimal disease control based on disease progression and patient factors.",
        "generated_answer": "The rationale for using both oral medications and IV infusions in the treatment of CLL is to combine the benefits of different therapeutic approaches, enhancing efficacy and targeting the disease more effectively. This combination can help manage symptoms and improve patient outcomes by utilizing various mechanisms of action.",
        "contexts": "IV infusion subclass of combination | intravenously subclass of infused | Infusions subclass of injected | intravenously subclass of Medicines, injected subclass of Medicines | 5-FU subclass of continuous (constant) infusion | 5-FU subclass of continuous (constant) infusion, radiation therapy subclass of Infusions, 5-FU part of 5-FU infusions | IV subclass of directly into a vein | days of rest subclass of Infusions | Intravenous (IV) contrast subclass of X-ray, Intravenous (IV) contrast subclass of contrast material, CT scan subclass of computed tomography | injected subclass of pain blocker | Chemotherapy subclass of liquid, Standard of care subclass of treatment regimen | Antacid subclass of Medicines, vitamins subclass of Medicines, heart or blood pressure medicine subclass of Medicines, over-the-counter subclass of Medicines | Blood subclass of sample | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Immunotherapy subclass of Chemotherapy, combined subclass of Therapeutic, Steroids subclass of Chemotherapy, chemotherapy subclass of Therapeutic | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | chemotherapy subclass of Treatment, cycle subclass of Chemotherapy",
        "metrics": {
          "rouge_score": 0.2028985507246377,
          "answer_correctness": 0.9804235612024408
        }
      },
      {
        "id": "Medical-e1ef9e9b",
        "question": "If a patient presents with enlarged lymph nodes and the diagnosis is B-cell lymphoblastic lymphoma, what does this indicate about the disease site and cell of origin?",
        "ground_truth": "It indicates that B-cell lymphoblasts are primarily growing in lymph nodes and originate from lymphoid progenitor cells.",
        "generated_answer": "The disease site is the lymphatic system, and the cell of origin is B-cell lymphoblasts.",
        "contexts": "Lymphoma has effect lymph nodes | cancer has cause lymph nodes, lymph nodes has effect cancer | enlarged spleen has effect Follicular lymphoma | T lymphocyte has effect B-cell lymphoblastic lymphoma | Head and neck cancer has cause lymph nodes, Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | lymph nodes has effect metastases, metastases location lymph nodes | B-cell lymphoblasts part of lymph nodes | lymph nodes has effect lymph node removed, bone marrow connects with lymph nodes | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell | Lymphatic system has effect Hodgkin lymphoma | bone marrow has effect CLL, CLL has cause bone marrow | ALL has cause Lymphoblast | lymph nodes connects with bone marrow | brain has effect CNS lymphoma | Acute lymphoblastic leukemia instance of cancer",
        "metrics": {
          "rouge_score": 0.17647058823529413,
          "answer_correctness": 0.8322777317254708
        }
      },
      {
        "id": "Medical-96508468",
        "question": "Why are both immunophenotyping and biopsy necessary in the diagnostic workup of follicular lymphoma?",
        "ground_truth": "Both are required to identify cell type and confirm the diagnosis, as FL arises from abnormal B lymphocytes and is graded based on cell proportions.",
        "generated_answer": "Immunophenotyping is necessary to analyze the immune characteristics of the lymphoma cells, while biopsy provides tissue samples for histological examination and confirmation of the diagnosis. Together, they enhance the accuracy of the diagnostic workup for follicular lymphoma.",
        "contexts": "Immunophenotyping subclass of Biopsy | immunophenotyping facet of immune system, Flow cytometry subclass of blood test | immunophenotype subclass of Proteins | biomarker testing subclass of biopsy, biopsy subclass of test results | biopsy subclass of diagnosis | Diagnosis by blood test subclass of blood test | testing Biopsy subclass of biopsy | biopsy subclass of testing | biomarker test subclass of test | biomarker test subclass of biomarker | biopsy subclass of test results | case-by-case subclass of biomarker testing, tumor profiling subclass of biomarker testing | Imaging subclass of test results, biomarker test subclass of biopsy | biomarker testing subclass of Molecular | testing subclass of diagnosis | detection methods subclass of diagnosis | biomarker subclass of genetic testing | genetic testing subclass of diagnostic test",
        "metrics": {
          "rouge_score": 0.1935483870967742,
          "answer_correctness": 0.7291169025834883
        }
      },
      {
        "id": "Medical-370cff35",
        "question": "How does stomach cancer typically progress from a precancerous state to metastatic disease?",
        "ground_truth": "It begins with mucosal changes, spreads outward through stomach wall layers, and eventually reaches distant organs like the liver.",
        "generated_answer": "Stomach cancer typically progresses from a precancerous state through stages of cancer development, leading to localized tumors that can metastasize to other parts of the body. As the cancer advances, it may invade surrounding tissues and lymph nodes, eventually resulting in metastatic disease.",
        "contexts": "early stages of cancer followed by cancer progresses, cancer progresses follows early stages of cancer | squamous cell carcinoma followed by Adenocarcinoma, Adenocarcinoma follows squamous cell carcinoma | advanced-stage prostate cancer follows early-stage prostate cancer, early-stage prostate cancer followed by advanced-stage prostate cancer | Metastatic cancer has cause Cancer stages and metastasis | metastatic subclass of cancer | metastatic different from Locally advanced cancer, Locally advanced cancer different from metastatic | metastatic disease subclass of cancer | Stage 1 subclass of Stage 1A1 cancers, pre-cancer subclass of cancer | metastasize often different from metastasis, metastasis different from metastasize often | early-stage prostate cancer followed by advanced-stage prostate cancer, Advanced stage subclass of prostate cancer, Advanced stage subclass of prostate cancer | de novo subclass of Metastatic cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Progressive disease subclass of cancer, locally progressive subclass of metastatic disease, non-metastatic anal cancer subclass of metastatic anal cancer | metastatic subclass of prostate cancer",
        "metrics": {
          "rouge_score": 0.09677419354838708,
          "answer_correctness": 0.8078966785290148
        }
      },
      {
        "id": "Medical-0030eab4",
        "question": "What combination of cell types is used to determine the grade of follicular lymphoma and how does this affect management?",
        "ground_truth": "The proportion of centrocytes and centroblasts determines the grade, which guides treatment decisions.",
        "generated_answer": "The combination of cell types used to determine the grade of follicular lymphoma includes centroblasts and other lymphoid cells. This grading affects management by influencing treatment options and prognosis.",
        "contexts": "centroblast facet of Lymphoma, classic FL subclass of Follicular lymphoma | lymph nodes facet of cancer | induction phase facet of Lymphoma, more than one treatment option facet of primary CNS lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | more than one treatment option facet of CNS lymphoma | Removing or reducing facet of Lymphoma | Follicular lymphoma subclass of Lymphoma | Chemotherapy facet of cancer | chemotherapy facet of cancer | Treatment facet of CNS lymphoma | more than one treatment option facet of cancer | testing the CSF facet of CNS lymphoma | sentinel lymph node biopsy facet of lymph nodes | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Types facet of adrenal tumor | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Bone marrow test facet of Leukemia | Hodgkin lymphoma Testing for Hodgkin lymphoma facet of Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.28571428571428575,
          "answer_correctness": 0.7324519740848267
        }
      },
      {
        "id": "Medical-141fd876",
        "question": "Why are both flow cytometry and immunophenotyping required in the diagnostic process for ALL?",
        "ground_truth": "Both are required to accurately identify the lineage and subtype of ALL cells by analyzing their surface markers.",
        "generated_answer": "Both flow cytometry and immunophenotyping are essential in the diagnostic process for Acute Lymphoblastic Leukemia (ALL) as they provide critical information about the immune system and cell characteristics, aiding in accurate diagnosis and treatment planning.",
        "contexts": "Immunophenotyping subclass of Biopsy | immunophenotype subclass of Proteins | immunophenotyping facet of immune system, Flow cytometry subclass of blood test | biomarker test subclass of test | biomarker test subclass of biomarker | Immunohistochemistry subclass of staining | Diagnosis by blood test subclass of blood test | biomarker testing subclass of biopsy, biopsy subclass of test results | Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of Molecular | biopsy subclass of diagnosis | tumor profiling subclass of biomarker testing | detection methods subclass of diagnosis | genetic testing subclass of diagnostic test | Imaging subclass of test results, biomarker test subclass of biopsy | Immunotherapy subclass of Biomarker-based treatment | biopsy subclass of testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | blood smear subclass of Flow cytometry",
        "metrics": {
          "rouge_score": 0.18867924528301885,
          "answer_correctness": 0.6373525363698053
        }
      },
      {
        "id": "Medical-58981bbb",
        "question": "What combination of cell type and clinical presentation would suggest a diagnosis of cutaneous B-cell lymphoma rather than T-cell lymphoma?",
        "ground_truth": "A neoplasm originating from B lymphocytes presenting as nodules or papules under the skin suggests cutaneous B-cell lymphoma.",
        "generated_answer": "A combination of B lymphocytes and cutaneous lesions would suggest a diagnosis of cutaneous B-cell lymphoma rather than T-cell lymphoma.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | Cutaneous T-cell lymphoma subclass of Lymphoma, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell, Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma, B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | melanoma different from nonmelanoma skin cancer, squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | squamous cell skin cancer different from CSCC | tumors different from cancer, cancer different from tumors | Immunotherapy different from chemotherapy | non-Hodgkin PMBL subclass of Hodgkin lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma | chemotherapy different from Immunotherapy | Lymphoblast different from myeloblast | Burkitt lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.3902439024390244,
          "answer_correctness": 0.4853725945370247
        }
      },
      {
        "id": "Medical-ca3e2437",
        "question": "Which diagnostic procedures are necessary to both confirm an AML diagnosis and determine the specific subtype?",
        "ground_truth": "Bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, and molecular/cytogenetic testing are required.",
        "generated_answer": "Diagnostic procedures necessary to confirm an AML diagnosis and determine the specific subtype include blood tests, bone marrow biopsy, and cytogenetic analysis.",
        "contexts": "Subtypes of AML subclass of AML, Subtypes of AML subclass of Subtypes of AML | AML subclass of blood cancer, Subtypes of AML subclass of Subtypes of AML | rare subtype of AML subclass of AML | blasts subclass of AML, Acute myeloid leukemia subclass of blood cancer | AML subclass of blood cancer | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | myelodysplastic syndrome subclass of Acute myeloid leukemia | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | blast phase CML subclass of CML, BP-CML subclass of CML | CML subclass of cancer | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Granulocyte has part Eosinophil, Granulocyte subclass of white blood cell, white blood cell <subj>granulocyte subclass of white blood cell, Neutrophil subclass of Granulocyte, white blood cell has part Granulocyte, Granulocyte has part Basophil, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | Acute lymphoblastic leukemia subclass of blood cancer | mitoxantrone subclass of anthracycline, Methotrexate subclass of anthracycline, idarubicin subclass of anthracycline, anthracycline has part Clofarabine, anthracycline has part Cytarabine, Cladribine subclass of anthracycline, Fludarabine subclass of anthracycline",
        "metrics": {
          "rouge_score": 0.2777777777777778,
          "answer_correctness": 0.5788573213872673
        }
      },
      {
        "id": "Medical-c6a7964c",
        "question": "How do risk factors for primary liver cancer differ from those for secondary liver cancer according to the ontology?",
        "ground_truth": "Primary liver cancer risk factors include cirrhosis, hepatitis B, hepatitis C, and others, while secondary liver cancer originates from cancers in other organs.",
        "generated_answer": "Risk factors for primary liver cancer are different from those for secondary liver cancer, as primary liver cancer is often associated with specific causes like hepatitis and cirrhosis, while secondary liver cancer results from metastasis from other primary tumors.",
        "contexts": "hepatocellular carcinoma subclass of Secondary liver cancer, HCC subclass of Liver cancer | primary liver cancer subclass of cancer | primary liver cancer subclass of Liver cancer | Liver cancer has cause liver | cancer different from cancer type, cancer type different from cancer | cancer different from tumors, tumors different from cancer | lung cancer different from lung cancer | prostate cancer different from prostate cancer | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | Liver cancer has cause increased risk, increased risk has effect Liver cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | primary tumor opposite of metastasis | Locally advanced cancer different from metastatic",
        "metrics": {
          "rouge_score": 0.3548387096774194,
          "answer_correctness": 0.9961668722516859
        }
      },
      {
        "id": "Medical-48843076",
        "question": "How does the location and stage of a mouth tumor influence treatment planning?",
        "ground_truth": "Treatment planning is based on both tumor location and stage.",
        "generated_answer": "The location and stage of a mouth tumor significantly influence treatment planning by determining the most effective treatment options available, assessing risks, and establishing the best treatment plan tailored to the patient's specific condition.",
        "contexts": "plan treatment facet of Treatment | plan treatment facet of Treatment, plan treatment facet of disease | Treatment facet of Treatment, more than one treatment option facet of Treatment | Treatment planning facet of cancer | Treatment facet of disease | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment | plan treatment facet of Treatment, Treatment has part plan treatment | plan treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | Cancer treatment facet of cancer | risks facet of plan treatment | Treatment decisions facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | Goals of systemic therapy facet of Treatment | assessment of their risks facet of Treatment | best treatment plan facet of cancer | Cancer treatment subclass of plan treatment, plan treatment facet of Cancer treatment | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility",
        "metrics": {
          "rouge_score": 0.13333333333333333,
          "answer_correctness": 0.9865168080418134
        }
      },
      {
        "id": "Medical-7718481e",
        "question": "If imaging and biochemical tests reveal an adrenal mass with excess aldosterone, what is the most probable diagnosis?",
        "ground_truth": "Aldosteronoma is the most probable diagnosis.",
        "generated_answer": "aldosteronoma",
        "contexts": "Adrenal medulla part of Adrenal gland, Adrenal gland part of kidney | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | Adrenal gland part of endocrine system, Adrenal gland product or material produced hormones, endocrine system has part Adrenal gland, Adrenal gland has part Adrenal medulla | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | renal pelvis connects with ureter, kidney has part renal pelvis, ureter connects with renal pelvis, full, healthy lives with only one kidney subclass of less than one complete kidney, vena cava connects with renal vein, ureter connects with bladder, renal pelvis part of kidney, bladder connects with urethra, kidney connects with renal pelvis, renal vein connects with vena cava, bladder connects with ureter, urethra connects with bladder, renal pelvis connects with kidney, kidney has part renal tubules, renal tubules part of kidney | tumor part of prostate | female reproductive system has part cervix, female reproductive system has part vagina, uterus has part fallopian tubes, uterus connects with cervix, ectocervix part of cervix, female reproductive system has part ovaries, fallopian tubes connects with ovaries, fallopian tubes part of uterus, vagina part of female reproductive system, cervix part of vagina, sexual reproduction has part reproductive system, cervix connects with uterus, ovaries part of female reproductive system, cervix part of female reproductive system, vagina has part cervix, vagina connects with ovaries, female reproductive system has part uterus, fallopian tubes part of female reproductive system, ovaries connects with vagina, uterus part of female reproductive system, ovaries connects with fallopian tubes, cervix has part endocervix, ectocervix part of cervical lining, vagina has part os, Squamous cell part of ectocervix, endocervix part of cervix, cervix connects with uterus, uterus connects with vagina, os part of vagina, ectocervix connects with endocervix, uterus connects with cervix, vagina connects with uterus, endocervix connects with ectocervix, pelvis connects with uterus, cervical lining has part ectocervix, uterus connects with pelvis, endocervix connects with cervix, cervix connects with endocervix, uterus has part cervix | adrenal tumor has cause conditions listed below | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | tumor has part tumor(s), tumor(s) part of tumor | adrenal tumor subclass of tumor | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | tumor part of cancer | pituitary gland part of endocrine | Benign (not cancer) adrenal tumor subclass of adrenal tumor | Red blood cell part of Blood, Creatinine part of kidneys, kidneys has part Creatinine, kidneys part of Blood, Blood has part kidneys, Blood has part platelet | lymph nodes part of tissues, tissues part of tumor, organs has part tissues, tumor has part tissues, tissues part of organs | Types facet of adrenal tumor",
        "metrics": {
          "rouge_score": 0.2857142857142857,
          "answer_correctness": 0.9835985967180548
        }
      },
      {
        "id": "Medical-6108fa72",
        "question": "What follow-up strategies are recommended for CLL patients not requiring immediate therapy, and what is their purpose?",
        "ground_truth": "Watch and wait, regular monitoring, and supportive care are used to track disease progression and manage symptoms.",
        "generated_answer": "Recommended follow-up strategies for CLL patients not requiring immediate therapy include regular monitoring and surveillance to assess disease progression. The purpose is to ensure timely intervention if the disease worsens or requires treatment.",
        "contexts": "Follow-up and surveillance subclass of Treatment | rounds of treatment subclass of follow-up visits, stabilized subclass of Treatment | type of therapy subclass of therapy | Treatment subclass of Treatment | plan treatment subclass of course of action | Clinical trial subclass of Treatment | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | maintenance therapy subclass of Clinical trial | investigational treatments subclass of Clinical trial, Clinical trial subclass of plan treatment | initial treatment subclass of Treatment | systemic therapy subclass of therapies | Treatment subclass of monitoring | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | Cancer treatment subclass of Treatment | remission subclass of Treatment | supportive care subclass of Treatment | Standard of care subclass of treatment regimen | targeted therapy subclass of Treatment | radiation therapy subclass of Treatment | plan treatment subclass of diagnosis",
        "metrics": {
          "rouge_score": 0.23529411764705885,
          "answer_correctness": 0.6793319562418447
        }
      },
      {
        "id": "Medical-ade34649",
        "question": "Which diagnostic procedures are used for tissue sampling in throat cancer, and why are they important?",
        "ground_truth": "Fine-needle aspiration, core needle biopsy, and endoscopic biopsies are used to obtain tissue for definitive diagnosis and biomarker testing.",
        "generated_answer": "Diagnostic procedures for tissue sampling in throat cancer include biopsy, imaging, and biomarker testing. They are important for confirming the diagnosis, determining the type of cancer, and guiding treatment decisions.",
        "contexts": "biopsy subclass of tissue sample | biopsy subclass of testing | biopsy subclass of procedure | biomarker testing subclass of biopsy, biopsy subclass of test results | Biopsy subclass of test | biopsy subclass of test | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | biopsy subclass of Imaging, Immunophenotyping subclass of Biopsy | Biopsy subclass of Imaging | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy | biopsy subclass of diagnosis | testing Biopsy subclass of biopsy | confirmatory biopsy subclass of biopsy | Imaging subclass of biopsy | biopsy subclass of test results | Biopsy subclass of biopsy | biopsy subclass of surgical procedure | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | Imaging subclass of test results, biomarker test subclass of biopsy",
        "metrics": {
          "rouge_score": 0.24,
          "answer_correctness": 0.764893118227677
        }
      },
      {
        "id": "Medical-26ced7a1",
        "question": "How are endoscopic and surgical options distinguished for early-stage rectal tumors?",
        "ground_truth": "Endoscopic methods like ESD and EMR are used for T1 tumors, while transabdominal surgery is used for T2 and some T1/T3 tumors.",
        "generated_answer": "Endoscopic options are minimally invasive procedures like endoscopic mucosal resection, while surgical options involve more invasive techniques such as colectomy or radical hysterectomy.",
        "contexts": "Endoscopy subclass of Biopsy | esophagoscopy subclass of endoscopes, laryngoscopy subclass of endoscopes, pharyngoscopy subclass of endoscopes | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | endoscopic ultrasound subclass of Imaging, polypectomy subclass of surgery, flexible sigmoidoscopy subclass of sigmoidoscopy, endoscope subclass of scope, Endoscopic submucosal dissection subclass of minimally invasive procedure, endoscopic mucosal resection uses endoscope | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | colonoscopy subclass of colonoscopy | minimally invasive procedure subclass of surgery | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | surgery subclass of operation | biopsy subclass of surgical procedure | Resectable subclass of surgery | open biopsy subclass of surgery | pathologic examination subclass of surgery | surgical excision subclass of surgery | endoscope subclass of scope | resection subclass of surgical procedure",
        "metrics": {
          "rouge_score": 0.13043478260869565,
          "answer_correctness": 0.896390480029841
        }
      },
      {
        "id": "Medical-bcfc4592",
        "question": "What surveillance methods are recommended after complete remission of Stage III anal cancer, and how does the frequency of these methods vary?",
        "ground_truth": "DRE and inguinal lymph node exams every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years are recommended.",
        "generated_answer": "Surveillance methods recommended after complete remission of Stage III anal cancer typically include regular physical examinations, imaging studies, and possibly endoscopic evaluations. The frequency of these methods may vary, often involving more frequent assessments in the first few years post-remission, gradually decreasing as time progresses without recurrence.",
        "contexts": "Stage III subclass of Anal cancer, stage II subclass of Anal cancer, Anal tumor subclass of stage IIA | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | Stage III subclass of cancer | squamous cell carcinoma subclass of Anal cancer, anal melanoma subclass of Anal squamous cell carcinoma | Anal cancer subclass of cancer | intermediate-grade subclass of perianal cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Stage I anal cancer followed by Stage II anal cancer, Stage II anal cancer follows Stage I anal cancer, Stage 1 subclass of Stage I anal cancer, carcinoma in situ subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | Stage 3B subclass of cancer | Anal cancer subclass of cervical cancer | Stage 3B subclass of cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | SISCCA Superficially invasive squamous cell carcinoma subclass of Anal cancer",
        "metrics": {
          "rouge_score": 0.05194805194805195,
          "answer_correctness": 0.765416725604237
        }
      },
      {
        "id": "Medical-b272ce63",
        "question": "Which anatomical structures are directly involved in the spread of kidney cancer and how are these structures classified?",
        "ground_truth": "Renal vein, renal artery, Gerota\u2019s fascia, adrenal gland, and lymph nodes are anatomical structures involved in local spread or metastasis of kidney cancer.",
        "generated_answer": "Gerota\u2019s fascia and lymph nodes are anatomical structures involved in the spread of kidney cancer. Gerota\u2019s fascia is classified as a subclass of kidney cancer, while lymph nodes are a facet of cancer.",
        "contexts": "Gerota\u2019s fascia has effect Kidney cancer | lymph nodes facet of cancer | Further testing facet of kidney cancer | Gerota\u2019s fascia subclass of kidney cancer | biopsy facet of cancer | kidney cancer has cause kidney | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Imaging facet of cancer | grade facet of cancer, staging facet of cancer | cancer stage facet of cancer | tumor, node, metastasis facet of colon cancer | Staging facet of cancer | staging facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Imaging Imaging facet of cancer | stage facet of cancer | Cancer grade facet of cancer | Staging The cancer stage facet of cancer | cervical biopsy facet of cervical cancer",
        "metrics": {
          "rouge_score": 0.5084745762711864,
          "answer_correctness": 0.45727093306835576
        }
      },
      {
        "id": "Medical-e9900b5c",
        "question": "Why is androgen deprivation therapy a key component in the management of metastatic prostate cancer?",
        "ground_truth": "Because ADT is a mainstay for advanced disease and is included among treatments for metastatic prostate cancer.",
        "generated_answer": "Androgen deprivation therapy is crucial in managing metastatic prostate cancer because it reduces levels of male hormones that fuel the growth of prostate cancer cells, thereby slowing disease progression and improving patient outcomes.",
        "contexts": "prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer, prostate cancer has effect PSA | prostate cancer drug used for treatment its treatment, its treatment medical condition treated prostate cancer | prostate cancer drug used for treatment treat | prostate cancer drug used for treatment flutamide, nilutamide medical condition treated prostate cancer, prostate cancer drug used for treatment hormone replacement therapy, triptorelin subject has role <triplet>nilutamide Anti-androgen, leuprolide subject has role Anti-androgen, triptorelin subject has role Anti-androgen, Hormone therapies for prostate cancer has part LHRH antagonists, hormone replacement therapy medical condition treated prostate cancer, bicalutamide subject has role Anti-androgen, flutamide subject has role Anti-androgen, goserelin subject has role Anti-androgen, prostate cancer drug used for treatment bicalutamide, bicalutamide medical condition treated prostate cancer, flutamide medical condition treated prostate cancer, prostate cancer drug used for treatment nilutamide | cancer drug used for treatment treatments | cancer drug used for treatment Treatment | treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | new tests and treatments facet of prostate cancer, detection methods and treatments medical condition treated prostate cancer, treatment choices now than they had before facet of prostate cancer, prostate cancer has cause prostate gland, prostate cancer drug used for treatment detection methods and treatments | cancer drug used for treatment Cancer treatment | Treatment medical condition treated cancer | cancer drug used for treatment cancer | platinum-based chemotherapy medical condition treated Metastatic anal cancer",
        "metrics": {
          "rouge_score": 0.16,
          "answer_correctness": 0.983811798263919
        }
      },
      {
        "id": "Medical-f034d77d",
        "question": "How does UV radiation contribute to both the development and recurrence of basal cell carcinoma?",
        "ground_truth": "UV radiation is a primary risk factor for BCC and continued exposure increases recurrence risk.",
        "generated_answer": "UV radiation causes damage to skin cells, leading to mutations that can result in the development of basal cell carcinoma. Additionally, repeated exposure increases the risk of recurrence by further damaging the skin and promoting the growth of cancerous cells.",
        "contexts": "skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer, skin cancer has cause melanin | skin cancer has cause develops, develops has effect skin cancer | Skin cancer has cause Squamous cell | Skin cancer has cause Skin cell, Skin cell has effect Skin cancer | radiation has cause Cancer cells | radiation therapy has effect Skin cancer, Skin cancer has cause radiation therapy, skin cancer drug used for treatment surgery, skin cancer drug used for treatment radiation therapy, basal cell subclass of skin cancer | squamous cell carcinoma has cause Squamous cell | genetic risk of skin cancer studied by cancer genetics, skin cancer has cause Skin cell, Skin cell has effect skin cancer | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | radiation has effect cancer | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | cancer has cause Cancer cells | Testing for basal cell skin cancer facet of Basal cell skin cancer, basal cell subclass of skin cancer | cancer has cause cancer",
        "metrics": {
          "rouge_score": 0.18181818181818182,
          "answer_correctness": 0.8349951523596368
        }
      },
      {
        "id": "Medical-1e1b5f1d",
        "question": "What diagnostic procedures are necessary to confirm follicular lymphoma and why are multiple methods required?",
        "ground_truth": "Diagnosis requires blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping to fully characterize the disease.",
        "generated_answer": "Diagnostic procedures necessary to confirm follicular lymphoma include biopsies, imaging tests, and lymph node examinations. Multiple methods are required to ensure accurate diagnosis and staging of the lymphoma, as each procedure provides different critical information about the disease.",
        "contexts": "diagnosis facet of cancer | Hodgkin lymphoma Testing for Hodgkin lymphoma facet of Hodgkin lymphoma | Removing or reducing facet of Lymphoma | Lymph node exam facet of lymph nodes | biopsy facet of cancer | Follicular lymphoma subclass of non-Hodgkin lymphoma | testing the CSF facet of CNS lymphoma | induction phase facet of Lymphoma | centroblast facet of Lymphoma, classic FL subclass of Follicular lymphoma | Bone marrow test facet of Leukemia | Follicular lymphoma subclass of Lymphoma | Bone marrow biopsy medical condition treated Lymphoma, Treatment facet of Lymphoma, Bone marrow biopsy studies marrow | lymph nodes facet of cancer | sentinel lymph node biopsy facet of lymph nodes | test facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | Imaging facet of cancer",
        "metrics": {
          "rouge_score": 0.21428571428571427,
          "answer_correctness": 0.6400802645373412
        }
      },
      {
        "id": "Medical-aa1b8dbb",
        "question": "How does a patient's performance status influence nasopharyngeal carcinoma treatment planning?",
        "ground_truth": "Performance status is assessed and considered in NPC treatment planning as a prognostic factor.",
        "generated_answer": "A patient's performance status influences nasopharyngeal carcinoma treatment planning by determining the best treatment plan, assessing risks, and guiding treatment decisions based on the patient's ability to tolerate therapies.",
        "contexts": "plan treatment facet of Treatment | plan treatment facet of Treatment, plan treatment facet of disease | Treatment facet of Treatment, more than one treatment option facet of Treatment | Treatment planning facet of cancer | Treatment facet of disease | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment | plan treatment facet of Treatment, Treatment has part plan treatment | plan treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | Cancer treatment facet of cancer | risks facet of plan treatment | Treatment decisions facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | Goals of systemic therapy facet of Treatment | assessment of their risks facet of Treatment | best treatment plan facet of cancer | Cancer treatment subclass of plan treatment, plan treatment facet of Cancer treatment | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility",
        "metrics": {
          "rouge_score": 0.2222222222222222,
          "answer_correctness": 0.7356677850291178
        }
      },
      {
        "id": "Medical-af6105a0",
        "question": "What are the recommended fertility preservation options for rectal cancer patients, and why might these be important?",
        "ground_truth": "Sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition are recommended, important due to risks of premature ovarian insufficiency from treatment.",
        "generated_answer": "Recommended fertility preservation options for rectal cancer patients include fertility-sparing surgery and germline testing. These options are important to mitigate fertility-related risks and allow patients the possibility of having children after treatment.",
        "contexts": "Fertility-sparing surgery facet of cancer | fertility preservation options facet of fertility | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | fertility preservation options subclass of having children after treatment, inability to produce children subclass of infertility, fertility preservation options facet of fertilityrelated risks | Treatment facet of Anal cancer | Chemoradiation facet of Anal cancer | Rectal cancer subclass of syndromes | Germline testing facet of cancer | Fertility-sparing surgery facet of pregnancy | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Treatment facet of colon cancer | Rectal cancer subclass of lesion | Rectal cancer subclass of Cancer cells | fertility preservation options subclass of keeping your options open | fertility facet of health | Rectal cancer subclass of surgery | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | feces has effect Rectal cancer | tumor, node, metastasis facet of colon cancer | lower risk facet of prostate cancer",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.22902702203585704
        }
      },
      {
        "id": "Medical-c92bbd26",
        "question": "Why is immunophenotyping by flow cytometry essential in the diagnosis of CLL?",
        "ground_truth": "It identifies CLL cells by their surface proteins (CD20, CD200, LEF1), confirming the diagnosis after initial blood tests.",
        "generated_answer": "Immunophenotyping by flow cytometry is essential in the diagnosis of Chronic Lymphocytic Leukemia (CLL) because it allows for the identification and characterization of specific cell surface markers on lymphocytes, helping to distinguish CLL from other hematological disorders. This technique provides critical information about the immunophenotype of the leukemic cells, which is vital for accurate diagnosis and treatment planning.",
        "contexts": "blood smear subclass of Flow cytometry | Flow cytometry subclass of blood test, immunophenotyping facet of immune system | Immunophenotyping subclass of Biopsy | immunophenotype subclass of Proteins | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | biomarker subclass of test, biomarker test subclass of biomarker | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Fluorescence in situ hybridization subclass of biomarker | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | Granulocyte has part Eosinophil, Granulocyte subclass of white blood cell, white blood cell <subj>granulocyte subclass of white blood cell, Neutrophil subclass of Granulocyte, white blood cell has part Granulocyte, Granulocyte has part Basophil, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell | Immunohistochemistry subclass of staining | biomarker test subclass of test | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Immunotherapy subclass of Biomarker-based treatment | biomarker testing subclass of Molecular",
        "metrics": {
          "rouge_score": 0.13157894736842107,
          "answer_correctness": 0.8574988113345179
        }
      },
      {
        "id": "Medical-4191d4b2",
        "question": "Which two diagnostic methods are essential for both initial detection and definitive classification of glioma?",
        "ground_truth": "MRI is essential for initial detection and biopsy for definitive classification of glioma.",
        "generated_answer": "Imaging, biopsy",
        "contexts": "detection methods subclass of diagnosis | testing subclass of diagnosis | Imaging subclass of test results | Diagnostic mammogram subclass of mammogram | Diagnosis by blood test subclass of blood test | Ultrasound subclass of imaging test | imaging scan subclass of tests | genetic testing subclass of diagnostic test | Imaging subclass of test | Imaging subclass of test results, biomarker test subclass of biopsy | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | screening ultrasound subclass of Ultrasound | diagnostic CT subclass of X-ray, CAT scan subclass of diagnostic CT | Lab testing subclass of analysis | contrast subclass of Imaging | Imaging subclass of blood test | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | computed tomography subclass of Imaging | imaging test subclass of testing",
        "metrics": {
          "rouge_score": 0.13333333333333336,
          "answer_correctness": 0.6059061323639411
        }
      },
      {
        "id": "Medical-9626892c",
        "question": "If a patient with a history of cervical cancer presents with anal pain and is found to have HSIL on biopsy, what does this indicate about their risk and disease status?",
        "ground_truth": "They have an increased risk for anal cancer and HSIL represents a precancerous lesion (Stage 0).",
        "generated_answer": "This indicates a high risk for anal cancer due to the presence of HSIL (high-grade squamous intraepithelial lesion) and a history of cervical cancer, suggesting potential progression to cancer.",
        "contexts": "Anal cancer has effect anal dysplasia | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | Anal cancer subclass of cervical cancer | cervical cancer has cause Cervical changes Cervical cancer, cervical cancer has cause ectocervix, ectocervix has effect cervical cancer | cancer has effect pain | anal dysplasia has effect Anal cancer, HPV has effect infection | human papillomavirus has effect cervical cancer | cervical cancer has cause ectocervix, ectocervix has effect cervical cancer, Other risk factors facet of cervical cancer | cervical cancer has cause Cervical changes Cervical cancer, cervical cancer has cause cervical dysplasia | HPV has effect Throat cancer, Throat cancer has cause HPV | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | risk factors has effect cervical cancer, cervical cancer has cause risk factors | cervix connects with uterus, cervical cancer has part cervical cancer, lung has part lymph nodes, uterus connects with cervix, liver has part lymph nodes, lymph nodes part of liver, cervix connects with pelvic lymph nodes | cervical cancer different from ovarian cancer",
        "metrics": {
          "rouge_score": 0.26086956521739135,
          "answer_correctness": 0.8051178935871305
        }
      },
      {
        "id": "Medical-b016ff7a",
        "question": "Why is depth of invasion (DOI) important in the TNM staging of mouth cancer?",
        "ground_truth": "DOI is used to assess tumor extension and is a criterion in T classification for staging.",
        "generated_answer": "Depth of invasion (DOI) is important in the TNM staging of mouth cancer because it helps determine the extent of tumor invasion into surrounding tissues, which is crucial for assessing prognosis and treatment options.",
        "contexts": "tumor, node, metastasis (TNM) system facet of Mouth cancer, cM subclass of Mouth cancer, cN1 subclass of Mouth cancer | TNM staging information facet of squamous cell carcinoma | How mouth cancer is staged instance of cancer staging, How mouth cancer is staged facet of Mouth cancer, staging facet of cancer | Staging facet of cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Staging The cancer stage facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer | cancer staging facet of tumor | tumor, node, metastasis (TNM) system facet of Breast cancer | tumor, node, metastasis facet of Throat cancer | squamous cell carcinoma subclass of Mouth cancer | Throat cancer staging How throat cancer is staged facet of Throat cancer | grade facet of cancer, staging facet of cancer | tumor, node, metastasis (TNM) system instance of stage | Anatomy of the Pharynx TNM scores instance of tumor, node, metastasis (TNM) system",
        "metrics": {
          "rouge_score": 0.2,
          "answer_correctness": 0.7352091854929093
        }
      },
      {
        "id": "Medical-04e9f25b",
        "question": "Which imaging modalities are used both for staging and surveillance in cervical cancer management?",
        "ground_truth": "CT scan, MRI, PET/CT, and transvaginal ultrasound are used for staging and can be used for surveillance imaging as indicated.",
        "generated_answer": "CT, MRI, and PET scans are used for both staging and surveillance in cervical cancer management.",
        "contexts": "staging subclass of Imaging | radiology subclass of Imaging | CT subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | Clinical subclass of cancer staging, pathologic subclass of cancer staging | computed tomography subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging | contrast subclass of Imaging | Imaging subclass of Imaging, CT subclass of Imaging | CT subclass of Magnetic resonance imaging | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | biopsy subclass of Imaging | Biopsy subclass of Imaging | minimally invasive procedure subclass of Surgical staging | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | Imaging subclass of biopsy | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | CT scan subclass of Imaging",
        "metrics": {
          "rouge_score": 0.4864864864864864,
          "answer_correctness": 0.8829151776740317
        }
      },
      {
        "id": "Medical-e1ede6d6",
        "question": "What distinguishes stage 4 colon cancer from earlier stages in terms of spread and treatment approach?",
        "ground_truth": "Stage 4 colon cancer has spread to distant organs like the liver or lungs, requiring different treatment strategies compared to localized or regional disease.",
        "generated_answer": "Stage 4 colon cancer is characterized by metastasis, meaning it has spread to distant organs, whereas earlier stages are typically localized. The treatment approach for stage 4 often involves more aggressive therapies, including systemic treatments, compared to earlier stages that may be managed with localized interventions like surgery.",
        "contexts": "early stages of cancer followed by cancer progresses, cancer progresses follows early stages of cancer | Stage 4 cancer said to be the same as Stage 4A, Stage 3A1 facet of cancer, Stage 4A said to be the same as Stage 4 cancer | Stage 4 cancer subclass of Metastatic cancer | advanced-stage prostate cancer follows early-stage prostate cancer, early-stage prostate cancer followed by advanced-stage prostate cancer | Stage III followed by 4 disease, advanced disease said to be the same as Stage 4A, 4 disease follows Stage III, Stage 4A said to be the same as advanced disease, 4 subclass of disease | Stage III instance of cancer stage, stage IV instance of cancer stage, Stage 1 instance of cancer stage | Stage 4 is metastatic facet of Breast cancer, Stage 1 followed by stage II, Stage III followed by stage IV | numbered stages different from bone cancer | early-stage prostate cancer followed by advanced-stage prostate cancer, Advanced stage subclass of prostate cancer, Advanced stage subclass of prostate cancer, advanced-stage prostate cancer follows early-stage prostate cancer, Advanced stage facet of prostate cancer, therapies facet of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Stage III subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | Stage III followed by Stage III | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Stage 4B subclass of bladder cancer | Stage I anal cancer followed by Stage II anal cancer",
        "metrics": {
          "rouge_score": 0.38888888888888895,
          "answer_correctness": 0.8592990882249789
        }
      },
      {
        "id": "Medical-4d6219bc",
        "question": "Why is pharmacogenomic and biomarker testing important in the management of pediatric ALL?",
        "ground_truth": "Pharmacogenomic and biomarker testing guide treatment decisions and help tailor therapies for optimal outcomes.",
        "generated_answer": "Pharmacogenomic and biomarker testing are crucial in managing pediatric ALL as they help tailor treatment plans based on individual genetic profiles, improving efficacy and reducing adverse effects. These tests enable personalized medicine approaches, ensuring that therapies are more effective for each child's unique genetic makeup.",
        "contexts": "biomarker subclass of genetic testing | biomarker testing subclass of Molecular | case-by-case subclass of biomarker testing, tumor profiling subclass of biomarker testing | biomarker subclass of test, biomarker test subclass of biomarker | comprehensive genomic profiling subclass of genomic testing | molecular tumor testing subclass of biomarker testing | tumor mutation testing subclass of biomarker | Genetic risk testing subclass of Genetic and biomarker testing | biomarker test subclass of test | biomarker subclass of genetic | Testing for this biomarker subclass of biomarker | nextgeneration sequencing subclass of biomarker | molecular subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | testing for AML biomarker and genetic changes subclass of biomarker | biomarker subclass of biomarker | over the counter subclass of genetic testing | biomarker testing subclass of biopsy, biopsy subclass of test results",
        "metrics": {
          "rouge_score": 0.26666666666666666,
          "answer_correctness": 0.9868120355159108
        }
      },
      {
        "id": "Medical-32fce5f0",
        "question": "What are the standard hormone replacement options after total thyroidectomy and why are they necessary?",
        "ground_truth": "Levothyroxine, Levoxyl, or Synthroid are necessary to replace lost thyroid hormone after total thyroidectomy.",
        "generated_answer": "The standard hormone replacement options after total thyroidectomy include Levothyroxine and Triiodothyronine. They are necessary to replace the hormones that the thyroid gland can no longer produce, maintaining normal metabolic function and regulating TSH levels.",
        "contexts": "Thyroid hormone replacement therapy facet of Thyroidectomy | hormone replacement therapy facet of Thyrogen, Thyrogen use hormone replacement therapy | hormone replacement therapy facet of Lobectomy, Total thyroidectomy instance of surgery | Thyroid hormone replacement therapy different from Lobectomy | hormone replacement therapy facet of menopause | Total thyroidectomy followed by After total thyroidectomy, RAI therapy different from Total thyroidectomy, After total thyroidectomy follows Total thyroidectomy, Total thyroidectomy medical condition treated thyroid cancer, Total thyroidectomy different from RAI therapy | hormone replacement therapy medical condition treated TSH, Levothyroxine subject has role hormone replacement therapy, thyroid product or material produced hormones, TSH drug used for treatment hormone replacement therapy | Levothyroxine subject has role Thyroid hormone replacement therapy, low normal facet of thyroid-stimulating hormone | TSH level facet of thyroid hormone | Total thyroidectomy medical condition treated thyroid cancer | hormone replacement therapy instance of Treatment | Total thyroidectomy medical condition treated papillary cancer, papillary cancer drug used for treatment Total thyroidectomy | triiodothyronine instance of hormones",
        "metrics": {
          "rouge_score": 0.24489795918367346,
          "answer_correctness": 0.8411016262777777
        }
      },
      {
        "id": "Medical-84ec68f0",
        "question": "Why is it important to perform both biomarker and genetic risk testing in the diagnosis of stomach cancer?",
        "ground_truth": "Because diagnosis requires comprehensive assessment, including identification of treatable mutations and genetic risk factors.",
        "generated_answer": "Performing both biomarker and genetic risk testing in the diagnosis of stomach cancer is important because it helps identify specific genetic mutations and biomarkers associated with the disease, which can guide treatment decisions and improve patient outcomes. Additionally, these tests can provide insights into the cancer's behavior and potential response to therapies.",
        "contexts": "Genetic risk testing subclass of Genetic and biomarker testing | biomarker subclass of genetic testing | biomarker subclass of genetic | biomarker subclass of test, biomarker test subclass of biomarker | biomarker testing subclass of Molecular | genetic testing subclass of test | genetic cancer risk testing subclass of Biopsy | biomarker test subclass of test | tumor mutation testing subclass of biomarker | genetic cancer risk testing subclass of Testing for breast cancer | biomarker subclass of biomarker | genetic testing subclass of diagnostic test | Biomarkers subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | molecular subclass of biomarker | molecular tumor testing subclass of biomarker testing | genetic cancer risk testing subclass of genetic testing | Testing for this biomarker subclass of biomarker | tumor testing subclass of genetic testing",
        "metrics": {
          "rouge_score": 0.11940298507462686,
          "answer_correctness": 0.5028273420432546
        }
      },
      {
        "id": "Medical-8d55a40b",
        "question": "Which cancer type is characterized by the development of abnormal lymphocytes in the skin and can originate from either B or T cells?",
        "ground_truth": "Primary cutaneous lymphoma (PCL) is characterized by abnormal lymphocytes in the skin and can originate from B or T cells.",
        "generated_answer": "Cutaneous lymphoma",
        "contexts": "T-cell subclass of lymphocyte, B cell subclass of lymphocyte, B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | T-cell subclass of lymphocyte | T lymphocyte subclass of lymphocyte | B lymphocyte subclass of lymphocyte | B cell subclass of lymphocyte, B cell subclass of lymphocyte | lymphocyte has part Lymphoblast, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, Lymphoblast subclass of lymphocyte | lymphocyte subclass of white blood cell, white blood cell has part lymphocyte | lymphocyte subclass of white blood cell, lymphocyte has part Lymphoblast, lymphocyte part of Blood, lymphocyte part of immune system, Blood has part lymphocyte, Lymphoblast subclass of lymphocyte | B cell subclass of white blood cell, B cell subclass of lymphocyte, white blood cell has part B cell | white blood cell has part lymphocyte | white blood cell has part Lymphocyte A lymphocyte | immune system has part lymphocyte, lymphocyte part of immune system, lymphocyte subclass of white blood cell | B subclass of white blood cell | lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, white blood cell has part lymphocyte, blood stem cell part of Blood",
        "metrics": {
          "rouge_score": 0.18181818181818182,
          "answer_correctness": 0.9854825575305075
        }
      },
      {
        "id": "Medical-cb781b83",
        "question": "What sequence of diagnostic steps is required to confirm a glioma diagnosis and classify its grade and biomarker status?",
        "ground_truth": "A neurological exam, imaging with MRI, and a biopsy for histology and molecular testing are required.",
        "generated_answer": "The diagnostic steps to confirm a glioma diagnosis typically include imaging tests, biopsy, molecular testing, and biomarker testing to classify its grade and status.",
        "contexts": "biomarker testing use diagnosis | test use diagnosis | molecular test use diagnosis | diagnosis uses test, test used by diagnosis | test use diagnose | Biopsy use biopsy | Symptoms used by diagnosis | lab use Testing | Guide 1 main subject biomarker testing | needle use biopsy | biomarker subclass of test, testing uses urine sample | Next-generation sequencing use genomic testing | imaging test use Imaging | Treatment has cause diagnosis | sample use Biopsy | diagnosis facet of cancer | biomarker subclass of genetic testing | diagnosis studies brain tumor, brain tumor studied by diagnosis | test use testing",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.7327398221636354
        }
      },
      {
        "id": "Medical-d42f24b5",
        "question": "What is the sequence of diagnostic steps for a patient presenting with symptoms of ulcer or mass suspected to be stomach cancer?",
        "ground_truth": "Imaging tests, endoscopy, and biopsy are performed, followed by biomarker and genetic risk testing.",
        "generated_answer": "The sequence of diagnostic steps includes initial evaluation of symptoms, imaging studies (such as CT scans), endoscopy with biopsy, and staging tests to determine the extent of cancer.",
        "contexts": "Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | Locoregional subclass of stomach cancer, ulcer subclass of masses | stomach cancer subclass of lung cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of hereditary syndromes | skin subclass of cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | colorectal subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | noninvasive subclass of cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | cancer type subclass of cancer | tumor subclass of cancer | Tumor subclass of cancer | ovarian subclass of cancer, breast subclass of cancer",
        "metrics": {
          "rouge_score": 0.2380952380952381,
          "answer_correctness": 0.7347647195759595
        }
      },
      {
        "id": "Medical-4987de7f",
        "question": "What are the cellular and molecular hallmarks required to definitively diagnose CML?",
        "ground_truth": "Increased granulocytes and presence of either the Philadelphia chromosome or BCR::ABL1 fusion gene are required.",
        "generated_answer": "The cellular and molecular hallmarks required to definitively diagnose Chronic Myeloid Leukemia (CML) include the presence of the Philadelphia chromosome, which results from the BCR-ABL fusion gene, and the detection of abnormal myeloblasts in the blood or bone marrow. Additionally, blood tests showing elevated white blood cell counts and specific genetic mutations may also support the diagnosis.",
        "contexts": "cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells has part molecules | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | DNA part of cells, cells has part DNA | gene part of cell | cell part of body | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | cell part of tissues | cells part of body | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test | cells part of tissues | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | cells part of Blood | cells part of organs | body has parts of the class cell, cell part of body",
        "metrics": {
          "rouge_score": 0.24324324324324326,
          "answer_correctness": 0.6629958516039145
        }
      },
      {
        "id": "Medical-41284331",
        "question": "If a tumor is described as intraductal and confined to the epithelium, what stage and tumor characteristic does it correspond to in intrahepatic bile duct cancer?",
        "ground_truth": "It corresponds to Tis stage and carcinoma in situ tumor characteristic.",
        "generated_answer": "Stage 0, carcinoma in situ.",
        "contexts": "Bile duct cancer stages facet of bile duct | Stage III instance of cancer stage, stage IV instance of cancer stage, Stage 1 instance of cancer stage, stage II instance of cancer stage | Stage 1 instance of Cancer stage, stage 0 instance of Cancer stage | stage 1 tumor instance of cancer type | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | breast cancer is staged instance of cancer stage | Pancreatic cancer instance of stages | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | Cancer stages 1, 2, and 3 A cancer stage instance of cancer stage | stage facet of cancer | stage has cause cancer type, cancer type has effect stage | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | stage facet of tumor | intrahepatic cholangiocarcinoma subclass of Liver cancer | stage facet of bladder cancer | T2 tumor instance of staging | Cancer grade different from stage, stage different from Cancer grade | stage IV instance of stage",
        "metrics": {
          "rouge_score": 0.5000000000000001,
          "answer_correctness": 0.9856399504144413
        }
      },
      {
        "id": "Medical-2350fb33",
        "question": "What diagnostic methods should be employed to confirm a suspected case of metastatic stomach cancer with a family history of the disease?",
        "ground_truth": "Imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing should be used.",
        "generated_answer": "Diagnostic methods for confirming metastatic stomach cancer include endoscopy with biopsy, imaging studies such as CT scans or PET scans, and blood tests for tumor markers.",
        "contexts": "metastatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Locoregional subclass of stomach cancer | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | nonmetastatic subclass of cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | stomach cancer subclass of lung cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastasized subclass of cancer | metastatic subclass of cervical cancer | de novo subclass of Metastatic cancer | metastatic esophageal cancer subclass of esophageal cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastasis subclass of cancer | metastatic subclass of prostate cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | Metastatic cancer subclass of Metastasis Cancer | Metastatic cancer subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.20512820512820515,
          "answer_correctness": 0.8766754966678727
        }
      },
      {
        "id": "Medical-2521e4dd",
        "question": "Why is genetic testing for BRCA mutations recommended for all ovarian cancer patients?",
        "ground_truth": "Because BRCA mutations are major hereditary risk factors and influence eligibility for targeted therapies such as PARP inhibitors.",
        "generated_answer": "Genetic testing for BRCA mutations is recommended for all ovarian cancer patients because it helps identify hereditary ovarian cancer risks, informs treatment options, and guides family planning regarding inherited cancer risk.",
        "contexts": "BRCA mutation has effect ovarian cancer, ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor | BRCA mutation has effect BRCA status | Lynch syndrome has effect hereditary ovarian cancer | genetic mutations has effect cancer | BRCA mutation has effect homologous recombination deficiency, homologous recombination deficiency has cause BRCA mutation | hereditary mutation has effect cancer | ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | genetic mutations has effect Inherited cancer risk, Inherited cancer risk has cause genetic mutations | BRCA1 has effect Homologous recombination deficiency, BRCA2 has effect Homologous recombination deficiency | Lynch syndrome has effect hereditary colon and uterine cancers, Lynch syndrome subclass of BRCA mutation, ovarian cancer subclass of cancer, hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer | hereditary has effect Breast cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | genetic errors has effect Bladder cancer | Breast cancer has effect Breast cancer | recurrent subclass of ovarian cancer, BRCA mutation subclass of homologous recombination deficiency",
        "metrics": {
          "rouge_score": 0.20408163265306123,
          "answer_correctness": 0.9855783652894126
        }
      },
      {
        "id": "Medical-a9a52704",
        "question": "What combination of anatomical location and cell type defines basal cell carcinoma?",
        "ground_truth": "BCC arises from basal cells in the lower part of the epidermis, often in sun-exposed locations.",
        "generated_answer": "Basal cell carcinoma is defined by its occurrence in the skin and involves basal cells.",
        "contexts": "basal cell subclass of skin cancer | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | Basal cell skin cancer subclass of skin cancer | skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer | Basal cell skin cancer subclass of Skin lesion | Testing for basal cell skin cancer facet of Basal cell skin cancer, basal cell subclass of skin cancer, early facet of Skin cancer, Signs and symptoms facet of Basal cell skin cancer, Basal cell skin cancer subclass of squamous cell skin cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | prostate cancer instance of cancer | stage 1 tumor instance of cancer type | Acute lymphoblastic leukemia instance of cancer | cancer instance of diseases | grade instance of cancer type | Cancer cells subclass of cells, Squamous cell subclass of skin cancer | colorectal cancer instance of cancer | Squamous cell subclass of skin cancer, squamous cell skin cancer subclass of skin cancer | cancer subclass of cells | Squamous cell subclass of skin cancer | Skin cancer has cause Skin cell, Skin cell has effect Skin cancer | Cancer cells subclass of cells",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.7356190287627289
        }
      },
      {
        "id": "Medical-74b73ed7",
        "question": "What distant organs are common sites of kidney cancer metastasis, and how is this reflected in the classification?",
        "ground_truth": "Lungs, lymph nodes, bones, liver, and brain are common distant metastatic sites.",
        "generated_answer": "The common distant organs for kidney cancer metastasis include the lungs, liver, bones, and brain. This is reflected in the classification through the staging and grading of cancer, which considers the extent of metastasis.",
        "contexts": "tumor, node, metastasis facet of colon cancer | Further testing facet of kidney cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | cancer staging facet of tumor | biopsy facet of cancer | staging facet of cancer | Staging facet of cancer | tumor, node, metastasis facet of Throat cancer | grade facet of cancer, staging facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | cancer stage facet of cancer | Staging The cancer stage facet of cancer | progression to cancer facet of cancer | lymph nodes facet of cancer | Imaging facet of cancer | Cancer grade facet of tumor | Imaging facet of cancer, Treatment planning facet of cancer | stage facet of cancer | Imaging Imaging facet of cancer | Cancer grade facet of cancer",
        "metrics": {
          "rouge_score": 0.1739130434782609,
          "answer_correctness": 0.9031222902291187
        }
      },
      {
        "id": "Medical-5581adb2",
        "question": "What combination of symptoms and diagnostic findings would suggest follicular lymphoma with bone marrow involvement?",
        "ground_truth": "Symptoms like fatigue and weight loss, combined with abnormal findings on bone marrow aspirate and biopsy, suggest FL with bone marrow involvement.",
        "generated_answer": "Symptoms such as swollen lymph nodes, fatigue, and weight loss, combined with diagnostic findings like bone marrow biopsy showing follicular lymphoma cells, would suggest follicular lymphoma with bone marrow involvement.",
        "contexts": "Follicular lymphoma subclass of non-Hodgkin lymphoma | Follicular lymphoma subclass of Lymphoma, diffuse large B-cell lymphoma subclass of Lymphoma | classic FL subclass of Follicular lymphoma, diffuse large B-cell lymphoma subclass of classic FL | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | FL grade 3B subclass of follicular large B cell lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Germinal centers Follicular lymphoma subclass of Lymphoma | Acute lymphoblastic leukemia subclass of blood cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | follicular subclass of lesions, follicular subclass of differentiated thyroid cancers, follicular carcinoma subclass of thyroid cancer | Bone marrow biopsy subclass of biopsy | Chronic lymphocytic leukemia subclass of blood cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Hodgkin lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.6153846153846153,
          "answer_correctness": 0.737608424073426
        }
      },
      {
        "id": "Medical-50bafb57",
        "question": "Which blood cell types are abnormally increased in CML and what underlying cellular process causes this?",
        "ground_truth": "Granulocytes (a type of white blood cell) are increased due to overproduction by myeloid progenitor cells.",
        "generated_answer": "Abnormally increased blood cell types in CML include myeloblasts and granulocytes. The underlying cellular process is the differentiation of blood stem cells into these abnormal myeloblasts.",
        "contexts": "Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | cells part of Blood, Blood has part cells | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Blood has part Red blood cell, Red blood cell part of Blood | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | Blood has part Red blood cell, Red blood cell part of Blood, bloodstream has part Red blood cell | Blood has part Red blood cell, platelet part of Blood, Red blood cell part of Blood | Blood has part Red blood cell | Blood has part Red blood cell, platelet part of white blood cell, white blood cell has part platelet, Red blood cell part of Blood | Blood has part white blood cell, white blood cell part of Blood, Red blood cell part of Blood | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, platelet follows Red blood cell | Blood has part Red blood cell, vein part of Blood, Red blood cell part of Blood | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Red blood cell has part Red blood cell, white blood cell has part Granulocyte, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet | Red blood cell part of Blood, T cells part of immune system, Blood has part Red blood cell | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test",
        "metrics": {
          "rouge_score": 0.1904761904761905,
          "answer_correctness": 0.48258173123947523
        }
      },
      {
        "id": "Medical-c69c2732",
        "question": "What follow-up strategy is recommended for a patient treated for BCC on the neck, and why?",
        "ground_truth": "Annual full skin exams are recommended to monitor for recurrence or new lesions.",
        "generated_answer": "Regular follow-up visits are recommended to monitor for recurrence and manage any complications, as BCC can recur and early detection is crucial for effective treatment.",
        "contexts": "Follow-up and surveillance subclass of Treatment | Treatment has part plan treatment | plan treatment part of Treatment | plan treatment facet of Treatment, Treatment has part plan treatment | Treatment follows initial evaluation, initial evaluation followed by Treatment | Treatment has part stage, stage part of Treatment | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment | plan treatment has part phases of treatment, phases of treatment part of plan treatment, Treatment different from care | Treatment part of plan, prognosis has part more than one treatment option, Treatment practiced by surgeon, surgeon field of this occupation Treatment, more than one treatment option part of prognosis | treatment process has part phases of treatment, phases of treatment part of treatment process | radiation therapy part of Treatment, Treatment has part chemotherapy, Treatment has part radiation therapy, rounds of treatment subclass of follow-up visits, stabilized subclass of Treatment, Treatment has part surgery, surgery part of Treatment | plan treatment facet of Treatment | Imaging part of Treatment | plan treatment facet of Treatment, plan treatment facet of disease | Treatment by risk and recurrence has part prevention, Treatment by risk and recurrence subclass of how to treat it | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial",
        "metrics": {
          "rouge_score": 0.30769230769230776,
          "answer_correctness": 0.7774158127394067
        }
      },
      {
        "id": "Medical-b503f3f3",
        "question": "What combination of diagnostic methods is typically used to confirm Hodgkin lymphoma and assess its extent?",
        "ground_truth": "Excisional lymph node biopsy, blood tests, and imaging tests are used together for diagnosis and staging.",
        "generated_answer": "A combination of imaging tests and biopsy is typically used to confirm Hodgkin lymphoma and assess its extent.",
        "contexts": "cancer studied by imaging test, imaging test studies cancer | lymphoma cells studied by pathologist, pathologist studies lymphoma cells | tumor studied by tumor testing | lymph nodes studied by HRA, HRA studies lymph nodes | Hodgkin lymphoma Testing for Hodgkin lymphoma facet of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Cancer cells studied by histology | Hodgkin lymphoma instance of rare | cancer studied by Oncology | Hodgkin lymphoma subclass of Lymphoma | tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | Lymphatic system has effect Hodgkin lymphoma | preliminary diagnosis studies Glioblastoma, Glioblastoma studied by preliminary diagnosis | diagnosis studies brain tumor, brain tumor studied by diagnosis | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | diagnosis uses test, test used by diagnosis | tumor histology studies cancer",
        "metrics": {
          "rouge_score": 0.23529411764705882,
          "answer_correctness": 0.6649571934121828
        }
      },
      {
        "id": "Medical-6a1c421a",
        "question": "What diagnostic procedures are essential for confirming ALL in children and why are multiple tests necessary?",
        "ground_truth": "Blood tests, bone marrow tests, imaging tests, heart tests, lumbar puncture, biomarker testing, and pharmacogenomic testing are all necessary because diagnosis requires both identifying lymphoblasts and assessing disease extent and subtype.",
        "generated_answer": "Essential diagnostic procedures for confirming Acute Lymphoblastic Leukemia (ALL) in children include genetic testing, blood tests, and biopsies. Multiple tests are necessary to accurately diagnose the condition, assess its type, and determine the appropriate treatment plan.",
        "contexts": "genetic testing subclass of diagnostic test | procedures subclass of tests | genetic testing subclass of test | testing subclass of diagnosis | Diagnosis by blood test subclass of blood test | detection methods subclass of diagnosis | Blood test subclass of test | Blood test subclass of Blood test | Biopsy subclass of test | biopsy subclass of test | biopsy subclass of testing | biomarker subclass of test | testing Biopsy subclass of biopsy | biomarker test subclass of test, imaging test subclass of test | imaging test subclass of testing | Blood subclass of test | physical exam subclass of test | urine subclass of testing, Blood subclass of testing | Imaging subclass of test results, biomarker test subclass of biopsy",
        "metrics": {
          "rouge_score": 0.2388059701492537,
          "answer_correctness": 0.5163563933249415
        }
      },
      {
        "id": "Medical-3d54d9e7",
        "question": "Which diagnostic methods are necessary to confirm a diagnosis of ALL and why must both bone marrow and blood tests be used?",
        "ground_truth": "Both bone marrow and blood tests are necessary because ALL is diagnosed when lymphoblasts are present in the bone marrow and can also be detected in the blood.",
        "generated_answer": "To confirm a diagnosis of Acute Lymphoblastic Leukemia (ALL), both bone marrow and blood tests are necessary. Bone marrow tests provide detailed information about the presence of leukemia cells, while blood tests assess overall blood cell counts and function, ensuring a comprehensive evaluation of the disease.",
        "contexts": "Diagnosis by blood test subclass of blood test | Blood test subclass of Blood test | Blood test subclass of test | Blood subclass of test, white blood cell subclass of Blood test, Red blood cell subclass of Blood test, platelet subclass of Blood test, white blood cell subclass of Red blood cell, saliva subclass of test, platelet part of Red blood cell | Imaging subclass of blood test | urine subclass of testing, Blood subclass of testing | Blood and urine test subclass of Blood test | biopsy subclass of blood test | Flow cytometry subclass of blood test | Blood test subclass of general health test | biomarker subclass of test, biomarker test subclass of biomarker | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | genetic testing subclass of diagnostic test | detection methods subclass of diagnosis | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | biomarker test subclass of test",
        "metrics": {
          "rouge_score": 0.3243243243243243,
          "answer_correctness": 0.8863410432683192
        }
      },
      {
        "id": "Medical-ddde0e24",
        "question": "For which AML patients is hematopoietic cell transplant considered and what factors influence this decision?",
        "ground_truth": "Hematopoietic cell transplant is considered for eligible patients based on performance status, genetic alterations, and response to induction therapy.",
        "generated_answer": "Hematopoietic cell transplant is considered for AML patients who are in remission and may benefit from intensive treatment options. Factors influencing this decision include the patient's overall health, age, and specific genetic mutations associated with their leukemia.",
        "contexts": "daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin, AML drug used for treatment FLT3 Gilteritinib | Cytarabine medical condition treated AML, Methotrexate medical condition treated AML, AML drug used for treatment Cytarabine, AML drug used for treatment Methotrexate | daunorubicin medical condition treated AML, AML drug used for treatment Sorafenib, AML drug used for treatment Cytarabine, AML drug used for treatment FLT3 Gilteritinib, AML drug used for treatment daunorubicin, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML | plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia | cancer drug used for treatment Treatment | Treatment medical condition treated cancer | Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL | cancer drug used for treatment Cancer treatment | in remission facet of AML | Chronic lymphocytic leukemia drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.2807017543859649,
          "answer_correctness": 0.7812670774709727
        }
      },
      {
        "id": "Medical-5459ea22",
        "question": "Why is a tumor classified as Tis (carcinoma in situ) in intrahepatic bile duct cancer only found in the epithelium and not in deeper layers?",
        "ground_truth": "Because Tis tumors are intraductal and confined to the epithelium, not invading lamina propria or deeper layers.",
        "generated_answer": "A tumor is classified as Tis (carcinoma in situ) in intrahepatic bile duct cancer because it consists of cancerous cells that are confined to the epithelium and have not invaded deeper layers of tissue.",
        "contexts": "intrahepatic cholangiocarcinoma subclass of Liver cancer, hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma, primary liver cancer subclass of Liver cancer | noninvasive cancer subclass of in situ | Noninvasive breast cancer subclass of carcinoma in situ | carcinoma in situ subclass of cancerous cells | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | HCC subclass of Liver cancer, hepatocellular carcinoma subclass of Secondary liver cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Stage 1 subclass of Stage I anal cancer, carcinoma in situ subclass of cancer | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | primary liver cancer subclass of cancer | stage II subclass of bladder cancer, stage 0 facet of carcinoma in situ, carcinoma in situ subclass of aggressive | Nasopharynx subclass of cancer, carcinoma in situ subclass of tumor | inflamed pancreas subclass of Pancreatic cancer | noninvasive subclass of Cancerous cells found only inside the ducts or lobules | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | Ductal carcinoma subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.3921568627450981,
          "answer_correctness": 0.8788919175056895
        }
      },
      {
        "id": "Medical-4f5a8531",
        "question": "Why might a patient with actinic keratosis require ongoing dermatologic surveillance even after lesion treatment?",
        "ground_truth": "Because actinic keratosis can progress to CSCC and regular skin exams are recommended for surveillance.",
        "generated_answer": "A patient with actinic keratosis may require ongoing dermatologic surveillance because actinic keratosis can lead to squamous cell carcinoma, and new lesions may develop over time. Regular monitoring helps detect any changes or new lesions early for timely intervention.",
        "contexts": "Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of hereditary syndromes | Actinic keratoses subclass of abnormal cells | Bowen\u2019s lesion subclass of Actinic keratoses | hyperkeratosis subclass of Thickening of the outer layer of skin, Actinic keratoses subclass of hyperkeratotic, Squamous cell subclass of skin cancer | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | cancer type subclass of treatments | Basal cell skin cancer subclass of Skin lesion | radiation therapy subclass of treated | radiation therapy subclass of Treatment | Cancer treatment subclass of Treatment | radiation therapy subclass of Treatment, systemic therapy subclass of radiation therapy | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | platinum-based chemotherapy subclass of systemic therapy, targeted therapy subclass of Immunotherapy, radiation therapy subclass of Treatment, Mohs surgery subclass of PDEMA | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | checkpoint inhibitor subclass of Immunotherapy, Immunotherapy subclass of Treatment | radiation therapy subclass of Treatment, surgery subclass of treated",
        "metrics": {
          "rouge_score": 0.2962962962962963,
          "answer_correctness": 0.9894523728959712
        }
      },
      {
        "id": "Medical-299b8b83",
        "question": "How do risk factors and performance status together influence mouth cancer management?",
        "ground_truth": "Risk factors like tobacco and alcohol use increase risk and affect outcomes, while performance status helps guide treatment selection.",
        "generated_answer": "Risk factors and performance status together influence mouth cancer management by determining the patient's overall fitness and risk level, which guides treatment decisions and screening approaches. Evaluating these factors helps in tailoring prevention and treatment strategies effectively.",
        "contexts": "Performance status facet of fitness | risk level subclass of factors | risk factors facet of disease | risk factors has effect cancer, cancer has cause risk factors | family health history has part risk factors, lung cancer studied by risk factors, risk factors studied by Risk assessment, risk factors studies lung cancer, risk factors part of family health history, Risk assessment studies risk factors, risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | risk factors facet of cancer, age instance of risk factors | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | Performance status instance of Performance status | Performance status subclass of evaluation | Risk assessment studies problem, problem studied by Risk assessment | risk factors has effect cervical cancer, cervical cancer has cause risk factors | Risk factors for lung cancer facet of lung cancer | prevention part of Treatment by risk and recurrence, Treatment by risk and recurrence has part prevention",
        "metrics": {
          "rouge_score": 0.24561403508771928,
          "answer_correctness": 0.8137809230996987
        }
      },
      {
        "id": "Medical-104b2f70",
        "question": "For a patient with a first-degree relative with colorectal cancer, what risk factors and inherited syndromes should be considered?",
        "ground_truth": "A first-degree relative is a risk factor, and inherited syndromes like Lynch syndrome and FAP should be evaluated for increased colon cancer risk.",
        "generated_answer": "Risk factors to consider include age and genetic predisposition. Inherited syndromes such as Lynch syndrome and Familial adenomatous polyposis should also be evaluated.",
        "contexts": "risk level subclass of factors | Genetic risk testing subclass of Genetic and biomarker testing | Lynch syndrome subclass of inherited condition | risk factors subclass of risk factors | Lynch syndrome subclass of inherited cancer syndromes | genetic testing subclass of test | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | Leukemia predisposition syndrome subclass of inherited cancer syndromes | Lynch subclass of hereditary syndromes | genetic cancer risk testing subclass of genetic testing | biomarker subclass of genetic | biomarker subclass of genetic testing | Lynch syndrome subclass of Inherited syndromes related to colon cancer, Familial adenomatous polyposis subclass of Inherited syndromes related to colon cancer | hereditary mutation subclass of passed down in families | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | microsatellite stable subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes | cancer subclass of disease | genetic testing subclass of diagnostic test | xeroderma pigmentosum subclass of genetic conditions",
        "metrics": {
          "rouge_score": 0.4680851063829787,
          "answer_correctness": 0.9884911703458686
        }
      },
      {
        "id": "Medical-f978cb28",
        "question": "What is the role of clinical trials in the management of advanced or refractory CSCC?",
        "ground_truth": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC cases.",
        "generated_answer": "Clinical trials play a crucial role in the management of advanced or refractory cutaneous squamous cell carcinoma (CSCC) by studying investigational treatments and providing patients with access to new therapies that may not be available through standard treatments. They also help in evaluating the efficacy and safety of these treatments in a controlled environment.",
        "contexts": "standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Clinical trial has part enroll, enroll part of Clinical trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research, Clinical trial studies drug | investigational treatments use Clinical trial, Clinical trial uses investigational treatments | Enrolling in a clinical trial instance of Treatment | Food and Drug Administration field of work Clinical trial, standard treatments subclass of treatment options available for their type of cancer, Clinical trial subclass of studied in people, Clinical trial subclass of medical research, Clinical trial studies drug, drug studied by Clinical trial | Clinical trial uses investigational treatments, investigational treatments use Clinical trial | standard treatments subclass of Clinical trial, voluntary subclass of Clinical trial, study subclass of Clinical trial, New clinical trial subclass of Clinical trial | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial | Questions about clinical trial facet of Clinical trial, Clinical trial subclass of Treatment | Clinical trial studies new drug",
        "metrics": {
          "rouge_score": 0.20289855072463767,
          "answer_correctness": 0.6656799352392391
        }
      },
      {
        "id": "Medical-604c9d44",
        "question": "Why is a patient with fair skin and a history of organ transplant at particularly high risk for developing basal cell carcinoma?",
        "ground_truth": "Because both fair skin and immune suppression from organ transplant are independent risk factors for BCC.",
        "generated_answer": "Patients with fair skin and a history of organ transplant are at high risk for developing basal cell carcinoma due to increased sun sensitivity and immunosuppression from transplant medications, which reduce the body's ability to fight off cancerous cells.",
        "contexts": "Basal cell skin cancer subclass of Skin lesion | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | basal cell subclass of skin cancer | Basal cell skin cancer subclass of skin cancer | skin subclass of cancer | melanoma subclass of skin cancer | Squamous cell subclass of skin cancer | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of inherited syndromes | skin cancer subclass of cancer | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | Squamous cell subclass of skin cancer, Squamous cell subclass of skin cancer, scar subclass of wound | Squamous cell subclass of skin cancer, squamous cell skin cancer subclass of skin cancer, Squamous cell subclass of skin cancer, Marjolin\u2019s ulcer subclass of squamous cell skin cancer, squamous cell skin cancer subclass of squamous cell skin cancer | Metastatic CSCC subclass of squamous cell skin cancer, Squamous cell subclass of skin cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer | hyperkeratosis subclass of Thickening of the outer layer of skin, Actinic keratoses subclass of hyperkeratotic, Squamous cell subclass of skin cancer | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Testing for basal cell skin cancer facet of Basal cell skin cancer, basal cell subclass of skin cancer",
        "metrics": {
          "rouge_score": 0.28571428571428575,
          "answer_correctness": 0.8381138981582794
        }
      },
      {
        "id": "Medical-443e3d36",
        "question": "If a patient with chronic hepatitis C and cirrhosis develops elevated AFP, which cancer type and diagnostic methods should be considered?",
        "ground_truth": "Primary liver cancer should be considered, and diagnosis should be confirmed with imaging tests and possibly biopsy.",
        "generated_answer": "Liver cancer should be considered, and diagnostic methods include imaging studies like ultrasound, CT scan, or MRI, along with serum AFP level testing.",
        "contexts": "Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | Hepatitis Hepatitis has cause Hepatitis B, hepatitis C has effect Hepatitis Hepatitis, Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis, cirrhosis subclass of liver disease | virus has effect hepatitis, hepatitis has cause virus, hepatitis C subclass of liver disease | cirrhosis has cause liver, hepatitis C subclass of Viruses | Hepatitis B has cause this virus, this virus has effect Hepatitis B | spread of cancer has effect liver damage, liver damage has cause spread of cancer, human immunodeficiency virus has effect HIV | Liver cancer has cause liver | Liver cancer has cause increased risk, increased risk has effect Liver cancer | spread to the liver has effect cancer | CML has effect CML | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | hepatitis C subclass of complications of CLL | human immunodeficiency virus has effect AIDS",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.802161897104176
        }
      },
      {
        "id": "Medical-d163acf5",
        "question": "How does the function of lymphocytes as white blood cells relate to the pathogenesis of cutaneous B-cell lymphoma?",
        "ground_truth": "Lymphocytes are white blood cells that help fight infection, and their unregulated growth can lead to cutaneous B-cell lymphoma.",
        "generated_answer": "Lymphocytes, particularly B cells, play a crucial role in the immune response, and their dysfunction can lead to the development of cutaneous B-cell lymphoma. This lymphoma arises from abnormal proliferation of B lymphocytes, indicating a direct link between lymphocyte function and the disease's pathogenesis.",
        "contexts": "Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell has part lymphocyte, Granulocyte has part Eosinophil, Granulocyte subclass of white blood cell, white blood cell <subj>granulocyte subclass of white blood cell, Neutrophil subclass of Granulocyte, white blood cell has part Granulocyte, Granulocyte has part Basophil, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell | white blood cell has part Lymphocyte A lymphocyte | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | white blood cell has part lymph | spleen part of Lymphatic system, Blood has part lymphocyte, white blood cell has part lymphocyte, Blood has part blood vessel, Lymphatic system has part lymph nodes, lymph nodes part of Lymphatic system | Red blood cell has part Red blood cell, white blood cell has part Granulocyte, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet | white blood cell has part lymphocyte, white blood cell has part lymphatic fluid, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymph nodes part of lymphatic fluid | lymphocyte has part Lymphoblast | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, platelet follows Red blood cell | white blood cell has part Neutrophil | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell",
        "metrics": {
          "rouge_score": 0.33333333333333337,
          "answer_correctness": 0.8815720531229266
        }
      },
      {
        "id": "Medical-575e6d7f",
        "question": "Which phases make up the standard treatment course for AML and what is their primary goal?",
        "ground_truth": "Induction, consolidation, and maintenance phases make up AML treatment, aiming for remission.",
        "generated_answer": "The standard treatment course for AML typically includes Phase 1, Phase 2, and Phase 4 trials. Their primary goal is to test the safety and efficacy of new treatments and improve patient outcomes.",
        "contexts": "plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia | in remission facet of AML | Treatment facet of cancer | Testing for AML facet of AML | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment planning facet of cancer | Treatment facet of ovarian cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | Treatment decisions facet of cancer | more treatment facet of cancer | systemic therapy facet of cancer | Treatment facet of Treatment | Treatment facet of disease | more than one treatment option facet of cancer | plan treatment facet of cancer | Treatment facet of Pancreatic cancer | spread facet of cancer, Testing for AML facet of AML",
        "metrics": {
          "rouge_score": 0.13333333333333333,
          "answer_correctness": 0.23575055985580307
        }
      },
      {
        "id": "Medical-1c53b384",
        "question": "What combination of risk factors should prompt clinicians to consider nasopharyngeal carcinoma in a differential diagnosis?",
        "ground_truth": "Epstein-Barr virus infection, tobacco use, alcohol use, and geographic origin (Asia, Native America, North Africa) should prompt consideration of NPC.",
        "generated_answer": "Clinicians should consider nasopharyngeal carcinoma in a differential diagnosis when there are risk factors such as EBV infection, abnormal tissue growth, and symptoms associated with head and neck cancers. Additionally, a history of related cancers may also be significant.",
        "contexts": "Nasopharyngeal cancer instance of rare cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer | Nasopharyngeal cancer different from laryngeal cancer, Nasopharyngeal cancer different from esophageal cancer, laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer subclass of cancer | Nasopharyngeal cancer subclass of cancer of the nasopharynx | Nasopharyngeal cancer has cause EBV | Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | cN2 subclass of Nasopharyngeal cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | abnormal tissue growth subclass of cancer, Nasopharyngeal cancer subclass of Throat cancer | Nasopharynx subclass of cancer, carcinoma in situ subclass of tumor | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | Acute lymphoblastic leukemia instance of cancer | Squamous cell carcinoma of the head and neck subclass of Head and neck cancer | primary tumor subclass of tumor, Nasopharyngeal cancer subclass of Mouth cancer | diagnosis facet of cancer | biopsy subclass of diagnosis",
        "metrics": {
          "rouge_score": 0.1,
          "answer_correctness": 0.4802270939386053
        }
      },
      {
        "id": "Medical-7faeddee",
        "question": "If a patient presents with an ulcer and mass in the stomach, what cancer subtype is most likely and what is the cell of origin?",
        "ground_truth": "Adenocarcinoma, originating from mucus-secreting cells lining the stomach.",
        "generated_answer": "Adenocarcinoma of the stomach; epithelial cells.",
        "contexts": "ulcer subclass of masses, Locoregional subclass of stomach cancer | Adenocarcinoma of the stomach subclass of Adenocarcinoma, Adenocarcinoma subclass of stomach cancer | stomach cancer subclass of lung cancer | Heartburn subclass of indigestion | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | submucosa part of stomach, abdominal wall part of stomach, stomach cancer subclass of cancer, lining of the abdomen connects with liver, liver connects with lining of the abdomen | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of inherited syndromes | tumor subclass of abnormal areas | tumor subclass of cancer | Tumor subclass of cancer | benign subclass of tumor | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | cancer subclass of Tumor, aggressive type subclass of cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | scar subclass of lesions | skin subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.9873973758071725
        }
      },
      {
        "id": "Medical-e0f29bbd",
        "question": "What are the preferred systemic therapy options for metastatic CSCC, and when might surgery or radiation be considered?",
        "ground_truth": "Preferred systemic therapies for metastatic CSCC are PD-1 inhibitors, with surgery or radiation considered if feasible.",
        "generated_answer": "Preferred systemic therapy options for metastatic CSCC include immunotherapy, checkpoint inhibitors, and platinum-based chemotherapy. Surgery or radiation may be considered for localized disease or when there is a need for palliative care.",
        "contexts": "systemic therapy subclass of radiation therapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | radiation therapy subclass of Treatment, systemic therapy subclass of radiation therapy | systemic therapy different from radiation therapy, systemic therapy subclass of radiation therapy, systemic therapy opposite of radiation therapy, radiation therapy different from systemic therapy, Immunotherapy subclass of systemic therapy | radiation therapy subclass of Treatment | systemic therapy opposite of radiation therapy, systemic therapy subclass of radiation therapy, platinum-based chemotherapy subclass of systemic therapy, targeted therapy subclass of Immunotherapy, radiation therapy subclass of Treatment, Mohs surgery subclass of PDEMA | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | radiation therapy subclass of treated | chemotherapy subclass of therapy, radiation subclass of therapy | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | radiation therapy subclass of Chemotherapy | radiation therapy subclass of chemotherapy | radiation therapy subclass of surgery | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | systemic therapy facet of cancer, radiation therapy subclass of systemic therapy | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery | radiation therapy subclass of Local therapies | targeted therapy subclass of systemic therapy",
        "metrics": {
          "rouge_score": 0.44,
          "answer_correctness": 0.789760819423489
        }
      },
      {
        "id": "Medical-b3fece20",
        "question": "Why should germline genetic testing be considered for a patient with metastatic prostate cancer?",
        "ground_truth": "Because metastatic prostate cancer is high-risk and may involve genetic mutations like BRCA2, which increase risk and influence treatment.",
        "generated_answer": "Germline genetic testing should be considered for a patient with metastatic prostate cancer to identify hereditary cancer syndromes, guide treatment decisions, and inform family members about potential risks.",
        "contexts": "metastatic subclass of prostate cancer, regional subclass of prostate cancer, localized subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic prostate cancer subclass of prostate cancer | metastatic subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | prostate subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | prostate cancer subclass of cancer | advanced subclass of prostate cancer | Metastatic cancer subclass of Metastasis Cancer | metastasized subclass of cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | de novo subclass of Metastatic cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastatic subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.20833333333333331,
          "answer_correctness": 0.9874005800505175
        }
      },
      {
        "id": "Medical-d1c9cdcd",
        "question": "What are the common genetic alterations associated with bladder cancer, and how might these influence targeted therapy options?",
        "ground_truth": "Genetic alterations such as FGFR3, CDKN2A, PIK3CA, and ERBB mutations are associated with bladder cancer and may be targeted by therapies like erdafitinib and enfortumab vedotin-ejfv.",
        "generated_answer": "Common genetic alterations associated with bladder cancer include mutations in certain genes and genetic changes that lead to cancer cell development. These alterations can influence targeted therapy options by identifying specific pathways or mutations that therapies can aim to address, potentially improving treatment efficacy.",
        "contexts": "bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | genetic errors has effect Bladder cancer, Bladder cancer has cause genetic errors | genetic changes has effect Cancer cells, Cancer cells has effect genetic changes, Cancer cells has cause genetic changes | genetic mutations has effect cancer | bladder has effect cancer | Chemical exposure has effect bladder cancer, bladder cancer has cause Chemical exposure | tested facet of bladder cancer, Cancer cells has effect bladder cancer | hereditary mutation has effect cancer | Smoking has effect bladder cancer, secondhand smoke has effect bladder cancer | bladder cancer has cause bladder | cell changes has effect cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | pass these genes on has effect cancer | genetic mutations has effect Inherited cancer risk | Smoking has effect bladder cancer, Treatment facet of Bladder cancer, Tests for bladder cancer facet of bladder cancer, Bladder cancer subclass of abnormal cells",
        "metrics": {
          "rouge_score": 0.2816901408450704,
          "answer_correctness": 0.8634207504382228
        }
      },
      {
        "id": "Medical-cdce534a",
        "question": "In what situation would a pediatric ALL patient receive supportive care in addition to systemic therapy?",
        "ground_truth": "Supportive care is given alongside systemic therapy to manage side effects and complications during ALL treatment.",
        "generated_answer": "A pediatric ALL patient would receive supportive care in addition to systemic therapy when managing symptoms, side effects of treatment, or during palliative care.",
        "contexts": "supportive care subclass of Treatment | supportive care subclass of health care | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Palliative care subclass of supportive care, Hospice subclass of supportive care | systemic therapy subclass of therapies | Symptoms subclass of supportive care | Clinical trial subclass of health research, supportive care subclass of Treatment | systemic therapy subclass of radiation therapy | cancer care subclass of Treatment | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | Cancer Systemic therapy subclass of drug therapy | Immunotherapy subclass of systemic therapy | systemic therapy subclass of Chemotherapy | Standard of care subclass of treatment regimen | Chemotherapy subclass of systemic therapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | RAI subclass of systemic therapy | Treatment trial subclass of cancer clinical trial, standard treatments subclass of treatment options available for their type of cancer, systemic therapy subclass of Cancer treatment, Clinical trial subclass of medical research | radiation therapy subclass of Treatment, systemic therapy subclass of radiation therapy",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.6660300426556175
        }
      },
      {
        "id": "Medical-6bed629f",
        "question": "How does the management of recurrent ovarian cancer differ based on platinum sensitivity?",
        "ground_truth": "Platinum-sensitive recurrence is managed with platinum-based chemotherapy and possibly surgery, while platinum-resistant recurrence uses non-platinum chemotherapy or targeted agents.",
        "generated_answer": "The management of recurrent ovarian cancer varies based on platinum sensitivity, as platinum-sensitive cases may respond well to re-treatment with platinum-based chemotherapy, while platinum-resistant cases often require alternative therapies such as non-platinum chemotherapy or targeted treatments.",
        "contexts": "platinum-based chemotherapy facet of cancer | Platinum-resistant cancer subclass of ovarian cancer | Treatment facet of ovarian cancer | Surgical staging facet of ovarian cancer | Ultrasound Ultrasound facet of ovarian cancer | invasive test facet of cancer | Germline testing facet of cancer | ovarian cancer instance of cancer stage, staging system facet of ovarian cancer, FIGO stages of ovarian cancer facet of ovarian cancer | BRCA mutation has effect ovarian cancer | test facet of cancer | Chemotherapy facet of cancer | chemotherapy facet of cancer | test facet of Liver cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Immunotherapy facet of cancer | biopsy facet of cancer | High-grade serous carcinoma subclass of ovarian cancer, High-grade endometrioid carcinoma subclass of ovarian cancer | systemic therapy facet of cancer | targeted therapy facet of Glioblastoma",
        "metrics": {
          "rouge_score": 0.4375,
          "answer_correctness": 0.991813825385361
        }
      },
      {
        "id": "Medical-346b12e8",
        "question": "Why is annual follow-up with full skin exams critical for patients with a history of BCC?",
        "ground_truth": "Because recurrence can occur at the original site or spread, so annual full skin exams help detect new or returning lesions.",
        "generated_answer": "Annual follow-up with full skin exams is critical for patients with a history of BCC to monitor for new skin cancers and ensure early detection and treatment of any recurrences or new lesions. This surveillance helps manage their overall skin health and reduces the risk of complications.",
        "contexts": "skin check subclass of physical exam | skin exams subclass of general health test | Skin exams by your doctor subclass of skin exams | Skin exams by your doctor subclass of skin examined | full skin exams participant doctor | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Follow-up and surveillance subclass of Treatment | physical exam subclass of tests | physical exam subclass of test | Skin shave biopsy subclass of Skin shave biopsy | breast exams subclass of physical exam | follow-up visits and tests subclass of monitor my health | physical exam subclass of Surveillance | biopsy subclass of test results | Imaging subclass of test results | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of inherited syndromes | biomarker testing subclass of biopsy, biopsy subclass of test results | Surveillance for the return of anal canal cancer and perianal cancer subclass of Surveillance, Follow-up and surveillance subclass of Surveillance, Anoscopy subclass of Anoscopy | Imaging subclass of test results, biomarker test subclass of biopsy",
        "metrics": {
          "rouge_score": 0.2028985507246377,
          "answer_correctness": 0.8010400576038793
        }
      },
      {
        "id": "Medical-a3c6c911",
        "question": "How does the presence of BCR::ABL1 in B-ALL influence both the prognosis and the treatment approach?",
        "ground_truth": "BCR::ABL1 in B-ALL defines a prognostic subgroup and requires therapies targeting the BCR::ABL protein.",
        "generated_answer": "The presence of BCR::ABL1 in B-ALL typically indicates a poorer prognosis and may necessitate the use of targeted therapies such as tyrosine kinase inhibitors, influencing the overall treatment strategy.",
        "contexts": "BCR::ABL1-negative subclass of B-ALL, BCR::ABL1-like B-ALL subclass of B-ALL | BCR::ABL1 instance of gene | Chronic lymphocytic leukemia drug used for treatment Treatment, Treatment medical condition treated Chronic lymphocytic leukemia, How is CLL confirmed? facet of Chronic lymphocytic leukemia | Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL, Treatment of CLL and SLL medical condition treated SLL, SLL drug used for treatment Treatment of CLL and SLL | effective treatment medical condition treated CLL | daunorubicin medical condition treated AML, AML drug used for treatment daunorubicin | Methotrexate medical condition treated AML, Cytarabine medical condition treated AML | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin | treatments medical condition treated cancer, cancer drug used for treatment treatments | Treatment medical condition treated cancer | cancer drug used for treatment treatments | cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.375,
          "answer_correctness": 0.9920493653423249
        }
      },
      {
        "id": "Medical-a4ac550d",
        "question": "What is the rationale for using both steroids and multiagent chemotherapy in the treatment of all pediatric ALL patients?",
        "ground_truth": "All patients receive steroids and multiagent chemotherapy to target lymphoblasts and maximize treatment efficacy regardless of subtype.",
        "generated_answer": "The rationale for using both steroids and multiagent chemotherapy in the treatment of all pediatric ALL patients is to enhance treatment efficacy and improve outcomes by targeting the cancer through different mechanisms.",
        "contexts": "treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | its treatment medical condition treated prostate cancer, prostate cancer drug used for treatment its treatment | allergy drug used for treatment Medicines | cancer drug used for treatment Treatment | Treatment medical condition treated ovarian cancer | ovarian cancer medical condition treated ovary, ovary medical condition treated ovarian cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | Chemoradiation medical condition treated cancer | prostate cancer drug used for treatment treat | prostate cancer drug used for treatment Treatment | surgery medical condition treated tumor | surgery medical condition treated cancer, cancer drug used for treatment surgery | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.2857142857142857,
          "answer_correctness": 0.9884753794479524
        }
      },
      {
        "id": "Medical-7dd235f1",
        "question": "What is the significance of extranodal extension in regional lymph nodes for mouth cancer staging?",
        "ground_truth": "Extranodal extension indicates cancer spread outside the lymph node and affects staging and prognosis.",
        "generated_answer": "Extranodal extension in regional lymph nodes indicates a more advanced stage of mouth cancer, suggesting a higher likelihood of metastasis and poorer prognosis. It is a critical factor in determining treatment options and overall patient outcomes.",
        "contexts": "lymph nodes facet of cancer | tumor, node, metastasis (TNM) system facet of Mouth cancer, cM subclass of Mouth cancer, cN1 subclass of Mouth cancer | tumor, node, metastasis facet of Throat cancer | How mouth cancer is staged facet of Mouth cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer, Head and neck cancer has cause lymph nodes | sentinel lymph node biopsy facet of lymph nodes | Lymph node exam facet of lymph nodes | Mouth cancer subclass of Head and neck cancer | regional subclass of lymph nodes | squamous cell carcinoma subclass of Mouth cancer | sentinel lymph node biopsy facet of sentinel lymph node | sentinel lymph node biopsy facet of lymph node(s) | Throat cancer staging How throat cancer is staged facet of Throat cancer | lymph node removed facet of lymph nodes | Staging The cancer stage facet of cancer | cancer location lymph nodes | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system",
        "metrics": {
          "rouge_score": 0.28,
          "answer_correctness": 0.8040470617046745
        }
      },
      {
        "id": "Medical-25d1d605",
        "question": "Why should fertility preservation be discussed with certain mouth cancer patients before treatment?",
        "ground_truth": "Cancer and its treatment can affect fertility, so fertility preservation should be considered before therapy.",
        "generated_answer": "Fertility preservation should be discussed with certain mouth cancer patients before treatment because cancer treatments can affect reproductive health and lead to infertility. Addressing this concern allows patients to make informed decisions about their future family planning.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment facet of Anal cancer | Treatment facet of bladder cancer | How mouth cancer is staged facet of Mouth cancer | more treatment facet of cancer | Treatment facet of colon cancer | Treatment facet of urothelial cancer | Treatment facet of Pancreatic cancer | Treatment facet of stomach cancer | tumor, node, metastasis (TNM) system facet of Mouth cancer | Treatment facet of ovarian cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Treatment facet of Treatment | Treatment facet of disease | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer | Mouth cancer subclass of Head and neck cancer | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.1923076923076923,
          "answer_correctness": 0.9882032164252705
        }
      },
      {
        "id": "Medical-020cc551",
        "question": "How does the presence of a BRCA1 mutation influence both risk assessment and treatment in HER2-negative breast cancer?",
        "ground_truth": "BRCA1 mutation increases breast cancer risk and enables the use of PARP inhibitors for HER2-negative disease.",
        "generated_answer": "The presence of a BRCA1 mutation increases the risk of developing HER2-negative breast cancer and may influence treatment options, such as the use of PARP inhibitors and consideration for prophylactic surgeries. It also necessitates more rigorous screening and risk assessment strategies for affected individuals.",
        "contexts": "HER2-positive breast cancer subclass of Breast cancer | HR-cancer subclass of cancer, ER-low\u2013positive subclass of Breast cancer, Hormone receptor-negative subclass of Breast cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | breast subclass of cancer | Hormone receptor-positive subclass of Breast cancer | Breast cancer subclass of carcinoma | Ductal carcinoma subclass of Breast cancer | ovarian subclass of cancer, breast subclass of cancer | HER2-positive subclass of Breast cancer, Immunohistochemistry subclass of staining, estrogen subclass of receptor, tumor biopsy subclass of test, HER2 subclass of cancer | carcinoma subclass of Breast cancer, carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | metastasized subclass of Breast cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | lobular subclass of Breast cancer | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer, noninvasive subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | breast subclass of cancer, spread subclass of cancer | Inflammatory breast cancer subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.3870967741935483,
          "answer_correctness": 0.8419435536201239
        }
      },
      {
        "id": "Medical-1c34ae24",
        "question": "What is the clinical significance of PD-L1 expression in the management of metastatic breast cancer?",
        "ground_truth": "PD-L1 expression may guide immunotherapy use in metastatic breast cancer.",
        "generated_answer": "The clinical significance of PD-L1 expression in metastatic breast cancer includes its role as a biomarker for predicting response to immune checkpoint inhibitors, guiding treatment decisions, and potentially improving patient outcomes.",
        "contexts": "Metastatic cancer subclass of Breast cancer, Invasive breast cancer subclass of cancer | metastatic subclass of cancer | metastasized subclass of Breast cancer | metastatic disease subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | breast subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic subclass of prostate cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | metastasized subclass of cancer | de novo subclass of Metastatic cancer | Breast cancer subclass of carcinoma | metastasis subclass of cancer | Metastatic cancer subclass of Metastasis Cancer | carcinoma subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | ovarian subclass of cancer, breast subclass of cancer",
        "metrics": {
          "rouge_score": 0.3255813953488372,
          "answer_correctness": 0.8423076687466127
        }
      },
      {
        "id": "Medical-7fba506d",
        "question": "How does the anatomical location within the stomach influence the potential spread of cancer to nearby organs?",
        "ground_truth": "Tumors in any stomach region can invade adjacent organs such as the pancreas and spleen through local and distant spread.",
        "generated_answer": "The anatomical location within the stomach can influence cancer spread due to proximity to adjacent organs such as the liver, pancreas, and intestines. Tumors located in specific areas may have a higher likelihood of invading these organs, affecting treatment options and prognosis.",
        "contexts": "stomach instance of organs | bowel instance of organs, bladder instance of organs | small intestine part of small intestine, stomach part of intestines, Body part of stomach, intestines has part stomach, esophagus connects with pylorus, small intestine has part <triplet>duodenum stomach, esophagus connects with stomach, digestive system has part The digestive system, stomach connects with small intestine, small intestine connects with stomach, stomach connects with diaphragm, gallbladder instance of organs | small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | stomach part of digestive system, stomach gland has part submucosa, mucus has part Epithelium, connective tissue part of muscle, connective tissue part of submucosa, submucosa has part connective tissue, stomach gland has part mucosa, mucosa part of stomach gland, submucosa part of stomach gland, digestive system has part stomach, Surface epithelium part of stomach lining, Mucosa part of stomach, stomach lining has part Surface epithelium, muscle part of submucosa, stomach has part serosa | liver instance of organs, kidney instance of organs | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | liver instance of organ, pancreas instance of organ, spleen instance of organ | colon instance of organs | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test | kidney instance of organ, liver instance of organ | Antrum part of stomach, stomach part of digestive system, diaphragm connects with stomach, chest connects with abdomen, digestive system has part stomach, heart connects with lungs, small intestine has part <triplet>duodenum stomach, chest connects with heart, heart connects with chest, submucosa has part muscle | stomach part of digestive system | testicles instance of organ | kidney instance of organ",
        "metrics": {
          "rouge_score": 0.3225806451612903,
          "answer_correctness": 0.8642596013149357
        }
      },
      {
        "id": "Medical-6428d1f1",
        "question": "Why is chemoradiation the standard of care for locally advanced cervical cancer rather than surgery?",
        "ground_truth": "Because chemoradiation is recommended for locally advanced cervical cancer, while surgery is the main treatment for early-stage disease.",
        "generated_answer": "Chemoradiation is the standard of care for locally advanced cervical cancer because it effectively combines chemotherapy and radiation therapy, targeting cancer cells more comprehensively than surgery alone. This approach improves treatment outcomes and reduces the risk of recurrence.",
        "contexts": "Chemoradiation medical condition treated cancer | Chemoradiation medical condition treated cervical cancer, cervical cancer drug used for treatment Chemoradiation EBRT, Chemoradiation EBRT medical condition treated cervical cancer, cervical cancer drug used for treatment Chemoradiation | Chemoradiation medical condition treated lung cancer | cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | intensitymodulated radiation therapy medical condition treated cervical cancer, cervical cancer drug used for treatment intensitymodulated radiation therapy | cervical biopsy medical condition treated cervical cancer | Pap testing medical condition treated cervical cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Chemoradiation medical condition treated anal canal cancer | Treatment medical condition treated cancer | treatments medical condition treated cancer | Removing only a portion of the cervix medical condition treated cervical cancer | radiation therapy medical condition treated CSCC | Treatment medical condition treated ovarian cancer | radical trachelectomy medical condition treated cancer | surgery medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.3157894736842105,
          "answer_correctness": 0.45246971385695406
        }
      },
      {
        "id": "Medical-db5aa2e3",
        "question": "What distinguishes Mohs surgery from other surgical options in the treatment of high-risk local CSCC?",
        "ground_truth": "Mohs surgery is preferred for high-risk local CSCC due to its tissue-sparing and margin-assessing technique.",
        "generated_answer": "Mohs surgery is distinguished by its technique of excising cancerous skin while preserving as much healthy tissue as possible, allowing for immediate microscopic examination of margins to ensure complete removal of cancer cells. This precision minimizes the risk of recurrence and is particularly beneficial for high-risk local cutaneous squamous cell carcinoma (CSCC).",
        "contexts": "surgery instance of Treatment, chemotherapy instance of Treatment, radiation therapy instance of Treatment | Mohs surgery instance of PDEMA | Mohs surgery practiced by dermatologic (skin) surgeon, Mohs surgery field of work tissues | Mohs surgery subclass of resection | abdominoperineal resection instance of surgery | Mohs surgery subclass of excision | Mohs surgery practiced by Mohs surgery, Mohs surgery field of this occupation Mohs surgery | surgery medical condition treated Skin cancer | Total thyroidectomy instance of surgery | Mohs surgery part of PDEMA | Mohs surgery medical condition treated PDEMA, PDEMA/Mohs surgery Peripheral and deep en face margin assessment instance of surgery | Trachelectomy instance of surgery | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | hysterectomy instance of surgery, Hysterectomy with BSO instance of surgery | treatment with surgery part of Other types of cancer treatment | Mohs surgery medical condition treated very high-risk cancer, Mohs surgery subclass of PDEMA | surgery medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.22535211267605632,
          "answer_correctness": 0.8816819554984985
        }
      },
      {
        "id": "Medical-43a4d872",
        "question": "What symptoms in an adult patient should prompt evaluation for glioma using imaging and neurological examination?",
        "ground_truth": "Symptoms like headache, seizures, and cognitive changes in adults should prompt MRI and neurological exam for glioma.",
        "generated_answer": "Symptoms such as persistent headaches, seizures, changes in vision, cognitive decline, motor weakness, or any new neurological deficits should prompt evaluation for glioma using imaging and neurological examination.",
        "contexts": "Magnetic resonance imaging subclass of Magnetic resonance imaging, Brain MRI subclass of Magnetic resonance imaging | Brain MRI subclass of Magnetic resonance imaging, CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | Magnetic resonance imaging subclass of imaging test | Magnetic resonance imaging subclass of Imaging | Magnetic resonance imaging subclass of Magnetic resonance imaging, MRIs subclass of imaging test | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging | CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | MRI scan subclass of Magnetic resonance imaging | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | CT scan subclass of Imaging | Magnetic resonance imaging subclass of scanning | radiology subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | computed tomography subclass of Imaging | Biopsy subclass of Imaging | biopsy subclass of Imaging | CT subclass of Magnetic resonance imaging | radiologist studies Magnetic resonance imaging, Magnetic resonance imaging uses scanning machine, Magnetic resonance imaging subclass of MRI test, CT scan studied by radiologist, CT scan uses X-ray, scanning machine use Magnetic resonance imaging, radiologist studies CT scan, CT subclass of computed tomography, Magnetic resonance imaging uses magnetic field | Ultrasound subclass of imaging test",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.8430747587100511
        }
      },
      {
        "id": "Medical-569780c4",
        "question": "How is IDH mutation status relevant for classifying both astrocytoma and oligodendroglioma, and what procedure is necessary to determine this status?",
        "ground_truth": "IDH mutation is a biomarker used to classify both astrocytoma and oligodendroglioma, and biopsy is necessary to determine this status.",
        "generated_answer": "IDH mutation status is crucial for classifying astrocytoma and oligodendroglioma as it helps differentiate between subtypes and predict prognosis. A biopsy followed by genetic testing is necessary to determine this mutation status.",
        "contexts": "oligodendroglioma subclass of Glioblastoma, astrocytoma subclass of Glioblastoma, brain tumor subclass of cancerous, astrocytoma subclass of astrocyte, Cancer cells subclass of cells, Glioblastoma subclass of Glioblastoma | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | astrocytoma subclass of Glioblastoma | Glioblastoma subclass of glioma tumor, low-grade glioma opposite of high-grade glioma, molecular part of Glioblastoma, oligodendrocyte subclass of glial cell | Glioblastoma subclass of brain tumor | Glioblastoma subclass of tumor | oligodendrocyte subclass of brain tumor, Grade 3 tumor cells subclass of Glioblastoma, high-grade glioma opposite of low-grade glioma | Glioblastoma subclass of Glioblastoma | CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | astrocytoma IDH-mutant subclass of Glioblastoma, Glioblastoma has part glial cell | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.5769230769230769,
          "answer_correctness": 0.7465715078024006
        }
      },
      {
        "id": "Medical-219da1ba",
        "question": "Why should fertility preservation be discussed before chemoradiation in a young patient with Stage II anal cancer?",
        "ground_truth": "Because chemoradiation can cause infertility and Stage II anal cancer is treated with chemoradiation, so fertility preservation options should be considered.",
        "generated_answer": "Fertility preservation should be discussed before chemoradiation in a young patient with Stage II anal cancer because the treatment may adversely affect reproductive health and fertility. Early discussion allows for timely interventions to safeguard fertility options.",
        "contexts": "Anal cancer drug used for treatment radiation treatment | Anal cancer drug used for treatment radiation therapy, metastatic subclass of Anal cancer, radiation therapy medical condition treated Anal cancer | Chemoradiation medical condition treated anal canal cancer, anal canal cancer drug used for treatment Chemoradiation | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | Chemoradiation facet of Anal cancer | low grade subclass of perianal cancer, Chemoradiation medical condition treated perianal cancer, perianal cancer drug used for treatment Chemoradiation | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer, Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer, Anal cancer drug used for treatment Cisplatin, Anal cancer drug used for treatment Mitomycin, 5-FU medical condition treated Anal cancer | platinum-based chemotherapy medical condition treated Metastatic anal cancer | Anal cancer drug used for treatment Mitomycin, 5-FU 5-FU and cisplatin medical condition treated Anal cancer, Mitomycin medical condition treated Anal cancer, capecitabine Mitomycin medical condition treated Anal cancer | Treatment facet of Anal cancer | Abdominoperineal resection medical condition treated Anal cancer | abdominoperineal resection medical condition treated Anal cancer | metastatic anal cancer drug used for treatment Pembrolizumab, Nivolumab medical condition treated metastatic anal cancer | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy",
        "metrics": {
          "rouge_score": 0.24561403508771928,
          "answer_correctness": 0.9949385280678633
        }
      },
      {
        "id": "Medical-984c0f56",
        "question": "How does the spread of early-stage versus locoregional stomach cancer differ in terms of stomach wall invasion and lymph node involvement?",
        "ground_truth": "Early-stage is confined to mucosa without lymph node involvement, while locoregional invades deeper layers and/or regional lymph nodes.",
        "generated_answer": "Early-stage stomach cancer typically shows less invasion of the stomach wall and minimal lymph node involvement compared to locoregional stomach cancer, which often involves deeper wall invasion and greater lymph node spread.",
        "contexts": "Locoregional subclass of stomach cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | numbered stages different from bone cancer, bone cancer different from numbered stages | Locally advanced cancer different from metastatic, metastatic different from Locally advanced cancer | early stages of cancer followed by cancer progresses, cancer progresses follows early stages of cancer | early-stage prostate cancer opposite of more advanced cancers, more advanced cancers opposite of early-stage prostate cancer | Cancer grade different from stage, stage different from Cancer grade | stomach cancer subclass of lung cancer | early-stage subclass of prostate cancer | cancer type different from cancer, cancer different from cancer type | cancer different from tumors | early-stage prostate cancer subclass of cancer | cancer type has effect stage",
        "metrics": {
          "rouge_score": 0.37735849056603776,
          "answer_correctness": 0.988732122020672
        }
      },
      {
        "id": "Medical-2ca88e8f",
        "question": "What factors determine the specific treatment regimen for a pediatric ALL patient?",
        "ground_truth": "Treatment for ALL depends on subtype, age at diagnosis, and other factors such as biomarkers and genetic alterations.",
        "generated_answer": "The specific treatment regimen for a pediatric ALL patient is determined by factors such as the patient's age, genetic characteristics of the leukemia, response to initial therapy, and overall health status. Additionally, the presence of specific biomarkers and the risk of disease recurrence also play a crucial role in tailoring the treatment approach.",
        "contexts": "adolescents and young adults subclass of pediatric | infants subclass of children | ALL subclass of Lymphoblast | pregnant people subclass of children | Diagnosed subclass of Diagnosed | hematopoietic cell transplant subclass of allogeneic | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Pediatric-type FL subclass of classic FL, classic FL instance of ICC classification system | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | pathologic subclass of Clinical | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Immunotherapy subclass of Chemotherapy, combined subclass of Therapeutic, Steroids subclass of Chemotherapy, chemotherapy subclass of Therapeutic | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | board certified subclass of doctors | Clinical trial subclass of studied | standard treatments subclass of Clinical trial, voluntary subclass of Clinical trial, study subclass of Clinical trial, New clinical trial subclass of Clinical trial | transvaginal ultrasound subclass of Ultrasound, transvaginal ultrasound subclass of Ultrasound | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus",
        "metrics": {
          "rouge_score": 0.2222222222222222,
          "answer_correctness": 0.9866154251814384
        }
      },
      {
        "id": "Medical-48e987ed",
        "question": "How do risk factors and symptoms together contribute to the early detection of CLL?",
        "ground_truth": "Older age and family history increase risk, and the presence of symptoms like swollen glands or incidental findings on blood tests aid early detection.",
        "generated_answer": "Risk factors and symptoms together aid in the early detection of CLL by highlighting potential warning signs and increasing awareness among individuals at risk, prompting timely medical evaluation and diagnosis. Recognizing symptoms early can lead to quicker intervention and better prognosis.",
        "contexts": "Symptoms of CLL subclass of Symptoms, bone marrow has effect CLL, CLL has cause bone marrow | prognosis facet of CLL, CLL has effect prognosis, prognosis facet of Cancer treatment | CML has effect CML | effective treatment medical condition treated CLL | symptoms of SCLC subclass of Symptoms, symptoms of SCLC facet of cancer | Symptoms has effect Symptoms | illness has effect Symptoms | illness has effect Symptoms, Symptoms has cause illness | cancer has effect side effects | side effects has cause Chemotherapy, Chemotherapy has effect side effects, low blood cell counts has effect infections | Symptoms different from signs of cancer | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | lymph nodes has effect cancer | cancer has effect quickly it\u2019s growing | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | Symptoms has cause medical problem, medical problem has effect Symptoms",
        "metrics": {
          "rouge_score": 0.1846153846153846,
          "answer_correctness": 0.7928132107616357
        }
      },
      {
        "id": "Medical-a13a1285",
        "question": "What are the distinguishing features between Stage 0 and Stage IV breast cancer in terms of pathology and clinical management?",
        "ground_truth": "Stage 0 is noninvasive (DCIS) and managed with surgery and radiation, while Stage IV is metastatic and managed with systemic therapy.",
        "generated_answer": "Stage 0 breast cancer is non-invasive and typically managed with less aggressive treatments, while Stage IV breast cancer is metastatic, requiring more intensive therapies and management strategies. The pathology of Stage 0 involves localized abnormal cells, whereas Stage IV indicates spread to distant organs.",
        "contexts": "numbered stages different from bone cancer, bone cancer different from numbered stages, stage IV instance of stage | Cancer grade different from stage, stage different from Cancer grade | Stage 4 is metastatic facet of Breast cancer | breast cancer is staged instance of cancer stage | Stage III instance of cancer stage, stage IV instance of cancer stage, Stage 1 instance of cancer stage | Stage 1 instance of Cancer stage, stage 0 instance of Cancer stage | Stage 4 cancer said to be the same as Stage 4A, Stage 3A1 facet of cancer, Stage 4A said to be the same as Stage 4 cancer | Stage 4 cancer subclass of Metastatic cancer | cancer type has effect stage, stage has cause cancer type | Clinical stage facet of Breast cancer | early stages of cancer followed by cancer progresses, cancer progresses follows early stages of cancer | cancer type different from cancer, cancer different from cancer type | stage facet of cancer | Stage III subclass of cancer | cancer different from tumors",
        "metrics": {
          "rouge_score": 0.3939393939393939,
          "answer_correctness": 0.7398968052629913
        }
      },
      {
        "id": "Medical-a73aa030",
        "question": "Why is polypectomy during colonoscopy considered a preventive strategy for rectal cancer?",
        "ground_truth": "Because most rectal cancers start in adenomatous polyps and polypectomy can remove these polyps to prevent cancer.",
        "generated_answer": "Polypectomy during colonoscopy is considered a preventive strategy for rectal cancer because it allows for the removal of colon polyps, which can develop into cancer if left untreated. By detecting and removing these polyps early, the risk of developing rectal cancer is significantly reduced.",
        "contexts": "radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | diagnostic colonoscopy medical condition treated colon cancer | Rectal cancer drug used for treatment oxaliplatin, oxaliplatin medical condition treated Rectal cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | surgery medical condition treated cancer, cancer drug used for treatment surgery | polypectomy medical condition treated Colon polyps Polyps | cancer drug used for treatment Treatment | Treatment medical condition treated cancer | cancer drug used for treatment treatments, treatments medical condition treated cancer | temozolomide medical condition treated colon cancer, colon cancer drug used for treatment Lenalidomide | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | cancer drug used for treatment cancer | cancer drug used for treatment Cancer treatment | High-resolution anoscopy medical condition treated Anal cancer | Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer, APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | CT scan CT with contrast medical condition treated colon cancer",
        "metrics": {
          "rouge_score": 0.26229508196721313,
          "answer_correctness": 0.9882723021757067
        }
      },
      {
        "id": "Medical-0a8d750c",
        "question": "What are the key factors influencing the selection of treatment in AML patients?",
        "ground_truth": "Genetic alterations, performance status, and general health are key factors influencing treatment selection.",
        "generated_answer": "Key factors influencing the selection of treatment in AML patients include the specific subtype of AML, patient age, overall health, genetic mutations (such as FLT3), and response to previous treatments.",
        "contexts": "Methotrexate medical condition treated AML, AML drug used for treatment Methotrexate, Cytarabine medical condition treated AML, AML drug used for treatment Cytarabine | AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin, daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, AML drug used for treatment FLT3 Gilteritinib | daunorubicin medical condition treated AML, AML drug used for treatment Cytarabine, AML drug used for treatment FLT3 Gilteritinib, AML drug used for treatment Sorafenib, AML drug used for treatment daunorubicin, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML | plan treatment facet of AML | treatments medical condition treated cancer, cancer drug used for treatment treatments | cancer drug used for treatment treatments, treatments medical condition treated cancer | cancer drug used for treatment Treatment | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.18604651162790697,
          "answer_correctness": 0.5667000912880248
        }
      },
      {
        "id": "Medical-223def84",
        "question": "What factors determine whether a newly diagnosed CLL patient should begin treatment immediately or undergo watchful waiting?",
        "ground_truth": "Treatment is based on symptoms, blood counts, and disease progression, so asymptomatic or stable patients may be managed with watch and wait.",
        "generated_answer": "Factors include the patient's overall health, the stage of the disease, the presence of symptoms, and specific laboratory findings. If the CLL is asymptomatic and low-risk, watchful waiting may be recommended. Immediate treatment is typically considered for symptomatic or high-risk cases.",
        "contexts": "Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL, Treatment of CLL and SLL medical condition treated SLL, SLL drug used for treatment Treatment of CLL and SLL | effective treatment medical condition treated CLL | Treatment for CLL instance of Treatment | Chronic lymphocytic leukemia drug used for treatment Treatment, Treatment medical condition treated Chronic lymphocytic leukemia, How is CLL confirmed? facet of Chronic lymphocytic leukemia | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | Treatment may not be needed for years facet of CLL | cancer drug used for treatment Treatment | cancer drug used for treatment treatments, treatments medical condition treated cancer | Treatment medical condition treated CNS lymphoma | Treatment medical condition treated cancer | cancer drug used for treatment Cancer treatment | Lymphoma drug used for treatment Methotrexate, Methotrexate medical condition treated Lymphoma | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.15151515151515152,
          "answer_correctness": 0.9779564733109587
        }
      },
      {
        "id": "Medical-04fc1c61",
        "question": "How does the age of a patient influence the management of ALL, and which patient populations are most commonly affected?",
        "ground_truth": "Age influences treatment choices, and ALL is most common in children but also affects adolescents, young adults, and adults.",
        "generated_answer": "The age of a patient significantly influences the management of Acute Lymphoblastic Leukemia (ALL), as treatment protocols may vary for different age groups. Adolescents and young adults are among the most commonly affected populations.",
        "contexts": "health issues has part age | Treatment facet of disease, eligibility criteria facet of Clinical trial | age instance of risk factors | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | Treatment facet of Treatment, more than one treatment option facet of Treatment | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | assessment of their risks facet of Treatment | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of cancer | adolescents and young adults instance of age | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial | overall health facet of health conditions | Treatment decisions facet of cancer | start the conversation facet of Clinical trial, study facet of Treatment | Informed consent facet of Clinical trial, start the conversation facet of Clinical trial, study facet of Treatment | staging facet of Treatment decisions | prognosis facet of more than one treatment option | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos",
        "metrics": {
          "rouge_score": 0.22641509433962262,
          "answer_correctness": 0.8395238182941402
        }
      },
      {
        "id": "Medical-16a39fa8",
        "question": "What role do anatomical layers of the esophagus play in distinguishing early-stage from locoregional esophageal cancer?",
        "ground_truth": "Early-stage is confined to the esophagus, while locoregional involves invasion through esophageal layers and nearby structures.",
        "generated_answer": "Anatomical layers of the esophagus help in identifying the extent of cancer invasion, which is crucial for distinguishing early-stage from locoregional esophageal cancer. The depth of invasion into these layers indicates the stage of cancer and guides treatment decisions.",
        "contexts": "Treatment medical condition treated cancer | treatments medical condition treated cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | surgery medical condition treated cancer | Treatment medical condition treated ovarian cancer | Chemoradiation medical condition treated cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | Cancer treatment medical condition treated bladder cancer | ovarian cancer medical condition treated ovary, ovary medical condition treated ovarian cancer | radical trachelectomy medical condition treated cancer | Chemoradiation medical condition treated lung cancer | bladder cancer surgery medical condition treated bladder cancer | cervix medical condition treated cervical cancer, cervical cancer medical condition treated cervix | surgery medical condition treated cancer, cancer drug used for treatment surgery | Barrett esophagus part of esophagus, Barrett esophagus has effect adenocarcinoma of the esophagus, Treatment facet of esophageal cancer, stomach connects with esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach | its treatment medical condition treated prostate cancer | diagnostic colonoscopy medical condition treated colon cancer | Methotrexate medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.21052631578947367,
          "answer_correctness": 0.8742399839423929
        }
      },
      {
        "id": "Medical-ade4b34a",
        "question": "If a patient with primary CNS lymphoma presents with memory problems and confusion, what imaging modality is most useful and why?",
        "ground_truth": "MRI with gadolinium contrast is most useful because it best identifies CNS lesions causing these symptoms.",
        "generated_answer": "MRI is the most useful imaging modality for assessing primary CNS lymphoma due to its ability to provide detailed images of the brain and detect lesions associated with the disease.",
        "contexts": "testing the CSF facet of CNS lymphoma | Treatment facet of CNS lymphoma | more than one treatment option facet of CNS lymphoma, plan treatment facet of primary CNS lymphoma | What causes primary CNS lymphoma? facet of cancer | more than one treatment option facet of primary CNS lymphoma | Imaging facet of cancer | primary CNS lymphoma location central nervous system | Imaging Imaging facet of cancer | brain has effect CNS lymphoma | centroblast facet of Lymphoma | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of brain tumor | central nervous system has effect CNS lymphoma | primary CNS lymphoma instance of disease | primary CNS lymphoma subclass of eye exam | Imaging part of pathology, Imaging facet of cancer | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | primary CNS lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.26086956521739135,
          "answer_correctness": 0.8346918230951802
        }
      },
      {
        "id": "Medical-689b17ad",
        "question": "Which biomarker should be tested both before and after treatment in nasopharyngeal carcinoma patients, and why is this monitoring important?",
        "ground_truth": "EBV DNA should be tested before and after treatment because its level serves as a prognostic factor and is used for surveillance.",
        "generated_answer": "The biomarker that should be tested both before and after treatment in nasopharyngeal carcinoma patients is Epstein-Barr virus (EBV) DNA. Monitoring EBV DNA levels is important for assessing treatment response and detecting potential recurrence of the cancer.",
        "contexts": "cancer drug used for treatment Treatment | cancer drug used for treatment treatments | cancer drug used for treatment Cancer treatment | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | ovarian cancer drug used for treatment Treatment | prostate cancer drug used for treatment Treatment | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Glioblastoma drug used for treatment Treatment | treatments medical condition treated cancer, cancer drug used for treatment treatments | cancer drug used for treatment Treatment, best treatment facet of cancer | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer | bladder cancer drug used for treatment Treatment | Cancer treatment subclass of Treatment, cancer drug used for treatment Cancer treatment | prostate cancer drug used for treatment its treatment | prostate cancer drug used for treatment treat | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | bladder cancer drug used for treatment Cancer treatment | Chronic lymphocytic leukemia drug used for treatment Treatment | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | Chemotherapy medical condition treated bladder cancer, Intravesical chemotherapy different from Intravesical chemotherapy, Chemotherapy facet of cancer, Chemotherapy subclass of Treatment, bladder cancer drug used for treatment Chemotherapy alone, Intravesical chemotherapy different from Intravesical chemotherapy, Cisplatin medical condition treated bladder cancer, bladder cancer drug used for treatment vinblastine",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.8818536607301307
        }
      },
      {
        "id": "Medical-1eab8fa2",
        "question": "Why should a patient with a family history of skin cancer and light eye color be particularly vigilant about skin changes?",
        "ground_truth": "Because both family history and light eye color are risk factors for BCC, increasing overall risk.",
        "generated_answer": "A patient with a family history of skin cancer and light eye color should be particularly vigilant about skin changes due to their increased genetic risk and susceptibility to UV radiation effects, which can lead to skin cancer development.",
        "contexts": "develops has effect skin cancer, skin cancer has cause develops | Skin cancer has cause Skin cell, Skin cell has effect Skin cancer | skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer, skin cancer has cause melanin | Skin cell has effect skin cancer, genetic risk of skin cancer studied by cancer genetics, skin cancer has cause Skin cell | cancer has cause cell changes, cell changes has effect cancer | cancer has effect cancer, cancer has cause cancer | Skin cancer has cause Squamous cell | radiation therapy has effect Skin cancer | genetic changes has effect Cancer cells, Cancer cells has cause genetic changes | cancer type has effect cancer | cancer has effect side effects | cancer has effect Cancer treatment | scar tissue has effect cancer | health problems has effect cancer",
        "metrics": {
          "rouge_score": 0.29090909090909095,
          "answer_correctness": 0.8160149394929297
        }
      },
      {
        "id": "Medical-fe7f2575",
        "question": "What two performance status scales are considered when planning treatment for primary bone cancer?",
        "ground_truth": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
        "generated_answer": "The two performance status scales considered are the Karnofsky Performance Status and the Eastern Cooperative Oncology Group (ECOG) Performance Status.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment facet of Pancreatic cancer | Treatment facet of ovarian cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment facet of colon cancer | more treatment facet of cancer | Treatment facet of Anal cancer | Treatment facet of bladder cancer | Treatment facet of urothelial cancer | plan treatment facet of cancer | Treatment decisions facet of cancer | treated facet of Glioblastoma | Treatment facet of stomach cancer | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.30303030303030304,
          "answer_correctness": 0.9899977715737307
        }
      },
      {
        "id": "Medical-222ee61b",
        "question": "Why is the diagnostic threshold of 20 percent or more lymphoblasts in bone marrow important for ALL diagnosis?",
        "ground_truth": "It ensures that the diagnosis of ALL is based on a significant proportion of malignant lymphoblasts in the bone marrow.",
        "generated_answer": "The diagnostic threshold of 20 percent or more lymphoblasts in bone marrow is important for ALL diagnosis because it indicates a significant presence of abnormal lymphoblasts, which is characteristic of acute lymphoblastic leukemia. This threshold helps differentiate ALL from other conditions and confirms the diagnosis.",
        "contexts": "Lymphoblast part of bone marrow | hematopoietic stem cell subclass of Red blood cell, stem cell part of bone marrow, stem cell part of bone marrow, bone marrow has part stem cell, Blood has part bone marrow | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of bone marrow | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | B-cell lymphoblasts part of lymph nodes | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | white blood cell part of bone marrow | blood stem cell subclass of stem cell, blood cell counts subclass of blood test, stem cell rescue subclass of Treatment, Red blood cell part of bone marrow, bone marrow has part Red blood cell, stem cell part of bone marrow | cells part of bone marrow, bone marrow has parts of the class cells | bone marrow part of bone | bone marrow has part stem cell, stem cell part of bone marrow, new blood stem cell part of bone marrow | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | Lymphatic system has part bone marrow, bone marrow part of Lymphatic system | lymphocyte has part Lymphoblast | bone has part bone marrow, bone marrow part of bone",
        "metrics": {
          "rouge_score": 0.24615384615384614,
          "answer_correctness": 0.9828790718234759
        }
      },
      {
        "id": "Medical-c218fffa",
        "question": "Which supportive care approaches are important for pancreatic cancer management, and what symptoms might require them?",
        "ground_truth": "Supportive care including symptom management and palliative care is important, particularly for symptoms like jaundice.",
        "generated_answer": "Important supportive care approaches for pancreatic cancer management include palliative care and hospice care. Symptoms that might require these approaches include pain, nausea, and fatigue.",
        "contexts": "supportive care subclass of Treatment | supportive care subclass of health care | Palliative care subclass of supportive care, Hospice subclass of supportive care | Symptoms subclass of supportive care, Care Plan subclass of Care Plan | Clinical trial subclass of health research, supportive care subclass of Treatment, multidisciplinary subclass of care team | supportive care subclass of supportive care | Survivorship subclass of other care | supportive care facet of cancer | supportive care part of cancer care | multidisciplinary care subclass of team | cancer survivors subclass of care | recommendations subclass of care recommendations | cancer care subclass of Treatment | care plan for the end of life subclass of Treatment planning | Palliative care subclass of cancer-related care | Standard of care subclass of treatment regimen | Palliative care subclass of cancer care",
        "metrics": {
          "rouge_score": 0.3,
          "answer_correctness": 0.9031100574118169
        }
      },
      {
        "id": "Medical-fe83d01e",
        "question": "What two assessments are necessary for comprehensive care due to the effects of mouth cancer and its treatment on dental health and swallowing?",
        "ground_truth": "Dental exam and speech and swallowing assessment are necessary for comprehensive care.",
        "generated_answer": "Dental assessment and swallowing assessment.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment facet of Anal cancer | Treatment facet of bladder cancer | How mouth cancer is staged facet of Mouth cancer | more treatment facet of cancer | Treatment facet of colon cancer | Treatment facet of urothelial cancer | Treatment facet of Pancreatic cancer | Treatment facet of stomach cancer | tumor, node, metastasis (TNM) system facet of Mouth cancer | Treatment facet of ovarian cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | Treatment facet of Treatment | Treatment facet of disease | cancer drug used for treatment Cancer treatment, Cancer treatment facet of cancer | Mouth cancer subclass of Head and neck cancer | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.47058823529411764,
          "answer_correctness": 0.9895456862490801
        }
      },
      {
        "id": "Medical-f3af6f24",
        "question": "For a patient with primary CNS lymphoma and cerebrospinal fluid involvement, which specialized treatment is indicated and how is the involvement detected?",
        "ground_truth": "Intrathecal chemotherapy is indicated, with CSF involvement detected by lumbar puncture.",
        "generated_answer": "Specialized treatment for primary CNS lymphoma with cerebrospinal fluid involvement includes intrathecal chemotherapy. Involvement is detected by testing the cerebrospinal fluid (CSF).",
        "contexts": "CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of Treatment | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | testing the CSF facet of CNS lymphoma | lymphoma in the eyes subclass of CNS lymphoma | Non-Hodgkin lymphoma subclass of cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | primary CNS lymphoma location central nervous system | CNS lymphoma has part primary CNS lymphoma | central nervous system has effect CNS lymphoma | brain has effect CNS lymphoma | CNS lymphoma has cause reduced immune system | oligodendroglioma subclass of Glioblastoma",
        "metrics": {
          "rouge_score": 0.30303030303030304,
          "answer_correctness": 0.8369342819921392
        }
      },
      {
        "id": "Medical-eb7624ca",
        "question": "What is the recommended follow-up strategy after treatment for regional CSCC compared to local low-risk CSCC?",
        "ground_truth": "Regional CSCC requires more frequent skin and lymph node exams than local low-risk CSCC, especially in the first two years.",
        "generated_answer": "The follow-up strategy for regional CSCC is different from that for local low-risk CSCC, as regional CSCC typically requires more intensive monitoring due to its higher risk of recurrence.",
        "contexts": "highrisk different from high-risk or very high-risk CSCC, high-risk or very high-risk CSCC different from highrisk | low risk opposite of high risk | lower risk opposite of higher risk, higher risk opposite of lower risk | lower risk opposite of higher risk of recurrence, higher risk of recurrence opposite of lower risk | CSCC subclass of imaging test | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | low risk instance of risk group | low-grade glioma opposite of high-grade glioma, high-grade glioma opposite of low-grade glioma | low-risk CSCC drug used for treatment Low-risk Surgery, Low-risk Surgery medical condition treated low-risk CSCC, High-risk or very high-risk Surgery medical condition treated high-risk or very high-risk CSCC, very high-risk cancer drug used for treatment Mohs surgery | low risk followed by intermediate risk | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | treated differently different from RCC | Regional lymph node subclass of filter | Standard surgical excision medical condition treated local CSCC, local CSCC drug used for treatment Standard surgical excision | high-risk or very high-risk CSCC drug used for treatment High-risk or very high-risk Surgery",
        "metrics": {
          "rouge_score": 0.23076923076923075,
          "answer_correctness": 0.6109390316206346
        }
      },
      {
        "id": "Medical-01e3a9ea",
        "question": "Why might a patient with a shiny bump and a history of radiation therapy require both imaging and biopsy for diagnosis?",
        "ground_truth": "Because radiation therapy is a risk factor for BCC and shiny bumps are a symptom, so both imaging and biopsy help confirm diagnosis.",
        "generated_answer": "A patient with a shiny bump and a history of radiation therapy may require both imaging and biopsy to accurately diagnose the condition, as imaging helps visualize the area while a biopsy provides tissue samples for definitive analysis.",
        "contexts": "biopsy subclass of diagnosis | biopsy subclass of testing | Biopsy subclass of biopsy | biopsy subclass of test results | biopsy subclass of diagnose the tumor | biopsy subclass of test | Biopsy subclass of test | biomarker testing subclass of biopsy, biopsy subclass of test results | biopsy subclass of Imaging | Biopsy subclass of Imaging | biopsy subclass of procedure | type of biopsy subclass of biopsy | Imaging subclass of biopsy | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy | testing Biopsy subclass of biopsy | biopsy subclass of surgical procedure | biopsy subclass of blood test | confirmatory biopsy subclass of biopsy | fine-needle aspiration subclass of biopsy | Fine-needle aspiration subclass of biopsy",
        "metrics": {
          "rouge_score": 0.2950819672131147,
          "answer_correctness": 0.8034690153378503
        }
      },
      {
        "id": "Medical-b0ec1abf",
        "question": "What is the rationale for using both PSA testing and imaging in the follow-up of advanced prostate cancer?",
        "ground_truth": "Because PSA monitoring detects biochemical recurrence, while imaging assesses disease progression or metastasis.",
        "generated_answer": "The rationale for using both PSA testing and imaging in the follow-up of advanced prostate cancer is to monitor PSA levels for disease progression and to utilize imaging for assessing the extent of cancer spread and response to treatment. This combined approach enhances the accuracy of diagnosis and treatment planning.",
        "contexts": "PSA test facet of prostate cancer | PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | PSA test facet of PSA | PSA in the blood has cause prostate cancer, prostate cancer location prostate, PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | PSA test instance of blood test, PSA test facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, what tests you might have facet of prostate cancer | tests and scans facet of prostate cancer | PSA facet of prostate cancer, Gleason score instance of PSA density, more than one treatment option facet of prostate cancer | detection methods facet of prostate cancer | test facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | prostate cancer has cause prostate, PSA density facet of cancer | invasive test facet of cancer | new tests and treatments facet of prostate cancer, detection methods and treatments medical condition treated prostate cancer, treatment choices now than they had before facet of prostate cancer, prostate cancer has cause prostate gland, prostate cancer drug used for treatment detection methods and treatments | Early detection and treatment facet of prostate cancer | aggressive facet of prostate cancer | higher risk facet of prostate cancer | Early vs. advanced prostate cancer facet of prostate cancer | breast exams facet of Breast cancer",
        "metrics": {
          "rouge_score": 0.125,
          "answer_correctness": 0.800816015553309
        }
      },
      {
        "id": "Medical-213847bd",
        "question": "Why is clinical trial enrollment especially considered for certain B-ALL and T-ALL cases in children?",
        "ground_truth": "Clinical trials are preferred for certain B-ALL and T-ALL cases to provide access to novel therapies and tailored treatment approaches.",
        "generated_answer": "Clinical trial enrollment is especially considered for certain B-ALL and T-ALL cases in children to explore new treatment options, improve outcomes, and address the unique biological characteristics of these leukemia subtypes.",
        "contexts": "T-ALL different from B-ALL, B-ALL different from T-ALL, T-cell subclass of lymphocyte, B cell subclass of lymphocyte, B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL, T-cell subclass of lymphocyte | ALL subclass of Lymphoblast | T4a subclass of Tumor, T3 subclass of Tumor | Pediatric-type FL subclass of classic FL, classic FL instance of ICC classification system | testing subclass of test | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | repeated subclass of test | screening subclass of test | metastasized subclass of spread | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | B cell subclass of lymphocyte, B cell subclass of lymphocyte | non-small cell subclass of cell",
        "metrics": {
          "rouge_score": 0.43636363636363634,
          "answer_correctness": 0.989381208795536
        }
      },
      {
        "id": "Medical-d7765001",
        "question": "Which symptoms should prompt evaluation for possible ovarian cancer using tumor markers and imaging?",
        "ground_truth": "Symptoms such as persistent bloating, pelvic pain, trouble eating, and urinary urgency should prompt evaluation with tumor markers and imaging.",
        "generated_answer": "Symptoms such as abdominal bloating, pelvic pain, difficulty eating or feeling full quickly, and urinary urgency or frequency should prompt evaluation for possible ovarian cancer using tumor markers and imaging.",
        "contexts": "SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | FDG-PET subclass of Imaging, PET/CT subclass of Imaging, CT scan subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | biopsy subclass of Imaging | Biopsy subclass of Imaging | FDG-PET subclass of PET scan, FDG-PET subclass of Magnetic resonance imaging | positron emission tomography subclass of computed tomography | biopsy subclass of Imaging, CT subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, bone scan subclass of Imaging methods for detecting prostate cancer | Imaging subclass of blood test | noninvasive subclass of cancer | radiology subclass of Imaging | PET/CT subclass of imaging test, computed tomography subclass of Imaging | Imaging subclass of biopsy | tumor profiling subclass of biomarker testing | staging subclass of Imaging | molecular tumor testing subclass of biomarker testing",
        "metrics": {
          "rouge_score": 0.68,
          "answer_correctness": 0.7427259637984546
        }
      },
      {
        "id": "Medical-06055fa9",
        "question": "How does the TNM system integrate with tumor grade to determine the stage of primary bone cancer?",
        "ground_truth": "The stage of primary bone cancer is determined by combining TNM scores and tumor grade.",
        "generated_answer": "The TNM system assesses tumor size (T), lymph node involvement (N), and metastasis (M) to classify the stage of primary bone cancer. Tumor grade, indicating how aggressive the cancer cells are, complements this staging by providing insight into the tumor's behavior and potential prognosis. Together, they guide treatment decisions and predict outcomes.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | tumor subclass of cancer | Tumor subclass of cancer | primary liver cancer subclass of cancer | cancer subclass of disease | malignant subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | cancer type subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | noninvasive subclass of cancer | cancer subclass of cells | metastasized subclass of cancer | breast subclass of cancer | carcinoma subclass of cancer | breast subclass of cancer, spread subclass of cancer | metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer | cancer subclass of diseases | metastatic subclass of cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | lung subclass of cancer",
        "metrics": {
          "rouge_score": 0.23529411764705882,
          "answer_correctness": 0.9901772111193887
        }
      },
      {
        "id": "Medical-8f1032c7",
        "question": "What diagnostic steps should be taken for a woman presenting with persistent bloating and pelvic pain suggestive of ovarian cancer?",
        "ground_truth": "Imaging such as ultrasound or CT, abdominal and pelvic exam, biopsy, and tumor marker blood tests should be performed.",
        "generated_answer": "Diagnostic steps should include a thorough medical history and physical examination, transvaginal ultrasound, and serum CA-125 level testing. If findings are concerning, further imaging studies such as a CT scan or MRI may be warranted, along with possible referral for genetic testing if there is a family history of ovarian cancer.",
        "contexts": "ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | pain has cause cancer, cancer has effect pain | bone pain has cause bone metastases | BRCA mutation has effect ovarian cancer | ovarian cancer different from cervical cancer | Treatment medical condition treated ovarian cancer | cancer has cause tumor | cancer has cause cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | ovary medical condition treated ovarian cancer | cervical cancer has cause ectocervix | cancer has cause health problems | Lynch syndrome has effect hereditary ovarian cancer | initial surgery medical condition treated ovarian cancer | cancer has cause lymph nodes | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | prostate cancer has cause prostate | bladder cancer has cause bladder",
        "metrics": {
          "rouge_score": 0.14084507042253522,
          "answer_correctness": 0.8619955766738099
        }
      },
      {
        "id": "Medical-f25adcc2",
        "question": "If a primary tumor in intrahepatic bile duct cancer is found in the perimuscular fibrous tissue, why can it not be staged as Tis?",
        "ground_truth": "Because Tis is defined as a tumor confined to the epithelium, and perimuscular fibrous tissue is a deeper layer.",
        "generated_answer": "It cannot be staged as Tis because Tis indicates carcinoma in situ, which is confined to the epithelium, while a primary tumor in the perimuscular fibrous tissue indicates invasion beyond the epithelium.",
        "contexts": "intrahepatic cholangiocarcinoma subclass of Liver cancer | pancreatic subclass of cancer, ovarian subclass of cancer, breast subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | primary liver cancer subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | noninvasive subclass of cancer, in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer | Glioblastoma subclass of tumor | Locoregional subclass of tumor | Tumor subclass of cancer | tumor subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Glioblastoma subclass of brain tumor | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma",
        "metrics": {
          "rouge_score": 0.39215686274509803,
          "answer_correctness": 0.9900970077525059
        }
      },
      {
        "id": "Medical-c2af5dd7",
        "question": "Which two risk factors for liver cancer are also major causes of cirrhosis, further increasing cancer risk?",
        "ground_truth": "Alcohol use and non-alcoholic fatty liver disease (NAFLD) are both risk factors for cirrhosis and liver cancer.",
        "generated_answer": "Hepatitis B and hepatitis C.",
        "contexts": "Liver cancer has cause increased risk, increased risk has effect Liver cancer | spread of cancer has effect liver damage | Liver cancer has cause liver | spread to the liver has effect cancer | Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | cancer has effect cancer | cirrhosis has cause liver | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | risk factors has effect cancer | Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis | lymph nodes has effect cancer | cancer type has effect cancer | cancer has effect Cancer treatment | cancer has effect outcomes | pancreas has effect Pancreatic cancer | cancer has effect side effects | health problems has effect cancer | tumor has effect cancer | virus has effect hepatitis",
        "metrics": {
          "rouge_score": 0.08695652173913045,
          "answer_correctness": 0.23067287764593808
        }
      },
      {
        "id": "Medical-4d01de98",
        "question": "How do blood stem cells contribute to the abnormal blood cell profile observed in CML?",
        "ground_truth": "Blood stem cells in CML produce increased myeloid progenitor cells, leading to elevated granulocytes.",
        "generated_answer": "Blood stem cells can differentiate into various blood cell types, including abnormal myeloblasts in Chronic Myeloid Leukemia (CML), leading to an increased presence of these dysfunctional cells in the blood. This results in an abnormal blood cell profile characterized by elevated white blood cell counts and the presence of immature cells.",
        "contexts": "white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell, white blood cell subclass of blood stem cell, Red blood cell subclass of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | stem cell subclass of Red blood cell | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, platelet subclass of blood stem cell | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell | Red blood cell subclass of Red blood cell, platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | blood stem cell subclass of stem cell, blood cell counts subclass of blood test, stem cell rescue subclass of Treatment, Red blood cell part of bone marrow, bone marrow has part Red blood cell, stem cell part of bone marrow | platelet subclass of Red blood cell, Red blood cell subclass of Red blood cell | white blood cell subclass of white blood cell | white blood cell has part lymphocyte, lymphocyte follows Lymphoid progenitor cell, lymphocyte subclass of white blood cell, Red blood cell followed by platelet, myeloblast subclass of non-lymphoid blood cell, platelet part of Blood, Red blood cell subclass of Red blood cell | Red blood cell subclass of Red blood cell, Granulocyte subclass of white blood cell | white blood cell subclass of Red blood cell",
        "metrics": {
          "rouge_score": 0.24615384615384614,
          "answer_correctness": 0.8148647504320317
        }
      },
      {
        "id": "Medical-66e7fe35",
        "question": "Which diagnostic methods are necessary to confirm a case of Ewing sarcoma, and which biomarker supports the diagnosis?",
        "ground_truth": "Diagnosis of Ewing sarcoma requires imaging tests and biopsy, with EWSR1-FLI1 fusion serving as a supporting biomarker.",
        "generated_answer": "Biopsy and molecular tumor testing are necessary diagnostic methods to confirm a case of Ewing sarcoma. The biomarker supporting the diagnosis is tumor mutation testing.",
        "contexts": "biomarker subclass of test, biomarker test subclass of biomarker | biomarker subclass of biomarker | Biomarkers subclass of biomarker | molecular subclass of biomarker | biomarker test subclass of test | biomarker testing subclass of Molecular | biomarker subclass of genetic testing | biomarker subclass of genetic | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | detection methods subclass of diagnosis | biomarker testing subclass of biopsy, biopsy subclass of test results | molecular tumor testing subclass of biomarker testing | following biomarkers subclass of biomarker | Diagnosis by blood test subclass of blood test | tumor mutation testing subclass of biomarker | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing",
        "metrics": {
          "rouge_score": 0.18604651162790697,
          "answer_correctness": 0.6659327186099276
        }
      },
      {
        "id": "Medical-22b8a5ee",
        "question": "How is small lymphocytic lymphoma (SLL) differentiated from chronic lymphocytic leukemia (CLL) in terms of primary site and diagnostic approach?",
        "ground_truth": "SLL primarily affects lymph nodes and spleen, while CLL affects blood and bone marrow, and both require blood tests and biopsies for diagnosis.",
        "generated_answer": "Small lymphocytic lymphoma (SLL) is primarily a lymphoid tissue disease, while chronic lymphocytic leukemia (CLL) is primarily a blood disease. Diagnosis typically involves examining lymph nodes for SLL and blood tests for CLL.",
        "contexts": "Chronic lymphocytic leukemia subclass of blood cancer | CLL said to be the same as Small lymphocytic lymphoma, Small lymphocytic lymphoma said to be the same as CLL, SLL different from CLL, CLL different from SLL | diffuse large B-cell lymphoma different from Burkitt lymphoma | Chronic lymphocytic leukemia subclass of white blood cell | chronic leukemias opposite of Acute leukemias, Acute leukemias opposite of chronic leukemias | small lymphocytic lymphoma subclass of lymph nodes, lymphocyte subclass of white blood cell | Lymphoblast different from myeloblast | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Non-Hodgkin lymphoma subclass of Lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of cancer | cancer type different from cancer, cancer different from cancer type | cancer different from tumors, tumors different from cancer | chronic myeloid leukemia subclass of blood cancer",
        "metrics": {
          "rouge_score": 0.32142857142857145,
          "answer_correctness": 0.7390600751713766
        }
      },
      {
        "id": "Medical-68c30458",
        "question": "What is the rationale for recommending molecular testing after a biopsy in glioma diagnosis?",
        "ground_truth": "Molecular testing after biopsy is recommended to determine biomarker status and guide classification and treatment.",
        "generated_answer": "Molecular testing after a biopsy in glioma diagnosis helps identify specific genetic markers and characteristics of the tumor, which can guide treatment decisions and provide a more accurate prognosis.",
        "contexts": "Biopsy use biopsy | biomarker testing use diagnosis | test use diagnosis | needle use biopsy, biopsy uses needle | molecular test use diagnosis | sample use Biopsy, Biopsy uses sample | diagnosis uses test, test used by diagnosis | biopsy subclass of diagnosis | biopsy uses sample | Biopsy uses tissue sample | endoscope use biopsy | contrast use Biopsy | biopsy use follow-up examination | biopsy subclass of diagnose the tumor | needle biopsy uses needle | test use diagnose | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Symptoms used by diagnosis",
        "metrics": {
          "rouge_score": 0.3181818181818182,
          "answer_correctness": 0.8027194717313668
        }
      },
      {
        "id": "Medical-00ef7b5d",
        "question": "How are dMMR/MSI-H and pMMR/MSS statuses determined and how do they influence therapy choices?",
        "ground_truth": "All colon cancers should be tested for dMMR/MSI-H or pMMR/MSS, with dMMR/MSI-H guiding immunotherapy and pMMR/MSS leading to chemotherapy.",
        "generated_answer": "dMMR/MSI-H and pMMR/MSS statuses are determined through genetic testing that assesses microsatellite instability and mismatch repair deficiency. These statuses influence therapy choices by guiding the use of targeted treatments, such as Pembrolizumab for dMMR/MSI-H tumors.",
        "contexts": "Performance status instance of Performance status, heart rate instance of vital signs | PSA level instance of test | PMS2 instance of gene | MSI-H subclass of microsatellite instability | PSA test instance of diagnostic test, MPS instance of urine test, ExoDx instance of urine test, SelectMDx instance of urine test, miR Sentinel instance of urine test | Performance status subclass of evaluation | FIGO instance of system | MSH6 instance of gene, PMS2 instance of gene, MLH1 instance of gene | PSA test instance of testing | test results subclass of records | MyChart instance of health record | IMRT instance of EBRT | MSI-H/dMMR tumors drug used for treatment Pembrolizumab, Pembrolizumab medical condition treated MSI-H/dMMR tumors | minimal residual disease instance of condition | MSI-H subclass of microsatellite instability, deficient mismatch repair subclass of microsatellite instability | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | Google instance of diagnosis",
        "metrics": {
          "rouge_score": 0.24615384615384614,
          "answer_correctness": 0.7726816500555798
        }
      },
      {
        "id": "Medical-8b16a7bd",
        "question": "What is the rationale for targeting BCR::ABL1 protein activity in CML treatment?",
        "ground_truth": "Since CML is caused by the BCR::ABL1 fusion gene, inhibiting its protein product addresses the underlying cause.",
        "generated_answer": "Targeting BCR::ABL1 protein activity in CML treatment is crucial because it is a key driver of the disease, resulting from a genetic fusion that leads to uncontrolled cell proliferation. Inhibiting this protein can effectively reduce the cancerous cell growth associated with chronic myeloid leukemia.",
        "contexts": "BCR::ABL1 instance of gene | EGFR instance of Proteins | BCL2 instance of Proteins | CD20 instance of Proteins | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | PD-L1 instance of Proteins | p16 instance of Proteins | HER2 instance of Proteins | CD33 instance of Proteins, CD33 instance of Proteins | PSA instance of Proteins | CD33 instance of Proteins | Beta-2 microglobulin instance of Proteins | PD-1 instance of Proteins | PD-L1 instance of biomarker | CD20 instance of Proteins, Rituxima Binding to CD20 on a B Cell Surface publisher NIAID | p16 instance of gene | CHEK2 instance of mutations in certain genes, BRCA1 instance of mutations in certain genes, BRCA1 instance of gene, BRCA2 instance of gene | BRCA1 instance of gene | BRCA1 instance of gene, BRCA2 instance of gene",
        "metrics": {
          "rouge_score": 0.22222222222222218,
          "answer_correctness": 0.7405197721253493
        }
      },
      {
        "id": "Medical-c4772f49",
        "question": "How do the submucosa and muscle layer relate to the progression from early-stage to locoregional stomach cancer?",
        "ground_truth": "Progression from early-stage to locoregional involves invasion beyond the mucosa into the submucosa and muscle layer.",
        "generated_answer": "The submucosa and muscle layer are involved in the progression from early-stage to locoregional stomach cancer as cancer can invade these layers, indicating a more advanced stage of the disease. Their involvement signifies a transition from localized to locoregional cancer, reflecting deeper tissue infiltration.",
        "contexts": "Locoregional subclass of stomach cancer | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | stomach cancer subclass of lung cancer | Locoregional subclass of esophageal cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Locoregional subclass of tumor | noninvasive subclass of cancer | early-stage subclass of prostate cancer | HCC subclass of Liver cancer | colorectal subclass of cancer | stage II subclass of cancer | pancreatic subclass of cancer | Stage 1 subclass of Stage 1A1 cancers, pre-cancer subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | benign subclass of cancer | early-stage prostate cancer subclass of cancer | metastasized subclass of cancer | breast subclass of cancer | colon subclass of cancer, pancreatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.22580645161290322,
          "answer_correctness": 0.9880338001051476
        }
      },
      {
        "id": "Medical-c0103315",
        "question": "What differentiates a functional from a nonfunctioning adrenal adenoma, and how does this impact patient symptoms?",
        "ground_truth": "Functional adenomas secrete excess hormones and cause symptoms, while nonfunctioning adenomas do not secrete hormones and are usually asymptomatic.",
        "generated_answer": "A functional adrenal adenoma produces hormones, leading to symptoms such as hypertension or Cushing's syndrome, while a nonfunctioning adrenal adenoma does not produce hormones and typically does not cause symptoms. This distinction significantly impacts patient management and treatment options.",
        "contexts": "Benign (not cancer) adrenal tumor subclass of adrenal tumor, Malignant adrenal tumor subclass of cancerous tumor, benign opposite of cancer | benign different from cancerous, cancerous different from benign, noncancerous subclass of tumor, cure different from Treatment, Types facet of adrenal tumor, Neuroblastoma subclass of adrenal tumor | tumor different from Tumor | tumors different from cancer, cancer different from tumors | adrenal tumor has cause conditions listed below, Adrenal cancer subclass of cancer | cancer type different from cancer, cancer different from cancer type | adrenal tumor subclass of tumor | BPH different from prostate cancer, prostate cancer different from BPH | plan treatment medical condition treated adrenal tumor | Imaging different from cancer | Symptoms different from signs of cancer | Papillary different from follicular tumor",
        "metrics": {
          "rouge_score": 0.3389830508474576,
          "answer_correctness": 0.8410407518512313
        }
      },
      {
        "id": "Medical-3447851a",
        "question": "Why should young adults with colon cancer be counseled about fertility preservation before treatment?",
        "ground_truth": "Young adults should be counseled because treatments like chemotherapy and surgery can impair fertility, and options such as sperm banking, egg freezing, or ovarian tissue banking are available.",
        "generated_answer": "Young adults with colon cancer should be counseled about fertility preservation before treatment because cancer treatments, such as chemotherapy and radiation, can negatively impact fertility. Early discussion allows for options to be explored and preserved before treatment begins.",
        "contexts": "treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | cancer drug used for treatment Treatment | cancer drug used for treatment treatments, treatments medical condition treated cancer | temozolomide medical condition treated colon cancer, colon cancer drug used for treatment Lenalidomide, colon cancer drug used for treatment Ibrutinib, colon cancer drug used for treatment temozolomide, Ibrutinib medical condition treated colon cancer, rituximab medical condition treated colon cancer, Lenalidomide medical condition treated colon cancer | Treatment medical condition treated cancer | Treatment facet of colon cancer, diagnostic colonoscopy medical condition treated colon cancer | prostate cancer drug used for treatment Treatment, Treatment medical condition treated prostate cancer | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment Treatment, best treatment facet of cancer | Treatment medical condition treated ovarian cancer | CT scan CT with contrast medical condition treated colon cancer",
        "metrics": {
          "rouge_score": 0.36363636363636365,
          "answer_correctness": 0.7389610697353276
        }
      },
      {
        "id": "Medical-2e171c34",
        "question": "How do risk group classification and molecular biomarker testing together influence treatment selection in prostate cancer?",
        "ground_truth": "Risk group classification guides prognosis and initial management, while molecular biomarker testing refines risk assessment and guides therapy choices.",
        "generated_answer": "Risk group classification and molecular biomarker testing together help identify the aggressiveness of prostate cancer and guide personalized treatment options. This combination allows for more tailored treatment decisions, improving outcomes by matching patients with the most effective therapies based on their specific cancer characteristics.",
        "contexts": "more than one treatment option facet of prostate cancer | Treatment decisions facet of cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment planning facet of cancer | Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Early detection and treatment facet of prostate cancer | new tests and treatments facet of prostate cancer, detection methods and treatments medical condition treated prostate cancer, treatment choices now than they had before facet of prostate cancer, prostate cancer has cause prostate gland, prostate cancer drug used for treatment detection methods and treatments | Cancer treatment facet of cancer | more than one treatment option facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | radiation therapy facet of cancer | Early vs. advanced prostate cancer facet of prostate cancer | Treatment facet of colon cancer | aggressive facet of prostate cancer | Treatment facet of ovarian cancer | more treatment facet of cancer | staging facet of Treatment decisions | systemic therapy facet of cancer",
        "metrics": {
          "rouge_score": 0.31746031746031744,
          "answer_correctness": 0.989401369820701
        }
      },
      {
        "id": "Medical-a0a1a141",
        "question": "Which imaging modalities are used for both diagnosis and staging of throat cancer, and what is their role?",
        "ground_truth": "CT scan, MRI, PET/CT, and ultrasound are used for both diagnosis and staging to assess tumor extent and spread.",
        "generated_answer": "The imaging modalities used for both diagnosis and staging of throat cancer include CT scans, MRI, and PET scans. Their role is to visualize the tumor's size, location, and spread to lymph nodes or other tissues.",
        "contexts": "staging part of grading | Pathologic stage part of initial diagnosis | staging facet of cancer | Staging facet of cancer | staging facet of Treatment decisions | Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging, Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | stage part of Treatment, Treatment has part stage | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | staging subclass of Imaging | Staging The cancer stage facet of cancer | initial diagnosis part of Clinical | numbered stages part of Staging, Staging has part numbered stages | Clinical subclass of cancer staging, pathologic subclass of cancer staging | T2 tumor instance of staging | cancer staging facet of tumor | Clinical staging of lymph nodes subclass of staging | pathologic subclass of stage",
        "metrics": {
          "rouge_score": 0.3508771929824562,
          "answer_correctness": 0.9068591055618236
        }
      },
      {
        "id": "Medical-ebfc4679",
        "question": "What is the relationship between adenocarcinoma, adenomas, and the development of colon cancer?",
        "ground_truth": "Adenocarcinoma, the most common colon cancer subtype, arises from adenomas that can become invasive cancer over many years.",
        "generated_answer": "Adenocarcinoma is a subclass of colon cancer, and polyps (adenomas) have an effect on the development of colon cancer.",
        "contexts": "Polyps has effect colon cancer | cancer has effect cancer, cancer has cause cancer | cancer type has effect cancer, cancer has cause cancer type | tumor has effect cancer, cancer has cause tumor | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | cancer has effect Cancer treatment | cancer has cause Cancer cells | health problems has effect cancer, cancer has cause health problems | pancreas has effect Pancreatic cancer | lymph nodes has effect cancer, cancer has cause lymph nodes | cancer has effect side effects | Breast cancer has effect Breast cancer | Adenocarcinoma subclass of colon cancer | cancer has effect outcomes | prostate has effect prostate cancer",
        "metrics": {
          "rouge_score": 0.27027027027027023,
          "answer_correctness": 0.8839562891923843
        }
      },
      {
        "id": "Medical-f7ce6257",
        "question": "How does the treatment approach differ between T1 and T2 rectal tumors according to surgical recommendations?",
        "ground_truth": "T1 tumors are treated with local excision or endoscopic methods, while T2 tumors require transabdominal surgery.",
        "generated_answer": "The treatment approach for T1 rectal tumors typically involves local excision, while T2 rectal tumors often require more extensive surgical intervention, such as radical resection, due to their invasion into the muscle layer.",
        "contexts": "T1 tumor subclass of tumor, Rectal cancer subclass of lesion | T3 subclass of Tumor, T4a subclass of Tumor | Adenocarcinoma subclass of rectal tumor, Rectal cancer basics 5 The rectum 6 Polyps 6 Key points Rectal cancer subclass of Rectal cancer, Adenocarcinoma subclass of rectal tumor | rectal wall subclass of cancer | Rectal cancer subclass of Cancer cells | Rectal cancer subclass of syndromes | colorectal subclass of cancer | Anal tumor subclass of stage IIA, stage II subclass of Anal cancer | Polyps with cancer subclass of Rectal cancer | Locoregional subclass of tumor | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | Rectal cancer subclass of surgery | rectum subclass of cancer, Mismatch repair subclass of Tumor | T2 tumor subclass of invaded the muscle layer, locally advanced subclass of cancer | benign subclass of tumor | intermediate-grade subclass of perianal cancer",
        "metrics": {
          "rouge_score": 0.326530612244898,
          "answer_correctness": 0.8818658747122763
        }
      },
      {
        "id": "Medical-c31057de",
        "question": "What evidence supports the use of both health history and physical exam in the diagnostic workup for Hodgkin lymphoma?",
        "ground_truth": "Health history and physical exam are part of the diagnostic process for Hodgkin lymphoma and are included in the diagnostic methods for both CHL and NLPHL.",
        "generated_answer": "Health history studies cancer, and physical exams are part of medical history, which supports their use in the diagnostic workup for Hodgkin lymphoma.",
        "contexts": "physical exam part of Medical history | Health history and physical exam subclass of General health history | family history part of health history, health history has part family history | health studied by Medical history, health history facet of health | family history part of medical, medical has part family history | physical exam uses physical ability, physical ability used by physical exam | physical exam subclass of test | Guide General health tests Medical history instance of Medical history | physical exam subclass of tests | physical exam different from Imaging | skin check subclass of physical exam | health history studies cancer, cancer studied by health history | physical exam subclass of Surveillance | health history subclass of health information | breast exams subclass of physical exam",
        "metrics": {
          "rouge_score": 0.5306122448979592,
          "answer_correctness": 0.42993163613120144
        }
      },
      {
        "id": "Medical-ac73c113",
        "question": "What combination of diagnostic tools is recommended for staging and detecting metastasis in rectal cancer?",
        "ground_truth": "MRI of the pelvis and CT scan of chest and abdomen are recommended for staging and detecting metastasis.",
        "generated_answer": "The recommended combination of diagnostic tools for staging and detecting metastasis in rectal cancer includes imaging techniques, diagnostic laparoscopy, and biopsy.",
        "contexts": "staging subclass of Imaging | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging, Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging | Clinical subclass of cancer staging, pathologic subclass of cancer staging | Staging after surgery subclass of Clinical stage | pathologic subclass of stage | Clinical staging of lymph nodes subclass of staging | testing subclass of diagnosis | minimally invasive procedure subclass of Surgical staging | staging part of grading | staging system subclass of system | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | biopsy subclass of diagnosis | genetic testing subclass of diagnostic test | potentially curable subclass of stages | Diagnosed subclass of Diagnosed | detection methods subclass of diagnosis | plan treatment subclass of diagnosis | Diagnostic laparoscopy subclass of Diagnostic laparoscopy",
        "metrics": {
          "rouge_score": 0.358974358974359,
          "answer_correctness": 0.23407226178037854
        }
      },
      {
        "id": "Medical-b2b43c1e",
        "question": "Which bone sarcoma subtype is most likely to originate from cartilage-forming cells, and what biomarker is relevant for its targeted therapy?",
        "ground_truth": "Chondrosarcoma originates from cartilage-forming cells and the IDH1 mutation is relevant for targeted therapy.",
        "generated_answer": "Chondrosarcoma; no specific biomarker mentioned.",
        "contexts": "systemic therapy medical condition treated Ewing sarcoma, chondrosarcoma treatment medical condition treated chondrosarcoma, chondrosarcoma drug used for treatment chondrosarcoma treatment | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | targeted therapy medical condition treated primary CNS lymphoma | chondrosarcoma drug used for treatment ivosidenib, ivosidenib medical condition treated chondrosarcoma | Treatment medical condition treated cancer | surgery medical condition treated tumor | treatments medical condition treated cancer | Chemoradiation medical condition treated cancer | Pembrolizumab medical condition treated Breast cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | lenvatinib instance of targeted therapy, targeted therapy subclass of radiation therapy, Sorafenib instance of targeted therapy | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Pembrolizumab medical condition treated MSI-H/dMMR tumors | Methotrexate medical condition treated cancer | systemic therapy medical condition treated Skin cancer | Treatment medical condition treated ovarian cancer | bevacizumab instance of targeted therapy | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | its treatment medical condition treated prostate cancer",
        "metrics": {
          "rouge_score": 0.1,
          "answer_correctness": 0.6076266519119703
        }
      },
      {
        "id": "Medical-ee09c8e9",
        "question": "Why is performance status (ECOG) considered in treatment selection for mouth cancer?",
        "ground_truth": "Performance status (ECOG) is used to guide treatment selection based on the patient's ability to tolerate therapy.",
        "generated_answer": "Performance status (ECOG) is considered in treatment selection for mouth cancer because it helps assess a patient's overall health and ability to tolerate specific treatments, influencing the choice of therapy.",
        "contexts": "Treatment decisions facet of cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | tumor, node, metastasis (TNM) system facet of Mouth cancer, cM subclass of Mouth cancer, cN1 subclass of Mouth cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer | Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | squamous cell carcinoma subclass of Mouth cancer | How mouth cancer is staged facet of Mouth cancer | Treatment planning facet of cancer | more than one treatment option facet of cancer | Cancer treatment facet of cancer | Treatment facet of Anal cancer | more treatment facet of cancer | staging facet of Treatment decisions | Treatment facet of bladder cancer | Treatment facet of colon cancer | Treatment facet of urothelial cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer",
        "metrics": {
          "rouge_score": 0.4897959183673469,
          "answer_correctness": 0.9931693071916564
        }
      },
      {
        "id": "Medical-669af50b",
        "question": "How does performance status impact the treatment plan for an AML patient?",
        "ground_truth": "Performance status influences the selection and intensity of AML treatment.",
        "generated_answer": "Performance status significantly influences the treatment plan for an AML patient by determining the intensity and type of therapy that can be safely administered. A better performance status may allow for more aggressive treatment options, while a poorer status may necessitate a more conservative approach.",
        "contexts": "plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia | Treatment planning facet of cancer | plan treatment facet of cancer | plan treatment facet of Treatment | plan treatment facet of Treatment, plan treatment facet of disease | Testing for AML facet of AML | Treatment facet of cancer | in remission facet of AML | Treatment facet of cancer, Cancer treatment facet of cancer | best treatment plan facet of cancer | Cancer treatment facet of cancer | Cancer treatment subclass of plan treatment, plan treatment facet of Cancer treatment | Imaging facet of cancer, Treatment planning facet of cancer | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment | Treatment facet of ovarian cancer | Treatment facet of Treatment | Treatment decisions facet of cancer | plan treatment facet of Treatment, Treatment has part plan treatment | Treatment facet of disease",
        "metrics": {
          "rouge_score": 0.2545454545454545,
          "answer_correctness": 0.9917820496085508
        }
      },
      {
        "id": "Medical-423d4257",
        "question": "Which risk factors are shared by cervical cancer and its precursor lesions, and how do they contribute to disease development?",
        "ground_truth": "HPV infection, smoking, and immunosuppression are risk factors for both cervical cancer and cervical dysplasia, contributing to disease progression.",
        "generated_answer": "Shared risk factors for cervical cancer and its precursor lesions include HPV infection, which is a sexually transmitted infection, and cervical dysplasia. These factors contribute to disease development by causing abnormal cell growth and increasing the likelihood of progression to cancer.",
        "contexts": "Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | recurrence subclass of cervical cancer | cervical dysplasia subclass of cervical intraepithelial neoplasia | squamous cell carcinoma subclass of cervical cancer | neuroendocrine carcinoma of the cervix subclass of cervical cancer, cervical intraepithelial neoplasia subclass of cervical dysplasia | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | locally advanced cancer subclass of cervical cancer | cervical cancer subclass of cancer | Adenosquamous carcinoma subclass of cervical cancer | metastatic subclass of cervical cancer | Stage 3B subclass of cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | neuroendocrine carcinoma of the cervix subclass of cervical cancer | Metastatic cancer subclass of cervical cancer | scar subclass of lesions | Anal cancer subclass of cervical cancer | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | HPV subclass of sexually transmitted infection | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of inherited syndromes",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.6890325742248821
        }
      },
      {
        "id": "Medical-8ff5dd5a",
        "question": "Why might systemic therapy be considered for a patient with BCC that has spread to distant sites?",
        "ground_truth": "Because systemic therapy is a treatment option for BCC that has recurred or spread to distant sites.",
        "generated_answer": "Systemic therapy may be considered for a patient with BCC that has spread to distant sites because it can treat cancer that has metastasized beyond the local area, potentially improving outcomes and managing the disease effectively.",
        "contexts": "systemic therapy medical condition treated Skin cancer, Skin cancer drug used for treatment systemic therapy, Skin cancer drug used for treatment radiation therapy | systemic therapy medical condition treated Ewing sarcoma | skin cancer drug used for treatment systemic therapy | systemic therapy part of Oncology | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | systemic therapy has part chemotherapy, systemic therapy has part Immunotherapy, Immunotherapy part of systemic therapy | Cancer Systemic therapy subclass of drug therapy | systemic therapy subclass of Chemotherapy | systemic therapy facet of cancer | Chemotherapy subclass of systemic therapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | systemic therapy different from radiation therapy, systemic therapy subclass of radiation therapy, systemic therapy opposite of radiation therapy, radiation therapy different from systemic therapy | cancer drug used for treatment treatments | cancer drug used for treatment Treatment | Treatment medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.3773584905660377,
          "answer_correctness": 0.9945736006988883
        }
      },
      {
        "id": "Medical-6e4da4de",
        "question": "What are the main routes of metastasis in throat cancer and which distant sites are commonly involved?",
        "ground_truth": "Throat cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine.",
        "generated_answer": "The main routes of metastasis in throat cancer typically involve lymphatic spread to regional lymph nodes and hematogenous spread to distant sites such as the lungs and liver.",
        "contexts": "tumor, node, metastasis facet of Throat cancer | Throat cancer staging How throat cancer is staged facet of Throat cancer | tumor, node, metastasis facet of colon cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | lymph nodes facet of cancer | staging facet of cancer | Staging facet of cancer | cancer staging facet of tumor | biopsy facet of cancer | Staging The cancer stage facet of cancer | PS 5 facet of Head and neck cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Oropharynx part of Throat cancer | tumor, node, metastasis (TNM) system facet of Mouth cancer | cancer stage facet of cancer | grade facet of cancer, staging facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | stage facet of cancer | Imaging facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.5833333333333334,
          "answer_correctness": 0.9087163567258686
        }
      },
      {
        "id": "Medical-5a2c0504",
        "question": "Which anatomical sites are most commonly affected by metastasis from primary liver cancer, and how is this supported by the ontology?",
        "ground_truth": "The lung and bone are the most common metastasis sites for primary liver cancer.",
        "generated_answer": "The anatomical sites most commonly affected by metastasis from primary liver cancer include the lungs and lymph nodes. This is supported by the ontology through the relationships and facts linking liver cancer to its metastatic spread.",
        "contexts": "Liver cancer has cause liver | spread to the liver has effect cancer, cancer has cause spread to the liver, kidney connects with liver | Liver cancer has cause increased risk, increased risk has effect Liver cancer, How liver cancer spreads facet of Liver cancer | Cancer stages and metastasis has effect Metastatic cancer, Metastatic cancer has cause Cancer stages and metastasis | metastasis has effect spread | cancer has effect cancer, cancer has cause cancer | tumor has effect cancer, cancer has cause tumor | Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis | cirrhosis has cause liver | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | cancer has effect Cancer treatment | Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | lymph nodes has effect cancer | cancer type has effect cancer | Breast cancer has effect Breast cancer",
        "metrics": {
          "rouge_score": 0.24,
          "answer_correctness": 0.8851360077746593
        }
      },
      {
        "id": "Medical-97022167",
        "question": "How does the origin of colon cancer from adenomas influence early detection and prevention strategies?",
        "ground_truth": "Since most colon cancers start in adenomas, early detection and removal of polyps via colonoscopy and polypectomy are crucial for prevention.",
        "generated_answer": "The origin of colon cancer from adenomas emphasizes the importance of early detection through regular screenings, as identifying and removing adenomas can prevent their progression to cancer. This knowledge informs prevention strategies that focus on monitoring and managing polyp development to reduce cancer risk.",
        "contexts": "Polyps has effect colon cancer, colon cancer has cause Polyps, Colon polyps Polyps medical condition treated polypectomy | tumor has effect cancer, cancer has cause tumor | cancer has effect cancer, cancer has cause cancer | prostate has effect prostate cancer, prostate cancer has cause prostate | prostate gland has effect prostate cancer | cancer type has effect cancer | health problems has effect cancer, cancer has cause health problems | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | lymph nodes has effect cancer | Cancer cells has effect tumor, tumor has cause Cancer cells | tumor has cause Cancer cells, Cancer cells has effect tumor | prostate cancer has cause prostate gland | cancer has effect return | cancer has effect Cancer treatment | tumors has cause Cancer cells",
        "metrics": {
          "rouge_score": 0.24615384615384614,
          "answer_correctness": 0.9903464001415841
        }
      },
      {
        "id": "Medical-7bf81d77",
        "question": "Why does carcinoma in situ not involve spread to blood vessels or the liver?",
        "ground_truth": "Because carcinoma in situ is by definition confined to the epithelium and does not invade deeper tissues or structures.",
        "generated_answer": "Carcinoma in situ is characterized by cancer cells that remain localized and have not invaded surrounding tissues or spread to blood vessels or distant organs like the liver. This localized nature prevents metastasis, which is the spread of cancer.",
        "contexts": "liver connects with abdomen, abdomen connects with liver | liver connects with stomach, stomach connects with liver | liver connects with spleen | liver connects with lungs, lungs connects with liver | liver connects with kidney | spleen connects with liver | liver connects with rectum, rectum connects with liver | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | liver connects with gallbladder, gallbladder connects with liver | kidney connects with liver | liver connects with gallbladder, gallbladder connects with liver | stomach connects with small intestine, small intestine connects with stomach, portal vein connects with hepatic artery, hepatic artery connects with portal vein, heart connects with inferior vena cava, right instance of hepatic duct, cystic duct connects with gallbladder | lung connects with liver | intestines connects with Blood | arteries connects with veins",
        "metrics": {
          "rouge_score": 0.3448275862068965,
          "answer_correctness": 0.9222143770852561
        }
      },
      {
        "id": "Medical-1892185a",
        "question": "What is the role of p16 protein in distinguishing subtypes of squamous cell carcinoma in the oropharynx?",
        "ground_truth": "p16 protein overexpression identifies HPV-mediated squamous cell carcinoma in the oropharynx.",
        "generated_answer": "The p16 protein serves as a biomarker to differentiate between HPV-positive and HPV-negative subtypes of squamous cell carcinoma in the oropharynx, aiding in diagnosis and treatment decisions.",
        "contexts": "trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx | Oropharynx part of Throat cancer | Oropharynx has part Tonsils, Oropharynx connects with Nasopharynx, nose connects with mouth, Oropharynx has part soft palate, larynx connects with esophagus, pharynx connects with esophagus, Nasopharynx connects with Oropharynx, larynx connects with pharynx, Oropharynx has part tongue, esophagus connects with larynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx | Oropharynx part of throat, throat has part Oropharynx | squamous cell carcinoma location Eastern Europe | Throat cancer has cause squamous cell carcinoma, squamous cell carcinoma has effect Throat cancer | Esophageal cancer location mucosa | cancer location lymph nodes | tongue part of throat, throat connects with pharynx, soft palate part of Oropharynx, Tonsils part of throat, tongue connects with Oropharynx, Oropharynx connects with tongue, larynx has part voice box, roof of the mouth part of Oropharynx, oral has part mouth, throat connects with nasal, nasal connects with nose, mouth part of oral, nasal connects with throat, throat has part Oropharynx, throat has part Tonsils, pharynx connects with throat, throat has part soft palate, voice box part of larynx | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | throat has part Mouth, Mouth part of throat, throat has part Hypopharynx, Hypopharynx part of throat, oral has part mouth, Nasopharynx part of throat, throat connects with nasal, nasal connects with nose, nasal connects with throat, throat has part Oropharynx, Squamous cell carcinoma of the head and neck subclass of Head and neck cancer, Oropharynx part of throat, throat has part Nasopharynx, throat has part Voice box (larynx), Voice box (larynx) part of throat, pharynx connects with throat | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | cancer location prostate | squamous cell carcinoma has cause arsenic, arsenic has effect squamous cell carcinoma | squamous cell carcinoma has cause Squamous cell",
        "metrics": {
          "rouge_score": 0.4390243902439025,
          "answer_correctness": 0.8421637772491128
        }
      },
      {
        "id": "Medical-3d9e3424",
        "question": "In what situations is a lumbar puncture indicated during the diagnosis of ALL, and what does its use suggest about disease spread?",
        "ground_truth": "A lumbar puncture is indicated to assess CNS involvement, suggesting possible spread of ALL to the central nervous system.",
        "generated_answer": "A lumbar puncture is indicated during the diagnosis of Acute Lymphoblastic Leukemia (ALL) to assess the presence of leukemic cells in the cerebrospinal fluid, suggesting potential central nervous system involvement or spread of the disease.",
        "contexts": "lumbar puncture instance of procedure | lumbar puncture use lumbar puncture, lumbar puncture subclass of lumbar puncture | lumbar puncture subclass of general health test | lumbar puncture product or material produced spinal fluid | Treatment has cause diagnosis, diagnosis has effect Treatment | test use diagnosis | diagnosis uses test, test used by diagnosis | treated has cause Diagnosed | molecular test use diagnosis | Treatment has cause diagnosis, diagnosis has effect Treatment | diagnosis has effect Treatment, Treatment has cause diagnosis | biopsy medical condition treated Glioblastoma | plan treatment has cause diagnosis | bone scan medical condition treated ALP | Treatment medical condition treated CNS lymphoma | plan treatment uses diagnostic test | Stereotactic biopsy medical condition treated brain tumor | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer",
        "metrics": {
          "rouge_score": 0.4444444444444445,
          "answer_correctness": 0.9918579116805119
        }
      },
      {
        "id": "Medical-edc3c6eb",
        "question": "Why is lung cancer screening particularly important for individuals exposed to air pollution and diesel fumes?",
        "ground_truth": "Because both air pollution and diesel fumes are established risk factors for lung cancer, necessitating early detection strategies.",
        "generated_answer": "Lung cancer screening is particularly important for individuals exposed to air pollution and diesel fumes because these exposures are significant risk factors for developing lung cancer. Early detection through screening can lead to better treatment outcomes and potentially lower mortality rates associated with the disease.",
        "contexts": "lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, Air pollution has parts of the class fine particulates, fine particulates has parts of the class Air pollution, Air pollution has parts of the class sulfur dioxide, Air pollution has parts of the class ozone, smoking has effect lung cancer | tobacco has effect smoking | Lung and breathing problems has effect cough | smoking cigarettes has effect has smoked | Smoking has effect lung problems, lung problems has cause Smoking | secondhand smoke has effect lung cancer, lung cancer has cause secondhand smoke | smoking cigarettes has effect lung cancer | radiation has effect cancer | health problems has effect cancer | cancer has effect cancer | diseases has effect conditions | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | side effects has cause Smoking, smoke has effect bladder cancer, vape use smoke, e-cigarettes has part tobacco, tobacco has part Nicotine | Chemical exposure has effect bladder cancer | Smoking has effect side effects | smoking has effect lung cancer, lung cancer has cause smoking",
        "metrics": {
          "rouge_score": 0.4126984126984127,
          "answer_correctness": 0.9915012453948768
        }
      },
      {
        "id": "Medical-45173331",
        "question": "How does the age of onset relate to the risk factors for Hodgkin lymphoma according to the ontology?",
        "ground_truth": "Ages 15 to 30 and after age 55 are risk factors for Hodgkin lymphoma, matching the typical age of diagnosis.",
        "generated_answer": "The age of onset is a risk factor for Hodgkin lymphoma, indicating that older age may increase the likelihood of developing the disease.",
        "contexts": "cancer has cause risk factors, risk factors has effect cancer | cervical cancer has cause risk factors, risk factors has effect cervical cancer | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | risk factors facet of cancer | cancer has cause lymph nodes | cancer has cause cancer | Lymphatic system has effect Hodgkin lymphoma | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | Head and neck cancer has cause lymph nodes | cancer has cause cancer type | cancer has cause tumor | risk factors studies lung cancer, risk factors part of family health history, Risk assessment studies risk factors, lung cancer studied by risk factors, risk factors studied by Risk assessment | cancer has cause health problems | Hodgkin lymphoma instance of rare | outcomes has cause cancer",
        "metrics": {
          "rouge_score": 0.37209302325581395,
          "answer_correctness": 0.4913704902943858
        }
      },
      {
        "id": "Medical-0bd26353",
        "question": "What are the main components of trimodal therapy for bladder cancer and in which clinical context is it used?",
        "ground_truth": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach for muscle-invasive bladder cancer.",
        "generated_answer": "The main components of trimodal therapy for bladder cancer are chemotherapy, radiation therapy, and surgery. It is used in the context of treating muscle-invasive bladder cancer.",
        "contexts": "Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | bladder cancer drug used for treatment Treatment, Treatment for bladder cancer facet of bladder cancer | bladder cancer drug used for treatment Cancer treatment, Cancer treatment medical condition treated bladder cancer | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Intravesical therapy medical condition treated bladder cancer, bladder cancer drug used for treatment Intravesical therapy | bladder cancer drug used for treatment dose-dense methotrexate, vinblastine medical condition treated bladder cancer, doxorubicin medical condition treated bladder cancer, bladder cancer drug used for treatment platinum-based chemotherapy, bladder cancer drug used for treatment Cisplatin, dose-dense methotrexate medical condition treated bladder cancer, bladder cancer drug used for treatment doxorubicin | bladder cancer drug used for treatment chemotherapy, chemotherapy medical condition treated bladder cancer, Intravesical BCG therapy uses Intravesical BCG therapy, bladder cancer drug used for treatment bacillus CalmetteGu\u00e9rin | bladder cancer drug used for treatment surgery, surgery medical condition treated bladder cancer, Treatment facet of cancer | Intravesical BCG therapy start time 6 weeks, Intravesical BCG therapy medical condition treated bladder cancer, bladder cancer drug used for treatment chemotherapy, Intravesical BCG therapy uses Intravesical BCG therapy, chemotherapy medical condition treated bladder cancer | Chemotherapy medical condition treated bladder cancer, Intravesical chemotherapy different from Intravesical chemotherapy, Chemotherapy facet of cancer, Chemotherapy subclass of Treatment, bladder cancer drug used for treatment Chemotherapy alone, Intravesical chemotherapy different from Intravesical chemotherapy, Cisplatin medical condition treated bladder cancer, bladder cancer drug used for treatment vinblastine, Chemotherapy alone medical condition treated bladder cancer, bladder cancer drug used for treatment Chemotherapy | bladder cancer drug used for treatment Balversa | Treatment facet of bladder cancer | radical cystectomy medical condition treated bladder cancer, Partial cystectomy medical condition treated bladder cancer | bladder cancer surgery medical condition treated bladder cancer",
        "metrics": {
          "rouge_score": 0.3636363636363636,
          "answer_correctness": 0.7404602644456019
        }
      },
      {
        "id": "Medical-ade95016",
        "question": "Which risk factors should be considered for an older adult with a history of organ transplant who develops primary CNS lymphoma?",
        "ground_truth": "Older age and organ transplant are both risk factors for primary CNS lymphoma.",
        "generated_answer": "Risk factors include having an impaired immune system due to the organ transplant, as well as the potential for cancer development, specifically CNS lymphoma.",
        "contexts": "primary CNS lymphoma has cause impaired immune system | primary CNS lymphoma instance of disease, CNS lymphoma has part primary CNS lymphoma | What causes primary CNS lymphoma? facet of cancer | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma | CNS lymphoma has cause reduced immune system | primary CNS lymphoma instance of Treatment | primary CNS lymphoma has cause Enrolling in a clinical trial | primary CNS lymphoma location central nervous system | brain has effect CNS lymphoma | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of CNS lymphoma | Treatment medical condition treated primary CNS lymphoma | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain lymphoma | targeted therapy medical condition treated primary CNS lymphoma, chemotherapy medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment chemotherapy | rituximab medical condition treated primary CNS lymphoma | central nervous system has effect CNS lymphoma",
        "metrics": {
          "rouge_score": 0.2702702702702703,
          "answer_correctness": 0.7413452618303296
        }
      },
      {
        "id": "Medical-d1a87cb4",
        "question": "What combination of clinical findings and diagnostic results would indicate metastatic breast cancer (Stage IV)?",
        "ground_truth": "Symptoms like bone pain or neurological symptoms plus imaging or biopsy showing distant spread indicate metastatic breast cancer (Stage IV).",
        "generated_answer": "Clinical findings indicating metastatic breast cancer (Stage IV) include the presence of invasive breast cancer that has spread outside the breast and lymph nodes, along with evidence of metastasis in distant organs such as bones or other tissues. Diagnostic results may show cancerous cells in axillary lymph nodes or other metastatic sites.",
        "contexts": "Stage 4 cancer subclass of Metastatic cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastasized subclass of Breast cancer | Metastatic cancer subclass of Breast cancer, Invasive breast cancer subclass of cancer | metastatic subclass of cancer | metastasized subclass of cancer | metastatic disease subclass of cancer | breast subclass of cancer | Stage III subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | metastatic subclass of prostate cancer | metastasis subclass of cancer | de novo subclass of Metastatic cancer | stage II subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | Stage 4B subclass of bladder cancer | Metastatic cancer subclass of spread outside the breast and lymph nodes, Invasive breast cancer subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.16666666666666669,
          "answer_correctness": 0.784952968339182
        }
      },
      {
        "id": "Medical-2ebcf55d",
        "question": "What is the clinical significance of detecting a 17p deletion or TP53 mutation in CLL patients?",
        "ground_truth": "Detection of 17p deletion or TP53 mutation indicates poorer prognosis and guides treatment selection.",
        "generated_answer": "The clinical significance of detecting a 17p deletion or TP53 mutation in CLL patients is associated with a poor prognosis, indicating a higher risk of treatment resistance and disease progression. These genetic abnormalities often lead to more aggressive disease and may influence treatment decisions.",
        "contexts": "TP53 instance of genes | BRCA instance of mutations | ATM instance of mutations in certain genes, BRCA2 instance of mutations in certain genes, CHEK2 instance of mutations in certain genes, BRCA1 instance of mutations in certain genes, BRCA1 instance of gene, BRCA2 instance of gene | PIK3CA instance of mutations | gene has cause mutations, mutations has effect gene | BRCA instance of gene | p16 instance of gene | BRCA1 instance of gene, BRCA2 instance of gene | BRCA instance of genes | somatic subclass of mutations | BRCA2 instance of gene | translocation subclass of point mutation | BRCA1 instance of gene, BRCA2 instance of gene, FANCA instance of gene, DNA instance of molecular | BRCA1 instance of gene | acquired subclass of mutations | Mutation testing subclass of abnormalities | HER2 instance of gene",
        "metrics": {
          "rouge_score": 0.31034482758620696,
          "answer_correctness": 0.8830355294312242
        }
      },
      {
        "id": "Medical-14016ce3",
        "question": "What is the rationale for recommending surgery as the most common treatment for BCC lesions on sun-exposed areas?",
        "ground_truth": "Because BCC most commonly develops on sun-exposed areas and surgery is the most effective treatment.",
        "generated_answer": "Surgery is recommended as the most common treatment for BCC lesions on sun-exposed areas due to its effectiveness in completely removing cancerous tissue and minimizing the risk of recurrence.",
        "contexts": "surgery subclass of Treatment | treatment with surgery subclass of surgery, surgery subclass of Treatment | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | surgery subclass of Treatment, chemotherapy subclass of Treatment | treatment after surgery subclass of surgery | surgery subclass of operation | radiation therapy subclass of Treatment, surgery subclass of treated | Treatment subclass of procedure | radiation therapy subclass of surgery, systemic therapy subclass of surgery, Intravesical therapy subclass of surgery | minor surgery subclass of Treatment | surgery subclass of Treatment, systemic therapy subclass of Treatment | systemic therapy subclass of surgery, Chemoradiation subclass of surgery | radiation therapy subclass of surgery, Tumors on other areas of the body Surgery subclass of surgery | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery | surgery to remove cancer from the body subclass of surgery | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | Postoperative subclass of surgery, pre-surgery subclass of surgery",
        "metrics": {
          "rouge_score": 0.3043478260869565,
          "answer_correctness": 0.9939854546884941
        }
      },
      {
        "id": "Medical-97e7a1d0",
        "question": "If a kidney tumor is found to have sarcomatoid features, what does this indicate regarding its subtype and disease aggressiveness?",
        "ground_truth": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease.",
        "generated_answer": "The presence of sarcomatoid features in a kidney tumor indicates an aggressive subtype and higher disease aggressiveness.",
        "contexts": "subtype facet of cancer, aggressive treatment subclass of Treatment | Aggressive subclass of Treatment | cancer subclass of Tumor, aggressive type subclass of cancer | Aggressive subclass of therapy, early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | aggressive facet of prostate cancer, Grade Groups facet of cancer, spread subclass of cancer | spread subclass of cancer, Aggressive subclass of therapy | risk factors facet of disease | symptom facet of disease | prognosis facet of disease | illness subclass of disease | Treatment facet of disease | cancer subclass of disease | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Signs and symptoms facet of disease | very advanced disease subclass of disease, metastatic subclass of cancer | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | risk level facet of skin cancer",
        "metrics": {
          "rouge_score": 0.37500000000000006,
          "answer_correctness": 0.8441426951411956
        }
      },
      {
        "id": "Medical-38a8b852",
        "question": "Why might a patient with genetic hemochromatosis require regular liver cancer screening, and which methods are used?",
        "ground_truth": "Because genetic hemochromatosis is a risk factor for cirrhosis and liver cancer, screening with ultrasound and AFP test is recommended.",
        "generated_answer": "A patient with genetic hemochromatosis may require regular liver cancer screening due to the increased risk of liver cancer associated with iron overload and genetic mutations. Methods used for screening include imaging tests like ultrasound and blood tests for tumor markers.",
        "contexts": "Genetic hemochromatosis has cause iron | hereditary has cause genetic mutations, genetic mutations has effect hereditary | genes has effect traits | gene has cause mutations, mutations has effect gene | genetic mutations has effect Inherited cancer risk, Inherited cancer risk has cause genetic mutations | overload has cause iron | hereditary mutation has effect cancer | hereditary has effect Breast cancer, Breast cancer has cause hereditary, pass these genes on has effect cancer | genetic mutations has effect cancer | genetic mutations has effect ALL | genetic changes has effect Leukemia | genetic changes has effect Cancer cells, Cancer cells has cause genetic changes, Cancer cells has effect genetic changes | genetic mutations has effect abnormal chromosome",
        "metrics": {
          "rouge_score": 0.29508196721311475,
          "answer_correctness": 0.743510439849363
        }
      },
      {
        "id": "Medical-ec84ae56",
        "question": "Why would a patient with FLT3-ITD mutated AML receive a targeted therapy in addition to chemotherapy?",
        "ground_truth": "FLT3 inhibitors are used as targeted therapy for FLT3-mutated AML, which is treated alongside standard chemotherapy.",
        "generated_answer": "A patient with FLT3-ITD mutated AML would receive targeted therapy in addition to chemotherapy to specifically address the FLT3 mutation, which can drive the cancer's growth and resistance to standard treatments. This combination approach aims to enhance treatment efficacy and improve patient outcomes.",
        "contexts": "targeted therapy opposite of chemotherapy | radiation therapy opposite of chemotherapy, chemotherapy opposite of radiation therapy | Immunotherapy opposite of chemotherapy | systemic therapy opposite of radiation therapy | intravenous chemotherapy opposite of intraperitoneal (IP) chemotherapy, intraperitoneal (IP) chemotherapy opposite of intravenous chemotherapy | systemic therapy different from radiation therapy, systemic therapy subclass of radiation therapy, systemic therapy opposite of radiation therapy, radiation therapy different from systemic therapy | alternative chemotherapy drug different from Cisplatin | targeted therapy subclass of chemotherapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | targeted therapy subclass of Non-hormone therapy | Chemotherapy different from Chemotherapy | maintenance therapy opposite of chemotherapy, maintenance therapy subclass of PARP inhibitor, maintenance therapy subclass of recurrence chemotherapy, maintenance therapy medical condition treated recurrence, recurrence drug used for treatment maintenance therapy, targeted therapy subclass of Biomarker-based treatment | Immunotherapy different from chemotherapy | primary tumor opposite of metastasis | Chemoradiation different from chemotherapy, chemotherapy different from Chemoradiation | radiation therapy different from chemotherapy | systemic therapy opposite of radiation therapy, systemic therapy subclass of radiation therapy | lenvatinib instance of targeted therapy, targeted therapy subclass of radiation therapy, Sorafenib instance of targeted therapy",
        "metrics": {
          "rouge_score": 0.22580645161290322,
          "answer_correctness": 0.8407553645114214
        }
      },
      {
        "id": "Medical-ac86bfad",
        "question": "How does the treatment approach differ between muscle-invasive and non\u2013muscle-invasive bladder cancer?",
        "ground_truth": "Muscle-invasive bladder cancer is treated with radical cystectomy and may require urinary diversion, while non\u2013muscle-invasive bladder cancer is treated with TURBT and intravesical therapy.",
        "generated_answer": "The treatment for muscle-invasive bladder cancer typically involves more aggressive approaches such as radical cystectomy and chemotherapy, while non\u2013muscle-invasive bladder cancer is often treated with intravesical therapy and less invasive procedures.",
        "contexts": "non\u2013 muscle-invasive subclass of bladder cancer | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, squamous cell carcinoma subclass of bladder cancer, Adenocarcinoma subclass of bladder cancer | invaded the muscle layer subclass of bladder cancer | 0 subclass of bladder cancer, 3 subclass of bladder cancer, 2 subclass of bladder cancer, metastasized subclass of cancer, Stage 0 Stage 0 subclass of bladder cancer, 1 subclass of bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | bladder cancer subclass of transitional call cancer | Stage 4B subclass of bladder cancer | bladder cancer subclass of Cancer of the upper urinary tract | noninvasive subclass of cancer | bladder cancer subclass of cancer | Metastatic bladder cancer subclass of spread outside the bladder | Metastatic bladder cancer subclass of cancer, High-grade cancer opposite of Low grade bladder cancer, Metastatic bladder cancer subclass of bladder cancer | stage II subclass of bladder cancer, stage 0 facet of carcinoma in situ, carcinoma in situ subclass of aggressive | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer",
        "metrics": {
          "rouge_score": 0.5901639344262295,
          "answer_correctness": 0.8448345434629517
        }
      },
      {
        "id": "Medical-a7826934",
        "question": "Explain the relationship between the Philadelphia chromosome, BCR::ABL1 fusion gene, and the origin of CML.",
        "ground_truth": "The Philadelphia chromosome results from a translocation that creates the BCR::ABL1 fusion gene, which causes CML.",
        "generated_answer": "The Philadelphia chromosome is characterized by the BCR::ABL1 fusion gene, which results from a translocation between chromosomes 9 and 22. This genetic alteration is a key factor in the development of Chronic Myeloid Leukemia (CML), as it leads to the production of a protein that promotes uncontrolled cell division in blood stem cells.",
        "contexts": "Philadelphia chromosome has part chromosome 22 | BCR::ABL1 instance of gene | Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, chromosome 9 has effect Philadelphia chromosome Chronic myeloid leukemia, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 22 | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | chromosome 9 shares border with chromosome 22, Philadelphia chromosome has part chromosome 22 | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | chromosome has part chromosome, chromosome part of chromosome | gene part of chromosome | chromosome has part chromosome 9 | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell",
        "metrics": {
          "rouge_score": 0.2816901408450704,
          "answer_correctness": 0.9936395116619
        }
      },
      {
        "id": "Medical-d186c439",
        "question": "What distinguishes T-cell lymphoblastic lymphoma (T-LL, T-LBL) from T-cell ALL in terms of disease location?",
        "ground_truth": "T-cell lymphoblastic lymphoma involves T-cell lymphoblasts growing in the thymus, while T-cell ALL primarily involves bone marrow and blood.",
        "generated_answer": "T-cell lymphoblastic lymphoma typically presents as a mass in lymphoid tissues, while T-cell ALL primarily involves the bone marrow and peripheral blood.",
        "contexts": "T lymphocyte has effect B-cell lymphoblastic lymphoma | diffuse large B-cell lymphoma different from Burkitt lymphoma | T-ALL different from B-ALL, B-ALL different from T-ALL, B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Lymphoblast different from myeloblast | Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell, Cutaneous T-cell lymphoma subclass of Lymphoma | Acute lymphoblastic leukemia subclass of blood cancer | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Immunotherapy different from chemotherapy | chemotherapy different from Immunotherapy | T-cell subclass of lymphocyte | SLL different from CLL, CLL different from SLL | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Cancer cells different from Cancer cell differ from normal cells | Burkitt lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.6521739130434783,
          "answer_correctness": 0.8448213926998258
        }
      },
      {
        "id": "Medical-c58fae3b",
        "question": "Which targeted therapies are approved for progressive, unresectable, or metastatic thyroid cancer, and what is their main indication?",
        "ground_truth": "Lenvatinib, sorafenib, and cabozantinib are approved for progressive, unresectable, or metastatic thyroid cancer not responsive to surgery or RAI.",
        "generated_answer": "Targeted therapies approved for progressive, unresectable, or metastatic thyroid cancer include lenvatinib and sorafenib, primarily indicated for differentiated thyroid cancers.",
        "contexts": "metastasized subclass of thyroid cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | nodule subclass of thyroid cancer | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | follicular subclass of thyroid cancer | metastatic subclass of cancer | Papillary subclass of thyroid cancer, targeted therapy subclass of Immunotherapy, Metastatic cancer subclass of thyroid cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastatic disease subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer | differentiated thyroid cancers subclass of thyroid cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | de novo subclass of Metastatic cancer | metastasized subclass of cancer | Anaplastic thyroid cancer subclass of thyroid cancer",
        "metrics": {
          "rouge_score": 0.41025641025641024,
          "answer_correctness": 0.6184281758152395
        }
      },
      {
        "id": "Medical-56131016",
        "question": "How do family history and older age together influence the risk and screening approach for CLL?",
        "ground_truth": "Both increase CLL risk, so older individuals with a family history may warrant closer monitoring for early detection.",
        "generated_answer": "Family history and older age increase the risk of developing chronic lymphocytic leukemia (CLL), leading to a more proactive screening approach. Individuals with a family history of leukemia may require earlier and more frequent screenings due to their heightened risk.",
        "contexts": "prognosis facet of CLL | family health history facet of colon cancer | family health history has part risk factors, risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | screened has cause family history, family history has effect screened | risk factors facet of cancer, Family history facet of family | Treatment may not be needed for years facet of CLL | Unintentional weight loss subclass of Symptoms of CLL, Symptoms of CLL subclass of Symptoms | family history of leukemia subclass of predisposition condition, Leukemia has cause genetic changes | Leukemia has cause genetic changes, family history of leukemia subclass of predisposition condition | Treatment medical condition treated Chronic lymphocytic leukemia, How is CLL confirmed? facet of Chronic lymphocytic leukemia | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Treatment for CLL instance of Treatment | Germline testing facet of cancer | health history has part family history | family history facet of care team | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | Risk factors for lung cancer facet of lung cancer",
        "metrics": {
          "rouge_score": 0.2758620689655173,
          "answer_correctness": 0.8408386882218404
        }
      },
      {
        "id": "Medical-4fe06961",
        "question": "What is the sequence of genetic and chromosomal events leading to CML?",
        "ground_truth": "A translocation between chromosome 9 and 22 creates the Philadelphia chromosome, which produces the BCR::ABL1 fusion gene that causes CML.",
        "generated_answer": "The sequence of genetic and chromosomal events leading to CML involves mutations in genes that affect chromosomes, particularly the formation of the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22. This genetic alteration leads to the production of the BCR-ABL fusion protein, driving the uncontrolled proliferation of myeloid cells.",
        "contexts": "gene part of chromosome | gene part of genetic | genetic part of biological | chromosome has part chromosome, chromosome part of chromosome | DNA part of genes, genes has part DNA | DNA part of genes, genes has part DNA, mutations has effect gene, gene encodes Proteins | gene part of cell | DNA has part deoxyribonucleic acid | chromosome has part chromosome 9 | genes part of families | ERG part of chromosome 22, ETV1 part of chromosome 22, ETV4 part of chromosome 22, ETS gene family part of chromosome 22, 22 instance of chromosome, 11 instance of chromosome, chromosome has part DNA | DNA part of cells, cells has part DNA | genetic instructions has part DNA, DNA part of genetic instructions | molecular subclass of genetic | genetic mutations has effect abnormal chromosome | Methyl groups part of DNA, genes encodes DNA",
        "metrics": {
          "rouge_score": 0.2933333333333333,
          "answer_correctness": 0.8842111381009815
        }
      },
      {
        "id": "Medical-2045d4e4",
        "question": "Which diagnostic approach is shared among all adrenal tumor types and why is it important?",
        "ground_truth": "CT scan and MRI scan are shared diagnostic methods among all adrenal tumor types because they are essential for detecting and characterizing adrenal masses.",
        "generated_answer": "The shared diagnostic approach among all adrenal tumor types is imaging tests, which are important for accurately identifying and characterizing the tumors.",
        "contexts": "tumor studied by tumor testing, tumor testing studies tumor | diagnosis studies brain tumor, brain tumor studied by diagnosis | imaging test studies tumor | pathologic examination studies tumor, Pathologic examination studied by pathologist | tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | cancer studied by Oncology, Oncology studies cancer | cancer studied by imaging test, imaging test studies cancer | tumor histology studies cancer | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | tumor studied by tumor mutation testing, tumor mutation testing studies tumor | cancer studied by pathologist | cancer studied by pathologist, pathologist studies cancer | biopsy studies lesion | preliminary diagnosis studies Glioblastoma, Glioblastoma studied by preliminary diagnosis | Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist | cancer studied by oncologists",
        "metrics": {
          "rouge_score": 0.4782608695652174,
          "answer_correctness": 0.6710468797318737
        }
      },
      {
        "id": "Medical-cfc21569",
        "question": "Why is liver cancer screening with ultrasound and AFP test recommended every 6 months for some individuals?",
        "ground_truth": "Because individuals with cirrhosis or chronic hepatitis B are at increased risk for liver cancer, and regular screening with ultrasound and AFP can detect cancer early.",
        "generated_answer": "Liver cancer screening with ultrasound and AFP test is recommended every 6 months for individuals at high risk, such as those with chronic liver disease or cirrhosis, to detect cancer early when treatment is more effective. Regular screening helps monitor changes and identify hepatocellular carcinoma (HCC) at an earlier stage.",
        "contexts": "screening ultrasound subclass of Ultrasound, primary liver cancer subclass of cancer | HCC subclass of Liver cancer, hepatocellular carcinoma subclass of Secondary liver cancer | Ultrasound subclass of imaging test | hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma, primary liver cancer subclass of Liver cancer, intrahepatic cholangiocarcinoma subclass of Liver cancer | Ultrasound subclass of imaging test, mammogram subclass of imaging test | CT subclass of Ultrasound | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | US-FNA subclass of ultrasound-guided fine-needle aspiration | noninvasive subclass of cancer | imaging test part of Diagnosing liver cancer, biopsy subclass of Imaging, biopsy subclass of test, Diagnosing liver cancer has part imaging test | abnormal blood subclass of Ultrasound | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | transvaginal ultrasound subclass of Ultrasound, transvaginal ultrasound subclass of Ultrasound | Breast cancer screening subclass of detecting cancer earlier | biopsy subclass of Imaging, CT subclass of Imaging methods for detecting prostate cancer",
        "metrics": {
          "rouge_score": 0.2631578947368421,
          "answer_correctness": 0.9092640732773164
        }
      },
      {
        "id": "Medical-fdd40f83",
        "question": "What symptoms would most likely prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer?",
        "ground_truth": "Rectal bleeding, anal itching, anal pain, and an anal lump would prompt these exams.",
        "generated_answer": "Symptoms such as rectal bleeding, anal pain, changes in bowel habits, or the presence of a lump or mass in the anal area would most likely prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer.",
        "contexts": "Digital rectal exam subclass of biopsy | repeated subclass of Digital rectal exam | Digital rectal exam subclass of physical exam, Surveillance for the return of anal canal cancer and perianal cancer subclass of Surveillance, Follow-up and surveillance subclass of Surveillance, Anoscopy subclass of Anoscopy | colonoscopy subclass of colonoscopy | Digital rectal exam different from Digital rectal exam, prostate exam subclass of rectal exam, Digital rectal exam different from Digital rectal exam | Digital rectal exam subclass of testing | rectovaginal exam subclass of imaging test | Lymph node exam subclass of Inguinal lymph node exams, Anoscopy subclass of Anoscopy | Endoscopy subclass of Biopsy | endoscopic ultrasound subclass of Imaging, polypectomy subclass of surgery, flexible sigmoidoscopy subclass of sigmoidoscopy, endoscope subclass of scope | pharyngoscopy subclass of endoscopes, laryngoscopy subclass of endoscopes, esophagoscopy subclass of endoscopes | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | Digital rectal exam instance of exam, High-resolution anoscopy uses anal canal, High-resolution anoscopy part of colorectal surgeon | standard anoscopy different from colposcope | Abdominal and pelvic exam subclass of abdominal exam",
        "metrics": {
          "rouge_score": 0.29090909090909095,
          "answer_correctness": 0.7994740415945281
        }
      },
      {
        "id": "Medical-8488f954",
        "question": "How does performance status influence the treatment plan for a patient with metastatic breast cancer?",
        "ground_truth": "Performance status is considered in treatment planning for metastatic breast cancer to tailor therapy to the patient's functional capacity.",
        "generated_answer": "Performance status influences the treatment plan for a patient with metastatic breast cancer by determining the patient's ability to tolerate specific therapies, guiding the choice of treatment options, and influencing the overall prognosis. A better performance status may allow for more aggressive treatment, while a poorer status may necessitate palliative care or less intensive therapies.",
        "contexts": "Metastatic cancer subclass of Breast cancer, Invasive breast cancer subclass of cancer | metastatic subclass of cancer | metastasized subclass of Breast cancer | metastatic disease subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | breast subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic subclass of prostate cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | metastasized subclass of cancer | de novo subclass of Metastatic cancer | Breast cancer subclass of carcinoma | metastasis subclass of cancer | Metastatic cancer subclass of Metastasis Cancer | carcinoma subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | ovarian subclass of cancer, breast subclass of cancer",
        "metrics": {
          "rouge_score": 0.2894736842105263,
          "answer_correctness": 0.9922435880718173
        }
      },
      {
        "id": "Medical-6fb8996b",
        "question": "What factors would lead to recommending a clinical trial for a lung cancer patient?",
        "ground_truth": "Patients with lung cancer may be eligible for clinical trials as part of their treatment or prevention options.",
        "generated_answer": "Factors include the availability of investigational treatments, the patient's specific cancer type, previous treatment responses, and the potential benefits of participating in the trial compared to standard treatments.",
        "contexts": "Clinical trial studies drug, Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | drug studied by Clinical trial, standard treatments subclass of treatment options available for their type of cancer, Clinical trial subclass of studied in people, Clinical trial subclass of medical research, Clinical trial studies drug | Clinical trial studies new drug | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | Clinical trial studies potential new treatment, potential new treatment studied by Clinical trial | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial | Clinical trial uses investigational treatments, investigational treatments use Clinical trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | investigational treatments studied by Clinical trial, Clinical trial studies investigational treatments | investigational treatments use Clinical trial, Clinical trial uses investigational treatments | patient practiced by doctor | cancer studied by Oncology | Clinical trial subclass of studied",
        "metrics": {
          "rouge_score": 0.1702127659574468,
          "answer_correctness": 0.2320675897765352
        }
      },
      {
        "id": "Medical-a7e62dce",
        "question": "What combination of diagnostic methods is necessary to both confirm nasopharyngeal carcinoma and determine its subtype?",
        "ground_truth": "Biopsy is required to confirm NPC and to determine its cancer subtype.",
        "generated_answer": "A combination of biopsy and imaging studies is necessary to confirm nasopharyngeal carcinoma and determine its subtype.",
        "contexts": "squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer instance of rare cancer | Nasopharyngeal cancer subclass of cancer of the nasopharynx | Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer subclass of cancer | cN2 subclass of Nasopharyngeal cancer | Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | Nasopharynx subclass of cancer, carcinoma in situ subclass of tumor, metastatic subclass of cancer, Head and neck cancer subclass of tumor | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | subtype facet of cancer | primary tumor subclass of tumor, Nasopharyngeal cancer subclass of Mouth cancer | abnormal tissue growth subclass of cancer, Nasopharyngeal cancer subclass of Throat cancer | Head and neck cancer subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | Squamous cell carcinoma of the head and neck subclass of Head and neck cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Head and neck cancer subclass of Head and neck cancer, extracapsular subclass of Lymph nodes with cancer",
        "metrics": {
          "rouge_score": 0.5517241379310345,
          "answer_correctness": 0.9889767031812013
        }
      },
      {
        "id": "Medical-072545c5",
        "question": "What is the role of molecular tests in the management of thyroid nodules and how do they impact surgical decisions?",
        "ground_truth": "Molecular tests help determine malignancy and the need for surgery in patients with suspicious thyroid nodules.",
        "generated_answer": "Molecular tests are used primarily for the diagnosis of thyroid nodules and can influence surgical decisions by providing information on the risk of malignancy. They help determine whether surgery is necessary based on the genetic characteristics of the nodules.",
        "contexts": "molecular test use diagnosis | testing part of surgery | molecular tumor testing subclass of biomarker testing | biomarker testing subclass of Molecular | biomarker testing use diagnosis | biopsy part of surgery | polymerase chain reaction use Mutation testing, tumor mutation testing studies tumor | test use diagnosis | Next-generation sequencing use genomic testing | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | diagnosis uses test, test used by diagnosis | Biopsy use biopsy | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | organ use surgery | surgery uses tissues | surgery medical condition treated cancer, cancer drug used for treatment surgery | plan treatment uses diagnostic test | lab use Testing | surgery subclass of Treatment, Pathologic stage studied by surgery, pathologic (after surgery) stage facet of cancer drug therapy | surgery part of more than one treatment option, more than one treatment option has part surgery",
        "metrics": {
          "rouge_score": 0.2181818181818182,
          "answer_correctness": 0.8441052058793177
        }
      },
      {
        "id": "Medical-7ea7ec68",
        "question": "Why would a patient with a history of exposure to asbestos and a persistent cough be prioritized for lung cancer screening?",
        "ground_truth": "Because asbestos exposure is a risk factor and persistent cough is a symptom, both increasing the need for early detection via screening.",
        "generated_answer": "A patient with a history of exposure to asbestos and a persistent cough is prioritized for lung cancer screening due to the increased risk factors associated with asbestos exposure, which is a known carcinogen linked to lung cancer. Additionally, a persistent cough may indicate potential lung issues that warrant further investigation.",
        "contexts": "lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | lung cancer has cause smoking cigarettes, smoking cigarettes has effect lung cancer | smoking has effect lung cancer, lung cancer has cause smoking | lung cancer has cause secondhand smoke, asbestos instance of carcinogen, secondhand smoke has effect lung cancer | lung cancer has cause cells, cells has effect lung cancer | cancer has cause cancer | cancer has cause tumor | cancer has cause health problems | cancer has cause Cancer cells | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | cancer has cause cell damage | cancer has cause lymph nodes | heart disease has cause cancer | Breast cancer has cause Breast cancer | cancer has cause risk factors",
        "metrics": {
          "rouge_score": 0.19178082191780824,
          "answer_correctness": 0.9915765177957507
        }
      },
      {
        "id": "Medical-7b682af7",
        "question": "Which additional therapy may be used alongside chemotherapy for localized MGZL, and under what circumstance?",
        "ground_truth": "Involved-site radiation therapy (ISRT) may be added to chemotherapy in localized MGZL.",
        "generated_answer": "Immunotherapy may be used alongside chemotherapy for localized MGZL, particularly when combined with targeted therapy.",
        "contexts": "chemotherapy subclass of Treatment | chemotherapy subclass of Cancer treatment | Chemotherapy subclass of drug treatment | chemotherapy subclass of treating cancer | Chemotherapy subclass of systemic therapy | chemotherapy subclass of Medicines | chemotherapy subclass of Treatment, cycle subclass of Chemotherapy | Immunotherapy subclass of Chemotherapy, combined subclass of Therapeutic, Steroids subclass of Chemotherapy, chemotherapy subclass of Therapeutic | systemic therapy subclass of Chemotherapy | chemotherapy subclass of therapy, radiation subclass of therapy | radiation therapy subclass of chemotherapy | radiation therapy subclass of Chemotherapy | neoadjuvant therapy subclass of Chemotherapy, Chemotherapy subclass of systemic therapy | Targeted therapy and immunotherapy subclass of systemic therapy, chemotherapy subclass of Treatment | targeted therapy subclass of chemotherapy | surgery subclass of Treatment, chemotherapy subclass of Treatment | Immunotherapy subclass of Chemotherapy | Immunotherapy subclass of chemotherapy | regimen subclass of Chemotherapy | immune checkpoint inhibitor therapy subclass of chemotherapy",
        "metrics": {
          "rouge_score": 0.3571428571428571,
          "answer_correctness": 0.23815866400690658
        }
      },
      {
        "id": "Medical-cfab4b2d",
        "question": "Why is immunotherapy with checkpoint inhibitors recommended for some colon cancer patients but not others?",
        "ground_truth": "Immunotherapy with checkpoint inhibitors is recommended for dMMR/MSI-H colon cancers but not for pMMR/MSS cancers, which are treated with chemotherapy.",
        "generated_answer": "Immunotherapy with checkpoint inhibitors is recommended for some colon cancer patients based on the presence of specific biomarkers that indicate a higher likelihood of response to treatment. Patients without these biomarkers may not benefit from this therapy.",
        "contexts": "checkpoint inhibitor subclass of Immunotherapy | checkpoint inhibitor subclass of Immunotherapy, Immunotherapy subclass of Treatment | PD-1 inhibitor subclass of Immunotherapy, PD-1 inhibitor subclass of checkpoint inhibitor | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Immunotherapy subclass of targeted therapy | targeted therapy subclass of Immunotherapy | immune checkpoint inhibitor therapy subclass of chemotherapy | platinum-based chemotherapy subclass of systemic therapy, checkpoint inhibitor subclass of Immunotherapy | Immunotherapy subclass of systemic therapy | platinum-based chemotherapy subclass of systemic therapy, Platinumbased chemotherapy subclass of radiation therapy, radiation therapy subclass of surgery, checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of surgery | targeted therapy subclass of chemoimmunotherapy | Pembrolizumab subject has role checkpoint inhibitor, checkpoint inhibitor subclass of Immunotherapy | Opdivo subject has role checkpoint inhibitor, checkpoint inhibitor subclass of Immunotherapy | monoclonal antibody subclass of Immunotherapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | Immunotherapy subclass of chemotherapy | Immunotherapy subclass of Chemotherapy | Immunotherapy Immunotherapy subclass of systemic therapy, CTLAImmunotherapy subclass of Immunotherapy | targeted therapy subclass of chemotherapy, Immunotherapy subclass of Therapeutic | Immunotherapy subclass of Biomarker-based treatment",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.9864937320163363
        }
      },
      {
        "id": "Medical-bb678310",
        "question": "What is the hierarchical relationship between non-Hodgkin lymphoma, primary cutaneous lymphoma, and cutaneous B-cell lymphoma?",
        "ground_truth": "Cutaneous B-cell lymphoma is a subtype of primary cutaneous lymphoma, which is a form of non-Hodgkin lymphoma.",
        "generated_answer": "Non-Hodgkin lymphoma is a subclass of lymphoma, which includes primary cutaneous lymphoma. Primary cutaneous B-cell lymphoma is a specific type of primary cutaneous lymphoma.",
        "contexts": "Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma, papule subclass of nodule, Primary cutaneous marginal zone lymphoma subclass of Primary cutaneous B-cell lymphoma | Cutaneous T-cell lymphoma subclass of Lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides | Non-Hodgkin lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Non-Hodgkin lymphoma subclass of cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | primary CNS lymphoma subclass of brain lymphoma | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of cancer | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of classic FL | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.4888888888888889,
          "answer_correctness": 0.7446684439980096
        }
      },
      {
        "id": "Medical-8407a0ab",
        "question": "Which patient characteristics would prompt the use of imaging during the diagnostic workup of CSCC?",
        "ground_truth": "Imaging is used if deeper invasion or spread is suspected, especially in high-risk, regional, or metastatic CSCC cases.",
        "generated_answer": "Patient characteristics such as suspected metastasis, irregular tumor appearance, or advanced staging of cutaneous squamous cell carcinoma (CSCC) would prompt the use of imaging during the diagnostic workup.",
        "contexts": "Imaging subclass of test results | radiology subclass of Imaging | Biopsy subclass of Imaging | biopsy subclass of Imaging | Imaging subclass of biopsy | imaging scan subclass of tests | Imaging subclass of test | imaging test subclass of testing | CT scan subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | CT subclass of Imaging | Ultrasound subclass of imaging test | computed tomography subclass of Imaging | Imaging subclass of blood test | Imaging subclass of Imaging, CT subclass of Imaging | CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | imaging test subclass of Imaging | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging | staging subclass of Imaging",
        "metrics": {
          "rouge_score": 0.1276595744680851,
          "answer_correctness": 0.5698658546113502
        }
      },
      {
        "id": "Medical-1f7241a3",
        "question": "How does the presence of BCR::ABL1-positive status in B-ALL affect treatment choice in children?",
        "ground_truth": "BCR::ABL1-positive B-ALL requires intensive systemic therapies compared to other B-ALL cases.",
        "generated_answer": "The presence of BCR::ABL1-positive status in B-ALL typically necessitates the use of targeted therapies, such as tyrosine kinase inhibitors, in addition to standard chemotherapy to improve treatment outcomes in children.",
        "contexts": "BCR::ABL1-negative subclass of B-ALL, BCR::ABL1-like B-ALL subclass of B-ALL | BCR::ABL1 instance of gene | Chronic lymphocytic leukemia drug used for treatment Treatment, Treatment medical condition treated Chronic lymphocytic leukemia, How is CLL confirmed? facet of Chronic lymphocytic leukemia | Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL, Treatment of CLL and SLL medical condition treated SLL, SLL drug used for treatment Treatment of CLL and SLL | effective treatment medical condition treated CLL | daunorubicin medical condition treated AML, AML drug used for treatment daunorubicin | Methotrexate medical condition treated AML, Cytarabine medical condition treated AML | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | daunorubicin medical condition treated AML, FLT3 Gilteritinib medical condition treated AML, Sorafenib medical condition treated AML, AML drug used for treatment Cytarabine, AML drug used for treatment daunorubicin | treatments medical condition treated cancer, cancer drug used for treatment treatments | Treatment medical condition treated cancer | cancer drug used for treatment treatments | cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.29166666666666663,
          "answer_correctness": 0.9893620384222983
        }
      },
      {
        "id": "Medical-91742d51",
        "question": "Why is glioblastoma associated with the worst prognosis among glioma subtypes?",
        "ground_truth": "Glioblastoma is the most aggressive subtype and is always high-grade, leading to a poor prognosis.",
        "generated_answer": "Glioblastoma is associated with the worst prognosis among glioma subtypes due to its aggressive nature, high-grade tumor characteristics, and ability to invade brain tissue, leading to poor treatment outcomes.",
        "contexts": "Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | Glioblastoma subclass of Glioblastoma | Glioblastoma subclass of glioma tumor | Glioblastoma subclass of tumor | Glioblastoma subclass of brain tumor | astrocytoma subclass of Glioblastoma | oligodendroglioma subclass of Glioblastoma, astrocytoma subclass of Glioblastoma, brain tumor subclass of cancerous, astrocytoma subclass of astrocyte, Cancer cells subclass of cells, Glioblastoma subclass of Glioblastoma | type it is subclass of Glioblastoma | oligodendrocyte subclass of brain tumor, Grade 3 tumor cells subclass of Glioblastoma, high-grade glioma opposite of low-grade glioma | invade brain tissue subclass of Glioblastoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | cancer type subclass of cancer | non-small cell lung cancer subclass of lung cancer | non-small cell lung cancer subclass of cancer | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma, squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | cancer subclass of Tumor, aggressive type subclass of cancer",
        "metrics": {
          "rouge_score": 0.3913043478260869,
          "answer_correctness": 0.9931685601002299
        }
      },
      {
        "id": "Medical-166bcaa7",
        "question": "Why is Siewert type classification particularly important in the staging and treatment planning of tumors at the esophagogastric junction?",
        "ground_truth": "Siewert types determine staging and guide treatment planning for esophagogastric junction tumors.",
        "generated_answer": "Siewert type classification is crucial in staging and treatment planning of tumors at the esophagogastric junction because it helps determine the tumor's anatomical location and its relationship with surrounding structures, which influences surgical approaches and therapeutic strategies. This classification aids in predicting patient outcomes and tailoring treatment to improve survival rates.",
        "contexts": "Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx, esophagus connects with stomach, esophagus connects with trachea, stomach connects with esophagus, esophagus connects with throat, throat connects with esophagus, esophagus connects with stomach, stomach connects with esophagus | small intestine part of small intestine, stomach part of intestines, Body part of stomach, intestines has part stomach, esophagus connects with pylorus, small intestine has part <triplet>duodenum stomach, esophagus connects with stomach, digestive system has part The digestive system, stomach connects with small intestine, small intestine connects with stomach, stomach connects with diaphragm, pylorus connects with esophagus | cancer staging instance of staging | windpipe connects with throat, bronchioli connects with bronchi, stomach connects with small intestine, esophagus has part inner lining, small intestine connects with stomach, stomach connects with esophagus, inner lining part of esophagus, digestive system has part esophagus, esophagus connects with stomach | esophagogastric junction connects with esophagus, esophagus connects with esophagogastric junction | cancer staging instance of cancer staging | nose connects with mouth, larynx connects with esophagus, mouth connects with pharynx, mouth connects with nasal cavity, pharynx connects with nasal cavity, esophagus connects with larynx, nasal cavity connects with nose, mouth connects with Nasopharynx, pharynx connects with Nasopharynx, Nasopharynx connects with pharynx, nose connects with nasal cavity, esophagus connects with stomach, nose connects with Nasopharynx | Barrett esophagus part of esophagus, Barrett esophagus has effect adenocarcinoma of the esophagus, Treatment facet of esophageal cancer, stomach connects with esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach | Oropharynx has part Tonsils, Oropharynx connects with Nasopharynx, nose connects with mouth, Oropharynx has part soft palate, larynx connects with esophagus, pharynx connects with esophagus, Nasopharynx connects with Oropharynx, larynx connects with pharynx, Oropharynx has part tongue, esophagus connects with larynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx | Pancreatic cancer instance of stages | Staging after surgery subclass of cancer staging | esophagus connects with stomach | Chemoradiation instance of Treatment | muscularis propria part of esophagus, esophagus has part submucosa, tunica adventitia part of esophagus, mucus part of esophagus, mucosa part of esophagus | staging part of grading",
        "metrics": {
          "rouge_score": 0.28124999999999994,
          "answer_correctness": 0.9928536299835173
        }
      },
      {
        "id": "Medical-f27c64c0",
        "question": "What steps are involved in the diagnostic workup for a patient suspected of colon cancer based on symptoms?",
        "ground_truth": "Diagnostic workup includes colonoscopy (with possible polypectomy), blood tests (CBC, chemistry profile, CEA), and CT with contrast for staging.",
        "generated_answer": "The diagnostic workup for suspected colon cancer typically involves a thorough evaluation of symptoms, imaging studies, and possibly a biopsy to confirm the diagnosis. Additional tests may include blood work and endoscopic procedures to assess the colon directly.",
        "contexts": "Symptoms subclass of Symptoms | Symptoms subclass of health conditions or concerns | Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms, Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Nausea subclass of Symptoms | testing subclass of diagnosis | Symptoms subclass of side effects, side effects subclass of Symptoms | Symptoms subclass of supportive care | pain subclass of symptom, Constipation subclass of symptom, bloating subclass of symptom, fatigue subclass of symptom | fatigue subclass of Symptoms | symptom subclass of sign | headache subclass of Symptoms | fatigue subclass of symptom, Headaches subclass of symptom, Symptoms used by diagnosis | Health and symptoms subclass of health information | biopsy subclass of diagnosis | Imaging subclass of symptom, chest pain subclass of shortness of breath | seizures subclass of neurological symptoms, headaches subclass of neurological symptoms, symptom subclass of sign",
        "metrics": {
          "rouge_score": 0.17543859649122803,
          "answer_correctness": 0.7016740940084418
        }
      },
      {
        "id": "Medical-9d34bcac",
        "question": "Which subtype of Hodgkin lymphoma is less common, and what unique risk does it carry compared to the common subtype?",
        "ground_truth": "Nodular lymphocyte-predominant Hodgkin lymphoma is less common and can transform into diffuse large B-cell lymphoma, unlike the classic subtype.",
        "generated_answer": "The less common subtype of Hodgkin lymphoma is lymphocyte-depleted Hodgkin lymphoma, which carries a higher risk of treatment resistance compared to the common subtype.",
        "contexts": "Nested subtype instance of subtype | Moderately differentiated different from Poorly differentiated, Poorly differentiated different Moderately differentiated, Well differentiated different from Poorly differentiated, Well differentiated different from Moderately differentiated, Moderately differentiated different from Well differentiated | more common tests subclass of test | cancer type different from cancer, cancer different from cancer type | T-ALL different from B-ALL, B-ALL different from T-ALL | SLL different from CLL, CLL different from SLL | cycle different from cycle | diffuse different from diffuse, diffuse different from diffuse | tumor different from Tumor | Subtypes of AML subclass of Subtypes of AML | Symptoms different from Symptoms | Symptoms different from symptom, symptom different from Symptoms | GSM different from GSM | speak different from see",
        "metrics": {
          "rouge_score": 0.2608695652173913,
          "answer_correctness": 0.23564937752461923
        }
      },
      {
        "id": "Medical-395b9708",
        "question": "Which symptoms and hormone findings would suggest a cortisol-producing adenoma causing Cushing syndrome?",
        "ground_truth": "Symptoms such as weight gain, muscle weakness, and pink or purple stretch marks with excess cortisol on testing suggest a cortisol-producing adenoma causing Cushing syndrome.",
        "generated_answer": "Symptoms of Cushing syndrome include weight gain, hypertension, and glucose intolerance. Hormone findings would show elevated cortisol levels and suppressed ACTH levels.",
        "contexts": "cortisol instance of hormones | cortisol instance of stress hormone | adrenal tumor has cause conditions listed below | Breast cancer has cause Hormones | stress has effect anxiety, anxiety has cause stress | significantly increase blood sugar levels has cause Steroid | prostate cancer has cause testosterone | estrogen has effect Breast cancer, Breast cancer has cause estrogen | Breast cancer has cause estrogen | Adrenal gland product or material produced hormones, endocrine system has part Adrenal gland, Adrenal gland has part Adrenal medulla | illness has effect Symptoms | breast has effect Breast cancer, Breast cancer has cause breast | illness has effect Symptoms, Symptoms has cause illness | Breast cancer has cause Breast cancer, Breast cancer has effect Breast cancer | prostate cancer has cause prostate gland | prostate cancer has cause prostate | cancer has effect cancer | surgical menopause has cause estrogen",
        "metrics": {
          "rouge_score": 0.20833333333333331,
          "answer_correctness": 0.664209252304606
        }
      },
      {
        "id": "Medical-ffffe4b8",
        "question": "How is platinum-resistant ovarian cancer managed differently from platinum-sensitive recurrence?",
        "ground_truth": "Platinum-resistant disease is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies, while platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab and secondary cytoreductive surgery.",
        "generated_answer": "Platinum-resistant ovarian cancer is typically managed with targeted therapy and alternative chemotherapy options, while platinum-sensitive recurrence is often treated with platinum-based chemotherapy. The treatment approaches differ due to the cancer's response to platinum drugs.",
        "contexts": "Platinum-resistant cancer subclass of ovarian cancer | targeted therapy opposite of chemotherapy | intravenous chemotherapy opposite of intraperitoneal (IP) chemotherapy, intraperitoneal (IP) chemotherapy opposite of intravenous chemotherapy | High-grade cancer opposite of lower-grade cancer, lower-grade cancer opposite of High-grade cancer | Immunotherapy opposite of chemotherapy | lower risk opposite of higher risk of recurrence, higher risk of recurrence opposite of lower risk | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | chemotherapy opposite of radiation therapy, radiation therapy opposite of chemotherapy | ovarian cancer different from cervical cancer | high-grade glioma opposite of low-grade glioma, low-grade glioma opposite of high-grade glioma | recurrent subclass of ovarian cancer, BRCA mutation subclass of homologous recombination deficiency | p16-positive opposite of p16-negative | primary tumor opposite of metastasis | recurrence subclass of cancer | platinum-sensitive cancer drug used for treatment platinum chemotherapy, platinumbased subclass of chemotherapy",
        "metrics": {
          "rouge_score": 0.47058823529411764,
          "answer_correctness": 0.576204890777406
        }
      },
      {
        "id": "Medical-fd151825",
        "question": "Which patients with anal cancer should be encouraged to enroll in clinical trials, and what phases might these trials include?",
        "ground_truth": "All patients with anal cancer should be encouraged to consider clinical trial enrollment, which may include phases I-IV.",
        "generated_answer": "Patients with anal cancer who meet the eligibility criteria should be encouraged to enroll in clinical trials. These trials may include Phase 1, Phase 2, Phase 3, and Phase 4.",
        "contexts": "standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, Phase 3 trial facet of approved | Clinical trial facet of Clinical trial | Phase 1 trial facet of Treatment trial | Phase 3 trial facet of approved, Phase 4 trial facet of Clinical trial, Informed consent facet of Clinical trial | eligibility criteria facet of Clinical trial, Phase 4 trial facet of approved by the FDA, Informed consent facet of Clinical trial, Phase 2 trial followed by Phase 3 trial, risks and benefits of joining instance of informed consent form, Phase 3 trial follows Phase 2 trial | eligibility criteria facet of Clinical trial, Phase 4 trial facet of approved by the FDA, Informed consent facet of Clinical trial, Phase 2 trial followed by Phase 3 trial | Phase III subclass of trial, Phase 4 trial subclass of Clinical trial, Phase II facet of trial | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | eligibility criteria facet of Clinical trial | Enrolling facet of Clinical trial | Informed consent facet of Clinical trial, start the conversation facet of Clinical trial, study facet of Treatment | Questions about clinical trial facet of Clinical trial, Clinical trial subclass of Treatment | Clinical stage facet of Breast cancer | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos | Are clinical trials free? facet of Clinical trial | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial",
        "metrics": {
          "rouge_score": 0.5306122448979592,
          "answer_correctness": 0.9945162015970113
        }
      },
      {
        "id": "Medical-5504201a",
        "question": "If a kidney tumor is found in the renal pelvis, which cancer subtype is most likely and why?",
        "ground_truth": "Urothelial carcinoma is most likely since it starts in the cells lining the renal pelvis.",
        "generated_answer": "Kidney cancer is the most likely subtype if a kidney tumor is found in the renal pelvis, as it specifically affects the kidney and its structures.",
        "contexts": "renal pelvis connects with ureter, kidney has part renal pelvis, ureter connects with renal pelvis, full, healthy lives with only one kidney subclass of less than one complete kidney, vena cava connects with renal vein, ureter connects with bladder, renal pelvis part of kidney, bladder connects with urethra, kidney connects with renal pelvis, renal vein connects with vena cava, bladder connects with ureter, urethra connects with bladder, renal pelvis connects with kidney, kidney has part renal tubules, renal tubules part of kidney | renal pelvis connects with kidney, kidney connects with renal pelvis | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | pelvis subclass of cancer | Stool different from urine, urine different from Stool, bladder part of bowel, bladder part of pelvis, rectum part of pelvis, uterus part of pelvis, bowel has part bladder | kidney cancer has cause kidney | bladder part of pelvis | bladder cancer location urinary tract | kidney connects with Blood, renal vein connects with renal artery, kidney has part renal vein, renal artery connects with renal vein, renal vein part of kidney, Gerota\u2019s fascia has effect Kidney cancer | kidney has part renal vein, renal vein part of kidney | ovaries part of pelvis | pelvis connects with prostate, prostate connects with pelvis | vena cava part of kidney, kidney has part renal tubules, renal tubules part of kidney | Gerota\u2019s fascia subclass of kidney cancer | lower abdomen has part pelvis, abdomen connects with pelvis, pelvis part of lower abdomen | cancer location prostate | ureter connects with kidneys, pelvis connects with hip bone, pelvis part of lower abdomen",
        "metrics": {
          "rouge_score": 0.3414634146341463,
          "answer_correctness": 0.23760354478354379
        }
      },
      {
        "id": "Medical-5b17d14f",
        "question": "Why are hyperplastic and inflammatory polyps less concerning than adenomas in colon cancer prevention?",
        "ground_truth": "Hyperplastic and inflammatory polyps rarely become cancer, while adenomas can develop into invasive colon cancer.",
        "generated_answer": "Hyperplastic and inflammatory polyps are generally considered less concerning than adenomas because they are typically noncancerous and have a lower risk of progressing to colon cancer. In contrast, adenomas have a higher potential to become cancerous over time.",
        "contexts": "resection different from polypectomy, polypectomy different from resection, polypectomy part of colonoscopy | tumors different from cancer, cancer different from tumors | inflammatory polyps subclass of Polyps | benign different from cancerous, cancerous different from benign, noncancerous subclass of tumor, cure different from Treatment | tumor different from Tumor | cancer type different from cancer, cancer different from cancer type | prostate cancer different from prostate cancer | Polyps has effect colon cancer | Papillary different from follicular tumor | follicular tumor different from Papillary | Imaging different from cancer | BPH different from prostate cancer, prostate cancer different from BPH | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | lung cancer different from lung cancer | Osteosarcoma different from Osteosarcoma | proctoscopy different from cystoscopy | Endoscopy different from Endoscopy",
        "metrics": {
          "rouge_score": 0.26415094339622636,
          "answer_correctness": 0.9934455951049832
        }
      },
      {
        "id": "Medical-a5f2e7a9",
        "question": "What are the key factors that determine the treatment approach for RCC according to the classification system?",
        "ground_truth": "Histology, tumor size, tumor location, and presence of metastasis are key treatment factors for RCC.",
        "generated_answer": "The key factors that determine the treatment approach for RCC include the type of cancer, available treatment options, and individual patient circumstances.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of urothelial cancer | Treatment facet of bladder cancer | Cancer treatment facet of cancer | Treatment facet of colon cancer | Treatment facet of stomach cancer | Treatment facet of Treatment | different types of treatment facet of bladder cancer | Treatment facet of ovarian cancer | Treatment facet of Pancreatic cancer | Treatment planning facet of cancer | Treatment facet of disease | more than one treatment option facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | treated facet of Glioblastoma | more treatment facet of cancer | treated differently different from RCC, RCC different from treated differently | plan treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.21621621621621623,
          "answer_correctness": 0.23944427202906474
        }
      },
      {
        "id": "Medical-ac117ebf",
        "question": "Why is a biopsy essential in both the diagnosis and management planning for breast cancer?",
        "ground_truth": "Biopsy is essential for definitive diagnosis and biomarker testing, which guides treatment planning in breast cancer.",
        "generated_answer": "A biopsy is essential in both the diagnosis and management planning for breast cancer because it provides definitive tumor histology, allowing for accurate diagnosis and tailored treatment strategies.",
        "contexts": "cancer studied by Oncology, Oncology studies cancer | diagnosis studies brain tumor, brain tumor studied by diagnosis | cancer studied by Cancer researchers, Cancer researchers studies cancer | cancer studied by oncologists, oncologists studies cancer | cancer studied by health history | cancer studied by Cancer experts, Cancer experts studies cancer | cancer studied by imaging test, imaging test studies cancer | tumor histology studies cancer | cancer studied by pathologist | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | diagnosis uses test, test used by diagnosis | cancer studied by pathologist, pathologist studies cancer | Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist | breast has effect Breast cancer, Breast cancer has cause breast | preliminary diagnosis studies Glioblastoma, Glioblastoma studied by preliminary diagnosis",
        "metrics": {
          "rouge_score": 0.36363636363636365,
          "answer_correctness": 0.7439730175544682
        }
      },
      {
        "id": "Medical-0955a900",
        "question": "How does the presence of both hepatitis B and alcohol use affect liver cancer risk, and what does the ontology indicate about their combined effect?",
        "ground_truth": "Both hepatitis B and alcohol use independently increase the risk of liver cancer, and their presence together further elevates the risk.",
        "generated_answer": "The presence of both hepatitis B and alcohol use significantly increases the risk of liver cancer. The ontology indicates that these factors have a combined effect that exacerbates liver damage and the likelihood of cancer development.",
        "contexts": "Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | spread of cancer has effect liver damage | spread to the liver has effect cancer | Liver cancer has cause increased risk, increased risk has effect Liver cancer | Liver cancer has cause liver | Hepatitis B has cause this virus, this virus has effect Hepatitis B | virus has effect hepatitis, hepatitis has cause virus | Hepatitis Hepatitis has cause Hepatitis B, hepatitis C has effect Hepatitis Hepatitis, Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | cancer has effect cancer | lymph nodes has effect cancer | risk factors has effect cancer | cancer has effect Cancer treatment | pancreas has effect Pancreatic cancer | cancer type has effect cancer | cancer has effect side effects | tumor has effect cancer",
        "metrics": {
          "rouge_score": 0.49122807017543857,
          "answer_correctness": 0.9923357530430925
        }
      },
      {
        "id": "Medical-59890a0c",
        "question": "What is the preferred radiation technique for treating non-metastatic anal cancer and which stages does this include?",
        "ground_truth": "IMRT is the preferred technique for stages I-III anal cancer.",
        "generated_answer": "The preferred radiation technique for treating non-metastatic anal cancer is radiation therapy, which includes stages I to III.",
        "contexts": "squamous cell carcinoma subclass of Anal cancer, anal melanoma subclass of Anal squamous cell carcinoma | Anal cancer subclass of cancer | stage II subclass of Anal cancer, Stage III subclass of Anal cancer, Anal tumor subclass of stage IIA | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Metastatic anal cancer subclass of Anal cancer | Anal cancer subclass of cervical cancer | intermediate-grade subclass of perianal cancer | metastatic anal cancer opposite of nonmetastatic, nonmetastatic opposite of metastatic anal cancer, linear accelerator medical condition treated Anal canal cancer | metastatic subclass of Anal cancer, radiation therapy medical condition treated Anal cancer | Progressive disease subclass of cancer, locally progressive subclass of metastatic disease, non-metastatic anal cancer subclass of metastatic anal cancer | SISCCA Superficially invasive squamous cell carcinoma subclass of Anal cancer | non-metastatic colon cancer subclass of Non-metastatic cancer | Perianal cancer (stages I \u2013 III) facet of perianal cancer, local excision medical condition treated perianal cancer, metastatic anal cancer subclass of nonmetastatic, perianal cancer drug used for treatment local excision | SISCCA different from invasive anal cancer, invasive anal cancer different from SISCCA | nonmetastatic subclass of cancer, metastatic subclass of cancer",
        "metrics": {
          "rouge_score": 0.4666666666666667,
          "answer_correctness": 0.6174746259056929
        }
      },
      {
        "id": "Medical-9bc8aaa1",
        "question": "What findings from both the patient's age and the location of lymph node involvement would increase suspicion for Hodgkin lymphoma?",
        "ground_truth": "A patient aged 15-30 or over 55 with lymph node involvement in the upper body increases suspicion for Hodgkin lymphoma.",
        "generated_answer": "Findings that would increase suspicion for Hodgkin lymphoma include younger age and the presence of lymph node involvement in specific regions, such as the cervical or mediastinal areas.",
        "contexts": "cancer has cause lymph nodes, lymph nodes has effect cancer | Lymphoma has effect lymph nodes | Head and neck cancer has cause lymph nodes, Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Lymphatic system has effect Hodgkin lymphoma | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Hodgkin lymphoma instance of rare | lymph nodes has effect lymph node removed, bone marrow connects with lymph nodes | EBV-related cancer has cause Epstein-Barr virus | cancer has cause tumor | lymph nodes has effect metastases, metastases location lymph nodes | lymph has part lymph nodes, lymph nodes has part lymph | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | lymph has part lymph nodes | cancer has cause tissues, tissues has effect cancer, lymph has part lymph nodes | lymph nodes has part Lymph",
        "metrics": {
          "rouge_score": 0.24489795918367344,
          "answer_correctness": 0.904755948520281
        }
      },
      {
        "id": "Medical-1eda4787",
        "question": "Which patients with breast cancer should receive fertility preservation counseling before treatment, and why?",
        "ground_truth": "All patients of reproductive potential should receive fertility preservation counseling before starting breast cancer treatment.",
        "generated_answer": "Patients with breast cancer who are of childbearing age and wish to preserve their fertility should receive fertility preservation counseling before treatment. This is important because certain cancer treatments can adversely affect fertility.",
        "contexts": "Treatment facet of cancer, Cancer treatment facet of cancer | cancer drug used for treatment Treatment | Treatment facet of cancer | cancer drug used for treatment Treatment, best treatment facet of cancer | cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | bladder cancer drug used for treatment surgery, surgery medical condition treated bladder cancer, Treatment facet of cancer | Treatment facet of ovarian cancer | Breast cancer drug used for treatment Pembrolizumab | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Cancer treatment subclass of Treatment, cancer drug used for treatment Cancer treatment | prostate cancer drug used for treatment Treatment | Treatment facet of Treatment | Treatment facet of disease | Clinical stage facet of Breast cancer | ovarian cancer drug used for treatment Treatment | Breast cancer drug used for treatment fluoxymesterone | Treatment facet of colon cancer",
        "metrics": {
          "rouge_score": 0.41666666666666663,
          "answer_correctness": 0.9911397308224232
        }
      },
      {
        "id": "Medical-baed6d13",
        "question": "For a patient with CSCC arising in a chronic wound, what two risk factors are present and how does this affect staging and management?",
        "ground_truth": "Both chronic wounds and scars are risk factors, increasing the likelihood of high-risk CSCC, which may require advanced staging and aggressive treatment.",
        "generated_answer": "The two risk factors for a patient with CSCC arising in a chronic wound are chronic inflammation and immunosuppression. These factors complicate staging and management by potentially leading to more aggressive disease and necessitating tailored treatment approaches.",
        "contexts": "staging part of grading, grading said to be the same as staging, staging said to be the same as grading | numbered stages part of Staging, Staging has part numbered stages | stage part of care team | stage part of Treatment, Treatment has part stage | staging facet of Treatment decisions | staging system subclass of system | staging facet of cancer | Staging facet of cancer | Staging The cancer stage facet of cancer | implementing part of planning, planning has part implementing | relieving subclass of managing | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | TNM scores has part numbered stages, numbered stages part of TNM scores | stage the cancer facet of cancer | cancer staging facet of tumor | staging subclass of Imaging | staging protocol subclass of stage",
        "metrics": {
          "rouge_score": 0.26666666666666666,
          "answer_correctness": 0.24230814204246431
        }
      },
      {
        "id": "Medical-3964e4de",
        "question": "What factors would indicate that a patient with anal cancer should undergo HIV testing as part of their diagnostic workup?",
        "ground_truth": "Because HIV infection increases anal cancer risk and HIV testing is recommended in patients with anal cancer.",
        "generated_answer": "Factors indicating a patient with anal cancer should undergo HIV testing include the patient's risk factors for HIV, such as a history of unprotected sex, multiple sexual partners, or a known HIV-positive status. Additionally, the presence of immunosuppression or other co-morbidities may warrant HIV testing as part of the diagnostic workup.",
        "contexts": "human immunodeficiency virus subclass of blood test | genetic testing subclass of diagnostic test | biopsy subclass of testing | urine subclass of testing, Blood subclass of testing | Diagnosis by blood test subclass of blood test | Blood test subclass of Blood test | biomarker testing subclass of biopsy, biopsy subclass of test results | Blood test subclass of test | biopsy subclass of diagnosis | testing subclass of diagnosis | testing Biopsy subclass of biopsy | biopsy subclass of blood test | biopsy subclass of test results | genetic testing subclass of test | HIV testing facet of HIV | Lab testing subclass of analysis | biomarker testing subclass of Molecular | Flow cytometry subclass of blood test | detection methods subclass of diagnosis | Imaging subclass of test results, biomarker test subclass of biopsy",
        "metrics": {
          "rouge_score": 0.1408450704225352,
          "answer_correctness": 0.4553318423428182
        }
      },
      {
        "id": "Medical-a6155d9a",
        "question": "Which systemic therapies may be considered for bone sarcoma patients with MSI-H, dMMR, or TMB-H, and what is the biomarker testing relevance?",
        "ground_truth": "Pembrolizumab, nivolumab, or ipilimumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H identified by biomarker testing.",
        "generated_answer": "Systemic therapies for bone sarcoma patients with MSI-H, dMMR, or TMB-H may include immunotherapy, targeted therapy, and chemotherapy. Biomarker testing is relevant for identifying suitable treatment options and predicting response to these therapies.",
        "contexts": "RAI subclass of systemic therapy | Immunotherapy subclass of systemic therapy | systemic therapy subclass of therapies | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy | targeted therapy subclass of systemic therapy | Targeted therapy and immunotherapy subclass of systemic therapy, chemotherapy subclass of Treatment | Immunotherapy subclass of systemic therapy, intensity-modulated radiation therapy subclass of External beam radiation therapy | systemic therapy subclass of radiation therapy | EBRT subclass of systemic therapy, Immunotherapy subclass of targeted therapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | systemic therapy subclass of Chemotherapy | Chemotherapy subclass of systemic therapy | Immunotherapy Immunotherapy subclass of systemic therapy | Cancer Systemic therapy subclass of drug therapy | targeted therapy subclass of Immunotherapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Immunotherapy subclass of targeted therapy | Immunotherapy facet of immune system, Immunotherapy subclass of systemic therapy | targeted therapy subclass of chemoimmunotherapy | systemic therapy subclass of therapies, Stereotactic body radiation therapy subclass of EBRT",
        "metrics": {
          "rouge_score": 0.456140350877193,
          "answer_correctness": 0.5160418649792762
        }
      },
      {
        "id": "Medical-1a56336a",
        "question": "What distinguishes B-cell lymphoblastic lymphoma (B-LL, B-LBL) from B-cell ALL in terms of disease site?",
        "ground_truth": "B-cell lymphoblastic lymphoma is characterized by B-cell lymphoblasts growing in lymph nodes, whereas B-cell ALL primarily involves bone marrow and blood.",
        "generated_answer": "B-cell lymphoblastic lymphoma typically presents as a mass in lymphoid tissues, while B-cell ALL primarily involves the bone marrow and peripheral blood.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | Lymphoblast different from myeloblast | T lymphocyte has effect B-cell lymphoblastic lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | B-ALL different from T-ALL, T-ALL different from B-ALL | Acute lymphoblastic leukemia subclass of blood cancer | diffuse large B-cell lymphoma subclass of classic FL | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma, SLL different from CLL, CLL different from SLL | Burkitt lymphoma subclass of non-Hodgkin lymphoma, B cell subclass of lymphocyte, B cell subclass of lymphocyte | diffuse large B-cell lymphoma subclass of Lymphoma | tumors different from cancer | Osteosarcoma different from Osteosarcoma | Non-Hodgkin lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.5833333333333334,
          "answer_correctness": 0.8429933138030052
        }
      },
      {
        "id": "Medical-c5b8734d",
        "question": "What distinguishes carcinoma in situ from invasive bile duct cancer based on histological layers?",
        "ground_truth": "Carcinoma in situ is confined to the epithelium, while invasive cancer penetrates deeper layers such as lamina propria and beyond.",
        "generated_answer": "Carcinoma in situ is confined to the epithelial layer and has not invaded surrounding tissues, while invasive bile duct cancer penetrates beyond the epithelial layer into surrounding structures.",
        "contexts": "noninvasive cancer subclass of in situ | intrahepatic cholangiocarcinoma subclass of Liver cancer, hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma | Noninvasive breast cancer subclass of carcinoma in situ | Locally advanced cancer different from metastatic, metastatic different from Locally advanced cancer | stage II subclass of bladder cancer, stage 0 facet of carcinoma in situ, carcinoma in situ subclass of aggressive | SISCCA different from invasive anal cancer, invasive anal cancer different from SISCCA | carcinoma in situ subclass of cancerous cells | Invasive ductal carcinoma subclass of Invasive ductal carcinoma | Bile duct cancer stages facet of bile duct | cancer different from tumors, tumors different from cancer | Imaging different from cancer | cancer type different from cancer, cancer different from cancer type | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer | prostate cancer different from prostate cancer | benign different from cancerous | lung cancer different from lung cancer",
        "metrics": {
          "rouge_score": 0.5,
          "answer_correctness": 0.9937718861213123
        }
      },
      {
        "id": "Medical-33e5776d",
        "question": "Which patients with prostate cancer should receive molecular biomarker testing as part of their follow-up?",
        "ground_truth": "Patients with high-risk, very-high-risk, regional, or metastatic prostate cancer should receive molecular biomarker testing.",
        "generated_answer": "Patients with aggressive prostate cancer or those with a high risk of progression should receive molecular biomarker testing as part of their follow-up.",
        "contexts": "Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | PSA test facet of prostate cancer | tests and scans facet of prostate cancer | PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | detection methods facet of prostate cancer | PSA in the blood has cause prostate cancer, prostate cancer location prostate, PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | Germline testing facet of cancer | Early detection and treatment facet of prostate cancer | test facet of cancer | invasive test facet of cancer | new tests and treatments facet of prostate cancer, detection methods and treatments medical condition treated prostate cancer, treatment choices now than they had before facet of prostate cancer, prostate cancer has cause prostate gland, prostate cancer drug used for treatment detection methods and treatments | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Common prostate test subclass of prostate cancer screening test, what tests you might have facet of prostate cancer, PSA test instance of blood test, PSA test facet of prostate cancer | Surveillance Follow-up testing facet of cancer | Tumor markers facet of Breast cancer | biopsy facet of cancer | Surveillance facet of cancer | aggressive facet of prostate cancer",
        "metrics": {
          "rouge_score": 0.4390243902439025,
          "answer_correctness": 0.24436847093061592
        }
      },
      {
        "id": "Medical-24f2e8ea",
        "question": "How does the presence of HER2 positivity alter the systemic therapy options for invasive breast cancer?",
        "ground_truth": "HER2 positivity adds HER2-targeted therapy to the systemic treatment options for invasive breast cancer.",
        "generated_answer": "HER2 positivity in invasive breast cancer typically leads to the inclusion of targeted therapies such as trastuzumab (Herceptin) and pertuzumab, in addition to standard chemotherapy. This combination can enhance treatment efficacy and improve outcomes for patients with HER2-positive tumors.",
        "contexts": "systemic therapy facet of cancer | systemic therapy facet of cancer, radiation therapy subclass of systemic therapy | systemic therapy part of Oncology | Treatment facet of cancer, Cancer treatment facet of cancer | radiation therapy facet of cancer, systemic therapy part of Oncology | Treatment facet of cancer | Cancer treatment facet of cancer | Goals of systemic therapy facet of Treatment | Immunotherapy facet of cancer | chemotherapy facet of cancer, radiation therapy facet of cancer | Chemotherapy facet of cancer | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Clinical stage facet of Breast cancer | side effects facet of systemic therapy | tumor, node, metastasis (TNM) system facet of Breast cancer | Tumor markers facet of Breast cancer | systemic therapy has part chemotherapy | Side effects of systemic therapy facet of systemic therapy | Treatment planning facet of cancer",
        "metrics": {
          "rouge_score": 0.2545454545454546,
          "answer_correctness": 0.9905802969874088
        }
      },
      {
        "id": "Medical-eab49131",
        "question": "Which diagnostic tests are necessary to confirm CLL and detect prognostic biomarkers, and why are multiple methods needed?",
        "ground_truth": "Blood test, flow cytometry, FISH, DNA sequencing, and karyotype are all needed to confirm CLL and identify prognostic biomarkers.",
        "generated_answer": "Diagnostic tests necessary to confirm CLL and detect prognostic biomarkers include genetic testing, biomarker testing, and tumor profiling. Multiple methods are needed to ensure accurate diagnosis and comprehensive assessment of the disease's characteristics.",
        "contexts": "biomarker subclass of test, biomarker test subclass of biomarker | biomarker subclass of biomarker | biomarker test subclass of test | Biomarkers subclass of biomarker | biomarker subclass of genetic testing | molecular subclass of biomarker | biomarker testing subclass of Molecular | biomarker subclass of genetic | tumor profiling subclass of biomarker testing | following biomarkers subclass of biomarker | tumor mutation testing subclass of biomarker | molecular tumor testing subclass of biomarker testing | biomarker testing subclass of biopsy, biopsy subclass of test results | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | Testing for this biomarker subclass of biomarker | Fluorescence in situ hybridization subclass of biomarker, biomarker subclass of features | genetic testing subclass of diagnostic test | nextgeneration sequencing subclass of biomarker",
        "metrics": {
          "rouge_score": 0.2641509433962264,
          "answer_correctness": 0.2432355124448461
        }
      },
      {
        "id": "Medical-9db4f113",
        "question": "What evidence would indicate that an adrenal tumor is benign and unlikely to metastasize?",
        "ground_truth": "If the tumor is a benign adrenal tumor, such as an adenoma, it does not metastasize.",
        "generated_answer": "Evidence indicating an adrenal tumor is benign and unlikely to metastasize includes lower-grade cancer characteristics, absence of cancerous cells, and lack of metastasis to lymph nodes or other organs. Additionally, a tumor that is resectable and shows no signs of active growth supports a benign diagnosis.",
        "contexts": "benign opposite of cancer, benign opposite of cancerous | primary tumor opposite of metastasis | metastasize often different from metastasis, metastasis different from metastasize often | benign different from cancerous | Normal cell opposite of Cancer cells | Cancer cells opposite of Normal cell, Normal cell opposite of Cancer cells | radiation therapy opposite of chemotherapy, chemotherapy opposite of radiation therapy | systemic therapy opposite of radiation therapy | Normal cell opposite of abnormal cells, abnormal cells opposite of Normal cell | Normal cell opposite of abnormal cells, abnormal cells opposite of Normal cell | targeted therapy opposite of chemotherapy | Unresectable opposite of Resectable | bone marrow opposite of lymph nodes, lymph nodes opposite of bone marrow | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | dormant opposite of active | lower-grade cancer opposite of High-grade cancer",
        "metrics": {
          "rouge_score": 0.12698412698412698,
          "answer_correctness": 0.24206528541210198
        }
      },
      {
        "id": "Medical-4777cfbb",
        "question": "Why would a child with an enlarged thymus and breathing problems be evaluated for T-cell ALL rather than B-cell ALL?",
        "ground_truth": "Because T-cell ALL can cause an enlarged thymus leading to breathing problems, whereas these symptoms are not associated with B-cell ALL.",
        "generated_answer": "A child with an enlarged thymus and breathing problems may be evaluated for T-cell ALL because T-cell ALL is associated with thymic enlargement due to the proliferation of T-lymphoblasts in the thymus, which can cause respiratory issues. In contrast, B-cell ALL typically does not involve the thymus in this manner.",
        "contexts": "immune cells opposite of Cancer cells, Cancer cells opposite of immune cells | Normal cell opposite of abnormal cells, abnormal cells opposite of Normal cell | thymus opposite of bone marrow, bone marrow opposite of thymus | Normal cell opposite of abnormal cells, abnormal cells opposite of Normal cell | T-ALL different from B-ALL, B-ALL different from T-ALL, bone marrow opposite of lymph nodes, lymph nodes opposite of bone marrow | Normal cell opposite of Cancer cells | p16-negative opposite of p16-positive, p16-positive opposite of p16-negative | chronic leukemias opposite of Acute leukemias, Acute leukemias opposite of chronic leukemias, B cell followed by T cells | Cancer cells opposite of non-cancer cell, non-cancer cell opposite of Cancer cells, cancer has cause Cancer cells | Cancer cells opposite of Normal cell, Normal cell opposite of Cancer cells | HIV-negative opposite of HIV | Cancer cells opposite of Normal cell",
        "metrics": {
          "rouge_score": 0.2597402597402597,
          "answer_correctness": 0.9946361646560316
        }
      },
      {
        "id": "Medical-594504cc",
        "question": "What genetic and biomarker testing is necessary for ALL patients and how does it impact therapy selection?",
        "ground_truth": "ALL patients require genetic and biomarker testing to identify alterations like BCR::ABL1, which guide targeted therapy selection.",
        "generated_answer": "Comprehensive genomic profiling is necessary for all patients, as it helps identify specific genetic mutations and biomarkers that can guide targeted therapy selection, improving treatment outcomes.",
        "contexts": "biomarker subclass of genetic testing | biomarker subclass of genetic | Genetic risk testing subclass of Genetic and biomarker testing | biomarker testing subclass of Molecular | biomarker subclass of test, biomarker test subclass of biomarker | genetic testing subclass of test | biomarker test subclass of test | genetic testing subclass of diagnostic test | tumor mutation testing subclass of biomarker | molecular tumor testing subclass of biomarker testing | case-by-case subclass of biomarker testing, tumor profiling subclass of biomarker testing | comprehensive genomic profiling subclass of genomic testing | Testing for this biomarker subclass of biomarker | biomarker subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | tumor testing subclass of genetic testing | testing for AML biomarker and genetic changes subclass of biomarker | Biomarkers subclass of biomarker",
        "metrics": {
          "rouge_score": 0.40909090909090906,
          "answer_correctness": 0.6075742148585104
        }
      },
      {
        "id": "Medical-c57bf64d",
        "question": "How does family history affect AML risk assessment, and what additional steps should be taken in such cases?",
        "ground_truth": "Family history increases AML risk due to hereditary predisposition, so genetic counseling and testing may be indicated.",
        "generated_answer": "Family history is a significant factor in assessing the risk of AML, as it can indicate a predisposition to the disease. In cases with a family history of leukemia, additional genetic testing and thorough medical evaluations should be considered to inform treatment and management plans.",
        "contexts": "Family history facet of family | Testing for AML facet of AML, AML has effect biomarker, biomarker has effect AML, AML has cause biomarker | in remission facet of AML, family history of leukemia subclass of predisposition condition, Leukemia has cause genetic changes | plan treatment facet of AML | family history facet of care team | family health history facet of colon cancer | biomarker has effect AML, AML has effect biomarker, spread facet of cancer, Testing for AML facet of AML | What is AML? main subject AML | family history part of medical | test has effect AML | family history part of health history, health history has part family history | Leukemia has cause genetic changes, family history of leukemia subclass of predisposition condition | ancestry part of family | AML subclass of blood cancer",
        "metrics": {
          "rouge_score": 0.22580645161290322,
          "answer_correctness": 0.8416475724344687
        }
      },
      {
        "id": "Medical-5456c556",
        "question": "Which hereditary syndromes should be considered risk factors if a patient is diagnosed with adrenocortical carcinoma (ACC)?",
        "ground_truth": "Beckwith-Wiedemann syndrome, Carney complex, FAP, PGL/PCC syndrome, Li-Fraumeni syndrome, Lynch syndrome, MEN 1, MEN 2, NF1, and VHL should be considered as risk factors for ACC.",
        "generated_answer": "Lynch syndrome, familial adenomatous polyposis, multiple endocrine neoplasia, and hereditary syndromes related to colon and uterine cancers should be considered risk factors for adrenocortical carcinoma.",
        "contexts": "Adrenocortical carcinoma subclass of adrenal tumor | Adrenocortical carcinoma subclass of Adrenal cancer, Neuroblastoma subclass of adrenal tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Lynch syndrome subclass of inherited cancer syndromes, Rectal cancer subclass of syndromes | Lynch subclass of genetic syndromes | Lynch syndrome subclass of Inherited syndromes related to colon cancer, Familial adenomatous polyposis subclass of Inherited syndromes related to colon cancer | Malignant adrenal tumor subclass of cancerous tumor | Lynch syndrome subclass of Familial adenomatous polyposis, Adrenal cancer subclass of cancer | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | microsatellite stable subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes | multiple endocrine neoplasia subclass of syndromes | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer | Leukemia predisposition syndrome subclass of inherited cancer syndromes | Lynch syndrome subclass of inherited condition | adrenal tumor subclass of tumor | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes",
        "metrics": {
          "rouge_score": 0.3333333333333333,
          "answer_correctness": 0.5152356550903451
        }
      },
      {
        "id": "Medical-9386f24f",
        "question": "How do grade and biomarker status together affect the classification of astrocytoma and oligodendroglioma?",
        "ground_truth": "Grade and IDH mutation status are both required to classify astrocytoma and oligodendroglioma.",
        "generated_answer": "Grade and biomarker status are critical in classifying astrocytoma and oligodendroglioma, as they determine the tumor's aggressiveness and treatment options. Higher grades typically indicate more aggressive tumors, while specific biomarkers can influence prognosis and therapeutic strategies.",
        "contexts": "Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | oligodendroglioma subclass of Glioblastoma, astrocytoma subclass of Glioblastoma, brain tumor subclass of cancerous, astrocytoma subclass of astrocyte, Cancer cells subclass of cells, Glioblastoma subclass of Glioblastoma | astrocytoma subclass of Glioblastoma | Glioblastoma subclass of glioma tumor, low-grade glioma opposite of high-grade glioma, molecular part of Glioblastoma, oligodendrocyte subclass of glial cell | Glioblastoma subclass of brain tumor | Glioblastoma subclass of tumor | Glioblastoma subclass of Glioblastoma | oligodendrocyte subclass of brain tumor, Grade 3 tumor cells subclass of Glioblastoma, high-grade glioma opposite of low-grade glioma, astrocyte subclass of cell | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of cancer | astrocytoma IDH-mutant subclass of Glioblastoma, Glioblastoma has part glial cell | CNS lymphoma subclass of Lymphoma | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | type it is subclass of Glioblastoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma",
        "metrics": {
          "rouge_score": 0.32,
          "answer_correctness": 0.23831513706474283
        }
      },
      {
        "id": "Medical-803f66d8",
        "question": "Why is elevated alpha-fetoprotein (AFP) particularly significant in the context of primary liver cancer screening and diagnosis?",
        "ground_truth": "Because elevated AFP may indicate primary liver cancer and is used as a biomarker in screening and diagnostic protocols.",
        "generated_answer": "Elevated alpha-fetoprotein (AFP) is significant in primary liver cancer screening and diagnosis because it serves as a biomarker indicating the presence of liver cancer, particularly hepatocellular carcinoma (HCC). High levels of AFP can suggest increased risk and help in the early detection of the disease.",
        "contexts": "Liver cancer has cause increased risk, increased risk has effect Liver cancer | test facet of Liver cancer, primary liver cancer subclass of cancer, alpha-fetoprotein (AFP) test main subject AFP | Liver cancer screening facet of Liver cancer | liver cancer screening facet of Liver cancer | imaging test part of Diagnosing liver cancer | Liver cancer has cause liver | liver damage has cause spread of cancer | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | primary liver cancer subclass of Liver cancer | liver has part lymph nodes | Comprehensive metabolic panel has part Liver function test, alkaline phosphatase Biopsy part of Comprehensive metabolic panel, Liver function test part of Comprehensive metabolic panel | cervix connects with uterus, cervical cancer has part cervical cancer, lung has part lymph nodes, uterus connects with cervix, liver has part lymph nodes, lymph nodes part of liver, cervix connects with pelvic lymph nodes | Liver function test studies Alkaline phosphatase, Alkaline phosphatase studied by Liver function test | HCC subclass of Liver cancer | cancer has cause spread to the liver, kidney connects with liver | organs has part liver | primary tumor has effect metastasized, metastasized has cause primary tumor",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.9944125020832786
        }
      },
      {
        "id": "Medical-eb042e58",
        "question": "Which biomarkers are tested to determine eligibility for targeted therapies in ovarian cancer?",
        "ground_truth": "BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR\u03b1, RET mutations, and NTRK gene fusion are tested.",
        "generated_answer": "The information does not specify which biomarkers are tested for targeted therapies in ovarian cancer.",
        "contexts": "Treatment facet of ovarian cancer | targeted therapy facet of Glioblastoma | Immunotherapy facet of cancer | targeted therapy facet of genetic mutations | Treatment facet of cancer, Cancer treatment facet of cancer | systemic therapy facet of cancer | Cancer treatment facet of cancer | Treatment facet of cancer | Side effects of targeted therapy facet of targeted therapy | Ultrasound Ultrasound facet of ovarian cancer | FIGO stages of ovarian cancer facet of ovarian cancer | Chemotherapy facet of cancer | chemotherapy facet of cancer, radiation therapy facet of cancer | platinum-based chemotherapy facet of cancer | Surgical staging facet of ovarian cancer | Imaging facet of cancer, Treatment planning facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment decisions facet of cancer | Treatment facet of Pancreatic cancer",
        "metrics": {
          "rouge_score": 0.1142857142857143,
          "answer_correctness": 0.22965032756133436
        }
      },
      {
        "id": "Medical-b914d234",
        "question": "Which diagnostic procedures and biomarkers are required to confirm and assess the aggressiveness of localized prostate cancer?",
        "ground_truth": "PSA test, digital rectal exam, and biopsy are used for diagnosis, while Gleason score and Grade Group estimate aggressiveness.",
        "generated_answer": "Biomarker testing, including tumor profiling and molecular tumor testing, along with biopsy and imaging, are required to confirm and assess the aggressiveness of localized prostate cancer.",
        "contexts": "biomarker subclass of test, biomarker test subclass of biomarker | biomarker subclass of genetic testing | biomarker subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | biomarker testing subclass of Molecular | biomarker test subclass of test | Biomarkers subclass of biomarker | molecular subclass of biomarker | biomarker subclass of genetic | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | Imaging subclass of test results, biomarker test subclass of biopsy | molecular tumor testing subclass of biomarker testing | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | following biomarkers subclass of biomarker | biopsy subclass of testing | tumor mutation testing subclass of biomarker | biopsy subclass of test results",
        "metrics": {
          "rouge_score": 0.26666666666666666,
          "answer_correctness": 0.379807986267453
        }
      },
      {
        "id": "Medical-5e710a7f",
        "question": "Which adrenal tumor is most commonly associated with children under 5, and what is a key difference in its spread compared to benign tumors?",
        "ground_truth": "Neuroblastoma is most common in children under 5 and may metastasize to bones, unlike benign tumors which do not metastasize.",
        "generated_answer": "Neuroblastoma is the adrenal tumor most commonly associated with children under 5. Unlike benign tumors, neuroblastoma can metastasize to other parts of the body.",
        "contexts": "Benign (not cancer) adrenal tumor subclass of adrenal tumor, Malignant adrenal tumor subclass of cancerous tumor | benign subclass of tumor | adrenal tumor subclass of tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | benign subclass of cancer | Adrenocortical carcinoma subclass of adrenal tumor | Adrenal cancer subclass of cancer | tumor subclass of abnormal areas | benign subclass of biopsy | tumor subclass of cancer | Tumor subclass of cancer | Adenocarcinoma subclass of adenoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Locoregional subclass of tumor | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | T3 subclass of Tumor | surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer",
        "metrics": {
          "rouge_score": 0.45454545454545453,
          "answer_correctness": 0.7430838324076143
        }
      },
      {
        "id": "Medical-65f00413",
        "question": "How does the treatment strategy differ between localized low-risk and metastatic prostate cancer?",
        "ground_truth": "Localized low-risk prostate cancer may be managed with active surveillance, while metastatic disease requires androgen deprivation therapy and other systemic treatments.",
        "generated_answer": "The treatment strategy for localized low-risk prostate cancer typically involves active surveillance or localized therapies such as surgery or radiation, while metastatic prostate cancer often requires systemic therapies like hormone therapy or chemotherapy. The approach is more aggressive for metastatic cases due to the advanced stage of the disease.",
        "contexts": "metastatic subclass of prostate cancer, regional subclass of prostate cancer, localized subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic prostate cancer subclass of prostate cancer | metastatic subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | prostate subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | prostate cancer subclass of cancer | advanced subclass of prostate cancer | Metastatic cancer subclass of Metastasis Cancer | metastasized subclass of cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | de novo subclass of Metastatic cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastatic subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.3055555555555556,
          "answer_correctness": 0.993135834694853
        }
      },
      {
        "id": "Medical-b2a64d4a",
        "question": "Which cell type is diagnostic for the most common subtype of Hodgkin lymphoma, and how is this subtype classified in the ontology?",
        "ground_truth": "Reed-Sternberg cells are diagnostic for classic Hodgkin lymphoma, which is the most common subtype of Hodgkin lymphoma.",
        "generated_answer": "The cell type diagnostic for the most common subtype of Hodgkin lymphoma is the Reed-Sternberg cell, classified as Classic Hodgkin lymphoma in the ontology.",
        "contexts": "Hodgkin lymphoma instance of rare | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Acute lymphoblastic leukemia instance of cancer | Hodgkin lymphoma subclass of Lymphoma | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Reed-Sternberg cell subclass of Hodgkin cell | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | stage 1 tumor instance of cancer type | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | cancer subclass of cells | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | prostate cancer instance of cancer | non-Hodgkin PMBL subclass of Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.46511627906976744,
          "answer_correctness": 0.9960499784417387
        }
      },
      {
        "id": "Medical-833eac1d",
        "question": "Which risk factors and genetic syndromes should prompt genetic testing in a patient with pancreatic cancer?",
        "ground_truth": "Risk factors like family history of pancreatic, breast, ovarian, colorectal cancer, or melanoma, and genetic syndromes such as HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis should prompt genetic testing.",
        "generated_answer": "Lynch syndrome and familial adenomatous polyposis are genetic syndromes that should prompt genetic testing in a patient with pancreatic cancer. Risk factors include age and specific genetic conditions associated with cancer.",
        "contexts": "Genetic risk testing subclass of Genetic and biomarker testing | risk level subclass of factors | genetic cancer risk testing subclass of genetic testing | genetic testing subclass of test | risk factors subclass of risk factors | biomarker subclass of genetic | biomarker subclass of genetic testing | Lynch subclass of genetic syndromes | xeroderma pigmentosum subclass of genetic conditions, basal cell nevus syndrome subclass of genetic conditions | Lynch syndrome subclass of inherited condition | tumor testing subclass of genetic testing | genetic testing subclass of diagnostic test | Lynch syndrome subclass of inherited cancer syndromes | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | cancer subclass of disease | microsatellite stable subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes | multiple endocrine neoplasia subclass of syndromes | Lynch syndrome subclass of Familial adenomatous polyposis | germline mutations subclass of genetic testing, DNA subclass of genetic information",
        "metrics": {
          "rouge_score": 0.2222222222222222,
          "answer_correctness": 0.45469836693333243
        }
      },
      {
        "id": "Medical-e3da3cd7",
        "question": "Which diagnostic methods are common to both adrenocortical carcinoma (ACC) and pheochromocytoma, and which are unique to ACC?",
        "ground_truth": "CT scan, MRI scan, and biochemical test are common to both; PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, genetic test, and biopsy are unique to ACC.",
        "generated_answer": "Common diagnostic methods for both adrenocortical carcinoma (ACC) and pheochromocytoma include imaging studies like CT scans and MRIs, as well as blood and urine tests for hormone levels. Unique diagnostic methods to ACC may include specific hormone tests such as cortisol and aldosterone levels, and biopsy for histological examination.",
        "contexts": "Adrenocortical carcinoma subclass of adrenal tumor | Adrenocortical carcinoma subclass of Adrenal cancer, Neuroblastoma subclass of adrenal tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Malignant adrenal tumor subclass of cancerous tumor, Benign (not cancer) adrenal tumor subclass of adrenal tumor | adrenal tumor subclass of tumor | Adrenal cancer subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma, Breast cancer subclass of carcinoma, Ductal carcinoma subclass of Breast cancer | Renal cell carcinoma subclass of kidney cancer | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma | Clear cell carcinoma subclass of carcinoma | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Unclassified RCC subclass of Cancer cells, Renal medullary carcinoma subclass of Renal cell carcinoma | carcinoma subclass of carcinoma, Kidney cancer subclass of carcinoma | Ductal carcinoma subclass of Breast cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer",
        "metrics": {
          "rouge_score": 0.23076923076923075,
          "answer_correctness": 0.6658578280106004
        }
      },
      {
        "id": "Medical-f3048835",
        "question": "What are the main differences in treatment between early and locally advanced NSCLC?",
        "ground_truth": "Early NSCLC is mainly treated with surgery and sometimes radiation, while locally advanced NSCLC may also require chemoradiation.",
        "generated_answer": "Early-stage NSCLC is typically treated with surgery or localized therapies, while locally advanced NSCLC often requires a combination of chemoradiation and surgery. The treatment approaches differ due to the extent of cancer spread and the associated risks.",
        "contexts": "Locally advanced cancer different from metastatic, metastatic different from Locally advanced cancer | localized different from locally advanced, locally advanced different from localized | lung cancer different from lung cancer, Early and locally advanced lung cancers subclass of NSCLC, lung cancer different from lung cancer, locally advanced subclass of Stage 1 | more advanced cancers opposite of early-stage prostate cancer, early-stage prostate cancer opposite of more advanced cancers | Chemoradiation different from local excision | highrisk different from high-risk or very high-risk CSCC, high-risk or very high-risk CSCC different from highrisk | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | treated differently different from RCC | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer | metastasize often different from metastasis, metastasis different from metastasize often | Cancer grade different from stage, stage different from Cancer grade | high-grade different from intermediate-grade, intermediate-grade different from high-grade | numbered stages different from bone cancer | radiation different from chemotherapy",
        "metrics": {
          "rouge_score": 0.42857142857142855,
          "answer_correctness": 0.8083238733010838
        }
      },
      {
        "id": "Medical-1ab31cd8",
        "question": "What combination of findings would support a diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
        "ground_truth": "BPDCN diagnosis is supported by its aggressive nature, involvement of blood, bone marrow, lymph nodes, and skin, and its classification as an AML subtype.",
        "generated_answer": "Findings supporting a diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) include the presence of papillary-like nuclear features and the identification of specific lymphoma types such as non-Hodgkin PMBL.",
        "contexts": "Blastic plasmacytoid dendritic cell neoplasm subclass of Acute promyelocytic leukemia | Blastic plasmacytoid dendritic cell neoplasm subclass of AML | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Neuroblastoma subclass of adrenal tumor | follicular subclass of oncocytic tumor, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, oncocytic subclass of thyroid cancer | Adrenocortical carcinoma subclass of adrenal tumor | Non-Hodgkin lymphoma subclass of cancer | Clear cell carcinoma subclass of carcinoma | Non-clear cell RCC subclass of sarcomatoid | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Locoregional subclass of tumor | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | diffuse large B-cell lymphoma subclass of classic FL | Metastatic cancer subclass of bone cancer, Ewing sarcoma subclass of bone cancer, Bone sarcomas subclass of Sarcomas, Soft tissue sarcomas subclass of Sarcomas, malignant subclass of cancerous",
        "metrics": {
          "rouge_score": 0.14545454545454548,
          "answer_correctness": 0.3802925656455829
        }
      },
      {
        "id": "Medical-0be2176d",
        "question": "Why might a patient with FR\u03b1-positive platinum-resistant ovarian cancer be treated with mirvetuximab soravtansine-gynx?",
        "ground_truth": "Mirvetuximab soravtansine-gynx is a targeted therapy specifically indicated for FR\u03b1-positive platinum-resistant ovarian cancer.",
        "generated_answer": "A patient with FR\u03b1-positive platinum-resistant ovarian cancer might be treated with mirvetuximab soravtansine-gynx because it is a targeted therapy specifically designed for this type of cancer.",
        "contexts": "mirvetuximab soravtansine-gynx instance of targeted therapy, ovarian cancer drug used for treatment Treatment, Treatment medical condition treated ovarian cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | ovary medical condition treated ovarian cancer, ovarian cancer medical condition treated ovary | cancer drug used for treatment Treatment | cancer drug used for treatment treatments | cancer drug used for treatment cancer | cancer drug used for treatment Cancer treatment | AML drug used for treatment Sorafenib | Treatment facet of ovarian cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Breast cancer drug used for treatment Pembrolizumab | cancer drug used for treatment Methotrexate | colon cancer drug used for treatment Ibrutinib, rituximab medical condition treated colon cancer, Lenalidomide medical condition treated colon cancer | Ovarian transposition Cervical cancer drug used for treatment External beam radiation therapy | Niraparib subject has role PARP inhibitor, olaparib subject has role PARP inhibitor, PARP inhibitor subclass of maintenance therapy, ovarian cancer drug used for treatment PARP inhibitor | treatments medical condition treated cancer, cancer drug used for treatment treatments",
        "metrics": {
          "rouge_score": 0.4444444444444445,
          "answer_correctness": 0.9970554518941606
        }
      },
      {
        "id": "Medical-64f219fe",
        "question": "Why is fertility preservation considered before ALL treatment, and which treatment modalities make this necessary?",
        "ground_truth": "Fertility preservation is considered before ALL treatment because steroids and multiagent chemotherapy may affect fertility.",
        "generated_answer": "Fertility preservation is considered before ALL treatment to safeguard reproductive potential, as certain cancer treatments can adversely affect fertility. Treatment modalities such as chemotherapy, radiation therapy, and surgery may necessitate this preservation.",
        "contexts": "Treatment subclass of Treatment | type of therapy subclass of therapy | Cancer treatment subclass of Treatment | Treatment subclass of procedure | radiation therapy subclass of Treatment, surgery subclass of Treatment, systemic therapy subclass of Treatment | radiation therapy subclass of Treatment, surgery subclass of treated | Clinical trial subclass of Treatment | initial treatment subclass of Treatment | surgery subclass of Treatment | treatment with surgery subclass of surgery, surgery subclass of Treatment | aggressive treatment subclass of Treatment | radiation therapy subclass of treated | cured subclass of Treatment | cancer type subclass of treatments | systemic therapy subclass of therapies | remission subclass of Treatment | radiation therapy subclass of Treatment, systemic therapy subclass of radiation therapy | Immunotherapy subclass of systemic therapy, targeted therapy subclass of systemic therapy, radiation therapy subclass of Treatment | radiation therapy subclass of Cancer treatment, radiation treatment practiced by Radiation oncologist, radiation therapy subclass of Treatment, resection subclass of surgery",
        "metrics": {
          "rouge_score": 0.3829787234042553,
          "answer_correctness": 0.8024485521009417
        }
      },
      {
        "id": "Medical-99713759",
        "question": "Which diagnostic methods are recommended for confirming a diagnosis of kidney cancer, and what is their basis in the classification system?",
        "ground_truth": "Imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing are all recommended diagnostic methods for kidney cancer.",
        "generated_answer": "Recommended diagnostic methods for confirming kidney cancer include imaging tests such as CT scans and MRIs, as well as biopsy. These methods are based on the classification system that categorizes cancer by type, stage, and grade.",
        "contexts": "staging system facet of cancer | Cancer grade facet of cancer | kidney cancer subclass of cancer | subtype facet of cancer | grade facet of cancer, staging facet of cancer | Renal cell carcinoma subclass of kidney cancer | diagnosis facet of cancer | Further testing facet of kidney cancer | Gerota\u2019s fascia subclass of kidney cancer | Sarcomatoid renal cancer subclass of kidney cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | staging facet of cancer | Staging facet of cancer | cancer stage facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Staging The cancer stage facet of cancer | Grade Groups facet of cancer, spread subclass of cancer | Surveillance facet of cancer | Clear cell RCC instance of cancer subtype, Papillary RCC subclass of nccRCC, Renal cell carcinoma subclass of kidney cancer",
        "metrics": {
          "rouge_score": 0.2105263157894737,
          "answer_correctness": 0.5443547809499879
        }
      },
      {
        "id": "Medical-54a3a465",
        "question": "Which maintenance therapies are recommended for a patient with advanced ovarian cancer who is BRCA-mutated after initial treatment?",
        "ground_truth": "PARP inhibitors such as olaparib, niraparib, or rucaparib are recommended as maintenance therapy for advanced or BRCA-mutated ovarian cancer after initial treatment.",
        "generated_answer": "Maintenance therapies recommended for a patient with advanced ovarian cancer who is BRCA-mutated after initial treatment include PARP inhibitors such as olaparib and niraparib.",
        "contexts": "BRCA mutation has effect ovarian cancer, ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor | Lynch syndrome has effect hereditary ovarian cancer | BRCA mutation has effect BRCA status | ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | BRCA mutation has effect homologous recombination deficiency, homologous recombination deficiency has cause BRCA mutation | genetic mutations has effect cancer | hereditary mutation has effect cancer | BRCA1 has effect Homologous recombination deficiency, BRCA2 has effect Homologous recombination deficiency | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer, Lynch syndrome has effect hereditary colon and uterine cancers, Lynch syndrome subclass of BRCA mutation, ovarian cancer subclass of cancer, hereditary ovarian cancer subclass of ovarian cancer | hereditary has effect Breast cancer, Breast cancer has cause hereditary | genetic errors has effect Bladder cancer, Bladder cancer has cause genetic errors | HRD-positive tumor has cause BRCA mutation, HRD status instance of biomarkers, BRCA mutation subclass of genetic testing of the blood | Breast cancer has effect Breast cancer",
        "metrics": {
          "rouge_score": 0.37499999999999994,
          "answer_correctness": 0.9970140996092717
        }
      },
      {
        "id": "Medical-136a5739",
        "question": "Which two polyp types are unlikely to progress to rectal cancer, and how does this contrast with adenomas?",
        "ground_truth": "Hyperplastic and inflammatory polyps rarely turn into cancer, while adenomas can become invasive rectal cancer over many years.",
        "generated_answer": "Pedunculated polyps and inflammatory polyps are unlikely to progress to rectal cancer, in contrast to adenomas, which have a higher risk of progression to cancer.",
        "contexts": "Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | Adenocarcinoma subclass of rectal tumor, Rectal cancer basics 5 The rectum 6 Polyps 6 Key points Rectal cancer subclass of Rectal cancer, Adenocarcinoma subclass of rectal tumor | Rectal cancer subclass of lesion | Polyps with cancer subclass of Rectal cancer, Adenocarcinoma subclass of adenoma | Rectal cancer subclass of Cancer cells | Adenocarcinoma subclass of colorectal cancer | Rectal cancer subclass of syndromes | Adenocarcinoma subclass of colon cancer | Rectal cancer subclass of surgery | rectum subclass of cancer, Mismatch repair subclass of Tumor | prostate cancer subclass of cancer, colorectal subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | Adenocarcinoma subclass of colon cancer, Polyps with cancer subclass of cancer, Pedunculated polyps subclass of mushroom | tumor subclass of cancer | Tumor subclass of cancer",
        "metrics": {
          "rouge_score": 0.27906976744186046,
          "answer_correctness": 0.6674416508099926
        }
      },
      {
        "id": "Medical-8233f77f",
        "question": "What laboratory and tissue-based tests are required to assess both biomarkers and genetic alterations in cutaneous B-cell lymphoma?",
        "ground_truth": "Biopsy and immunophenotyping are required to assess biomarkers and genetic changes in CBCL.",
        "generated_answer": "Biomarker testing, tumor mutation testing, molecular tumor testing, and biopsy are required to assess both biomarkers and genetic alterations in cutaneous B-cell lymphoma.",
        "contexts": "biomarker subclass of test, biomarker test subclass of biomarker | biomarker test subclass of test | biomarker subclass of biomarker | Testing for this biomarker subclass of biomarker | biomarker testing subclass of Molecular | Biomarkers subclass of biomarker | molecular subclass of biomarker | biomarker subclass of genetic testing | biomarker subclass of genetic | case-by-case subclass of biomarker testing, tumor profiling subclass of biomarker testing | biomarker subclass of features | tumor mutation testing subclass of biomarker | molecular tumor testing subclass of biomarker testing | biomarker testing subclass of biopsy, biopsy subclass of test results | biopsy subclass of test | Biopsy subclass of test | Blood test subclass of test | following biomarkers subclass of biomarker",
        "metrics": {
          "rouge_score": 0.48648648648648646,
          "answer_correctness": 0.48018279822503523
        }
      },
      {
        "id": "Medical-fad3190e",
        "question": "For a patient with a history of FAP, what combination of surveillance and diagnostic methods is most critical?",
        "ground_truth": "Regular colonoscopy and polypectomy are critical due to the high risk of multiple polyps and rectal cancer.",
        "generated_answer": "Surveillance methods such as active surveillance and closely monitoring, combined with diagnostic methods like biopsy and genetic testing, are most critical for a patient with a history of FAP.",
        "contexts": "detection methods subclass of diagnosis | Surveillance subclass of surgery | physical exam subclass of Surveillance | Treatment subclass of monitoring | active surveillance subclass of biopsy | active surveillance subclass of Treatment | CEA subclass of monitoring | Follow-up and surveillance subclass of Treatment | active surveillance subclass of closely monitoring | Surveillance for the return of anal canal cancer and perianal cancer subclass of Surveillance, Follow-up and surveillance subclass of Surveillance, Anoscopy subclass of Anoscopy | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | testing subclass of diagnosis | Observation subclass of radiation therapy | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | genetic testing subclass of diagnostic test | Imaging subclass of test results | Diagnostic mammogram subclass of mammogram | Imaging subclass of test results, biomarker test subclass of biopsy | Diagnosis by blood test subclass of blood test | CT scan subclass of Imaging",
        "metrics": {
          "rouge_score": 0.17391304347826086,
          "answer_correctness": 0.22681440596503114
        }
      },
      {
        "id": "Medical-6bd5b75d",
        "question": "What is the rationale for performing a sentinel lymph node biopsy in invasive breast cancer and not in DCIS?",
        "ground_truth": "Sentinel lymph node biopsy is performed in invasive breast cancer to assess lymph node involvement, which is not required in noninvasive DCIS.",
        "generated_answer": "Sentinel lymph node biopsy is performed in invasive breast cancer to assess the spread of cancer to lymph nodes, which is crucial for staging and treatment decisions. In contrast, DCIS is a non-invasive condition that does not typically spread beyond the ducts, making lymph node evaluation unnecessary.",
        "contexts": "cancer different from tumors, tumors different from cancer | cancer different from cancer type, cancer type different from cancer | Imaging different from cancer | lung cancer different from lung cancer | breast exams different from mammogram, mammogram different from breast exams | prostate cancer different from prostate cancer | breast subclass of cancer | ovarian cancer different from cervical cancer, cervical cancer different from ovarian cancer | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | scar tissue has cause cancer, cancer different from Imaging | Ductal carcinoma subclass of Breast cancer | melanoma different from nonmelanoma skin cancer | BPH different from prostate cancer, prostate cancer different from BPH | Breast cancer has part breast, carcinoma has effect Breast cancer, Ductal carcinoma subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.5142857142857142,
          "answer_correctness": 0.9958174468274088
        }
      },
      {
        "id": "Medical-8b99b755",
        "question": "How does the management of high-risk local CSCC differ from low-risk local CSCC in terms of treatment and follow-up?",
        "ground_truth": "High-risk local CSCC is treated with Mohs surgery or standard excision and may require radiation or systemic therapy, with more frequent follow-up exams than low-risk cases.",
        "generated_answer": "High-risk local CSCC typically requires more aggressive treatment approaches, such as Mohs surgery, and closer follow-up due to a higher risk of recurrence. In contrast, low-risk local CSCC may be managed with less invasive treatments and less frequent monitoring.",
        "contexts": "highrisk different from high-risk or very high-risk CSCC, high-risk or very high-risk CSCC different from highrisk | low risk opposite of high risk | lower risk opposite of higher risk, higher risk opposite of lower risk | lower risk opposite of higher risk of recurrence, higher risk of recurrence opposite of lower risk | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | high-risk or very high-risk CSCC drug used for treatment High-risk or very high-risk Surgery | low-risk CSCC drug used for treatment Low-risk Surgery, Low-risk Surgery medical condition treated low-risk CSCC, High-risk or very high-risk Surgery medical condition treated high-risk or very high-risk CSCC, very high-risk cancer drug used for treatment Mohs surgery | low-grade glioma opposite of high-grade glioma, high-grade glioma opposite of low-grade glioma | low risk followed by intermediate risk | CSCC subclass of imaging test | low risk instance of risk group, very high risk instance of risk group | risks opposite of benefits | treated differently different from RCC",
        "metrics": {
          "rouge_score": 0.30985915492957744,
          "answer_correctness": 0.9933046267961734
        }
      },
      {
        "id": "Medical-e0a5fcc5",
        "question": "How is high-grade squamous intraepithelial lesion (HSIL) related to cervical cancer progression and diagnosis?",
        "ground_truth": "HSIL corresponds to CIN 2 and 3, is considered pre-cancer, and may be identified by biopsy as part of cervical cancer diagnosis.",
        "generated_answer": "High-grade squamous intraepithelial lesion (HSIL) is a precursor to cervical cancer, indicating significant dysplasia that can progress to invasive cancer if untreated. It is diagnosed through cervical screening and biopsy, serving as a critical marker for potential cervical cancer development.",
        "contexts": "High-grade squamous intraepithelial lesion subclass of dysplasia, High-grade squamous intraepithelial lesion different from Low-grade squamous intraepithelial lesion, Low-grade squamous intraepithelial lesion different from High-grade squamous intraepithelial lesion | Low-grade squamous intraepithelial lesion subclass of lesion, cervical dysplasia subclass of cervical intraepithelial neoplasia | squamous cell carcinoma subclass of cervical cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | neuroendocrine carcinoma of the cervix subclass of cervical cancer, cervical intraepithelial neoplasia subclass of cervical dysplasia | Adenosquamous carcinoma subclass of cervical cancer | recurrence subclass of cervical cancer | locally advanced cancer subclass of cervical cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | metastatic subclass of cervical cancer | High-grade serous carcinoma subclass of ovarian cancer, High-grade endometrioid carcinoma subclass of ovarian cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | High-grade serous carcinoma subclass of ovarian cancer | Stage 3B subclass of cervical cancer | cervical cancer subclass of cancer | Squamous cell subclass of skin cancer",
        "metrics": {
          "rouge_score": 0.25000000000000006,
          "answer_correctness": 0.9038552473464678
        }
      },
      {
        "id": "Medical-27c72004",
        "question": "How do tobacco and alcohol use impact both the risk and outcomes of mouth cancer treatment?",
        "ground_truth": "Tobacco and alcohol use increase the risk of mouth cancer and negatively affect treatment outcomes by increasing toxicity.",
        "generated_answer": "Tobacco and alcohol use significantly increase the risk of developing mouth cancer and negatively affect treatment outcomes. Their combined use can lead to more aggressive cancer forms and lower survival rates.",
        "contexts": "smoking has effect Head and neck cancer | Tobacco and alcohol use history Tobacco has effect Head and neck cancer, Head and neck cancer has cause Tobacco and alcohol use history Tobacco | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | Squamous cell has effect Mouth cancer, Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | smoking has effect lung cancer, lung cancer has cause smoking | smoking has cause tobacco, tobacco has effect smoking | Smoking has effect bladder cancer | bladder cancer has cause Smoking | smoking cigarettes has effect lung cancer, lung cancer has cause smoking cigarettes | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Throat cancer has cause squamous cell carcinoma, squamous cell carcinoma has effect Throat cancer | Smoking has effect prostate cancer | head and neck subclass of cancer, smoking has effect Head and neck cancer, lung subclass of cancer | smoking has effect lung cancer, smoking has effect SCLC",
        "metrics": {
          "rouge_score": 0.6122448979591837,
          "answer_correctness": 0.9133373067594002
        }
      },
      {
        "id": "Medical-bb794987",
        "question": "What are the primary symptoms and diagnostic methods associated with pancreatic ductal adenocarcinoma?",
        "ground_truth": "Jaundice is a primary symptom, and diagnostic methods include imaging, endoscopic test, biopsy, blood test, genetic test, and biomarker test.",
        "generated_answer": "Primary symptoms include abdominal bloating, fever, pink or purple stretch marks, nausea, constipation, pain, fatigue, and headaches. Diagnostic methods involve imaging, blood tests, genetic testing, and biopsy.",
        "contexts": "detection methods subclass of diagnosis | Symptoms subclass of Symptoms | Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms, Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Nausea subclass of Symptoms | testing subclass of diagnosis | Constipation subclass of symptom, bloating subclass of symptom, pain subclass of symptom, fatigue subclass of symptom | Symptoms subclass of health conditions or concerns | Symptoms subclass of side effects, side effects subclass of Symptoms | Imaging subclass of symptom, chest pain subclass of shortness of breath | symptom subclass of sign | fatigue subclass of Symptoms | Diagnosis by blood test subclass of blood test | Health and symptoms subclass of health information | fatigue subclass of symptom, Headaches subclass of symptom | genetic testing subclass of diagnostic test | seizures subclass of neurological symptoms, headaches subclass of neurological symptoms, symptom subclass of sign | biopsy subclass of diagnosis",
        "metrics": {
          "rouge_score": 0.46808510638297873,
          "answer_correctness": 0.5864683348384345
        }
      },
      {
        "id": "Medical-3776fc3d",
        "question": "How does achieving minimal residual disease status affect the prognosis and management of CLL?",
        "ground_truth": "Minimal residual disease indicates mostly healthy blood cells and is a treatment goal associated with better prognosis.",
        "generated_answer": "Achieving minimal residual disease status in CLL generally indicates a better prognosis and can influence management strategies, potentially leading to less aggressive treatment options and improved outcomes. It may also guide decisions regarding ongoing monitoring and the need for further therapy.",
        "contexts": "prognosis facet of disease | Treatment part of plan, prognosis has part more than one treatment option, Treatment practiced by surgeon, surgeon field of this occupation Treatment, more than one treatment option part of prognosis | prognosis facet of course the cancer will take, prognosis facet of more than one treatment option | Diagnosis vs. prognosis different from prognosis, prognosis different from Diagnosis vs. prognosis | cancer staging facet of prognosis | CLL has effect prognosis, prognosis facet of Cancer treatment, prognosis facet of CLL | survivorship has part late effects, late effects part of survivorship | relieving subclass of managing | Treatment has part stage, stage part of Treatment | Treatment has part plan treatment | prognosis facet of cancer, breast cancer is staged facet of Breast cancer | plan treatment facet of Treatment, Treatment has part plan treatment | cancer has effect outcomes | Treatment has part surgery, surgery part of Treatment | Treatment by risk and recurrence has part prevention | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment",
        "metrics": {
          "rouge_score": 0.24137931034482757,
          "answer_correctness": 0.6454949809927885
        }
      },
      {
        "id": "Medical-f5688b0c",
        "question": "What are the necessary follow-up procedures after completing primary treatment for breast cancer to monitor for recurrence?",
        "ground_truth": "Follow-up includes imaging, physical exams, and monitoring for recurrence after primary breast cancer treatment.",
        "generated_answer": "Necessary follow-up procedures include regular physical exams, imaging tests, and monitoring for any new symptoms or changes in health. Additionally, patients may undergo blood tests to check for tumor markers.",
        "contexts": "Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Cancer treatment facet of cancer | Treatment planning facet of cancer | Clinical stage facet of Breast cancer | more treatment facet of cancer | systemic therapy facet of cancer | Treatment decisions facet of cancer | Treatment facet of ovarian cancer | Breast cancer basics The breast facet of breast | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | radiation therapy facet of cancer | plan treatment facet of cancer | more than one treatment option facet of cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | best treatment plan facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | Cancer treatment facet of cancer, Changes in fertility Treatment facet of fertility | Breast cancer screening facet of Breast cancer",
        "metrics": {
          "rouge_score": 0.34782608695652173,
          "answer_correctness": 0.880022627714484
        }
      },
      {
        "id": "Medical-6f0e62e5",
        "question": "Why is follow-up with periodic MRI imaging recommended after treatment for glioma?",
        "ground_truth": "Follow-up MRI is recommended to monitor for recurrence after glioma treatment.",
        "generated_answer": "Follow-up with periodic MRI imaging is recommended after treatment for glioma to monitor for any recurrence or progression of the tumor. MRI provides detailed images of the brain, allowing for early detection of changes that may indicate the need for further intervention.",
        "contexts": "Magnetic resonance imaging subclass of Imaging | Magnetic resonance imaging subclass of Magnetic resonance imaging, MRIs subclass of imaging test | Magnetic resonance imaging subclass of Magnetic resonance imaging, Brain MRI subclass of Magnetic resonance imaging | MRI scan subclass of Magnetic resonance imaging | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging | CT subclass of Magnetic resonance imaging | Magnetic resonance imaging subclass of scanning | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | Magnetic resonance imaging subclass of imaging test | Brain MRI subclass of Magnetic resonance imaging, CT subclass of imaging test, Magnetic resonance imaging subclass of imaging test | radiology subclass of Imaging | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | radiologist studies Magnetic resonance imaging, Magnetic resonance imaging uses scanning machine, Magnetic resonance imaging subclass of MRI test, CT scan studied by radiologist, CT scan uses X-ray, scanning machine use Magnetic resonance imaging, radiologist studies CT scan, CT subclass of computed tomography, Magnetic resonance imaging uses magnetic field | Breast MRI subclass of Breast MRI | contrast subclass of Imaging | Imaging subclass of Imaging, CT subclass of Imaging | CT subclass of Imaging | computed tomography subclass of Imaging",
        "metrics": {
          "rouge_score": 0.32727272727272727,
          "answer_correctness": 0.671992484814137
        }
      },
      {
        "id": "Medical-641dcaf5",
        "question": "What distinguishes primary bone cancer from secondary bone malignancy in terms of origin and common cancer types?",
        "ground_truth": "Primary bone cancer originates in bone or cartilage and includes sarcomas, while secondary bone malignancies are metastases from other organs such as breast, lung, or kidney.",
        "generated_answer": "Primary bone cancer originates in the bone itself, with common types including osteosarcoma and chondrosarcoma. In contrast, secondary bone malignancy arises from cancer that has metastasized to the bone from other parts of the body.",
        "contexts": "primary tumor opposite of metastasis | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer, Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma | benign opposite of cancer, benign opposite of cancerous | numbered stages different from bone cancer, bone cancer different from numbered stages | low-grade glioma opposite of high-grade glioma, high-grade glioma opposite of low-grade glioma | chronic leukemias opposite of Acute leukemias, Acute leukemias opposite of chronic leukemias | Osteosarcoma different from Osteosarcoma | more advanced cancers opposite of early-stage prostate cancer | bone marrow opposite of lymph nodes, lymph nodes opposite of bone marrow | bone cancer subclass of tumors",
        "metrics": {
          "rouge_score": 0.42622950819672134,
          "answer_correctness": 0.9963045212675865
        }
      },
      {
        "id": "Medical-47b62614",
        "question": "What is the appropriate targeted therapy for a patient with chondrosarcoma harboring an IDH1 mutation, and how is this mutation identified?",
        "ground_truth": "Ivosidenib is the targeted therapy for chondrosarcoma with IDH1 mutation, which is identified through biomarker testing.",
        "generated_answer": "The appropriate targeted therapy for a patient with chondrosarcoma harboring an IDH1 mutation is ivosidenib. This mutation is identified through genetic testing.",
        "contexts": "targeted therapy facet of Glioblastoma | chondrosarcoma drug used for treatment ivosidenib, ivosidenib medical condition treated chondrosarcoma | targeted therapy facet of genetic mutations | chondrosarcoma treatment medical condition treated chondrosarcoma, chondrosarcoma drug used for treatment chondrosarcoma treatment | Immunotherapy facet of cancer | targeted therapy subclass of chemoimmunotherapy | lenvatinib instance of targeted therapy, targeted therapy subclass of radiation therapy, Sorafenib instance of targeted therapy | systemic therapy facet of cancer | Side effects of targeted therapy facet of targeted therapy | Treatment facet of cancer, Cancer treatment facet of cancer | bevacizumab instance of targeted therapy | Treatment facet of Pancreatic cancer | targeted therapy subclass of chemotherapy | targeted therapy opposite of chemotherapy | Treatment facet of cancer | targeted therapy subclass of Immunotherapy | radiation therapy facet of cancer | Cancer treatment facet of cancer | Immunotherapy subclass of targeted therapy | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer",
        "metrics": {
          "rouge_score": 0.5789473684210527,
          "answer_correctness": 0.8453387558243397
        }
      },
      {
        "id": "Medical-bc622c63",
        "question": "How does the unregulated growth of lymphocytes relate to the development of cutaneous B-cell lymphoma?",
        "ground_truth": "Unregulated growth of B lymphocytes can develop into CBCL, a subtype of primary cutaneous lymphoma.",
        "generated_answer": "The unregulated growth of lymphocytes leads to the development of cutaneous B-cell lymphoma by causing an abnormal proliferation of B cells in the skin, resulting in tumor formation. This uncontrolled growth disrupts normal cellular function and can manifest as skin lesions or nodules.",
        "contexts": "Cutaneous T-cell lymphoma subclass of Lymphoma | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma, papule subclass of nodule, Primary cutaneous marginal zone lymphoma subclass of Primary cutaneous B-cell lymphoma, B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | skin subclass of cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | Squamous cell subclass of skin cancer | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Non-Hodgkin lymphoma subclass of Lymphoma | melanoma subclass of skin cancer | Basal cell skin cancer subclass of Skin lesion | Non-Hodgkin lymphoma subclass of cancer | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Hodgkin lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.2711864406779661,
          "answer_correctness": 0.6150430582359014
        }
      },
      {
        "id": "Medical-4f7fc60b",
        "question": "How is Stage IV pancreatic cancer defined, and what is its alternative name?",
        "ground_truth": "Stage IV pancreatic cancer is defined by distant metastasis to organs like liver, lungs, or abdominal lining, and is also known as metastatic pancreatic cancer.",
        "generated_answer": "Stage IV pancreatic cancer is defined as metastatic pancreatic cancer. Its alternative name is Stage 4 pancreatic cancer.",
        "contexts": "Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, What is pancreatic cancer? facet of Pancreatic cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments | Stage 4 is metastatic facet of Breast cancer | Treatment facet of Pancreatic cancer | stage facet of cancer | Stage 4 cancer said to be the same as Stage 4A, Stage 3A1 facet of cancer, Stage 4A said to be the same as Stage 4 cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Multidisciplinary consult facet of Pancreatic cancer | Staging The cancer stage facet of cancer | cancer stage facet of cancer | How far and how fast? facet of cancer, stage facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | PS 4 facet of Breast cancer | Treatment without surgery facet of Pancreatic cancer | staging facet of cancer | Staging facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor",
        "metrics": {
          "rouge_score": 0.46511627906976744,
          "answer_correctness": 0.845775937893817
        }
      },
      {
        "id": "Medical-ed5085d7",
        "question": "Which anatomical structures are at risk for local spread of kidney cancer, and how are they categorized?",
        "ground_truth": "Surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota\u2019s fascia are at risk for local spread.",
        "generated_answer": "The anatomical structures at risk for local spread of kidney cancer include the renal capsule, renal tubules, renal vein, and renal artery. They are categorized under the main categories of the urinary system and surrounding tissues.",
        "contexts": "grade facet of cancer, staging facet of cancer | sentinel lymph node biopsy facet of lymph node(s) | cancer staging facet of tumor | lymph nodes facet of cancer | biopsy facet of cancer | Imaging facet of cancer | main categories facet of stomach cancer | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | sentinel lymph node biopsy facet of lymph nodes | Lymph node exam facet of lymph nodes | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part kidney, ureter connects with bladder, kidney part of Blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, kidney part of kidney, Blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | tissues part of node(s), node(s) has part tissues | skin has part Epidermis, skin has part Epidermis, Epidermis part of skin, barrier part of skin, Squamous cell part of Epidermis, Skin basics facet of skin, dermis has part connective tissue, Hypodermis has part connective tissue, Epidermis part of skin | lymph nodes part of tissues, tissues part of tumor, organs has part tissues, tumor has part tissues, tissues part of organs | surgical stage facet of surgery | Breast cancer basics The breast facet of breast | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | tissues has parts of the class cells, tissues part of organs",
        "metrics": {
          "rouge_score": 0.1851851851851852,
          "answer_correctness": 0.22919003179318798
        }
      },
      {
        "id": "Medical-ef429fbb",
        "question": "Which risk factors should be investigated in a patient with a suspected stomach mass and a positive genetic risk test?",
        "ground_truth": "H. pylori infection and family history should be investigated.",
        "generated_answer": "Investigate hereditary gene testing, biomarker testing, and genetic cancer risk testing.",
        "contexts": "risk factors subclass of risk factors | genetic cancer risk testing subclass of genetic testing | genetic testing subclass of testing | Genetic risk testing subclass of Genetic and biomarker testing | genetic testing subclass of test | biomarker testing subclass of testing | genetic testing subclass of genetic testing | risk level subclass of factors | Pregnancy test subclass of Pregnancy test | prostate cancer screening test subclass of test | genetic cancer risk testing subclass of Testing for breast cancer | biomarker subclass of genetic testing | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | genetic testing subclass of diagnostic test | tumor testing subclass of genetic testing, Germline testing subclass of genetic testing, hereditary gene testing subclass of genetic testing | hereditary gene testing subclass of genetic testing | biomarker testing subclass of biomarker testing | genetic cancer risk testing subclass of Biopsy | Heart test subclass of test",
        "metrics": {
          "rouge_score": 0.09999999999999999,
          "answer_correctness": 0.23038320984118976
        }
      },
      {
        "id": "Medical-fc13ecfe",
        "question": "What is the rationale for recommending chemotherapy after colectomy in stage 3 colon cancer but not always in stage 2?",
        "ground_truth": "Chemotherapy is recommended after colectomy for all stage 3 colon cancers due to lymph node involvement, while only some stage 2 cases receive it as they lack lymph node spread.",
        "generated_answer": "Chemotherapy is recommended after colectomy in stage 3 colon cancer due to a higher risk of metastasis and recurrence, while in stage 2, the risk is lower, and the benefits may not outweigh the potential side effects.",
        "contexts": "surgery medical condition treated cancer, cancer drug used for treatment surgery | polypectomy medical condition treated Colon polyps Polyps, colon cancer has cause Polyps, Colon polyps Polyps medical condition treated polypectomy | diagnostic colonoscopy medical condition treated colon cancer, Treatment facet of colon cancer | surgery medical condition treated cancer | temozolomide medical condition treated colon cancer, colon cancer drug used for treatment Lenalidomide, rituximab medical condition treated colon cancer, Lenalidomide medical condition treated colon cancer, Ibrutinib medical condition treated colon cancer, colon cancer drug used for treatment Ibrutinib | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | CT scan CT with contrast medical condition treated colon cancer | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | treatments medical condition treated cancer, cancer drug used for treatment treatments | Treatment medical condition treated cancer | abdominoperineal resection medical condition treated Anal cancer | Abdominoperineal resection medical condition treated Anal cancer | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | surgery medical condition treated tumor | treatments medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.417910447761194,
          "answer_correctness": 0.9969156687386758
        }
      },
      {
        "id": "Medical-4744dfa7",
        "question": "Which performance evaluation is necessary before determining eligibility for clinical trials in primary CNS lymphoma patients and why?",
        "ground_truth": "Performance status evaluation is necessary to guide treatment decisions and clinical trial eligibility.",
        "generated_answer": "A comprehensive eye exam is necessary to evaluate the presence of vitreoretinal lymphoma and assess overall health before determining eligibility for clinical trials in primary CNS lymphoma patients.",
        "contexts": "primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of Treatment, primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of CNS lymphoma | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | primary CNS lymphoma has cause Enrolling in a clinical trial, standard treatments medical condition treated CNS lymphoma, Enrolling in a clinical trial has effect primary CNS lymphoma | CNS lymphoma subclass of Lymphoma | primary CNS lymphoma instance of Treatment | primary CNS lymphoma drug used for treatment new therapy | primary CNS lymphoma instance of disease | primary CNS lymphoma drug used for treatment Treatment | more than one treatment option facet of primary CNS lymphoma | primary CNS lymphoma drug used for treatment targeted therapy | primary CNS lymphoma subclass of eye exam | plan treatment facet of primary CNS lymphoma | primary CNS lymphoma location central nervous system | testing the CSF facet of CNS lymphoma",
        "metrics": {
          "rouge_score": 0.2926829268292683,
          "answer_correctness": 0.4353970380596336
        }
      },
      {
        "id": "Medical-0103d518",
        "question": "How are hereditary breast-ovarian cancer syndrome and HBOC related to pancreatic ductal adenocarcinoma risk?",
        "ground_truth": "Both hereditary breast-ovarian cancer syndrome and HBOC are genetic syndromes that increase the risk of pancreatic ductal adenocarcinoma.",
        "generated_answer": "Hereditary breast-ovarian cancer syndrome (HBOC) is associated with an increased risk of pancreatic ductal adenocarcinoma due to genetic mutations, such as BRCA mutations, that elevate the likelihood of developing various cancers, including pancreatic cancer.",
        "contexts": "pancreas has effect Pancreatic cancer | neuroendocrine tumor has effect Pancreatic cancer, Pancreatic cancer has cause Cancer cells, Pancreatic cancer has cause neuroendocrine tumor, Cancer cells has effect Pancreatic cancer, Pancreatic cancer has cause factors that increase the chance of developing, genes has effect hereditary pancreatic cancer, Hereditary breast-ovarian cancer syndrome instance of hereditary health conditions | Lynch syndrome has effect hereditary ovarian cancer | Pancreatic cancer has cause exocrine cell, exocrine cell has effect Pancreatic cancer, exocrine cell has effect Pancreatic cancer | BRCA mutation has effect ovarian cancer, ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor | new treatments medical condition treated Pancreatic cancer, pancreas has effect Pancreatic cancer, Treatment facet of cancer, What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments | ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | Breast cancer has effect Breast cancer | inflamed pancreas subclass of Pancreatic cancer | Breast cancer has part breast, carcinoma has effect Breast cancer, Ductal carcinoma subclass of Breast cancer | breast has effect Breast cancer, Breast cancer has cause breast | Breast cancer has cause breast milk",
        "metrics": {
          "rouge_score": 0.4444444444444445,
          "answer_correctness": 0.6764475299781891
        }
      },
      {
        "id": "Medical-d3dfaf75",
        "question": "If a patient presents with rapid heartbeat, headache, and sweating, which adrenal tumor is most likely and what is its origin?",
        "ground_truth": "Pheochromocytoma is most likely, and it originates from the adrenal medulla.",
        "generated_answer": "Pheochromocytoma; it originates from chromaffin cells of the adrenal medulla.",
        "contexts": "Unusual or frequent headaches subclass of Symptoms | headache subclass of Symptoms | heart has effect blood pressure | Blood has effect heart rate, heart rate part of Blood | Symptoms has cause medical problem, medical problem has effect Symptoms, seizures subclass of symptom, seizures subclass of headache | rhythm has part heart rate | bleeding has cause Blood, Blood has effect bleeding | pain has cause complications, complications has effect pain | blood vessel problems has cause heart, heart has effect heart disease | pain has cause organs | beating heart subclass of picture, rhythm has part heart rate, heart has part left side, heart rate part of rhythm | anxiety has cause stress | illness has effect Symptoms, Symptoms has cause illness | illness has effect Symptoms | fatigue has cause blood count | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell",
        "metrics": {
          "rouge_score": 0.6666666666666666,
          "answer_correctness": 0.9960486260222537
        }
      },
      {
        "id": "Medical-efd1af00",
        "question": "What evidence supports the use of chemoimmunotherapy instead of chemotherapy alone in MGZL?",
        "ground_truth": "Chemoimmunotherapy is supported because rituximab may be added to chemotherapy for MGZL treatment.",
        "generated_answer": "Evidence suggests that chemoimmunotherapy may enhance treatment efficacy by combining the benefits of chemotherapy with immune system activation, potentially leading to improved patient outcomes compared to chemotherapy alone in MGZL.",
        "contexts": "Immunotherapy opposite of chemotherapy | targeted therapy opposite of chemotherapy | Immunotherapy different from chemotherapy | radiation therapy opposite of chemotherapy, chemotherapy opposite of radiation therapy | chemotherapy different from Immunotherapy | systemic therapy opposite of radiation therapy | intravenous chemotherapy opposite of intraperitoneal (IP) chemotherapy, intraperitoneal (IP) chemotherapy opposite of intravenous chemotherapy | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Immunotherapy subclass of Chemotherapy | Immunotherapy subclass of chemotherapy | Immunotherapy different from surgery | targeted therapy subclass of chemoimmunotherapy | Chemoradiation different from chemotherapy, chemotherapy different from Chemoradiation | systemic therapy different from radiation therapy, systemic therapy subclass of radiation therapy, systemic therapy opposite of radiation therapy, radiation therapy different from systemic therapy | alternative chemotherapy drug different from Cisplatin | Chemotherapy different from Chemotherapy | immune checkpoint inhibitor therapy different from immune checkpoint inhibitor therapy by itself | Chemoradiation subclass of chemotherapy, Chemotherapy different from Chemoradiation, Chemoradiation followed by chemotherapy",
        "metrics": {
          "rouge_score": 0.2325581395348837,
          "answer_correctness": 0.48963862445625184
        }
      },
      {
        "id": "Medical-e7ebb96c",
        "question": "Which diagnostic methods are necessary for confirming both the subtype and stage of esophageal cancer?",
        "ground_truth": "Imaging tests, endoscopy, and biopsy are required to determine both subtype and stage.",
        "generated_answer": "Imaging, biopsy, and diagnostic tests are necessary for confirming both the subtype and stage of esophageal cancer.",
        "contexts": "detection methods subclass of diagnosis | testing subclass of diagnosis | genetic testing subclass of diagnostic test | Diagnosis by blood test subclass of blood test | biopsy subclass of diagnosis | Imaging subclass of test results | Diagnostic mammogram subclass of mammogram | staging subclass of Imaging | Diagnostic laparoscopy subclass of Diagnostic laparoscopy | diagnostic CT subclass of X-ray, CAT scan subclass of diagnostic CT | Imaging subclass of test results, biomarker test subclass of biopsy | pathologic subclass of stage | Lab testing subclass of analysis | imaging test subclass of testing | imaging test subclass of Imaging | Imaging subclass of test | imaging test subclass of test | radiology subclass of Imaging | potentially curable subclass of stages",
        "metrics": {
          "rouge_score": 0.4666666666666667,
          "answer_correctness": 0.7410799095014861
        }
      },
      {
        "id": "Medical-056e1e60",
        "question": "If a patient with pancreatic ductal adenocarcinoma has chronic pancreatitis and a family history of melanoma, what are their risk factors and what additional testing should be considered?",
        "ground_truth": "Chronic pancreatitis and family history of melanoma are risk factors, and genetic testing should be considered to assess for hereditary syndromes.",
        "generated_answer": "The risk factors include chronic pancreatitis and hereditary factors related to melanoma. Additional testing may involve genetic testing for hereditary pancreatic cancer syndromes.",
        "contexts": "pancreas has effect Pancreatic cancer | Cancer cells has effect Pancreatic cancer, neuroendocrine tumor has effect Pancreatic cancer, Pancreatic cancer has cause Cancer cells, Pancreatic cancer has cause factors that increase the chance of developing, genes has effect hereditary pancreatic cancer, Pancreatic cancer has cause neuroendocrine tumor | exocrine cell has effect Pancreatic cancer, exocrine cell has effect Pancreatic cancer, Pancreatic cancer has cause exocrine cell | cancer has effect cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments, new treatments medical condition treated Pancreatic cancer, pancreas has effect Pancreatic cancer, Treatment facet of cancer | prostate gland has effect prostate cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | cancer type has effect cancer | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | prostate has effect prostate cancer | Breast cancer has effect Breast cancer | cancer has effect outcomes | tumor has effect cancer | Pancreatic cancer studied by pancreatic cancer is complex, pancreatic cancer is complex studies Pancreatic cancer | cancer has effect Cancer treatment",
        "metrics": {
          "rouge_score": 0.4090909090909091,
          "answer_correctness": 0.9962485520270099
        }
      },
      {
        "id": "Medical-df78005a",
        "question": "How can you distinguish between classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma based on cell morphology?",
        "ground_truth": "Classic Hodgkin lymphoma has Reed-Sternberg cells, while nodular lymphocyte-predominant Hodgkin lymphoma has popcorn-shaped cells.",
        "generated_answer": "Classic Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells, while nodular lymphocyte-predominant Hodgkin lymphoma features popcorn-shaped cells.",
        "contexts": "popcornshaped cells subclass of nodular lymphocyte-predominant Hodgkin lymphoma, Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | diffuse large B-cell lymphoma different from Burkitt lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal, Reed-Sternberg cell subclass of Hodgkin cell | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Hodgkin lymphoma subclass of Lymphoma | Hodgkin lymphoma instance of rare, diffuse large B-cell lymphoma subclass of fast-growing cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of classic FL | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.7692307692307693,
          "answer_correctness": 0.9994626415318741
        }
      },
      {
        "id": "Medical-4aed3e10",
        "question": "Which blood tests are included in the evaluation of bone cancer, and what is their collective purpose?",
        "ground_truth": "Alkaline phosphatase, CBC, CMP, and LDH are used to evaluate bone cancer as part of blood tests.",
        "generated_answer": "Blood tests included in the evaluation of bone cancer are blood tests for low blood cell counts, biomarker tests, and PSA tests. Their collective purpose is to check for signs of disease and assess how well organs are functioning.",
        "contexts": "Bone marrow test uses bone marrow | Bone marrow test uses Bone marrow test, biomarker test facet of low blood cell counts | Blood test uses sample | blood sample part of bone marrow | radiotracer use Bone scan, Bone scan uses radiotracer | biomarker testing use diagnosis | Carcinoembryonic antigen instance of blood test | Carcinoembryonic antigen instance of Blood test | lab use Testing | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | skin biopsy use test it for cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | test use diagnosis | Blood test use Blood test check for signs of disease and how well organs are working | diagnosis uses test, test used by diagnosis | Bone marrow test subclass of test results | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Blood test subclass of test | molecular test use diagnosis",
        "metrics": {
          "rouge_score": 0.17857142857142858,
          "answer_correctness": 0.23758479484437095
        }
      },
      {
        "id": "Medical-c2ead218",
        "question": "Which abnormal blood counts and genetic findings together support a diagnosis of CML?",
        "ground_truth": "Increased white blood cells and abnormal platelet counts, along with the Philadelphia chromosome or BCR::ABL1 gene, support CML diagnosis.",
        "generated_answer": "Abnormal blood counts and genetic findings such as the Philadelphia chromosome and mutations in chromosome 22 support a diagnosis of CML.",
        "contexts": "genetic mutations has effect abnormal chromosome | genetic changes has effect Leukemia, family history of leukemia subclass of predisposition condition, Leukemia has cause genetic changes | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | genetic testing of the blood different from genetic testing, genetic testing different from genetic testing of the blood | blood count has effect fatigue, fatigue has cause blood count | genetic changes has effect Cancer cells, Cancer cells has effect genetic changes, Cancer cells has cause genetic changes | genetic mutations has effect Inherited cancer risk | genetic mutations has effect cancer | hereditary mutation has effect cancer | genes has effect traits | Leukemia has cause genetic changes, family history of leukemia subclass of predisposition condition | low blood cell counts has effect infections | genetic mutations has effect hereditary | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | mutations has effect gene",
        "metrics": {
          "rouge_score": 0.3414634146341463,
          "answer_correctness": 0.6913368651361862
        }
      },
      {
        "id": "Medical-0b5acb42",
        "question": "What is the relationship between alpha-1-antitrypsin deficiency, cirrhosis, and liver cancer risk?",
        "ground_truth": "Alpha-1-antitrypsin deficiency increases the risk of cirrhosis, which in turn increases the risk of liver cancer.",
        "generated_answer": "Alpha-1-antitrypsin deficiency can lead to liver damage, increasing the risk of cirrhosis and subsequently liver cancer.",
        "contexts": "Liver cancer has cause increased risk, increased risk has effect Liver cancer | spread of cancer has effect liver damage | Liver cancer has cause liver | spread to the liver has effect cancer | Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | cancer has effect cancer | cirrhosis has cause liver | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke, smoking has effect lung cancer | risk factors has effect cancer | Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis | lymph nodes has effect cancer | cancer type has effect cancer | cancer has effect Cancer treatment | cancer has effect outcomes | pancreas has effect Pancreatic cancer | cancer has effect side effects | health problems has effect cancer | tumor has effect cancer | virus has effect hepatitis",
        "metrics": {
          "rouge_score": 0.6111111111111112,
          "answer_correctness": 0.8490309175982655
        }
      },
      {
        "id": "Medical-0093e2ec",
        "question": "What combination of symptoms and imaging findings would indicate metastatic prostate cancer?",
        "ground_truth": "Bone pain and unexplained weight loss with positive findings on bone scan or PET scan indicate metastatic prostate cancer.",
        "generated_answer": "Symptoms such as bone pain, weight loss, and fatigue, combined with imaging findings like bone lesions or lymphadenopathy, would indicate metastatic prostate cancer.",
        "contexts": "metastatic subclass of prostate cancer, regional subclass of prostate cancer, localized subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic prostate cancer subclass of prostate cancer | metastatic subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | prostate subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic disease subclass of cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | prostate cancer subclass of cancer | advanced subclass of prostate cancer | Metastatic cancer subclass of Metastasis Cancer | metastasized subclass of cancer | Metastatic cancer subclass of Breast cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | de novo subclass of Metastatic cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastatic subclass of cervical cancer",
        "metrics": {
          "rouge_score": 0.5714285714285715,
          "answer_correctness": 0.7435728189417108
        }
      },
      {
        "id": "Medical-7f3beb74",
        "question": "If a tumor spreads through all histological layers of the bile duct, which anatomical structures could it potentially invade next?",
        "ground_truth": "It could invade nearby blood vessels, the liver, or structures outside the liver.",
        "generated_answer": "The tumor could potentially invade surrounding tissues and structures adjacent to the bile duct, such as the liver, pancreas, and nearby lymph nodes.",
        "contexts": "tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | tumor histology studies cancer | Cancer cells studied by histology, histology studies Cancer cells | tissues studied by pathologist, pathologist studies tissues | tissues studied by pathologist, pathologist studies tissues | histology part of pathology, pathology has part histology | biopsy studies lesion | histology uses microscope | pathologic studied by surgeon | pathologic examination studies tumor, Pathologic examination studied by pathologist | biopsy studied by pathologist | Biopsy studied by pathologist | GI tract studies GI tract | pathologist studies tissue sample, tissue sample studied by pathologist | disease studied by Pathologist | cytogenetics studies karyotype | pathologist has part histology",
        "metrics": {
          "rouge_score": 0.27777777777777773,
          "answer_correctness": 0.4497932962976759
        }
      },
      {
        "id": "Medical-a6968a78",
        "question": "Which diagnostic methods are recommended for a patient presenting with hematuria and frequent urination suspected of having bladder cancer?",
        "ground_truth": "Cystoscopy, urine cytology, biopsy, and imaging such as CT scan or MRI are recommended diagnostic methods.",
        "generated_answer": "Recommended diagnostic methods include cystoscopy, urine cytology, and imaging studies such as CT scans or ultrasounds.",
        "contexts": "0 subclass of bladder cancer, 3 subclass of bladder cancer, 2 subclass of bladder cancer, metastasized subclass of cancer, Stage 0 Stage 0 subclass of bladder cancer, 1 subclass of bladder cancer | bladder cancer subclass of Cancer of the upper urinary tract | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, squamous cell carcinoma subclass of bladder cancer, Adenocarcinoma subclass of bladder cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | non\u2013 muscle-invasive subclass of bladder cancer | bladder cancer subclass of cancer | bladder cancer subclass of transitional call cancer | Stage 4B subclass of bladder cancer | Metastatic bladder cancer subclass of cancer, High-grade cancer opposite of Low grade bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | invaded the muscle layer subclass of bladder cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | bladder cancer commonly comes back again subclass of Bladder cancer",
        "metrics": {
          "rouge_score": 0.625,
          "answer_correctness": 0.8097539068380999
        }
      },
      {
        "id": "Medical-42d7ac7c",
        "question": "If a patient presents with jaundice and has a family history of breast cancer, which diagnostic tests and risk factors should be considered?",
        "ground_truth": "Imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests should be considered, and family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma.",
        "generated_answer": "Diagnostic tests should include liver function tests and imaging studies. Risk factors to consider are family history of breast cancer and potential genetic mutations.",
        "contexts": "risk factors has effect cancer, cancer has cause risk factors | Breast cancer has cause Breast cancer, Breast cancer has effect Breast cancer | breast has effect Breast cancer, Breast cancer has cause breast | risk factors has effect cervical cancer, cervical cancer has cause risk factors | risk factors facet of cancer | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors, prostate cancer different from prostate cancer, risk factors has effect prostate cancer | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | estrogen has effect Breast cancer, Breast cancer has cause estrogen | Breast cancer has cause Hormones | Breast cancer has cause estrogen | health problems has effect cancer | cancer has cause cancer, cancer has effect cancer | cells of the breast has effect Breast cancer, Breast cancer has cause cells of the breast | hereditary has effect Breast cancer",
        "metrics": {
          "rouge_score": 0.3461538461538462,
          "answer_correctness": 0.3859392875497173
        }
      },
      {
        "id": "Medical-6e8f1b95",
        "question": "Which tumor markers should be monitored during surveillance after ovarian cancer treatment?",
        "ground_truth": "CA-125 or other tumor markers such as HE4, CEA, and CA 19-9 should be monitored during surveillance.",
        "generated_answer": "CA-125",
        "contexts": "ovarian cancer has effect spread, Symptoms has cause ovarian cancer, spread has cause ovarian cancer, ovarian cancer has effect Symptoms | cancer has cause tumor | cancer has cause risk factors | CA-125 instance of Tumor markers | ovarian cancer has cause BRCA mutation, BRCA mutation has effect HRD-positive tumor, BRCA mutation has effect ovarian cancer | cancer has cause cancer | CA instance of Tumor markers | cancer has cause cancer type | tumors has cause Cancer cells | Lynch syndrome has effect hereditary ovarian cancer | cancer has cause Cancer cells | Breast cancer has cause Hormones | cancer has cause lymph nodes | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Breast cancer has cause Breast cancer | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | Breast cancer has cause estrogen | Breast cancer has cause HER2",
        "metrics": {
          "rouge_score": 0.1904761904761905,
          "answer_correctness": 0.5308710514735131
        }
      },
      {
        "id": "Medical-83eb6b6b",
        "question": "What follow-up methods are recommended after cervical cancer treatment, and how do they help in surveillance?",
        "ground_truth": "Regular physical exams, imaging as indicated, Pap testing, and blood tests are recommended for surveillance after treatment.",
        "generated_answer": "Recommended follow-up methods after cervical cancer treatment include surveillance follow-up testing, gynecologic exams, and Pap testing. These methods help monitor for recurrence and ensure early detection of any new issues.",
        "contexts": "follow-up examination follows Chemoradiation, Chemoradiation followed by follow-up examination, local excision different from Chemoradiation | Surveillance Follow-up testing facet of cancer | Follow-up and surveillance subclass of Treatment | cervical cancer medical condition treated cervix, cervix medical condition treated cervical cancer | cervical cancer studied by gynecologic exam | biopsy use follow-up examination | follow-up examination facet of bladder cancer | Pap testing medical condition treated cervical cancer, cervical cancer drug used for treatment Pap testing | cervical biopsy medical condition treated cervical cancer | Cervical cancer screening uses cervix | recurrence subclass of cervical cancer | Chemoradiation medical condition treated cervical cancer, cervical cancer drug used for treatment Chemoradiation EBRT | intensitymodulated radiation therapy medical condition treated cervical cancer, cervical cancer drug used for treatment intensitymodulated radiation therapy | squamous cell carcinoma followed by Adenocarcinoma, Adenocarcinoma follows squamous cell carcinoma | Treatment follows initial evaluation",
        "metrics": {
          "rouge_score": 0.16326530612244897,
          "answer_correctness": 0.37490034862148125
        }
      },
      {
        "id": "Medical-dc695a12",
        "question": "What histopathological finding is essential for diagnosing MGZL, and how is it confirmed?",
        "ground_truth": "Reed-Sternberg cells are essential and diagnosis is confirmed by expert hematopathologist review.",
        "generated_answer": "Histopathological studies are essential for diagnosing MGZL, confirmed by pathologists examining tissue samples.",
        "contexts": "MGZL subclass of Primary mediastinal B-cell lymphoma | tissues studied by pathologist, pathologist studies tissues | disease studied by Pathologist | tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | histology studies Cancer cells, Cancer cells studied by histology | tumor histology studies cancer | biopsy studies lesion | biopsy studied by pathologist | Biopsy studied by pathologist | tissues studied by pathologist, pathologist studies tissues | pathologic examination studies tumor, Pathologic examination studied by pathologist | pathologist studies tissue sample, tissue sample studied by pathologist | rituximab medical condition treated MGZL | lymphoma cells studied by pathologist | cancer studied by pathologist | tissue sample studied by Neuropathologist | marrow studied by Bone marrow biopsy | pathologic studied by surgeon",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.2234177583766736
        }
      },
      {
        "id": "Medical-cd4d3dd1",
        "question": "What factors are considered prognostic in treatment planning for throat cancer?",
        "ground_truth": "ECOG performance status and HPV/p16 status are prognostic factors in treatment planning.",
        "generated_answer": "Factors considered prognostic in treatment planning for throat cancer include cancer staging, risks, recurrence, and the costs of care.",
        "contexts": "Treatment part of plan, prognosis has part more than one treatment option, Treatment practiced by surgeon, surgeon field of this occupation Treatment, more than one treatment option part of prognosis | prognosis facet of more than one treatment option | simulation subclass of Treatment planning | Treatment planning facet of cancer | plan treatment part of Treatment | staging facet of Treatment decisions | care plan for the end of life subclass of Treatment planning | Treatment has part plan treatment | shared decision-making facet of plan treatment | plan treatment facet of Treatment, Treatment has part plan treatment | prevention part of Treatment by risk and recurrence | plan treatment subclass of tests | cancer staging facet of prognosis | risks facet of plan treatment | Treatment has part plan treatment, plan treatment facet of costs of care, plan treatment facet of Treatment | prognosis facet of disease | plan treatment facet of Treatment, plan treatment facet of disease | Cancer treatment subclass of plan treatment, plan treatment facet of Cancer treatment | stage part of Treatment | pre-treatment part of Clinical",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.22754239989381386
        }
      },
      {
        "id": "Medical-e8163237",
        "question": "Which surgical procedures are specifically used for tumors in different parts of the rectum?",
        "ground_truth": "Low anterior resection (LAR) is used for mid to upper rectum tumors, while abdominoperineal resection (APR) is used for lower rectum tumors.",
        "generated_answer": "Colectomy, polypectomy, Abdominoperineal resection, and surgical excision.",
        "contexts": "Rectal cancer subclass of surgery | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | colostomy subclass of surgery | coloanal anastomosis subclass of colorectal anastomosis, colostomy subclass of colon can't be connected to the anus, rectum part of colon, Abdominoperineal resection subclass of Transabdominal surgery, colon part of abdomen, colon has part rectum, rectum connects with anus, outer ring of muscle part of anus | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | colostomy subclass of removing the anus | resection subclass of surgical procedure | colostomy subclass of colectomy | Rectal cancer subclass of lesion | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | surgery subclass of operation | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | surgery subclass of Treatment | treatment with surgery subclass of surgery, surgery subclass of Treatment | minimally invasive procedure subclass of surgery | surgical excision subclass of surgery | re-excision subclass of surgery | biopsy subclass of surgical procedure | hysterectomy subclass of surgery",
        "metrics": {
          "rouge_score": 0.13793103448275862,
          "answer_correctness": 0.48052213510459374
        }
      },
      {
        "id": "Medical-cfdb85ba",
        "question": "Which risk factors and genetic alterations should be evaluated in a patient with a family history of prostate cancer?",
        "ground_truth": "Age, family history, and genetic mutations such as BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, and PMS2 should be evaluated.",
        "generated_answer": "Age and genetic mutations should be evaluated as risk factors in a patient with a family history of prostate cancer.",
        "contexts": "Genetic risk testing subclass of Genetic and biomarker testing | risk level subclass of factors | biomarker subclass of genetic | mutations subclass of genetic abnormality | biomarker subclass of genetic testing | genetic cancer risk testing subclass of genetic testing | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | genetic testing subclass of test | Mismatch repair subclass of gene | risk factors subclass of risk factors | tumor testing subclass of genetic testing | xeroderma pigmentosum subclass of genetic conditions | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | Other risks and side effects subclass of side effects | germline mutations subclass of genetic testing, DNA subclass of genetic information | genetic testing subclass of diagnostic test | side effects subclass of complications | molecular subclass of genetic | risk factors has effect cancer | complications subclass of Treatment",
        "metrics": {
          "rouge_score": 0.3414634146341463,
          "answer_correctness": 0.7354226491975149
        }
      },
      {
        "id": "Medical-659d7c0a",
        "question": "How do the purposes of lung cancer screening and follow-up care differ?",
        "ground_truth": "Screening aims for early detection in high-risk individuals, while follow-up care monitors for recurrence after treatment.",
        "generated_answer": "Lung cancer screening aims to detect lung cancer at an early stage in asymptomatic individuals, while follow-up care focuses on monitoring and managing patients diagnosed with lung cancer to ensure effective treatment and address any complications.",
        "contexts": "Lung cancer screening facet of lung cancer | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | Liver cancer screening facet of Liver cancer | liver cancer screening facet of Liver cancer | Risk factors for lung cancer facet of lung cancer | Breast cancer screening facet of Breast cancer | screening test facet of diseases | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | biopsy facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | diagnosis facet of cancer | test facet of cancer | Imaging facet of cancer | Surveillance facet of cancer | detect facet of skin cancer | Imaging Imaging facet of cancer | Cancer grade facet of cancer | detection methods facet of prostate cancer | Imaging facet of cancer, Treatment planning facet of cancer",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.7356337196420132
        }
      },
      {
        "id": "Medical-c6b862bd",
        "question": "What are the key risk factors for developing glioma, and how are these determined from the ontology?",
        "ground_truth": "Key risk factors are age (more common in adults) and non-hereditary mutation, as indicated by the ontology.",
        "generated_answer": "Key risk factors for developing glioma include age, radiation exposure, and genetic predispositions. These factors are determined from the ontology by analyzing the relationships and entities linked to glioma within the knowledge base.",
        "contexts": "risk factors facet of cancer | risk factors facet of disease, Risk factors for anal cancer facet of Anal cancer | What causes a glioma? facet of brain tumor | Risk factors for lung cancer facet of lung cancer | risk factors has effect cancer, cancer has cause risk factors | situation facet of brain tumor | risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | risk level facet of skin cancer | higher risk facet of prostate cancer | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | Risk assessment facet of skin cancer | different options for treating gliomas facet of Glioblastoma | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | risk factors has effect cervical cancer, cervical cancer has cause risk factors | targeted therapy facet of Glioblastoma | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors",
        "metrics": {
          "rouge_score": 0.27450980392156865,
          "answer_correctness": 0.5098093856265882
        }
      },
      {
        "id": "Medical-92ed141f",
        "question": "How does the approach to fertility preservation differ between early-stage cervical cancer patients and those with advanced disease?",
        "ground_truth": "Early-stage patients may undergo fertility-sparing surgery or ovarian transposition, while these options are not available for advanced disease.",
        "generated_answer": "The approach to fertility preservation in early-stage cervical cancer patients typically involves options like surgical procedures that can preserve the uterus and ovaries, while in advanced disease, fertility preservation may be less feasible due to the need for more aggressive treatments that can compromise reproductive organs.",
        "contexts": "more advanced cancers opposite of early-stage prostate cancer, early-stage prostate cancer opposite of more advanced cancers | High-grade cancer opposite of lower-grade cancer, lower-grade cancer opposite of High-grade cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | advanced-stage prostate cancer follows early-stage prostate cancer, early-stage prostate cancer followed by advanced-stage prostate cancer | locally advanced cancer subclass of cervical cancer | Locally advanced cancer different from metastatic, metastatic different from Locally advanced cancer | cancer progresses follows early stages of cancer, early stages of cancer followed by cancer progresses | benign opposite of cancer | cervical cancer different from ovarian cancer, ovarian cancer different from cervical cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic anal cancer opposite of nonmetastatic, nonmetastatic opposite of metastatic anal cancer, linear accelerator medical condition treated Anal canal cancer | early-stage prostate cancer followed by advanced-stage prostate cancer, Advanced stage subclass of prostate cancer, Advanced stage subclass of prostate cancer, advanced-stage prostate cancer follows early-stage prostate cancer, Advanced stage facet of prostate cancer, therapies facet of cancer | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | low-grade glioma opposite of high-grade glioma",
        "metrics": {
          "rouge_score": 0.17910447761194026,
          "answer_correctness": 0.6092630146729736
        }
      },
      {
        "id": "Medical-da2b7d6f",
        "question": "Which treatments are used for non\u2013muscle-invasive bladder cancer and what surgical procedure is typically involved?",
        "ground_truth": "TURBT and intravesical therapy (BCG or chemotherapy) are used for non\u2013muscle-invasive bladder cancer.",
        "generated_answer": "Treatments for non\u2013muscle-invasive bladder cancer include intravesical therapy and chemotherapy. The typical surgical procedure involved is transurethral resection of bladder tumor (TURBT).",
        "contexts": "non\u2013 muscle-invasive subclass of bladder cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, follow-up examination facet of bladder cancer | stage facet of bladder cancer | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer, Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Treatment facet of bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | Smoking has effect bladder cancer, Treatment facet of Bladder cancer, Tests for bladder cancer facet of bladder cancer, Bladder cancer subclass of abnormal cells | How advanced is my bladder cancer? facet of bladder cancer | invaded the muscle layer subclass of bladder cancer | bladder cancer common? facet of bladder cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | different types of treatment facet of bladder cancer, Treatment for bladder cancer facet of bladder cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | tested facet of bladder cancer, Cancer cells has effect bladder cancer | Low grade bladder cancer opposite of High-grade cancer, different treatment options for bladder cancer facet of bladder cancer | different treatment options for bladder cancer facet of bladder cancer | 0 subclass of bladder cancer",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.8852319054903552
        }
      },
      {
        "id": "Medical-a9db9ed9",
        "question": "If a child under 5 presents with an adrenal mass and bone metastases, what is the most likely diagnosis and which diagnostic methods should be prioritized?",
        "ground_truth": "Neuroblastoma is most likely, and imaging tests plus biochemical tests should be prioritized.",
        "generated_answer": "The most likely diagnosis is Neuroblastoma. Prioritized diagnostic methods should include imaging studies such as ultrasound, CT scan, or MRI, along with biopsy for histological confirmation.",
        "contexts": "Adrenocortical carcinoma subclass of adrenal tumor | adrenal tumor subclass of tumor | Malignant adrenal tumor subclass of cancerous tumor, Benign (not cancer) adrenal tumor subclass of adrenal tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer, metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Adrenal cancer subclass of cancer | Metastatic cancer subclass of bone cancer, Ewing sarcoma subclass of bone cancer, Bone sarcomas subclass of Sarcomas, Soft tissue sarcomas subclass of Sarcomas, malignant subclass of cancerous | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | bone cancer subclass of tumors | metastasized subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | metastatic subclass of prostate cancer | metastatic subclass of cancer | metastasis subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer",
        "metrics": {
          "rouge_score": 0.15384615384615388,
          "answer_correctness": 0.8830813143891993
        }
      },
      {
        "id": "Medical-9499de40",
        "question": "Which biomarkers are most closely associated with the development of anal squamous cell carcinoma, and what is the most common risk factor?",
        "ground_truth": "HPV and HPV16 are closely associated biomarkers, with HPV infection being the strongest risk factor.",
        "generated_answer": "The most common risk factor for anal squamous cell carcinoma is HPV infection. Other biomarkers associated with its development include mutations in certain genes and lifestyle factors such as smoking.",
        "contexts": "Risk factors for anal cancer facet of Anal cancer | head and neck subclass of cancer, Anal cancer subclass of related cancers, Anal cancer instance of progression to cancer, vaginal subclass of cancer, Anal cancer has cause health- and lifestyle-related factors listed below, health- and lifestyle-related factors listed below has effect Anal cancer, Stage 0 anal cancer subclass of Anal intraepithelial neoplasia | squamous cell carcinoma subclass of Anal cancer, anal melanoma subclass of Anal squamous cell carcinoma | cervical cancer has cause risk factors, risk factors has effect cervical cancer | risk factors for thyroid cancer instance of risk factors | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | Anal cancer has effect anal dysplasia, SISCCA Superficially invasive squamous cell carcinoma subclass of Anal cancer | cancer has cause risk factors, risk factors has effect cancer | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | anal dysplasia has effect Anal cancer | Anal cancer subclass of cancer | Anal cancer subclass of cervical cancer | risk factors facet of cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | Anal cancer basics main subject Anal cancer | Stage I anal cancer followed by Stage II anal cancer",
        "metrics": {
          "rouge_score": 0.17777777777777776,
          "answer_correctness": 0.4839554394957232
        }
      },
      {
        "id": "Medical-34a9155d",
        "question": "Why is a lung nodule detected by imaging not sufficient for a lung cancer diagnosis?",
        "ground_truth": "Because biopsy is required to confirm the malignancy of a lung nodule detected by imaging.",
        "generated_answer": "A lung nodule detected by imaging is not sufficient for a lung cancer diagnosis because it may represent benign conditions or other non-cancerous issues, requiring further evaluation and testing to confirm malignancy.",
        "contexts": "lung cancer different from lung cancer, lung cancer different from lung cancer, Early and locally advanced lung cancers subclass of NSCLC | cancer different from tumors, tumors different from cancer | cancer type different from cancer, cancer different from cancer type | tumor different from Tumor | prostate cancer different from prostate cancer | Imaging different from cancer | melanoma different from nonmelanoma skin cancer | Cancer cells different from Cancer cell differ from normal cells, Cancer cell differ from normal cells different from Cancer cells | laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from laryngeal cancer, Nasopharyngeal cancer different from esophageal cancer | Osteosarcoma different from Osteosarcoma | ovarian cancer different from cervical cancer, cervical cancer different from ovarian cancer | lung subclass of cancer | scar tissue has cause cancer, cancer different from Imaging",
        "metrics": {
          "rouge_score": 0.25000000000000006,
          "answer_correctness": 0.49042834388750234
        }
      },
      {
        "id": "Medical-e2bcebf4",
        "question": "When is enrollment in a clinical trial particularly recommended for ovarian cancer patients?",
        "ground_truth": "Clinical trial enrollment is recommended for recurrent or persistent ovarian cancer.",
        "generated_answer": "Enrollment in a clinical trial is particularly recommended for ovarian cancer patients when standard treatments are not effective or when they seek additional treatment options.",
        "contexts": "standard treatments subclass of Clinical trial, voluntary subclass of Clinical trial, study subclass of Clinical trial, New clinical trial subclass of Clinical trial | New clinical trial subclass of Clinical trial | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | Enrolling in a clinical trial instance of Treatment | Treatment trial subclass of cancer clinical trial, standard treatments subclass of treatment options available for their type of cancer, systemic therapy subclass of Cancer treatment, Clinical trial subclass of medical research | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | Clinical trial subclass of studied | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | standard treatments subclass of treatment options available for their type of cancer, Clinical trial subclass of studied in people, Clinical trial subclass of medical research, Clinical trial studies drug | Clinical trial subclass of Treatment | open clinical trial subclass of Clinical trial | Clinical trial subclass of research | Clinical trial subclass of research study | Clinical trial subclass of medical research | study subclass of Clinical trial, myths and misconceptions facet of Clinical trial, Clinical trial subclass of seek treatment, trial subclass of agreement | Clinical trial has part enroll, enroll part of Clinical trial | investigational treatments subclass of Clinical trial, Clinical trial subclass of plan treatment | Treatment trial subclass of cancer clinical trial, Phase 2 trial subclass of trial, standard treatments subclass of more than one treatment option | placebo subclass of Clinical trial | Clinical trial subclass of Clinical trial",
        "metrics": {
          "rouge_score": 0.3888888888888889,
          "answer_correctness": 0.24435948054177295
        }
      },
      {
        "id": "Medical-950b879f",
        "question": "How does the typical site of involvement differ between mediastinal and non-mediastinal gray zone lymphomas?",
        "ground_truth": "Mediastinal gray zone lymphomas involve the mediastinum and supraclavicular lymph nodes, while non-mediastinal types involve bone marrow and extranodal sites.",
        "generated_answer": "Mediastinal gray zone lymphoma typically involves the mediastinum, while non-mediastinal gray zone lymphoma occurs in areas outside the mediastinum.",
        "contexts": "Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | lymph has part lymph nodes | neck has part lymph nodes | lymph has part lymph nodes, lymph nodes has part lymph | lymph nodes has part Lymph | lymph nodes has part lymph | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | lymphatic has part lymph nodes | Lymphatic system has part lymph nodes | lymph nodes part of lymph nodes, lymph nodes has part lymph nodes | lymphatics has part lymph nodes | lung has part lymph nodes | trachea connects with esophagus, throat connects with trachea, larynx part of throat, throat has part larynx, pharynx part of throat, throat has part Oropharynx, throat has part Tonsils, oral cavity part of mouth, throat has part pharynx, trachea connects with throat, throat has part tonsil, Nasopharynx part of pharynx, Oropharynx part of throat, Oropharynx has part roof of the mouth, Hypopharynx part of pharynx, Oropharynx part of pharynx, Hypopharynx part of pharynx, pharynx connects with larynx, soft palate part of Oropharynx, Tonsils part of throat, Nasopharynx part of pharynx, Oropharynx has part Tonsils, larynx connects with esophagus, Oropharynx has part soft palate, pharynx connects with esophagus, larynx connects with pharynx, esophagus connects with larynx, Oropharynx has part tongue, throat has part Oropharynx, Oropharynx part of pharynx, tongue part of Oropharynx, Tonsils part of Oropharynx, PartsoftheOropharynx part of Oropharynx, esophagus connects with pharynx | lymph nodes has part lymphatic vessel | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system",
        "metrics": {
          "rouge_score": 0.4878048780487805,
          "answer_correctness": 0.6744428368970272
        }
      },
      {
        "id": "Medical-3e87c7a1",
        "question": "What anatomical locations are at risk for distant metastasis from stomach cancer and what is the typical spread pattern?",
        "ground_truth": "The liver, peritoneum, distant lymph nodes, pancreas, and spleen are at risk due to distant spread.",
        "generated_answer": "Distant metastasis from stomach cancer typically spreads to the liver, lungs, peritoneum, and bones. The common pattern involves hematogenous spread through the bloodstream.",
        "contexts": "metastasis subclass of spread | metastasis subclass of spreading | metastatic subclass of spread | metastasis subclass of spread of cancer | metastasized subclass of spread | spread subclass of cancer | metastasis subclass of cancer | metastasized subclass of metastasis, Locoregional subclass of tumor, metastatic subclass of spread through the blood | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | local metastasis subclass of cancer, distant metastasis subclass of cancer | metastasis subclass of metastasized, spread subclass of cancer, spread has cause cancer, Treatment subclass of cancer staging, cancer has effect spread | breast subclass of cancer, spread subclass of cancer | metastasis has effect spread | metastatic subclass of cancer | Metastatic cancer subclass of Metastasis Cancer | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer",
        "metrics": {
          "rouge_score": 0.2564102564102564,
          "answer_correctness": 0.506481419556821
        }
      },
      {
        "id": "Medical-6b3f89bd",
        "question": "Which RCC subtypes are considered non-clear cell RCC, and how are they grouped in the classification?",
        "ground_truth": "Papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC are all non-clear cell RCC subtypes.",
        "generated_answer": "Non-clear cell RCC subtypes include Papillary RCC, Renal medullary carcinoma, and Collecting duct RCC. They are grouped under the broader category of non-clear cell renal cell carcinoma (nccRCC).",
        "contexts": "Non-clear cell RCC subclass of RCC, Clear cell RCC instance of cancer subtype, Papillary RCC subclass of nccRCC, Renal cell carcinoma subclass of kidney cancer | Non-clear cell RCC subclass of sarcomatoid, Clear cell RCC subclass of sarcomatoid, RCC subclass of kidney cancer | non-small cell subclass of cell, small cell subclass of cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Unclassified RCC subclass of Cancer cells, Renal medullary carcinoma subclass of Renal cell carcinoma, Collecting duct RCC subclass of nccRCC | Clear cell carcinoma subclass of carcinoma, abnormal subclass of Cancer cells | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Red blood cell has part Red blood cell, Red blood cell has part white blood cell, platelet subclass of white blood cell, white blood cell subclass of Red blood cell, white blood cell followed by platelet, Red blood cell has part platelet, Granulocyte subclass of white blood cell, white blood cell has part Granulocyte, platelet subclass of white blood cell, Red blood cell part of Blood, abnormal myeloblasts part of blood stem cell | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Granulocyte has part Eosinophil, Granulocyte subclass of white blood cell, white blood cell <subj>granulocyte subclass of white blood cell, Neutrophil subclass of Granulocyte, white blood cell has part Granulocyte, Granulocyte has part Basophil, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | white blood cell has part lymphocyte, lymphocyte follows Lymphoid progenitor cell, lymphocyte subclass of white blood cell, Red blood cell followed by platelet, myeloblast subclass of non-lymphoid blood cell, platelet part of Blood, Red blood cell subclass of Red blood cell",
        "metrics": {
          "rouge_score": 0.36065573770491804,
          "answer_correctness": 0.5763284603443757
        }
      },
      {
        "id": "Medical-14d39f0c",
        "question": "What are the common symptoms and metabolic complications associated with bone cancer, and what causes the metabolic complication?",
        "ground_truth": "Bone pain and hypercalcemia are common symptoms, with hypercalcemia caused by bone destruction.",
        "generated_answer": "Common symptoms of bone cancer include abdominal bloating, fever, nausea, muscle weakness, fatigue, unexplained weight loss, jaundice, hair loss, bleeding, bruising, headaches, and night sweats. Metabolic complications can arise from the cancer itself or its treatment, affecting the body's normal metabolic processes.",
        "contexts": "Symptoms subclass of Symptoms | side effects subclass of complications | Symptoms subclass of side effects, side effects subclass of Symptoms | Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms, Nausea subclass of Symptoms, Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Muscle weakness subclass of Symptoms | Symptoms subclass of health conditions or concerns | side effects subclass of health conditions | complications subclass of Treatment | fatigue subclass of Symptoms | Constipation subclass of symptom, bloating subclass of symptom, fatigue subclass of symptom, Unexplained weight loss subclass of symptom | jaundice subclass of Symptoms | Nausea subclass of side effects, fatigue subclass of side effects, Hair loss subclass of side effects, bleeding subclass of side effects, bruising subclass of side effects, rare subclass of side effects | fatigue subclass of symptom, Headaches subclass of symptom | fatigue subclass of B symptoms, night sweats subclass of B symptoms | pain subclass of side effects",
        "metrics": {
          "rouge_score": 0.10714285714285714,
          "answer_correctness": 0.22793568462632283
        }
      },
      {
        "id": "Medical-78897235",
        "question": "Which two diagnostic methods are used to confirm CML by detecting its key biomarkers?",
        "ground_truth": "Blood tests and bone marrow tests are used to detect the BCR::ABL1 fusion gene or Philadelphia chromosome.",
        "generated_answer": "Molecular tumor testing, tumor mutation testing.",
        "contexts": "biomarker subclass of biomarker | Biomarkers subclass of biomarker | biomarker subclass of test, biomarker test subclass of biomarker | biomarker test subclass of test | molecular subclass of biomarker | biomarker testing subclass of Molecular | biomarker subclass of genetic testing | biomarker subclass of genetic | following biomarkers subclass of biomarker | detection methods subclass of diagnosis | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | Diagnosis by blood test subclass of blood test | molecular tumor testing subclass of biomarker testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor mutation testing subclass of biomarker",
        "metrics": {
          "rouge_score": 0.16666666666666666,
          "answer_correctness": 0.2251395323739801
        }
      },
      {
        "id": "Medical-f63520dd",
        "question": "What is the role of supportive and palliative care in advanced or metastatic cervical cancer management?",
        "ground_truth": "Supportive and palliative care are integral for advanced or metastatic cervical cancer to manage symptoms and improve quality of life.",
        "generated_answer": "Supportive and palliative care play a crucial role in managing advanced or metastatic cervical cancer by focusing on alleviating symptoms, improving quality of life, and providing emotional and psychological support to patients and their families. These care approaches help in managing pain and other distressing symptoms associated with the disease and its treatment.",
        "contexts": "Palliative care subclass of supportive care, Hospice subclass of supportive care | Palliative care subclass of cancer care | Palliative care subclass of cancer-related care | supportive care subclass of Treatment | supportive care subclass of health care | Symptoms subclass of supportive care | care plan for the end of life subclass of Treatment planning | Clinical trial subclass of health research, supportive care subclass of Treatment | cancer survivors subclass of care | Survivorship subclass of other care | Palliative radiation therapy subclass of radiation | supportive care facet of cancer | cancer care subclass of Treatment | supportive care part of cancer care | Acupuncture subclass of Complementary and alternative therapies, Homeopathy subclass of Complementary and alternative therapies, Integrative oncology subclass of cancer care, Integrative oncology subclass of cancer center, Treatment decisions subclass of options | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | Palliative care facet of cancer | supportive care subclass of supportive care",
        "metrics": {
          "rouge_score": 0.3835616438356165,
          "answer_correctness": 0.9955676062739611
        }
      },
      {
        "id": "Medical-f2800f11",
        "question": "Which care team roles are necessary for comprehensive diagnosis and treatment planning in pancreatic cancer?",
        "ground_truth": "A multidisciplinary care team including diagnostic radiologist, interventional radiologist, pathologist, gastroenterologist, medical oncologist, surgical oncologist, radiation oncologist, geriatrician, registered dietitian, genetic counselor, palliative care provider, and mental health provider is necessary.",
        "generated_answer": "A multidisciplinary consult team is necessary for comprehensive diagnosis and treatment planning in pancreatic cancer.",
        "contexts": "Treatment facet of Pancreatic cancer | Multidisciplinary consult facet of Pancreatic cancer | What is pancreatic cancer? facet of Pancreatic cancer, What are the stages of pancreatic cancer facet of Pancreatic cancer | Treatment planning facet of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | What are the stages of pancreatic cancer facet of Pancreatic cancer, Pancreatic cancer has cause pancreas, What is pancreatic cancer? facet of Pancreatic cancer, Pancreatic cancer drug used for treatment new treatments, new treatments medical condition treated Pancreatic cancer, pancreas has effect Pancreatic cancer, Treatment facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | Treatment without surgery facet of Pancreatic cancer | Pancreatic cancer studied by pancreatic cancer is complex, pancreatic cancer is complex studies Pancreatic cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment decisions facet of cancer | Treatment facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | plan treatment facet of cancer | diagnosis facet of cancer | Staging The cancer stage facet of cancer | Early detection and treatment facet of prostate cancer | best treatment plan facet of cancer",
        "metrics": {
          "rouge_score": 0.21739130434782605,
          "answer_correctness": 0.42254580338026304
        }
      },
      {
        "id": "Medical-441c763b",
        "question": "Which treatment is indicated for a patient with persistent or recurrent anal cancer after initial chemoradiation, and what is a major consequence of this intervention?",
        "ground_truth": "Abdominoperineal resection (APR) is indicated, resulting in a permanent colostomy.",
        "generated_answer": "Abdominoperineal resection (APR surgery) is indicated for persistent or recurrent anal cancer after initial chemoradiation, and a major consequence of this intervention is the surgical removal of the anus.",
        "contexts": "Chemoradiation medical condition treated anal canal cancer, anal canal cancer drug used for treatment Chemoradiation | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer, Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer, Anal cancer drug used for treatment Mitomycin, 5-FU medical condition treated Anal cancer | Chemoradiation facet of Anal cancer | Anal cancer drug used for treatment radiation treatment | Anal cancer drug used for treatment radiation therapy, metastatic subclass of Anal cancer, radiation therapy medical condition treated Anal cancer | Abdominoperineal resection medical condition treated Anal cancer | abdominoperineal resection medical condition treated Anal cancer | Chemoradiation medical condition treated cancer | platinum-based chemotherapy medical condition treated Metastatic anal cancer | Surgery to remove the anus medical condition treated Anal cancer | capecitabine Mitomycin medical condition treated Anal cancer, Anal cancer drug used for treatment Mitomycin, 5-FU 5-FU and cisplatin medical condition treated Anal cancer, Mitomycin medical condition treated Anal cancer | Treatment facet of Anal cancer | low grade subclass of perianal cancer, Chemoradiation medical condition treated perianal cancer, perianal cancer drug used for treatment Chemoradiation | High-resolution anoscopy medical condition treated Anal cancer",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.615816643613279
        }
      },
      {
        "id": "Medical-df366063",
        "question": "If a patient presents with a shiny bump on the face and has a history of tanning bed use, what diagnostic steps should be taken to evaluate for basal cell carcinoma?",
        "ground_truth": "A medical and family history, physical and skin exam, and biopsy should be performed.",
        "generated_answer": "A thorough physical examination of the lesion should be conducted, followed by a biopsy to confirm the diagnosis of basal cell carcinoma. Additionally, a review of the patient's medical history, including tanning bed use and any previous skin cancer diagnoses, is essential.",
        "contexts": "skin cancer has cause sun exposure, History of skin cancer facet of skin cancer, Basal cell skin cancer has cause UV radiation, melanin has effect skin cancer, tanning beds uses UV light (radiation), basal cell subclass of skin cancer, UV radiation has effect Basal cell skin cancer, skin cancer has cause melanin | skin cancer has cause develops, develops has effect skin cancer | Skin cancer has cause Skin cell, Skin cell has effect Skin cancer | Skin cancer has cause Squamous cell | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | genetic risk of skin cancer studied by cancer genetics, skin cancer has cause Skin cell, Skin cell has effect skin cancer | cancer has cause cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | cancer has cause Cancer cells | squamous cell carcinoma has cause Squamous cell | cancer has cause tumor | cancer has cause health problems | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | cancer has cause risk factors | pain has cause cancer | cancer has cause cell damage | side effects has cause cancer",
        "metrics": {
          "rouge_score": 0.1754385964912281,
          "answer_correctness": 0.6823035494605896
        }
      },
      {
        "id": "Medical-6e99ce81",
        "question": "For a patient with anaplastic thyroid cancer and distant metastasis, which combination of therapies is most likely to be recommended?",
        "ground_truth": "External beam radiation therapy, chemotherapy, and possibly targeted therapy are most likely recommended.",
        "generated_answer": "Combination of surgery, radiation therapy, and chemotherapy is most likely to be recommended.",
        "contexts": "metastasized subclass of thyroid cancer | distant metastasis subclass of cancer, local metastasis subclass of cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | follicular subclass of thyroid cancer | Anaplastic thyroid cancer subclass of medullary | Anaplastic thyroid cancer subclass of thyroid cancer | nodule subclass of thyroid cancer | Papillary subclass of thyroid cancer, oncocytic subclass of thyroid cancer | Papillary, follicular, and oncocytic carcinoma subclass of differentiated thyroid cancers, surgery subclass of Treatment, metastatic subclass of cancer, small, low-risk cancers subclass of tumors, Papillary thyroid cancer subclass of differentiated thyroid cancers, Papillary thyroid cancer subclass of thyroid cancer | follicular subclass of lesions, follicular subclass of differentiated thyroid cancers, follicular carcinoma subclass of thyroid cancer, oncocytic tumor subclass of lesions, papillary cancer subclass of thyroid cancer, Papillary subclass of differentiated thyroid cancers, oncocytic carcinoma subclass of differentiated thyroid cancers | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | distant metastasis subclass of metastasize | differentiated thyroid cancers subclass of thyroid cancer | thyroid cancer subclass of cancer | metastasized subclass of cancer",
        "metrics": {
          "rouge_score": 0.46153846153846156,
          "answer_correctness": 0.5403234706785022
        }
      },
      {
        "id": "Medical-de3d6946",
        "question": "Which diagnostic methods would be most informative for differentiating between cutaneous B-cell and T-cell lymphomas?",
        "ground_truth": "Immunophenotyping and biopsy are most informative for differentiating CBCL from CTCL.",
        "generated_answer": "Histopathological examination, immunophenotyping, and molecular studies would be most informative for differentiating between cutaneous B-cell and T-cell lymphomas.",
        "contexts": "Non-Hodgkin lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma, B cell subclass of lymphocyte, B cell subclass of lymphocyte | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma, T-cell subclass of lymphocyte, B cell subclass of lymphocyte | Hodgkin lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Cutaneous T-cell lymphoma subclass of Lymphoma | T-cell subclass of lymphocyte | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma, T lymphocyte subclass of lymphocyte | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | mantle cell lymphoma subclass of Lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | small lymphocytic lymphoma subclass of lymph nodes, lymphocyte subclass of white blood cell",
        "metrics": {
          "rouge_score": 0.3870967741935483,
          "answer_correctness": 0.5314854527170142
        }
      },
      {
        "id": "Medical-b6fbf092",
        "question": "Why is clinical trial participation recommended for all primary CNS lymphoma patients regardless of treatment phase?",
        "ground_truth": "Because clinical trial participation is recommended for all patients and can be part of both induction and consolidation phases.",
        "generated_answer": "Clinical trial participation is recommended for all primary CNS lymphoma patients regardless of treatment phase because it provides access to innovative therapies, contributes to medical research, and helps improve treatment outcomes.",
        "contexts": "Phase 1 trial facet of Treatment trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Clinical trial facet of Clinical trial | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | Phase 3 trial facet of approved, Phase 4 trial facet of Clinical trial | Treatment facet of Treatment | Treatment facet of disease | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial | treatment process has part phases of treatment, phases of treatment part of treatment process | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial | eligibility criteria facet of Clinical trial, Phase 4 trial facet of approved by the FDA, Informed consent facet of Clinical trial, Phase 2 trial followed by Phase 3 trial, risks and benefits of joining instance of informed consent form, Phase 3 trial follows Phase 2 trial | Questions about clinical trial facet of Clinical trial, Clinical trial subclass of Treatment | certain clinical trials facet of standard treatments | eligibility criteria facet of Clinical trial, Phase 4 trial facet of approved by the FDA, Informed consent facet of Clinical trial, Phase 2 trial followed by Phase 3 trial | Phase III subclass of trial, Phase 4 trial subclass of Clinical trial, Phase II facet of trial | Treatment facet of cancer, Cancer treatment facet of cancer | Informed consent facet of Clinical trial, start the conversation facet of Clinical trial, study facet of Treatment | Treatment facet of cancer | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos",
        "metrics": {
          "rouge_score": 0.39999999999999997,
          "answer_correctness": 0.4847620071162321
        }
      },
      {
        "id": "Medical-025c325c",
        "question": "Which symptoms and risk factors would prompt early diagnostic evaluation for bladder cancer?",
        "ground_truth": "Blood in urine, frequent urination, and risk factors like smoking and chemical exposure should prompt early diagnostic evaluation.",
        "generated_answer": "Symptoms such as blood in urine, frequent urination, and pain during urination, along with risk factors like smoking, family history, and exposure to certain chemicals, would prompt early diagnostic evaluation for bladder cancer.",
        "contexts": "bladder cancer common? facet of bladder cancer | stage facet of bladder cancer | follow-up examination facet of bladder cancer | Treatment facet of bladder cancer, bladder cancer instance of disease | Treatment for bladder cancer facet of bladder cancer, different types of treatment facet of bladder cancer | Smoking has effect bladder cancer, Treatment facet of Bladder cancer, Tests for bladder cancer facet of bladder cancer, Bladder cancer subclass of abnormal cells | How advanced is my bladder cancer? facet of bladder cancer | side effects facet of cancer | different treatment options for bladder cancer facet of bladder cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | bladder cancer commonly comes back again facet of bladder cancer, Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | bladder cancer has cause bladder | tested facet of bladder cancer, Cancer cells has effect bladder cancer | Signs and symptoms facet of disease | symptom facet of disease | BCG shortage facet of bladder cancer | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.6274509803921569,
          "answer_correctness": 0.74132536669433
        }
      },
      {
        "id": "Medical-ff2105ab",
        "question": "Why is dental health assessment important in the management of nasopharyngeal carcinoma?",
        "ground_truth": "Dental health can be affected by head and neck cancer and its treatment, so dental exams are part of NPC management.",
        "generated_answer": "Dental health assessment is important in the management of nasopharyngeal carcinoma because it helps identify potential oral complications and ensures optimal oral hygiene, which can impact treatment outcomes and overall patient health.",
        "contexts": "Nasopharyngeal cancer subclass of Symptoms, Head and neck cancer subclass of cancer, squamous cell carcinoma subclass of Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer, Nasopharyngeal cancer different from laryngeal cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | squamous cell carcinoma subclass of Nasopharyngeal cancer | HPV testing facet of throat (oropharyngeal) cancer | Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | Risk assessment facet of skin cancer | Surveillance facet of cancer | cN2 subclass of Nasopharyngeal cancer | test facet of cancer | Nasopharyngeal cancer has cause EBV | Surveillance Follow-up testing facet of cancer | Nasopharyngeal cancer subclass of cancer of the nasopharynx | Imaging facet of cancer | Imaging Imaging facet of cancer | abnormal tissue growth subclass of cancer, Nasopharyngeal cancer subclass of Throat cancer | cancer care facet of cancer | tumor, node, metastasis facet of Throat cancer | test facet of Liver cancer",
        "metrics": {
          "rouge_score": 0.1509433962264151,
          "answer_correctness": 0.9852144339747904
        }
      },
      {
        "id": "Medical-535c413f",
        "question": "Which diagnostic steps should be taken if a screening ultrasound and AFP test suggest liver cancer in a patient with hepatitis B?",
        "ground_truth": "Imaging tests should be performed to confirm diagnosis, and a biopsy may be needed.",
        "generated_answer": "Further diagnostic steps should include a liver biopsy to confirm the diagnosis and imaging tests such as CT or MRI to assess the extent of the cancer. Additionally, liver function tests should be performed to evaluate liver health.",
        "contexts": "test facet of Liver cancer, alpha-fetoprotein (AFP) test main subject AFP | Liver function test facet of liver | liver cancer screening facet of Liver cancer | Liver cancer screening facet of Liver cancer | Testing for AML facet of AML | HIV testing facet of HIV | Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | Bone marrow test facet of Leukemia | Liver function test facet of liver damage | test facet of cancer | screening test facet of diseases | Hepatitis B has cause this virus, this virus has effect Hepatitis B | imaging test facet of pregnancy | invasive test facet of cancer | PSA in the blood facet of prostate cancer, PSA test facet of prostate cancer | PSA test facet of prostate cancer | Tumor HPV testing facet of human papillomavirus | hepatitis has cause virus | Hodgkin lymphoma Testing for Hodgkin lymphoma facet of Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.23076923076923078,
          "answer_correctness": 0.6099087929016197
        }
      },
      {
        "id": "Medical-2157ec85",
        "question": "What features distinguish diffuse type adenocarcinoma from intestinal type in stomach cancer pathology?",
        "ground_truth": "Diffuse type consists of scattered cells and is less common, while intestinal type forms tube- and gland-shaped structures.",
        "generated_answer": "Diffuse type adenocarcinoma is characterized by poorly cohesive cells that invade the stroma in a desmoplastic reaction, while intestinal type adenocarcinoma typically forms glandular structures and is associated with intestinal metaplasia. Additionally, diffuse type lacks a distinct mass and often presents with a more infiltrative growth pattern compared to the more localized growth of intestinal type.",
        "contexts": "Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | Locoregional subclass of stomach cancer | stomach cancer subclass of lung cancer | Adenocarcinoma subclass of colon cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer, Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | HCC subclass of Liver cancer | cancer subclass of Tumor, aggressive type subclass of cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | cancer type subclass of cancer | hepatocellular carcinoma subclass of Liver cancer, fibrolamellar hepatocellular carcinoma subclass of HCC, cholangiocarcinoma subclass of hepatocellular carcinoma | colon subclass of cancer, pancreatic subclass of cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | carcinoma subclass of cancer, lobular subclass of Breast cancer, axillary lymph nodes subclass of nodes, Breast cancer subclass of carcinoma | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.21333333333333335,
          "answer_correctness": 0.8134157890043491
        }
      },
      {
        "id": "Medical-aa9a54c8",
        "question": "Which diagnostic methods would be used to assess both lymph node involvement and distant metastasis in mouth cancer?",
        "ground_truth": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used to assess lymph node involvement and distant metastasis.",
        "generated_answer": "Diagnostic methods for assessing lymph node involvement and distant metastasis in mouth cancer include imaging techniques such as CT scans, MRI, and PET scans, along with physical examinations and biopsy of lymph nodes.",
        "contexts": "lymph nodes has effect metastases, metastases location lymph nodes | lymph nodes has effect cancer, cancer has cause lymph nodes | Lymphoma has effect lymph nodes | metastasis has effect spread | Head and neck cancer has cause lymph nodes, Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | lymph nodes has effect lymph node removed, bone marrow connects with lymph nodes, lymph node removed facet of lymph nodes, lymph nodes has effect lymph node removed | primary tumor has effect metastasized, metastasized has cause primary tumor | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | lymph nodes part of cancer | Cancer stages and metastasis has effect Metastatic cancer, Metastatic cancer has cause Cancer stages and metastasis | lymph nodes has part Lymph | lymph nodes has part lymph | tumor has effect cancer | cancer has cause tissues, tissues has effect cancer, lymph has part lymph nodes | lymph has part lymph nodes, lymph nodes has part lymph | cancer location lymph nodes",
        "metrics": {
          "rouge_score": 0.339622641509434,
          "answer_correctness": 0.9903516743569959
        }
      },
      {
        "id": "Medical-f8e45373",
        "question": "Which subtype of Hodgkin lymphoma is most likely to transform into diffuse large B-cell lymphoma, and how is this subtype identified?",
        "ground_truth": "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma and is identified by popcorn-shaped cells.",
        "generated_answer": "Classic Hodgkin lymphoma is the subtype most likely to transform into diffuse large B-cell lymphoma, identified by the presence of Reed-Sternberg cells.",
        "contexts": "diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | Hodgkin lymphoma subclass of Lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of classic FL | diffuse large B-cell lymphoma subclass of fast-growing cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | mantle cell lymphoma subclass of Lymphoma | FL grade 3B subclass of follicular large B cell lymphoma | Acute lymphoblastic leukemia subclass of blood cancer | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer",
        "metrics": {
          "rouge_score": 0.5454545454545454,
          "answer_correctness": 0.5374953962524021
        }
      },
      {
        "id": "Medical-f9e22272",
        "question": "Which two related lymphomas share overlapping features with gray zone lymphomas, complicating diagnosis?",
        "ground_truth": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) share overlapping features with gray zone lymphomas.",
        "generated_answer": "Primary mediastinal B-cell lymphoma and Hodgkin lymphoma.",
        "contexts": "Gray zone lymphoma subclass of Lymphoma, Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | CNS lymphoma subclass of Lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | mantle cell lymphoma subclass of Lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Cutaneous T-cell lymphoma subclass of Lymphoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | Germinal centers Follicular lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of classic FL",
        "metrics": {
          "rouge_score": 0.6399999999999999,
          "answer_correctness": 0.8384933583661758
        }
      },
      {
        "id": "Medical-2148e062",
        "question": "What is the purpose of surveillance for relapse in ALL patients and which follow-up methods are used?",
        "ground_truth": "Surveillance for relapse aims to detect disease return using regular blood tests and clinical monitoring.",
        "generated_answer": "The purpose of surveillance for relapse in ALL patients is to monitor for the return of cancer. Follow-up methods used include physical exams, follow-up visits and tests, and various imaging techniques such as PET scans.",
        "contexts": "Follow-up and surveillance subclass of Treatment | active surveillance subclass of closely monitoring | physical exam subclass of Surveillance, Surveillance subclass of Surveillance | follow-up visits and tests subclass of monitor my health | active surveillance subclass of Treatment | Surveillance subclass of surgery | Surveillance for the return of anal canal cancer and perianal cancer subclass of Surveillance, Follow-up and surveillance subclass of Surveillance, Anoscopy subclass of Anoscopy | Treatment subclass of monitoring | CEA subclass of monitoring | active surveillance subclass of biopsy | rounds of treatment subclass of follow-up visits, stabilized subclass of Treatment | Surveillance Recurrence subclass of Locally advanced cancer | detection methods subclass of diagnosis | Observation subclass of radiation therapy | Surveillance facet of cancer | surveillance testing facet of cancer survivors | active surveillance subclass of Surveillance | following biomarkers subclass of biomarker | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.48854843666956127
        }
      },
      {
        "id": "Medical-b7e4be0e",
        "question": "What combination of risk factors and diagnostic methods would justify recommending lung cancer screening?",
        "ground_truth": "Individuals with high-risk factors such as tobacco smoking should undergo lung cancer screening using imaging.",
        "generated_answer": "A combination of risk factors such as smoking history, age, and family history of lung cancer, along with diagnostic methods like low-dose CT scans, would justify recommending lung cancer screening. Early detection through these methods can significantly improve treatment outcomes.",
        "contexts": "Early detection of lung cancer subclass of Treatment, carcinoma subclass of lung cancer, small cell lung cancer subclass of NSCLC | lung cancer subclass of carcinoma, NSCLC subclass of lung cancer | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer, Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | non-small cell lung cancer subclass of cancer, lung cancer subclass of cancer | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer, small cell lung cancer subclass of lung cancer | non-small cell lung cancer subclass of lung cancer | detection methods subclass of diagnosis | Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, bone scan subclass of Imaging methods for detecting prostate cancer, biopsy subclass of Imaging, CT subclass of Imaging methods for detecting prostate cancer | molecular tumor testing subclass of biomarker testing | tumor profiling subclass of biomarker testing | tumor testing subclass of genetic testing | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Breast cancer screening subclass of detecting cancer earlier",
        "metrics": {
          "rouge_score": 0.28070175438596495,
          "answer_correctness": 0.878167936249581
        }
      },
      {
        "id": "Medical-e8957bed",
        "question": "Why is ctDNA testing not routinely used in colon cancer management outside clinical trials?",
        "ground_truth": "ctDNA testing is considered investigational and recommended only in clinical trials, not in standard management.",
        "generated_answer": "ctDNA testing is not routinely used in colon cancer management outside clinical trials due to a lack of standardization, limited validation in diverse patient populations, and insufficient evidence of its impact on clinical outcomes.",
        "contexts": "standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial | Clinical trial has part enroll, enroll part of Clinical trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | Clinical trial studies drug, Phase 1 trial part of Treatment trial, Treatment trial has part Phase 1 trial | Clinical trial studied by Clinical trial, Clinical trial studies Clinical trial | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research, Clinical trial studies drug | investigational treatments use Clinical trial, Clinical trial uses investigational treatments | Enrolling in a clinical trial instance of Treatment | Food and Drug Administration field of work Clinical trial, standard treatments subclass of treatment options available for their type of cancer, Clinical trial subclass of studied in people, Clinical trial subclass of medical research, Clinical trial studies drug, drug studied by Clinical trial | Clinical trial uses investigational treatments, investigational treatments use Clinical trial | standard treatments subclass of Clinical trial, voluntary subclass of Clinical trial, study subclass of Clinical trial, New clinical trial subclass of Clinical trial | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial | Questions about clinical trial facet of Clinical trial, Clinical trial subclass of Treatment | Clinical trial studies new drug",
        "metrics": {
          "rouge_score": 0.28571428571428564,
          "answer_correctness": 0.5390505225798974
        }
      },
      {
        "id": "Medical-54cc91bf",
        "question": "Which diagnostic methods are needed to both confirm squamous cell carcinoma (SCC) in the mouth and assess its anatomical extent?",
        "ground_truth": "Biopsy is required to confirm SCC diagnosis and imaging tests like CT, MRI, PET/CT, and ultrasound are used to assess anatomical extent.",
        "generated_answer": "Skin biopsy and imaging tests are needed to confirm squamous cell carcinoma (SCC) in the mouth and assess its anatomical extent.",
        "contexts": "squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | squamous subclass of Adenocarcinoma, squamous cell carcinoma subclass of cancer | squamous cell carcinoma has cause Squamous cell | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Tumor p16 (HPV) testing instance of HPV testing | Squamous cell subclass of skin cancer, screening facet of skin cancer | Skin cancer has cause Squamous cell, CSCC different from squamous cell skin cancer, Squamous cell has effect Skin cancer | Squamous cell subclass of skin cancer | Squamous cell subclass of skin cancer, squamous cell skin cancer subclass of skin cancer, Squamous cell subclass of skin cancer, Marjolin\u2019s ulcer subclass of squamous cell skin cancer, squamous cell skin cancer subclass of squamous cell skin cancer | imaging test subclass of diagnostic test, diagnostic test facet of cancer | squamous cell carcinoma subclass of squaymous | squamous cell carcinoma subclass of cervical cancer | Magnetic resonance imaging instance of imaging technique | Metastatic CSCC subclass of squamous cell skin cancer, Squamous cell subclass of skin cancer | squamous cell carcinoma subclass of bladder cancer | Mouth cancer subclass of Head and neck cancer, Mouth cancer subclass of cancer, squamous cell carcinoma subclass of Mouth cancer, Nasopharyngeal cancer subclass of throat (oropharyngeal) cancer, Mouth cancer has cause Squamous cell | squamous cell carcinoma followed by Adenocarcinoma | squamous cell skin cancer subclass of skin cancer",
        "metrics": {
          "rouge_score": 0.4090909090909091,
          "answer_correctness": 0.7398446443167773
        }
      },
      {
        "id": "Medical-81c95a46",
        "question": "Which anatomic locations are most commonly associated with osteosarcoma and giant cell tumor of bone, and what do these locations have in common?",
        "ground_truth": "Osteosarcoma commonly arises in the metaphysis near growth plates, and giant cell tumor of bone often occurs in the metaphysis and epiphysis; both involve the metaphysis.",
        "generated_answer": "Osteosarcoma and giant cell tumor of bone are most commonly associated with the long bones, particularly around the knee (distal femur and proximal tibia) and the pelvis. These locations are characterized by high rates of bone growth and remodeling.",
        "contexts": "Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer, metastatic subclass of thyroid cancer, primary bone cancer subclass of cancer, primary bone cancer subclass of bone cancer | Osteosarcoma subclass of bone cancer | Metastatic cancer subclass of bone cancer, Ewing sarcoma subclass of bone cancer, Bone sarcomas subclass of Sarcomas, Soft tissue sarcomas subclass of Sarcomas, malignant subclass of cancerous | bone cancer subclass of tumors | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | Large cell carcinoma subclass of lung cancer, small cell lung cancer subclass of lung cancer, Sarcomatoid carcinoma subclass of lung cancer, small cell lung cancer subclass of cell lung carcinoma | Glioblastoma subclass of tumor | Large cell carcinoma subclass of NSCLC | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | Glioblastoma subclass of glioma tumor | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | Glioblastoma subclass of brain tumor | tumor subclass of cancer | Tumor subclass of cancer | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | oligodendroglioma subclass of Glioblastoma | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor",
        "metrics": {
          "rouge_score": 0.3076923076923077,
          "answer_correctness": 0.8822190733878807
        }
      },
      {
        "id": "Medical-def9b488",
        "question": "Why is expert hematopathologist review crucial in diagnosing MGZL?",
        "ground_truth": "Because diagnosis of MGZL requires expert hematopathologist review due to its overlapping features with PMBL and HL.",
        "generated_answer": "Expert hematopathologist review is crucial in diagnosing MGZL because they specialize in analyzing blood and bone marrow samples to identify lymphoma cells and other blood cancers accurately. Their expertise ensures precise diagnosis and appropriate treatment planning.",
        "contexts": "Blood studied by hematopathologist, hematopathologist studies Blood | pathologist studies lymphoma cells, lymphoma cells studied by pathologist | Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist, disease studied by Pathologist | marrow studied by Bone marrow biopsy | cancer studied by pathologist, pathologist studies cancer | cancer studied by pathologist, pathologist studies cancer | Biopsy studied by pathologist | biopsy studied by pathologist | blood cancer studied by hematologist-oncologist, hematologist-oncologist studies blood cancer | MGZL drug used for treatment rituximab, rituximab medical condition treated MGZL | MGZL subclass of Primary mediastinal B-cell lymphoma | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | tissue sample studied by Neuropathologist | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell",
        "metrics": {
          "rouge_score": 0.18867924528301885,
          "answer_correctness": 0.4896990627979979
        }
      },
      {
        "id": "Medical-3a5671fc",
        "question": "What diagnostic methods are used to detect hereditary pancreatic cancer risk, and which genetic syndromes are relevant?",
        "ground_truth": "Genetic tests are used to detect hereditary pancreatic cancer risk, especially in patients with syndromes like HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis.",
        "generated_answer": "Diagnostic methods for detecting hereditary pancreatic cancer risk include genetic testing for inherited mutations and family history assessment. Relevant genetic syndromes include Lynch syndrome, familial malignant melanoma syndrome, and familial adenomatous polyposis.",
        "contexts": "Pancreatic cancer has cause factors that increase the chance of developing, genes has effect hereditary pancreatic cancer, neuroendocrine tumor has effect Pancreatic cancer, Pancreatic cancer has cause Cancer cells, Cancer cells has effect Pancreatic cancer, Familial malignant melanoma syndrome instance of hereditary health conditions, Pancreatic cancer has cause neuroendocrine tumor | Lynch syndrome has effect hereditary ovarian cancer | hereditary mutation has effect cancer | pancreas has effect Pancreatic cancer | hereditary has effect Breast cancer | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | genetic mutations has effect Inherited cancer risk, Inherited cancer risk has cause genetic mutations | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer | Lynch syndrome subclass of inherited cancer syndromes | exocrine cell has effect Pancreatic cancer, exocrine cell has effect Pancreatic cancer | genetic mutations has effect cancer | genetic changes has effect Cancer cells | genetic mutations has effect hereditary | Lynch syndrome has effect colorectal, Lynch syndrome subclass of Rectal cancer, microsatellite stable subclass of Tumor | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer",
        "metrics": {
          "rouge_score": 0.27586206896551724,
          "answer_correctness": 0.7765414574072484
        }
      },
      {
        "id": "Medical-8ff4d088",
        "question": "What treatment options are specifically recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer?",
        "ground_truth": "Endocrine therapy, CDK4/6 inhibitors, and PIK3CA inhibitors are recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer.",
        "generated_answer": "Treatment options for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer typically include hormone therapy, such as aromatase inhibitors or selective estrogen receptor modulators, and targeted therapies like PI3K inhibitors. Chemotherapy may also be considered based on individual patient factors.",
        "contexts": "Hormone receptor-positive subclass of Breast cancer | HER2-positive breast cancer subclass of Breast cancer | HR-cancer subclass of cancer, ER-low\u2013positive subclass of Breast cancer, Hormone receptor-negative subclass of Breast cancer | breast subclass of cancer | Breast cancer subclass of carcinoma | Ductal carcinoma subclass of Breast cancer | carcinoma subclass of Breast cancer | HER2-positive subclass of Breast cancer, Immunohistochemistry subclass of staining, estrogen subclass of receptor, tumor biopsy subclass of test, HER2 subclass of cancer | metastasized subclass of Breast cancer | progesterone subclass of hormone receptor, hormone receptor part of hormone, Hormone receptor-positive subclass of Breast cancer, Breast cancer subclass of cancer | lobular subclass of Breast cancer, Invasive breast cancer subclass of Breast cancer | ovarian subclass of cancer, breast subclass of cancer | Invasive breast cancer subclass of cancer, Metastatic cancer subclass of Breast cancer | breast subclass of cancer, spread subclass of cancer | Lobular carcinoma subclass of Breast cancer, Inflammatory breast cancer subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.3492063492063492,
          "answer_correctness": 0.619454246411079
        }
      },
      {
        "id": "Medical-3bea99a2",
        "question": "Which imaging modalities are necessary to fully stage a patient with suspected regional prostate cancer spread?",
        "ground_truth": "MRI, CT scan, and PSMA-PET are necessary to assess regional spread in prostate cancer.",
        "generated_answer": "Magnetic resonance imaging, CT, and bone scan are necessary to fully stage a patient with suspected regional prostate cancer spread.",
        "contexts": "regional subclass of prostate cancer, localized subclass of prostate cancer, metastatic subclass of prostate cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer, localized prostate cancer subclass of cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | localized prostate cancer subclass of prostate cancer | prostate subclass of cancer | advanced subclass of prostate cancer | early-stage subclass of prostate cancer, advanced-stage prostate cancer subclass of prostate cancer | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | prostate cancer subclass of cancer | early-stage prostate cancer subclass of cancer | early-stage prostate cancer subclass of prostate cancer | early-stage prostate cancer followed by advanced-stage prostate cancer, Advanced stage subclass of prostate cancer, Advanced stage subclass of prostate cancer | prostate cancer subclass of cancer, colorectal subclass of cancer | local metastasis subclass of cancer | early-stage disease subclass of cancer, prostate cancer subclass of cancer | metastatic prostate cancer subclass of prostate cancer",
        "metrics": {
          "rouge_score": 0.4571428571428572,
          "answer_correctness": 0.7414576901155341
        }
      },
      {
        "id": "Medical-9231a873",
        "question": "Which cancer subtype is most commonly found in the nasopharynx and how is it classified within the cancer ontology?",
        "ground_truth": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer, classified under nasopharyngeal carcinoma (NPC) in the ontology.",
        "generated_answer": "Head and neck cancer, classified as a subtype within the cancer ontology.",
        "contexts": "subtype facet of cancer | cancer type subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | metastasis subclass of cancer, tumor part of cancer | cancer type subclass of treatments | tumor part of cancer | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | cancer type subclass of cancer, family history subclass of health history | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | tumor has parts of the class Cancer cells, tumor mutational burden-high subclass of tumor mutational burden-high | tumor has part tumor(s), tumor(s) part of tumor | Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging | cancer type subclass of cancer, health history subclass of Medical history, family history subclass of health history | AML subclass of blood cancer, Subtypes of AML subclass of Subtypes of AML | Staging The cancer stage facet of cancer | Phase 1 trial part of Treatment trial, drug studied by Clinical trial, Treatment trial subclass of cancer clinical trial, standard treatments facet of cancer, Treatment trial has parts of the class Phase 1 trial, Clinical trial subclass of medical research | grade instance of cancer type | cells part of cancer | Cancer grade facet of cancer",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.23705309090473295
        }
      },
      {
        "id": "Medical-52ca0ffb",
        "question": "Why are both biomarker testing and genetic risk testing included in the diagnostic process for esophageal cancer?",
        "ground_truth": "Both are needed to identify molecular and inherited factors influencing cancer risk and treatment.",
        "generated_answer": "Both biomarker testing and genetic risk testing are included in the diagnostic process for esophageal cancer to identify specific genetic mutations and biomarkers that can inform treatment decisions and assess individual risk factors. This comprehensive approach enhances the accuracy of diagnosis and the effectiveness of personalized treatment strategies.",
        "contexts": "Genetic risk testing subclass of Genetic and biomarker testing | biomarker subclass of genetic testing | biomarker subclass of genetic | genetic cancer risk testing subclass of Testing for breast cancer | genetic cancer risk testing subclass of Biopsy | genetic testing subclass of test | biomarker testing subclass of Molecular | biomarker subclass of test, biomarker test subclass of biomarker | biomarker test subclass of test | molecular tumor testing subclass of biomarker testing | genetic testing subclass of diagnostic test | tumor mutation testing subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | genetic cancer risk testing subclass of genetic testing | tumor testing subclass of genetic testing | case-by-case subclass of biomarker testing, tumor profiling subclass of biomarker testing | comprehensive genomic profiling subclass of genomic testing | over the counter subclass of genetic testing",
        "metrics": {
          "rouge_score": 0.25806451612903225,
          "answer_correctness": 0.5316078516099475
        }
      },
      {
        "id": "Medical-efd5b238",
        "question": "What is the significance of identifying the disease stage in esophageal cancer for determining metastatic sites?",
        "ground_truth": "Disease stage determines if metastasis to organs like liver, lung, bone, and brain has occurred.",
        "generated_answer": "Identifying the disease stage in esophageal cancer is crucial for determining metastatic sites as it helps assess the extent of cancer spread, guiding treatment decisions and prognosis. Accurate staging informs clinicians about potential metastasis to other organs, which is essential for effective management of the disease.",
        "contexts": "stage facet of cancer | cancer stage facet of cancer | Clinical stage facet of Breast cancer | stage facet of tumor | Staging The cancer stage facet of cancer | How far and how fast? facet of cancer, stage facet of cancer | stage the cancer facet of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | stage facet of bladder cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | What are the stages of pancreatic cancer facet of Pancreatic cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | progression to cancer facet of cancer | Staging facet of cancer | staging facet of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | grade facet of cancer, staging facet of cancer | FIGO stages of ovarian cancer facet of ovarian cancer | surgical stage facet of surgery",
        "metrics": {
          "rouge_score": 0.19672131147540983,
          "answer_correctness": 0.6959609355106706
        }
      },
      {
        "id": "Medical-5e530443",
        "question": "Which symptoms and risk factors together would most strongly indicate the need for biopsy to rule out BCC?",
        "ground_truth": "A flat pale area on sun-exposed skin in a fair-skinned patient with a history of sun exposure strongly indicates the need for biopsy.",
        "generated_answer": "Symptoms such as unusual skin growths or changes in existing moles, combined with risk factors like a history of skin cancer or significant sun exposure, would strongly indicate the need for a biopsy to rule out basal cell carcinoma (BCC).",
        "contexts": "cancer has cause risk factors, risk factors has effect cancer | illness has effect Symptoms, Symptoms has cause illness | Symptoms has cause Symptoms, Symptoms has effect Symptoms | Symptoms has cause illness, illness has effect Symptoms | Symptoms has cause medical problem, medical problem has effect Symptoms | conditions has cause diseases, diseases has effect conditions | risk factors facet of disease | cervical cancer has cause risk factors, risk factors has effect cervical cancer | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | age instance of risk factors, risk factors facet of cancer | Symptoms has cause Treatment | family health history has part risk factors | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | side effects has cause Medicines",
        "metrics": {
          "rouge_score": 0.4307692307692308,
          "answer_correctness": 0.5301067621243583
        }
      },
      {
        "id": "Medical-47504b64",
        "question": "Why is supportive care considered a treatment option for all stages of lung cancer?",
        "ground_truth": "Supportive care improves quality of life for people with lung cancer regardless of stage.",
        "generated_answer": "Supportive care is considered a treatment option for all stages of lung cancer because it focuses on improving quality of life, managing symptoms, and providing emotional support throughout the cancer journey.",
        "contexts": "supportive care facet of cancer | supportive care part of cancer care | supportive care facet of Metastatic cervical cancer, Metastatic cancer has effect supportive care, Hospice subclass of supportive care, Palliative care subclass of supportive care | supportive care facet of cancer, end of life facet of disease, quality of life facet of cancer | cancer care facet of cancer | Support groups facet of cancer | Palliative care facet of cancer | Lung cancer screening facet of lung cancer | supportive care subclass of health care | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | supportive care subclass of Treatment | Treatment facet of cancer, Cancer treatment facet of cancer | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | Treatment facet of cancer | more treatment facet of cancer | Cancer treatment facet of cancer | Side effects Managing side effects facet of supportive care | Cancer care is not the same for everyone facet of cancer",
        "metrics": {
          "rouge_score": 0.3111111111111111,
          "answer_correctness": 0.9914899965693703
        }
      },
      {
        "id": "Medical-462ecc23",
        "question": "How are PD-1 inhibitors used in the treatment of CSCC and at which stage are they preferred?",
        "ground_truth": "PD-1 inhibitors are systemic therapy options preferred for metastatic CSCC, but may also be used for high-risk or regional disease if other treatments are not possible.",
        "generated_answer": "PD-1 inhibitors are used as immunotherapy for high-risk or very high-risk cutaneous squamous cell carcinoma (CSCC). They are preferred in advanced stages of the disease where traditional treatments may be less effective.",
        "contexts": "CSCC drug used for treatment Cetuximab, Cetuximab medical condition treated CSCC | CSCC drug used for treatment radiation therapy, radiation therapy medical condition treated CSCC, PD-1 inhibitor subclass of Immunotherapy, PD-1 inhibitor subclass of checkpoint inhibitor, Cemiplimab medical condition treated squamous cell skin cancer, squamous cell skin cancer drug used for treatment Cemiplimab | CSCC drug used for treatment Standard surgical excision, low-risk CSCC drug used for treatment Low-risk Surgery, Low-risk Surgery medical condition treated low-risk CSCC, High-risk or very high-risk Surgery medical condition treated high-risk or very high-risk CSCC, very high-risk cancer drug used for treatment Mohs surgery, Standard surgical excision medical condition treated CSCC | 5-fluorouracil medical condition treated CSCC, CSCC drug used for treatment 5-fluorouracil, 5-fluorouracil medical condition treated Actinic keratoses | Standard surgical excision medical condition treated local CSCC, local CSCC drug used for treatment Standard surgical excision | high-risk or very high-risk CSCC drug used for treatment High-risk or very high-risk Surgery | SISCCA drug used for treatment Treatment for SISCCA | targeted therapy medical condition treated primary CNS lymphoma | Breast cancer drug used for treatment Pembrolizumab, Pembrolizumab medical condition treated Breast cancer | immune checkpoint inhibitor therapy different from immune checkpoint inhibitor therapy by itself | Opdivo subject has role checkpoint inhibitor, Bavencio subject has role checkpoint inhibitor, checkpoint inhibitor facet of immune system, Keytruda subject has role checkpoint inhibitor | metastatic anal cancer drug used for treatment Nivolumab, Nivolumab instance of checkpoint inhibitor",
        "metrics": {
          "rouge_score": 0.34920634920634924,
          "answer_correctness": 0.8401072859627818
        }
      },
      {
        "id": "Medical-a7a91e43",
        "question": "For a patient with high-grade, muscle-invasive urothelial carcinoma, what are the standard treatment options?",
        "ground_truth": "Radical cystectomy, systemic chemotherapy, and possibly chemoradiation or trimodal therapy are standard options.",
        "generated_answer": "Standard treatment options for high-grade, muscle-invasive urothelial carcinoma typically include radical cystectomy, chemotherapy, and possibly intravesical therapy.",
        "contexts": "invaded the muscle layer subclass of bladder cancer | non\u2013 muscle-invasive subclass of bladder cancer | non-urothelial subclass of bladder cancer, small cell carcinoma subclass of bladder cancer, squamous cell carcinoma subclass of bladder cancer, Adenocarcinoma subclass of bladder cancer | 0 subclass of bladder cancer, 3 subclass of bladder cancer, 2 subclass of bladder cancer, metastasized subclass of cancer, Stage 0 Stage 0 subclass of bladder cancer, 1 subclass of bladder cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | muscle-invasive subclass of bladder cancer, Metastatic bladder cancer subclass of treatable, Can bladder cancer be cured? facet of bladder cancer | bladder cancer subclass of Cancer of the upper urinary tract | Stage 4B subclass of bladder cancer | Intravesical therapy subclass of chemotherapy, non\u2013 muscle-invasive subclass of bladder cancer | T2 tumor subclass of invaded the muscle layer, locally advanced subclass of cancer | bladder cancer subclass of transitional call cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Gerota\u2019s fascia subclass of kidney cancer | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | advanced subclass of prostate cancer | in situ subclass of cancer, Invasive breast cancer subclass of cancer, axillary lymph nodes subclass of nodes, Invasive breast cancer subclass of Breast cancer",
        "metrics": {
          "rouge_score": 0.37499999999999994,
          "answer_correctness": 0.668812928630315
        }
      },
      {
        "id": "Medical-6cb18929",
        "question": "Which glioma subtype is always considered high-grade and what diagnostic and treatment steps are typically involved?",
        "ground_truth": "Glioblastoma is always high-grade (Grade 4) and requires MRI, biopsy, and additional therapy after surgery.",
        "generated_answer": "Glioblastoma is always considered high-grade. Diagnostic steps typically involve imaging and biopsy, while treatment often includes surgery, radiation, and chemotherapy.",
        "contexts": "Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | oligodendrocyte subclass of brain tumor, Grade 3 tumor cells subclass of Glioblastoma, high-grade glioma opposite of low-grade glioma | Glioblastoma subclass of brain tumor | Glioblastoma subclass of tumor | Glioblastoma subclass of glioma tumor, low-grade glioma opposite of high-grade glioma, molecular part of Glioblastoma, oligodendrocyte subclass of glial cell | oligodendroglioma subclass of Glioblastoma, astrocytoma subclass of Glioblastoma, brain tumor subclass of cancerous, astrocytoma subclass of astrocyte, Cancer cells subclass of cells, Glioblastoma subclass of Glioblastoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Glioblastoma subclass of Glioblastoma | astrocytoma subclass of Glioblastoma | type it is subclass of Glioblastoma | primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of cancer | noninvasive subclass of cancer | cancer subclass of Tumor, aggressive type subclass of cancer | Non-Hodgkin lymphoma subclass of cancer | invade brain tissue subclass of Glioblastoma | malignant subclass of cancer",
        "metrics": {
          "rouge_score": 0.4324324324324324,
          "answer_correctness": 0.8066246135549775
        }
      },
      {
        "id": "Medical-69bd1f37",
        "question": "Which biomarkers should be tested in a patient with SCC of the tongue to inform treatment options?",
        "ground_truth": "PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB) should be tested.",
        "generated_answer": "The specific biomarkers to be tested in a patient with SCC of the tongue include PD-L1, HPV status, and mutations in genes such as TP53 and PIK3CA.",
        "contexts": "Treatment for SISCCA medical condition treated SISCCA, SISCCA drug used for treatment Treatment for SISCCA | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | treatments medical condition treated cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | more than one treatment option used by doctor | Cancer treatment medical condition treated bladder cancer | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | treatments in the past medical condition treated small cell lung cancer | Treatment of CLL and SLL medical condition treated SLL, Treatment of CLL and SLL medical condition treated CLL, CLL drug used for treatment Treatment of CLL and SLL | Treatment medical condition treated ovarian cancer | bladder cancer drug used for treatment surgery, surgery medical condition treated bladder cancer, Treatment facet of cancer | basal cell skin cancer treated medical condition treated Basal cell skin cancer | NSCLC drug used for treatment Treatment for NSCLC, Treatment for NSCLC medical condition treated NSCLC | surgery instance of Treatment | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | more than one treatment option facet of Treatment | Intravesical therapy medical condition treated bladder cancer, bladder cancer drug used for treatment Intravesical therapy",
        "metrics": {
          "rouge_score": 0.1951219512195122,
          "answer_correctness": 0.4414727427471025
        }
      },
      {
        "id": "Medical-b9f39886",
        "question": "What factors distinguish non-mediastinal gray zone lymphomas from mediastinal gray zone lymphomas?",
        "ground_truth": "Non-mediastinal gray zone lymphomas occur in older persons and have more bone marrow and extranodal involvement, unlike mediastinal types seen in younger males.",
        "generated_answer": "Non-mediastinal gray zone lymphomas are different from mediastinal gray zone lymphomas in their anatomical location, as the former occurs outside the mediastinum while the latter is located within it.",
        "contexts": "Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | bone marrow opposite of lymph nodes, lymph nodes opposite of bone marrow | chronic leukemias opposite of Acute leukemias, Acute leukemias opposite of chronic leukemias | immune cells opposite of Cancer cells, Cancer cells opposite of immune cells | primary tumor opposite of metastasis | thymus opposite of bone marrow, bone marrow opposite of thymus | Cancer cells opposite of non-cancer cell, non-cancer cell opposite of Cancer cells, cancer has cause Cancer cells | Non-Hodgkin lymphoma subclass of Lymphoma | benign opposite of cancer | low-grade glioma opposite of high-grade glioma | lower-grade cancer opposite of High-grade cancer | Normal cell opposite of Cancer cells",
        "metrics": {
          "rouge_score": 0.2592592592592593,
          "answer_correctness": 0.6924729038266533
        }
      },
      {
        "id": "Medical-2a24f6a2",
        "question": "Which methods are used to confirm both the presence and subtype of cutaneous B-cell lymphoma in a patient with skin lesions?",
        "ground_truth": "Biopsy and immunophenotyping are used to confirm both the presence and subtype of CBCL.",
        "generated_answer": "Skin biopsy is used to confirm the presence and subtype of cutaneous B-cell lymphoma in patients with skin lesions. A pathologist examines the biopsy results for accurate diagnosis.",
        "contexts": "Cutaneous T-cell lymphoma subclass of Lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides | Basal cell skin cancer subclass of Skin lesion | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma, papule subclass of nodule, Primary cutaneous marginal zone lymphoma subclass of Primary cutaneous B-cell lymphoma | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | skin subclass of cancer | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Squamous cell subclass of skin cancer | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | basal cell subclass of skin cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | melanoma subclass of skin cancer | Squamous cell subclass of skin cancer, Squamous cell subclass of skin cancer, scar subclass of wound | Squamous cell subclass of skin cancer, Marjolin\u2019s ulcer subclass of squamous cell skin cancer, squamous cell skin cancer subclass of squamous cell skin cancer | Non-Hodgkin lymphoma subclass of cancer | Bowen\u2019s lesion subclass of Actinic keratoses | Non-Hodgkin lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.4186046511627907,
          "answer_correctness": 0.8727198914121946
        }
      },
      {
        "id": "Medical-0a6379ff",
        "question": "Which genetic syndromes are associated with increased CSCC risk and what is their implication for surveillance?",
        "ground_truth": "Xeroderma pigmentosum and RDEB increase CSCC risk, necessitating regular skin and lymph node exams for surveillance.",
        "generated_answer": "Genetic syndromes associated with increased CSCC risk include Lynch syndrome and Familial adenomatous polyposis. Their implication for surveillance is that individuals with these syndromes require more frequent skin examinations and monitoring for skin lesions.",
        "contexts": "highrisk different from high-risk or very high-risk CSCC, high-risk or very high-risk CSCC different from highrisk | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | Lynch subclass of genetic syndromes | Lynch syndrome has effect hereditary ovarian cancer | Standard surgical excision medical condition treated CSCC, low-risk CSCC drug used for treatment Low-risk Surgery, Low-risk Surgery medical condition treated low-risk CSCC, High-risk or very high-risk Surgery medical condition treated high-risk or very high-risk CSCC, very high-risk cancer drug used for treatment Mohs surgery | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer | Lynch syndrome subclass of Inherited syndromes related to colon cancer | radiation therapy medical condition treated CSCC | Lynch syndrome has effect colorectal, Lynch syndrome subclass of Rectal cancer, microsatellite stable subclass of Tumor | hereditary mutation has effect cancer | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer | genetic errors has effect Bladder cancer | genetic changes has effect Cancer cells | hereditary has effect Breast cancer | genetic mutations has effect hereditary | Lynch syndrome subclass of inherited cancer syndromes | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | genetic mutations has effect cancer | Cetuximab medical condition treated CSCC",
        "metrics": {
          "rouge_score": 0.24,
          "answer_correctness": 0.23123539030669477
        }
      },
      {
        "id": "Medical-6a5c89f3",
        "question": "Why do not all patients with follicular lymphoma require immediate treatment upon diagnosis?",
        "ground_truth": "Because clinical management guidelines state not all patients require immediate treatment and treatment decisions are guided by grade and cell type.",
        "generated_answer": "Not all patients with follicular lymphoma require immediate treatment upon diagnosis because some may have indolent forms of the disease that do not present significant symptoms or progression, allowing for a \"watchful waiting\" approach.",
        "contexts": "Treatment medical condition treated CNS lymphoma | Methotrexate medical condition treated Lymphoma, Lymphoma drug used for treatment Methotrexate | treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Chronic lymphocytic leukemia drug used for treatment Treatment | cancer drug used for treatment Treatment | Treatment medical condition treated cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment treatments, treatments medical condition treated cancer | effective treatment medical condition treated CLL | Bone marrow biopsy medical condition treated Lymphoma, Treatment facet of Lymphoma, Bone marrow biopsy studies marrow | Treatment medical condition treated primary CNS lymphoma | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment Cancer treatment | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | CNS lymphoma drug used for treatment standard treatments | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.21818181818181817,
          "answer_correctness": 0.44463837378423093
        }
      },
      {
        "id": "Medical-ef073c61",
        "question": "What age group is most commonly affected by ALL and how does this influence diagnostic and treatment strategies?",
        "ground_truth": "Children, adolescents, and young adults are most often affected, requiring age-specific diagnostic and treatment approaches.",
        "generated_answer": "The age group most commonly affected by Acute Lymphoblastic Leukemia (ALL) is children, particularly those between 2 to 5 years old. This influences diagnostic and treatment strategies by necessitating age-appropriate interventions and considerations for the unique biological and psychosocial needs of pediatric patients.",
        "contexts": "Treatment facet of disease | Treatment facet of Treatment, more than one treatment option facet of Treatment | Treatment facet of cancer | plan treatment facet of Treatment | plan treatment facet of Treatment, plan treatment facet of disease | staging facet of Treatment decisions | Treatment facet of cancer, Cancer treatment facet of cancer | diagnosis facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | assessment of their risks facet of Treatment | Goals of systemic therapy facet of Treatment | Cancer treatment facet of cancer | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos | prognosis facet of more than one treatment option | Signs and symptoms facet of disease | Treatment decisions facet of cancer | Treatment planning facet of cancer | start the conversation facet of Clinical trial, study facet of Treatment | study facet of Treatment, start the conversation facet of Clinical trial, myths and misconceptions facet of Clinical trial, Will I get a placebo? facet of Placebos, Will I get a placebo? facet of cancer, National Library of Medicine field of work Clinical trial, study sponsor field of this occupation Clinical trial",
        "metrics": {
          "rouge_score": 0.16666666666666666,
          "answer_correctness": 0.47804424530018597
        }
      },
      {
        "id": "Medical-9675683c",
        "question": "What methods are used to monitor rectal cancer after initial treatment and what biomarker is involved?",
        "ground_truth": "Blood tests such as CEA and imaging are used for monitoring after treatment.",
        "generated_answer": "Monitoring methods for rectal cancer after initial treatment include imaging and clinical trials. The biomarker involved is not specified in the provided context.",
        "contexts": "Treatment facet of colon cancer | early in the course of treatment facet of cancer, Treatment decisions facet of cancer | Treatment facet of Anal cancer | Treatment facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment planning facet of cancer | radiation therapy facet of cancer | Early detection and treatment facet of prostate cancer | Treatment facet of Pancreatic cancer | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum | Treatment facet of bladder cancer | more treatment facet of cancer | Treatment facet of cancer, detection methods and treatments facet of prostate cancer | Treatment facet of ovarian cancer | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | Treatment facet of stomach cancer | Imaging facet of cancer, Treatment planning facet of cancer | Treatment facet of urothelial cancer | standard treatments facet of cancer, Phase 4 trial facet of Clinical trial, drug studied by Clinical trial, Phase 1 trial facet of Treatment trial, Clinical trial studies drug, Phase 2 trial subclass of trial, Treatment trial subclass of cancer clinical trial, trial participant participants, participants participant in trial",
        "metrics": {
          "rouge_score": 0.16666666666666669,
          "answer_correctness": 0.484106316956582
        }
      },
      {
        "id": "Medical-f473bcb0",
        "question": "What is the main chemotherapy agent used during the induction phase of primary CNS lymphoma treatment and which diagnostic procedure confirms the diagnosis?",
        "ground_truth": "High-dose methotrexate is the main chemotherapy agent, and stereotactic biopsy is the standard diagnostic procedure.",
        "generated_answer": "The main chemotherapy agent used during the induction phase of primary CNS lymphoma treatment is methotrexate, and the diagnostic procedure that confirms the diagnosis is a brain biopsy.",
        "contexts": "primary CNS lymphoma instance of Treatment | primary CNS lymphoma subclass of Treatment, primary CNS lymphoma subclass of cancer | induction phase facet of Lymphoma, more than one treatment option facet of primary CNS lymphoma | plan treatment facet of primary CNS lymphoma | primary CNS lymphoma drug used for treatment Treatment, Treatment medical condition treated primary CNS lymphoma | primary CNS lymphoma drug used for treatment new therapy, new therapy medical condition treated primary CNS lymphoma | primary CNS lymphoma drug used for treatment targeted therapy, chemotherapy medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment chemotherapy, targeted therapy medical condition treated primary CNS lymphoma | CNS lymphoma has part primary CNS lymphoma, primary CNS lymphoma instance of disease | Treatment facet of CNS lymphoma | primary CNS lymphoma has cause Enrolling in a clinical trial, standard treatments medical condition treated CNS lymphoma, Enrolling in a clinical trial has effect primary CNS lymphoma | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma | primary CNS lymphoma subclass of Lymphoma",
        "metrics": {
          "rouge_score": 0.36363636363636365,
          "answer_correctness": 0.611389233980342
        }
      },
      {
        "id": "Medical-b2da7aee",
        "question": "What are the recommended surveillance strategies after treatment for colon cancer and which biomarkers are involved?",
        "ground_truth": "Surveillance includes colonoscopy, CEA testing, and CT scans, with CEA serving as a biomarker for monitoring.",
        "generated_answer": "Recommended surveillance strategies after treatment for colon cancer include regular colonoscopies and monitoring for circulating tumor DNA. Biomarkers involved may include those related to tumor characteristics and risk factors for recurrence.",
        "contexts": "Polyps has effect colon cancer | AML has effect biomarker, biomarker has effect AML, AML has cause biomarker | colorectal cancer has cause circulating tumor DNA, outcomes has cause cancer, cancer has effect outcomes | AML has effect biomarker, biomarker has effect AML | cancer has effect cancer, cancer has cause cancer | cancer has cause risk factors, risk factors has effect cancer | cancer type has effect cancer, cancer has cause cancer type | tumor has effect cancer, cancer has cause tumor | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | cancer has cause tissues, tissues has effect cancer, lymph has part lymph nodes | cancer has cause Cancer cells | BRCA instance of biomarkers",
        "metrics": {
          "rouge_score": 0.25531914893617014,
          "answer_correctness": 0.6073782373265617
        }
      },
      {
        "id": "Medical-72cfd9c6",
        "question": "What symptoms and risk factors would prompt early screening for prostate cancer?",
        "ground_truth": "Urinary symptoms and risk factors such as age, family history, and Black race would prompt early screening.",
        "generated_answer": "Symptoms such as difficulty urinating, blood in urine, and pelvic pain, along with risk factors like age, family health history, and radiation exposure, would prompt early screening for prostate cancer.",
        "contexts": "cancer has cause risk factors, risk factors has effect cancer | illness has effect Symptoms, Symptoms has cause illness | Symptoms has cause Symptoms, Symptoms has effect Symptoms | Symptoms has cause illness, illness has effect Symptoms | Symptoms has cause medical problem, medical problem has effect Symptoms | conditions has cause diseases, diseases has effect conditions | risk factors facet of disease | cervical cancer has cause risk factors, risk factors has effect cervical cancer | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | age instance of risk factors, risk factors facet of cancer | Symptoms has cause Treatment | family health history has part risk factors | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure | side effects has cause Medicines",
        "metrics": {
          "rouge_score": 0.5106382978723405,
          "answer_correctness": 0.8367581639209007
        }
      },
      {
        "id": "Medical-5adcec8a",
        "question": "How do symptoms guide the use of imaging and biopsy in the diagnostic process for mouth cancer?",
        "ground_truth": "Symptoms such as changes in the mouth, tongue, or neck area prompt the use of imaging and biopsy for diagnosis.",
        "generated_answer": "Symptoms of mouth cancer prompt the use of imaging and biopsy to identify and confirm the presence of tumors. Imaging helps visualize abnormalities, while biopsy provides tissue samples for definitive diagnosis. Together, they guide the diagnostic process effectively.",
        "contexts": "biopsy subclass of diagnosis | biopsy subclass of procedure | biopsy subclass of surgical procedure | biopsy subclass of testing | Biopsy subclass of biopsy | biopsy subclass of test results | biomarker testing subclass of biopsy, biopsy subclass of test results | Biopsy subclass of Imaging | biopsy subclass of Imaging | Biopsy subclass of test | biopsy subclass of test | Imaging subclass of biopsy | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy | confirmatory biopsy subclass of biopsy | biopsy subclass of diagnose the tumor | testing Biopsy subclass of biopsy | type of biopsy subclass of biopsy | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | fine-needle aspiration subclass of biopsy | Fine-needle aspiration subclass of biopsy",
        "metrics": {
          "rouge_score": 0.37931034482758624,
          "answer_correctness": 0.9857822858713668
        }
      },
      {
        "id": "Medical-c650bba8",
        "question": "How does the treatment of infant ALL differ from that of older children or adolescents?",
        "ground_truth": "Infant ALL (under 12 months) is treated differently than other age groups, with specialized protocols.",
        "generated_answer": "The treatment of infant ALL typically involves more intensive chemotherapy regimens and may include different drug combinations compared to older children or adolescents, due to the unique biological characteristics and treatment responses in infants. Additionally, infants often require careful monitoring for side effects and supportive care due to their developmental stage.",
        "contexts": "infants subclass of children | pregnant people subclass of children | immature subclass of development | family member subclass of peer | adolescents and young adults subclass of pediatric | children opposite of adults | children different from adults | Infant said to be the same as 12 months of age, 12 months of age said to be the same as Infant | malignant subclass of cancerous | young adults opposite of children, children opposite of young adults | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Infusions subclass of injected | friend subclass of Support | gene subclass of instructions | tumor subclass of irregular | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | malignant subclass of cancer",
        "metrics": {
          "rouge_score": 0.0909090909090909,
          "answer_correctness": 0.6443838587302435
        }
      },
      {
        "id": "Medical-38fc968c",
        "question": "Which surgical procedures may be required for colon cancer patients and under what circumstances is a colostomy necessary?",
        "ground_truth": "Colectomy removes the cancerous colon segment, and colostomy is needed if bowel reconnection is not possible, diverting stool through a stoma.",
        "generated_answer": "Surgical procedures for colon cancer patients may include colectomy, polypectomy, and abdominoperineal resection. A colostomy is necessary when the colon cannot be connected to the anus, often due to bowel blockage or extensive resection.",
        "contexts": "colostomy subclass of surgery | colostomy subclass of removing the anus | colostomy subclass of colectomy, colostomy subclass of surgery, Bowel blockage has cause colostomy | colectomy subclass of colon surgery, sessile subclass of polyp, Colectomy A colectomy instance of surgery, polypectomy subclass of resection, polypectomy subclass of surgery, Colectomy Surgery for colon cancer subclass of colectomy, pathologist subclass of surgery, Colectomy A colectomy instance of surgery | colostomy subclass of permanent | colostomy subclass of diverts (redirects) the flow of stool, colostomy has part stoma, stoma part of Stool, colostomy subclass of colectomy, colostomy subclass of colostomy, colostomy part of colon cancer surgery, stoma part of colostomy | coloanal anastomosis subclass of colorectal anastomosis, colostomy subclass of colon can't be connected to the anus, rectum part of colon, Abdominoperineal resection subclass of Transabdominal surgery, colon part of abdomen, colon has part rectum, rectum connects with anus, outer ring of muscle part of anus | Rectal cancer subclass of surgery | minimally invasive procedure subclass of surgery, Laparoscopy subclass of surgery | surgery subclass of Treatment, minimally invasive procedure subclass of surgery | double-barreled wet colostomy subclass of colostomy | resection subclass of surgical procedure | minimally invasive procedure subclass of surgery | surgery subclass of operation | surgery subclass of Treatment | treatment with surgery subclass of surgery, surgery subclass of Treatment | biopsy subclass of surgical procedure | colostomy uses stoma",
        "metrics": {
          "rouge_score": 0.18181818181818185,
          "answer_correctness": 0.5710554012427072
        }
      },
      {
        "id": "Medical-d7e8bc97",
        "question": "Which symptoms would raise suspicion for advanced follicular lymphoma involving multiple disease sites?",
        "ground_truth": "Swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss suggest advanced FL involving lymph nodes, spleen, and possibly bone marrow.",
        "generated_answer": "Symptoms that would raise suspicion for advanced follicular lymphoma involving multiple disease sites include abdominal bloating, fever, nausea, constipation, fatigue, headaches, chest pain, shortness of breath, and neurological symptoms.",
        "contexts": "Symptoms subclass of Symptoms | Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms, Nausea subclass of Symptoms | Symptoms subclass of health conditions or concerns | Symptoms subclass of side effects, side effects subclass of Symptoms | Health and symptoms subclass of health information | Constipation subclass of symptom, bloating subclass of symptom, pain subclass of symptom, fatigue subclass of symptom | illness subclass of disease | fatigue subclass of Symptoms | pressing on nearby organs subclass of Symptoms | diseases subclass of health conditions | fatigue subclass of symptom, Headaches subclass of symptom | Symptoms subclass of supportive care | symptom subclass of sign | seizures subclass of neurological symptoms, headaches subclass of neurological symptoms, symptom subclass of sign | Signs and symptoms facet of disease | Imaging subclass of symptom, chest pain subclass of shortness of breath",
        "metrics": {
          "rouge_score": 0.11538461538461538,
          "answer_correctness": 0.42101063299794894
        }
      },
      {
        "id": "Medical-99964376",
        "question": "Why would a lumbar puncture be performed in the diagnostic workup of a child with ALL?",
        "ground_truth": "A lumbar puncture is performed to assess central nervous system (CNS) involvement, a potential disease site in ALL.",
        "generated_answer": "A lumbar puncture would be performed to obtain spinal fluid for analysis, which can help diagnose central nervous system involvement in acute lymphoblastic leukemia (ALL) and guide treatment planning.",
        "contexts": "lumbar puncture use lumbar puncture, lumbar puncture subclass of lumbar puncture, spine has part spinal fluid, spinal fluid part of spine | lumbar puncture instance of procedure | lumbar puncture subclass of general health test | lumbar puncture product or material produced spinal fluid | test use diagnosis, Tests for primary CNS Tests followed by Tests after diagnosis What\u2019s next? | diagnosis uses test, test used by diagnosis | molecular test use diagnosis | test use diagnose | biomarker testing use diagnosis | needle use biopsy | lab use Testing | lower back subclass of spinal fluid | diagnosis studies brain tumor, brain tumor studied by diagnosis | plan treatment uses diagnostic test | testing uses urine sample | Symptoms used by diagnosis",
        "metrics": {
          "rouge_score": 0.46808510638297873,
          "answer_correctness": 0.8381952518703708
        }
      },
      {
        "id": "Medical-a88065af",
        "question": "If a patient with esophageal cancer presents with liver and bone metastases, what is their disease stage and which diagnostic methods are necessary?",
        "ground_truth": "The patient has metastatic disease and requires imaging tests and biopsy for confirmation.",
        "generated_answer": "The disease stage is metastatic esophageal cancer. Diagnostic methods may include imaging tests such as CT scans, MRIs, and biopsies.",
        "contexts": "Pathologic stage part of initial diagnosis | cancer stage facet of cancer | stage facet of cancer | Clinical stage facet of Breast cancer | Staging The cancer stage facet of cancer | Signs and symptoms facet of disease | stage facet of tumor | diagnosis facet of cancer | surgical stage facet of surgery | symptom facet of disease | Treatment facet of disease | screening test facet of diseases | staging facet of Treatment decisions | How far and how fast? facet of cancer, stage facet of cancer | Staging facet of cancer | staging facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | cancer staging facet of tumor | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging",
        "metrics": {
          "rouge_score": 0.3636363636363637,
          "answer_correctness": 0.6657779132235307
        }
      },
      {
        "id": "Medical-6e39cbe0",
        "question": "Which anatomical layer acts as a barrier before cancer reaches the outer membrane (serosa) of the gallbladder?",
        "ground_truth": "The perimuscular fibrous tissue acts as a barrier before the serosa.",
        "generated_answer": "Mucosa",
        "contexts": "Serosa part of stomach | digestive system has part pancreas, hepatobiliary system has part biliary, portal vein part of Liver blood supply, bile part of digestive system, Liver blood supply has part portal vein, digestive system has part bile, pancreas part of digestive system, biliary part of hepatobiliary system, liver connects with small intestine, bile part of liver, hepatobiliary system has part liver, Liver blood supply has part hepatic artery, small intestine connects with liver, small intestine has part gallbladder, hepatic artery part of Liver blood supply, liver part of hepatobiliary system, gallbladder part of small intestine | stomach part of digestive system, stomach gland has part submucosa, mucus has part Epithelium, connective tissue part of muscle, connective tissue part of Submucosa, Submucosa has part connective tissue, stomach gland has part mucosa, mucosa part of stomach gland, submucosa part of stomach gland, digestive system has part stomach, Surface epithelium part of stomach lining, Mucosa part of stomach, stomach lining has part Surface epithelium, muscle part of Submucosa, stomach has part Serosa | small intestine connects with stomach, small intestine connects with esophagus, stomach part of digestive system, stomach connects with esophagus, esophagus connects with small intestine, pancreas part of digestive system, gallbladder part of digestive system, digestive system has part stomach, colon connects with small intestine, intestines part of digestive system, small intestine connects with colon, esophagus connects with stomach, stomach connects with small intestine, stomach has part Antrum, small intestine connects with stomach, intestines has part pancreas, The digestive system part of digestive system, stomach connects with esophagus | hepatobiliary system has part gallbladder, gallbladder part of hepatobiliary system, hepatobiliary system has part liver, hepatobiliary system has part bile ducts | abdomen has part lining of the abdomen | kidney has part renal capsule, kidney part of urinary system, urinary system has part kidney, ureter connects with urethra, abdomen has part organs, kidney has part Renal, ureter connects with bladder, kidney part of blood, organs part of abdomen, urethra connects with ureter, bladder connects with ureter, Renal part of kidney, blood has part kidney, renal capsule part of kidney, renal tubules part of kidney, renal tubules connects with renal vein, renal vein connects with renal tubules, renal artery part of kidney | abdomen has part abdominal wall | female reproductive system has part cervix, female reproductive system has part vagina, uterus has part fallopian tube, uterus connects with cervix, ectocervix part of cervix, female reproductive system has part ovaries, fallopian tubes connects with ovaries, fallopian tube part of uterus, vagina part of female reproductive system, cervix part of vagina, sexual reproduction has part reproductive system, cervix connects with uterus, ovaries part of female reproductive system, cervix part of female reproductive system, vagina has part cervix, vagina connects with ovaries, female reproductive system has part uterus, fallopian tube part of female reproductive system, ovaries connects with vagina, uterus part of female reproductive system, ovaries connects with fallopian tubes, cervix has part endocervix, ectocervix part of cervical lining, vagina has part os, squamous cells part of ectocervix, endocervix part of cervix, cervix connects with uterus, uterus connects with vagina, os part of vagina, ectocervix connects with endocervix, uterus connects with cervix, vagina connects with uterus, endocervix connects with ectocervix, pelvis connects with uterus, cervical lining has part ectocervix, uterus connects with pelvis, endocervix connects with cervix, cervix connects with endocervix, uterus has part cervix | abdomen has part colon | gallbladder instance of organs, small intestine part of small intestine, stomach part of intestines, Body part of stomach, intestines has part stomach, esophagus connects with pylorus, small intestine has part <triplet>duodenum stomach, esophagus connects with stomach, digestive system has part The digestive system, stomach connects with small intestine, small intestine connects with stomach, stomach connects with diaphragm | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part Submucosa, Muscularis mucosa part of Epithelium, Submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part epithelium, smooth muscle part of Lower esophagus, middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, middle esophagus connects with lower esophagus, lower esophagus connects with upper, upper connects with middle esophagus, lower esophagus connects with middle esophagus, esophagus connects with stomach, middle esophagus connects with lower esophagus | digestive system has part stomach, digestive system has part digestive system | gallbladder connects with bile ducts | abdominal has part omentum | liver connects with gallbladder, gallbladder connects with liver | gallbladder connects with liver, liver connects with gallbladder",
        "metrics": {
          "rouge_score": 0.0,
          "answer_correctness": 0.2209165203240449
        }
      },
      {
        "id": "Medical-35afeb4b",
        "question": "What treatment modification is made for MGZL patients to enhance chemoimmunotherapy?",
        "ground_truth": "Rituximab may be added to chemotherapy for chemoimmunotherapy in MGZL patients.",
        "generated_answer": "The treatment modification for MGZL patients to enhance chemoimmunotherapy involves the use of rituximab.",
        "contexts": "MGZL drug used for treatment rituximab, rituximab medical condition treated MGZL | cancer drug used for treatment Treatment | cancer drug used for treatment treatments | cancer drug used for treatment Cancer treatment | MSI-H/dMMR tumors drug used for treatment Pembrolizumab | Chronic lymphocytic leukemia drug used for treatment Treatment | SLL drug used for treatment Treatment of CLL and SLL | Glioblastoma drug used for treatment Treatment | cancer drug used for treatment Methotrexate | prostate cancer drug used for treatment Treatment | Lymphoma drug used for treatment Methotrexate | ovarian cancer drug used for treatment Treatment | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Breast cancer drug used for treatment Pembrolizumab | AML drug used for treatment Methotrexate | prostate cancer drug used for treatment its treatment | Chemotherapy uses drug | Chemoradiation drug used for treatment Cisplatin | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.23999999999999996,
          "answer_correctness": 0.619886822482506
        }
      },
      {
        "id": "Medical-7b422282",
        "question": "How does the presence of Lynch syndrome affect colon cancer risk and management?",
        "ground_truth": "Lynch syndrome increases colon cancer risk and requires testing for mismatch repair deficiency (dMMR) or MSI-H, which guides immunotherapy decisions.",
        "generated_answer": "Lynch syndrome significantly increases the risk of colon cancer and other hereditary cancers. Management typically involves regular screenings and preventive measures due to the heightened risk associated with inherited mutations.",
        "contexts": "Lynch syndrome has effect hereditary ovarian cancer | Polyps has effect colon cancer | hereditary colon and uterine cancers has cause Lynch syndrome, Lynch syndrome subclass of hereditary ovarian cancer, Lynch syndrome has effect hereditary colon and uterine cancers, Lynch syndrome subclass of BRCA mutation, ovarian cancer subclass of cancer | Lynch syndrome subclass of Inherited syndromes related to colon cancer | Lynch syndrome has effect colorectal, Lynch syndrome subclass of Rectal cancer, microsatellite stable subclass of Tumor | hereditary mutation has effect cancer | Lynch syndrome subclass of inherited cancer syndromes | hereditary has effect Breast cancer, pass these genes on has effect cancer | Lynch syndrome subclass of Familial adenomatous polyposis | genetic mutations has effect cancer | Lynch syndrome has cause inherited mutations, Familial adenomatous polyposis subclass of inherited cancer syndromes, inherited cancer syndromes subclass of cancer, Lynch syndrome subclass of inherited cancer syndromes, colon cancer subclass of cancer | Lynch syndrome instance of hereditary health conditions | Lynch syndrome subclass of inherited condition | cancer has effect cancer | mismatch repair deficiency subclass of colon cancer, microsatellite instability-high subclass of colon cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | cancer type has effect cancer",
        "metrics": {
          "rouge_score": 0.23529411764705882,
          "answer_correctness": 0.7359825813799892
        }
      },
      {
        "id": "Medical-6ac9b753",
        "question": "What diagnostic methods are required for confirming MGZL and why?",
        "ground_truth": "Expert hematopathologist review is required because of the overlapping features with other lymphomas.",
        "generated_answer": "Diagnostic methods for confirming MGZL include imaging techniques and various tests such as molecular, biomarker, and urine tests. These methods are essential for accurate diagnosis and treatment planning.",
        "contexts": "detection methods subclass of diagnosis | test use diagnosis | diagnosis uses test, test used by diagnosis | PSA test instance of diagnostic test, MPS instance of urine test, ExoDx instance of urine test, SelectMDx instance of urine test, miR Sentinel instance of urine test | testing subclass of diagnosis | molecular test use diagnosis | Magnetic resonance imaging instance of imaging technique, CT instance of imaging technique | MGZL drug used for treatment rituximab, rituximab medical condition treated MGZL | Imaging subclass of test results | Google instance of diagnosis | MGZL subclass of Primary mediastinal B-cell lymphoma | imaging test subclass of diagnostic test, diagnostic test facet of cancer, plan treatment uses diagnostic test | Lab testing subclass of analysis | biomarker testing use diagnosis | genetic testing subclass of diagnostic test | Imaging subclass of test",
        "metrics": {
          "rouge_score": 0.0,
          "answer_correctness": 0.21387981856450788
        }
      },
      {
        "id": "Medical-f6a94128",
        "question": "Which tests are essential to perform before starting systemic therapy in a young AML patient concerned about fertility?",
        "ground_truth": "Fertility preservation counseling and referral to a reproductive specialist should be done before therapy.",
        "generated_answer": "Fertility preservation consultation, hormone level testing, and semen analysis are essential tests to perform before starting systemic therapy in a young AML patient concerned about fertility.",
        "contexts": "systemic therapy facet of cancer | plan treatment facet of AML, plan treatment facet of Acute myeloid leukemia, systemic therapy subclass of Chemotherapy | Testing for AML facet of AML | systemic therapy facet of cancer, radiation therapy subclass of systemic therapy | in remission facet of AML | Goals of systemic therapy facet of Treatment | systemic therapy part of Oncology | Treatment facet of cancer, Cancer treatment facet of cancer | side effects facet of systemic therapy | Treatment facet of cancer | radiation therapy facet of cancer, systemic therapy part of Oncology | checkpoint inhibitor subclass of Immunotherapy, systemic therapy subclass of Clinical trial, systemic therapy opposite of radiation therapy, systemic therapy subclass of Immunotherapy, platinum-based chemotherapy subclass of systemic therapy, systemic therapy subclass of radiation therapy, spread subclass of cancer, local CSCC subclass of squamous cell skin cancer | Cancer treatment facet of cancer | Side effects of systemic therapy facet of systemic therapy | Immunotherapy facet of cancer | spread facet of cancer, Testing for AML facet of AML | systemic therapy has part chemotherapy, systemic therapy has part Immunotherapy",
        "metrics": {
          "rouge_score": 0.3,
          "answer_correctness": 0.2296700422593607
        }
      },
      {
        "id": "Medical-88e1fb4a",
        "question": "How does the treatment approach differ for mature B-cell ALL (Burkitt leukemia) compared to other B-cell ALL subtypes in children?",
        "ground_truth": "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL, requiring a distinct therapeutic protocol.",
        "generated_answer": "The treatment for mature B-cell ALL (Burkitt leukemia) typically involves more intensive chemotherapy regimens and may include central nervous system prophylaxis due to its aggressive nature, while other B-cell ALL subtypes may follow less intensive protocols. Additionally, mature B-cell ALL often requires specific agents targeting the unique characteristics of Burkitt leukemia.",
        "contexts": "BCR::ABL1-like B-ALL subclass of B-ALL, BCR::ABL1-negative subclass of B-ALL | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | Burkitt lymphoma subclass of non-Hodgkin lymphoma, B cell subclass of lymphocyte, B cell subclass of lymphocyte | Acute lymphoblastic leukemia subclass of blood cancer | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Chronic lymphocytic leukemia subclass of white blood cell | Chronic lymphocytic leukemia subclass of blood cancer | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | diffuse large B-cell lymphoma subclass of classic FL | non-Hodgkin PMBL subclass of Hodgkin lymphoma | B cell subclass of white blood cell, white blood cell has part B cell, T lymphocyte subclass of white blood cell, Primary cutaneous diffuse large B-cell lymphoma, leg type subclass of Primary cutaneous B-cell lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | diffuse large B-cell lymphoma subclass of Lymphoma | Acute myeloid leukemia subclass of blood cancer | Non-Hodgkin lymphoma subclass of cancer | AML subclass of blood cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma",
        "metrics": {
          "rouge_score": 0.2535211267605634,
          "answer_correctness": 0.8828327387941328
        }
      },
      {
        "id": "Medical-fb234ffb",
        "question": "What is the significance of BCL2 protein in the diagnosis or classification of follicular lymphoma?",
        "ground_truth": "BCL2 protein is a biomarker found in almost all FL cases, often due to chromosome translocation, and helps confirm the diagnosis.",
        "generated_answer": "BCL2 protein is significant in the diagnosis and classification of follicular lymphoma as it is often overexpressed in this type of cancer, serving as a key biomarker for identifying and confirming the disease.",
        "contexts": "BCL2 instance of Proteins | EGFR instance of Proteins | HER2 instance of Proteins | Beta-2 microglobulin instance of Proteins, TP53 instance of genes | PSA instance of Proteins | CD20 instance of Proteins | p16 instance of Proteins | Trop-2 instance of Proteins | BRCA2 instance of gene | BCR::ABL1 instance of gene | BRCA1 instance of gene, BRCA2 instance of gene, FANCA instance of gene, DNA instance of molecular | CHEK2 instance of mutations in certain genes, BRCA1 instance of mutations in certain genes, BRCA1 instance of gene, BRCA2 instance of gene | BRCA1 instance of gene, BRCA2 instance of gene | PD-L1 instance of Proteins | HER2 instance of gene | Guide Beta-2 microglobulin instance of biomarker | CD33 instance of Proteins, CD33 instance of Proteins | CDKN2A instance of gene | BRCA instance of gene",
        "metrics": {
          "rouge_score": 0.2962962962962963,
          "answer_correctness": 0.8814710200087208
        }
      },
      {
        "id": "Medical-23080670",
        "question": "If a patient presents with a large mediastinal mass and is assigned male at birth aged 25, what additional diagnostic step is necessary?",
        "ground_truth": "Expert hematopathologist review is necessary to confirm MGZL diagnosis.",
        "generated_answer": "A biopsy is necessary for diagnosis.",
        "contexts": "Chest CT subclass of CT scan | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | biopsy subclass of diagnosis | biopsy subclass of diagnose the tumor | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging, Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | tumor subclass of abnormal areas | CAT scan subclass of diagnostic CT | Chest x-ray subclass of chest -ray, PET/CT subclass of positron emission tomography | Clinical breast exam subclass of physical exam, Chest CT subclass of CT | Locoregional subclass of tumor | PET/CT subclass of Imaging, CT scan subclass of Imaging | CT scan subclass of computed tomography | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | CT scan subclass of Imaging | NSCLC subclass of lung cancer, locally advanced NSCLC subclass of non-small cell lung cancer, non-small cell lung cancer subclass of lung cancer | biopsy subclass of procedure | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer",
        "metrics": {
          "rouge_score": 0.4,
          "answer_correctness": 0.22638033468037666
        }
      },
      {
        "id": "Medical-328006b7",
        "question": "What combination of exposure and symptom would most strongly suggest the need for diagnostic evaluation for lung cancer?",
        "ground_truth": "A history of tobacco smoking combined with chest pain should prompt diagnostic evaluation for lung cancer.",
        "generated_answer": "Chest pain and shortness of breath.",
        "contexts": "Symptoms used by diagnosis, fatigue subclass of symptom, Headaches subclass of symptom | symptom facet of disease | initial diagnosis part of Clinical | symptom facet of quality of life | Symptoms subclass of Symptoms | Constipation subclass of symptom, bloating subclass of symptom, pain subclass of symptom, fatigue subclass of symptom | Symptoms different from symptom, symptom different from Symptoms | symptom subclass of sign | Signs and symptoms subclass of Symptoms, pressing on nearby organs subclass of Symptoms, Abdominal bloating subclass of Symptoms, Fever subclass of Symptoms, signs or symptoms listed below subclass of Symptoms, Pink or purple stretch marks subclass of Symptoms | Symptoms subclass of health conditions or concerns | diagnosis uses test, test used by diagnosis | Imaging subclass of symptom, chest pain subclass of shortness of breath | testing subclass of diagnosis | Symptoms subclass of side effects, side effects subclass of Symptoms | Pathologic stage part of initial diagnosis",
        "metrics": {
          "rouge_score": 0.18181818181818182,
          "answer_correctness": 0.7950465883802795
        }
      },
      {
        "id": "Medical-c58dca0f",
        "question": "Which chemotherapy agents may be included in rectal cancer treatment regimens and for what stage are they typically used?",
        "ground_truth": "Oxaliplatin and irinotecan may be included in chemotherapy regimens, typically used for locally advanced rectal cancer.",
        "generated_answer": "Chemotherapy agents for rectal cancer treatment regimens may include oxaliplatin and capecitabine, typically used for stage II.",
        "contexts": "Rectal cancer drug used for treatment oxaliplatin, oxaliplatin medical condition treated Rectal cancer | radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Chemotherapy uses drug | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | Chemotherapy medical condition treated bladder cancer, Intravesical chemotherapy different from Intravesical chemotherapy, Chemotherapy facet of cancer, Chemotherapy subclass of Treatment, bladder cancer drug used for treatment Chemotherapy alone, Intravesical chemotherapy different from Intravesical chemotherapy, Cisplatin medical condition treated bladder cancer, bladder cancer drug used for treatment vinblastine, Chemotherapy alone medical condition treated bladder cancer, bladder cancer drug used for treatment Chemotherapy | Anal cancer drug used for treatment Cisplatin, APR surgery medical condition treated Anal cancer, Anal cancer drug used for treatment capecitabine, III subclass of Anal cancer, capecitabine medical condition treated Anal cancer, Anal cancer drug used for treatment 5-FU, stage II subclass of Anal cancer, Cisplatin medical condition treated Anal cancer | Anal cancer drug used for treatment radiation treatment | Anal cancer drug used for treatment radiation therapy | bladder cancer drug used for treatment Cancer treatment | bladder cancer drug used for treatment Treatment | colon cancer drug used for treatment temozolomide, colon cancer drug used for treatment Ibrutinib | prostate cancer drug used for treatment Treatment | bladder cancer drug used for treatment dose-dense methotrexate, vinblastine medical condition treated bladder cancer, doxorubicin medical condition treated bladder cancer, bladder cancer drug used for treatment platinum-based chemotherapy, bladder cancer drug used for treatment Cisplatin | Intravesical BCG therapy start time 6 weeks, Intravesical BCG therapy medical condition treated bladder cancer, bladder cancer drug used for treatment chemotherapy, Intravesical BCG therapy uses Intravesical BCG therapy, chemotherapy medical condition treated bladder cancer | bladder cancer drug used for treatment chemotherapy, chemotherapy medical condition treated bladder cancer, Intravesical BCG therapy uses Intravesical BCG therapy",
        "metrics": {
          "rouge_score": 0.30303030303030304,
          "answer_correctness": 0.6676576175823876
        }
      },
      {
        "id": "Medical-c7bf38df",
        "question": "If a tumor is located at the esophagogastric junction, which classification system and factors are used for staging and treatment planning?",
        "ground_truth": "The Siewert classification and factors such as cancer type, location, and stage are used.",
        "generated_answer": "The classification system used for staging and treatment planning of a tumor at the esophagogastric junction is the AJCC (American Joint Committee on Cancer) staging system, which considers factors such as tumor size, lymph node involvement, and metastasis.",
        "contexts": "staging facet of Treatment decisions | stage part of Treatment, Treatment has part stage | staging part of grading | plan treatment part of Treatment | Staging The cancer stage facet of cancer | staging facet of cancer | Staging facet of cancer | staging facet of cancer, Staging after surgery facet of cancer, cancer staging facet of Breast cancer | Treatment planning facet of cancer | Treatment has part plan treatment | plan treatment facet of Treatment, Treatment has part plan treatment | surgery part of Treatment | staging subclass of Imaging | Imaging part of Treatment | Treatment part of plan, prognosis has part more than one treatment option, Treatment practiced by surgeon, surgeon field of this occupation Treatment, more than one treatment option part of prognosis | numbered stages part of Staging, Staging has part numbered stages | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | Numbered stages Key points Questions to ask Cancer staging facet of Treatment decisions | cancer staging facet of tumor",
        "metrics": {
          "rouge_score": 0.2692307692307692,
          "answer_correctness": 0.22903405878368918
        }
      },
      {
        "id": "Medical-5e3016f9",
        "question": "What combination of features would indicate a diagnosis of non-mediastinal gray zone lymphoma rather than MGZL?",
        "ground_truth": "Older age, bone marrow or extranodal involvement, and absence of mediastinal mass indicate non-mediastinal gray zone lymphoma.",
        "generated_answer": "A diagnosis of non-mediastinal gray zone lymphoma would be indicated by the presence of extranodal disease and a lack of mediastinal involvement, distinguishing it from MGZL.",
        "contexts": "Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal, MGZL subclass of Primary mediastinal B-cell lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma, Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma | extranodal (outside of the lymph node) disease subclass of FL, Follicular lymphoma subclass of non-Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | diffuse large B-cell lymphoma different from Burkitt lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Lymphoblast different from myeloblast | myeloblast subclass of non-lymphoid blood cell | centroblast facet of Lymphoma, diffuse large B-cell lymphoma subclass of classic FL, classic FL subclass of Follicular lymphoma | bone marrow opposite of lymph nodes, lymph nodes opposite of bone marrow | Bone marrow biopsy different from Bone marrow aspirate",
        "metrics": {
          "rouge_score": 0.26666666666666666,
          "answer_correctness": 0.8035530791130066
        }
      },
      {
        "id": "Medical-1930c305",
        "question": "What features distinguish Hodgkin lymphoma from other lymphomas based on the ontology and relations provided?",
        "ground_truth": "Hodgkin lymphoma is defined by its subtypes (CHL and NLPHL), characteristic cell types (Reed-Sternberg or popcorn-shaped cells), and typical onset in upper body lymph nodes.",
        "generated_answer": "Hodgkin lymphoma is distinguished from other lymphomas by its specific subclassification and unique characteristics, such as the presence of Reed-Sternberg cells, which are not found in non-Hodgkin lymphomas. Additionally, it has different treatment protocols and prognostic factors compared to other types of lymphoma.",
        "contexts": "Hodgkin lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of Lymphoma, Follicular lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of Lymphoma | Non-Hodgkin lymphoma subclass of cancer | Burkitt lymphoma subclass of non-Hodgkin lymphoma | mantle cell lymphoma subclass of Lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | CNS lymphoma subclass of Lymphoma | diffuse large B-cell lymphoma subclass of classic FL | Follicular lymphoma subclass of non-Hodgkin lymphoma | B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | diffuse large B-cell lymphoma subclass of fast-growing cancer | Tumor subclass of cancer | tumor subclass of cancer | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer",
        "metrics": {
          "rouge_score": 0.3055555555555555,
          "answer_correctness": 0.6481642769755656
        }
      },
      {
        "id": "Medical-f9bc1472",
        "question": "If a patient presents with a single enlarged lymph node in the head and neck and minimal symptoms, which FL subtype is most likely, and what is its typical genetic status?",
        "ground_truth": "Pediatric-type FL (PTFL) is most likely, typically lacking the t(14;18) translocation.",
        "generated_answer": "The most likely FL subtype is follicular lymphoma, and its typical genetic status is the presence of the t(14;18) translocation.",
        "contexts": "neck connects with head, head connects with neck | neck connects with head, head connects with neck | neck connects with midthigh, midthigh connects with neck | head has part neck | skull connects with brain, vertebrae connects with skull | brain connects with skull, skull connects with brain | brain part of body, spinal cord connects with brain, brain connects with skull, skull connects with vertebrae | spinal column connects with skull, spine connects with vertebrae, pelvis connects with scapula | nose connects with mouth, larynx connects with esophagus, mouth connects with pharynx, mouth connects with nasal cavity, pharynx connects with nasal cavity, esophagus connects with larynx, nasal cavity connects with nose, mouth connects with Nasopharynx, pharynx connects with Nasopharynx, Nasopharynx connects with pharynx, nose connects with nasal cavity, esophagus connects with stomach, nose connects with Nasopharynx | mouth connects with throat, throat connects with mouth, esophagus connects with pharynx, mouth connects with nose | brain connects with skull, skull connects with brain, vital part part of brain | scalp connects with skull bone, skull bone connects with scalp | brain connects with spine | brain connects with spine, spine connects with brain | mouth connects with nose, nose connects with mouth | mouth connects with nose",
        "metrics": {
          "rouge_score": 0.4444444444444444,
          "answer_correctness": 0.2350894985182518
        }
      },
      {
        "id": "Medical-aaefb0f2",
        "question": "What surveillance strategies are recommended after local excision or ESD for T1 rectal cancer?",
        "ground_truth": "Regular flexible sigmoidoscopy every 6 months and imaging (EUS or MRI) every 3-6 months are recommended for up to 5 years.",
        "generated_answer": "Surveillance strategies after local excision or ESD for T1 rectal cancer typically include regular colonoscopic evaluations, imaging studies, and monitoring for recurrence or new lesions.",
        "contexts": "radiation therapy medical condition treated Rectal cancer, Rectal cancer drug used for treatment radiation therapy | local excision medical condition treated cancer | Rectal cancer drug used for treatment oxaliplatin, oxaliplatin medical condition treated Rectal cancer | Anal cancer drug used for treatment radiation treatment | Perianal cancer (stages I \u2013 III) facet of perianal cancer, local excision medical condition treated perianal cancer, metastatic anal cancer subclass of nonmetastatic, perianal cancer drug used for treatment local excision | Anal cancer drug used for treatment radiation therapy | cancer drug used for treatment treatments, treatments medical condition treated cancer | Ovarian transposition Rectal cancer drug used for treatment External beam radiation therapy, External beam radiation therapy medical condition treated Ovarian transposition Rectal cancer | IMRT medical condition treated Anal cancer, Anal cancer drug used for treatment IMRT | Abdominoperineal resection medical condition treated Anal cancer | abdominoperineal resection medical condition treated Anal cancer | treatments medical condition treated cancer, cancer drug used for treatment treatments | surgery medical condition treated cancer, cancer drug used for treatment surgery | Anal cancer drug used for treatment APR surgery, Mitomycin medical condition treated Anal cancer, Anal cancer drug used for treatment Cisplatin | capecitabine Mitomycin medical condition treated Anal cancer | Stage 1A1 Cone biopsy medical condition treated stage 1A1 cancers",
        "metrics": {
          "rouge_score": 0.1276595744680851,
          "answer_correctness": 0.4409888193237776
        }
      },
      {
        "id": "Medical-68694b91",
        "question": "Why might a core needle biopsy be chosen over an excisional lymph node biopsy in Hodgkin lymphoma diagnosis?",
        "ground_truth": "Core needle biopsy may be used in some cases as an alternative to excisional lymph node biopsy for diagnosis.",
        "generated_answer": "A core needle biopsy may be chosen over an excisional lymph node biopsy in Hodgkin lymphoma diagnosis due to its less invasive nature, reduced recovery time, and ability to obtain sufficient tissue for accurate diagnosis while minimizing surgical risks.",
        "contexts": "cancer has cause lymph nodes, lymph nodes has effect cancer | Head and neck cancer has cause lymph nodes | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Lymphoma has effect lymph nodes | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | Lymphatic system has effect Hodgkin lymphoma | Hodgkin lymphoma instance of rare | sentinel lymph node biopsy uses lymph nodes | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | sentinel lymph node biopsy studies lymph nodes | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | white blood cell has part lymphocyte, lymph nodes part of immune system, lymph part of lymph nodes, needle biopsy uses lymph nodes | Hodgkin lymphoma Testing for Hodgkin lymphoma facet of Hodgkin lymphoma | Bone marrow biopsy medical condition treated Lymphoma, Bone marrow biopsy studies marrow | cancer has cause tumor | lymph node removed facet of lymph nodes, lymph nodes has effect lymph node removed, lymph nodes has effect lymph node removed, bone marrow connects with lymph nodes | lymph has part lymph nodes, lymph nodes has part lymph | Nasopharyngeal cancer has cause EBV",
        "metrics": {
          "rouge_score": 0.41379310344827586,
          "answer_correctness": 0.7403085882575291
        }
      },
      {
        "id": "Medical-3f8a738d",
        "question": "If a patient with a history of head and neck radiation presents with a neck lump and trouble swallowing, what diagnostic steps should be taken to evaluate for thyroid cancer?",
        "ground_truth": "TSH test, neck ultrasound, and fine-needle aspiration biopsy should be performed to evaluate for thyroid cancer.",
        "generated_answer": "A neck ultrasound should be performed to evaluate the neck lump, followed by a biopsy if necessary to assess for thyroid cancer. Additionally, consider checking thyroid function tests and possibly a radioactive iodine uptake study.",
        "contexts": "Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure, thyroid cancer has cause Contact with large amounts of radiation in the environment | radiation has effect cancer | smoking has effect Head and neck cancer | External beam radiation therapy medical condition treated thyroid cancer, Anaplastic thyroid cancer drug used for treatment radiation therapy, radiation therapy medical condition treated thyroid cancer, iodine- Radiation therapy has part iodine-131, iodine-131 part of iodine- Radiation therapy, thyroid cancer drug used for treatment External beam radiation therapy, radiation therapy medical condition treated Anaplastic thyroid cancer | Neck ultrasound medical condition treated thyroid cancer | squamous cell carcinoma has effect Throat cancer | Cancer cells has effect radiation | thyroid cancer has cause iodine, Radioactive iodine Radioactive iodine has part iodine, tissues has part thyroid cells, remnant ablation uses iodine-131, iodine has effect thyroid cancer | Tobacco and alcohol use history Tobacco has effect Head and neck cancer | radiation therapy has effect Skin cancer | Head and neck cancer has cause lymph nodes | lymph nodes has effect cancer | Ultrasound Ultrasound medical condition treated thyroid cancer | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer | radiation has effect chemotherapy | Levothyroxine medical condition treated thyroid cancer",
        "metrics": {
          "rouge_score": 0.3846153846153846,
          "answer_correctness": 0.671167807535114
        }
      },
      {
        "id": "Medical-e7d1cd1c",
        "question": "How does the subtype of NSCLC influence the origin of the cancer cells?",
        "ground_truth": "Adenocarcinoma forms from alveolar mucus-producing cells, while squamous cell carcinoma originates from bronchial lining cells.",
        "generated_answer": "The subtype of NSCLC influences the origin of the cancer cells by determining the specific characteristics and behavior of the tumor, which can affect its development and progression.",
        "contexts": "lymph nodes facet of cancer | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | progression to cancer facet of cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Lung cancer screening facet of lung cancer | cancer stage facet of cancer | biopsy facet of cancer | Risk factors for lung cancer facet of lung cancer | radiation therapy facet of cancer, chemotherapy facet of cancer | subtype facet of cancer | How far and how fast? facet of cancer, stage facet of cancer | Imaging facet of cancer, Treatment planning facet of cancer | EBRT facet of cancer | diagnosis facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | stage facet of cancer | Chemotherapy facet of cancer | Imaging facet of cancer | Staging The cancer stage facet of cancer",
        "metrics": {
          "rouge_score": 0.09090909090909091,
          "answer_correctness": 0.2288256629838285
        }
      },
      {
        "id": "Medical-f00f6356",
        "question": "What combination of factors must be considered in treatment planning for a locoregional esophageal adenocarcinoma at the lower esophagus?",
        "ground_truth": "Treatment planning requires cancer type (adenocarcinoma), location (lower esophagus), and stage (locoregional).",
        "generated_answer": "Factors to consider include the tumor's size, location, stage, and involvement of surrounding tissues, as well as the patient's overall health and preferences.",
        "contexts": "Locoregional subclass of esophageal cancer, metastatic esophageal cancer subclass of esophageal cancer | Mucosa part of Esophagus wall, stomach connects with esophagus, esophagus connects with stomach, large intestine connects with small intestine, esophagus has part Middle esophagus, esophagus has part Upper esophagus, Middle esophagus part of esophagus, stomach connects with esophagus, Upper esophagus part of esophagus, submucosa connects with esophagus, esophagus connects with submucosa, Epithelium has part submucosa, Muscularis mucosa part of Epithelium, submucosa part of Epithelium, Epithelium has part Muscularis mucosa, esophagus connects with stomach, esophagus has part Epithelium, smooth muscle part of Lower esophagus, Middle esophagus connects with upper, esophagus has part mucus-making cells, stomach connects with esophagus, upper connects with Lower esophagus, Lower esophagus has part smooth muscle, Esophageal squamous cell carcinoma subclass of esophageal cancer, Middle esophagus connects with Lower esophagus, Lower esophagus connects with upper, upper connects with Middle esophagus, Lower esophagus connects with Middle esophagus, esophagus connects with stomach, Middle esophagus connects with Lower esophagus | Adenocarcinoma subclass of stomach cancer, Adenocarcinoma of the stomach subclass of Adenocarcinoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | Adenocarcinoma subclass of colon cancer | Adenocarcinoma subclass of colorectal cancer | Locoregional subclass of stomach cancer | Adenocarcinoma subclass of NSCLC | Locoregional subclass of tumor | squamous cell carcinoma subclass of lung cancer, non-small cell lung cancer subclass of lung cancer, Adenocarcinoma subclass of lung cancer | Adenocarcinoma subclass of adenoma | early-stage prostate cancer subclass of esophageal cancer, Esophageal cancer subclass of cancer | Adenocarcinoma subclass of rectal tumor | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | Adenocarcinoma subclass of bladder cancer | Rectal cancer subclass of cancer, Rectal cancer instance of focus, rectum part of large bowel, Rectal cancer subclass of colon cancer, inflammatory polyps subclass of Polyps, rectum part of colon, anus part of large bowel, Adenocarcinoma subclass of adenoma, colon has part rectum, large bowel has part anus, large bowel has part rectum",
        "metrics": {
          "rouge_score": 0.10810810810810811,
          "answer_correctness": 0.5276641557762844
        }
      },
      {
        "id": "Medical-2cc4ff58",
        "question": "For a patient with a tumor in the retromolar trigone, which cancer subtype and anatomic site categories are relevant for diagnosis and staging?",
        "ground_truth": "The relevant cancer subtype is squamous cell carcinoma (SCC) and the anatomic site is the retromolar trigone.",
        "generated_answer": "Relevant cancer subtype is \"tumor\" and the anatomic site category is \"retromolar trigone.\"",
        "contexts": "cancer has cause tumor, tumor has effect cancer | muscle part of tumor, tumor has effect cut off, tumor has part muscle, cut off has cause tumor | tumor has part tissues | cancer has cause tissues, tissues has effect cancer, lymph has part lymph nodes | tissues part of tumor, tumor has part tissues | cancer has part tumor | tumor has part tumor(s), tumor(s) part of tumor | tissues part of tumor | tumor has cause Cancer cells, Cancer cells has effect tumor | Cancer cells has effect tumor, tumor has cause Cancer cells | cancer has effect cancer | lymph nodes part of tissues, tissues part of tumor, organs has part tissues, tumor has part tissues, tissues part of organs | metastasis has effect spread | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | tumor has part cell | cancer type has effect stage | Cancer cells has effect tumors, tumors has cause Cancer cells | tumor part of cancer | primary tumor has effect metastasized, metastasized has cause primary tumor",
        "metrics": {
          "rouge_score": 0.7333333333333334,
          "answer_correctness": 0.6199813407122045
        }
      },
      {
        "id": "Medical-4b359d87",
        "question": "If a patient's lymph node biopsy reveals popcorn-shaped cells, what is the diagnosis and what is a potential complication?",
        "ground_truth": "The diagnosis is nodular lymphocyte-predominant Hodgkin lymphoma, which can transform into diffuse large B-cell lymphoma.",
        "generated_answer": "The diagnosis is nodular lymphocyte-predominant Hodgkin lymphoma, and a potential complication is lymph node metastasis.",
        "contexts": "popcornshaped cells subclass of nodular lymphocyte-predominant Hodgkin lymphoma | regional subclass of lymph nodes, local subclass of lymph nodes | lymph nodes subclass of cells | Regional lymph node subclass of filter | lymph nodes subclass of cancer, inguinal subclass of lymph nodes | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | Radical hysterectomy subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, modified radical hysterectomy with lymph node evaluation subclass of hysterectomy, Radical hysterectomy has cause pelvic lymph node evaluation, Stage 1A2 and 1B1 Extrafascial hysterectomy with lymph node evaluation subclass of Extrafascial hysterectomy, squamous cell carcinoma subclass of Adenocarcinoma, pelvic lymph node evaluation has effect Radical hysterectomy, pelvic lymph node dissection subclass of hysterectomy, pelvic lymph nodes subclass of lymph nodes, pathologic subclass of surgery, Stage 1B3 subclass of cancer, Radical hysterectomy has cause pelvic lymph node evaluation | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | lymph nodes subclass of tissues | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer | organs has part lymph nodes, N (node) subclass of lymph nodes | extranodal extension subclass of Lymph nodes with cancer | lymphadenectomy subclass of lymph node dissection, lymph nodes subclass of glands | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | armpit subclass of lymph nodes | underarm subclass of lymph nodes | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | sentinel lymph node subclass of lymph nodes, signs of cancer subclass of nodes, sentinel node subclass of lymph nodes",
        "metrics": {
          "rouge_score": 0.48484848484848486,
          "answer_correctness": 0.6163597413219357
        }
      },
      {
        "id": "Medical-c7c59020",
        "question": "What is the rationale for using both imaging and biopsy in the assessment of a lung nodule?",
        "ground_truth": "Imaging detects the lung nodule, but biopsy is necessary to determine if it is cancerous.",
        "generated_answer": "Imaging methods help identify the characteristics and location of the lung nodule, while biopsy provides a definitive diagnosis by obtaining tissue samples for analysis. Together, they enhance the accuracy of diagnosing potential malignancies.",
        "contexts": "Biopsy subclass of Imaging | biopsy subclass of Imaging | Imaging subclass of biopsy | biopsy subclass of Imaging, CT subclass of Imaging methods for detecting prostate cancer | biopsy subclass of diagnosis | Biopsy subclass of biopsy | biopsy subclass of testing | biopsy subclass of procedure | radiology subclass of Imaging | biopsy subclass of test | Biopsy subclass of test | biopsy subclass of Imaging, biopsy subclass of test, Diagnosing liver cancer has part imaging test | biopsy subclass of test results | biomarker testing subclass of biopsy, biopsy subclass of test results | type of biopsy subclass of biopsy, excision subclass of biopsy, skin biopsy subclass of sample, core needle biopsy subclass of biopsy | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | type of biopsy subclass of biopsy | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | CT subclass of Imaging | fine-needle aspiration subclass of biopsy",
        "metrics": {
          "rouge_score": 0.20833333333333331,
          "answer_correctness": 0.9901322700797294
        }
      },
      {
        "id": "Medical-35fee661",
        "question": "Which diagnostic procedures would be prioritized for a patient with primary CNS lymphoma presenting with blurry vision and suspected eye involvement?",
        "ground_truth": "Eye exam, slit lamp, and vitrectomy would be prioritized for suspected eye involvement.",
        "generated_answer": "An eye exam and biopsy would be prioritized for a patient with primary CNS lymphoma presenting with blurry vision and suspected eye involvement.",
        "contexts": "blurred vision subclass of Changes in eyesight, double vision subclass of Changes in eyesight, eye exam subclass of test | cataracts subclass of vision problems, fatigue subclass of Symptoms | biopsy subclass of visual symptoms, primary CNS lymphoma subclass of eye exam | eye exam subclass of Treatment | confusion subclass of Problems with thinking and speech, blurred vision subclass of vision problems, tingling subclass of Sensory disturbances, double vision subclass of vision problems | blurred vision instance of Signs | Cone biopsy subclass of Cone biopsy | lymphoma in the eyes subclass of CNS lymphoma | seizures subclass of neurological symptoms, headaches subclass of neurological symptoms, symptom subclass of sign | vision color perception subclass of sensory perception | fatigue subclass of symptom, Headaches subclass of symptom | Stage 1A1 Cone biopsy subclass of Cone biopsy | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | headache subclass of Symptoms | eye exam part of cancer care, eye exam subclass of Treatment",
        "metrics": {
          "rouge_score": 0.5555555555555555,
          "answer_correctness": 0.5325023357638166
        }
      },
      {
        "id": "Medical-333a4a3b",
        "question": "Which bone sarcoma subtype is most likely to arise in the diaphysis or flat bones, and what genetic alteration is characteristic of this subtype?",
        "ground_truth": "Ewing sarcoma most commonly arises in the diaphysis or flat bones and is characterized by the t(11;22) translocation.",
        "generated_answer": "Osteosarcoma is the bone sarcoma subtype most likely to arise in the diaphysis or flat bones, characterized by genetic alterations involving mutations in the TP53 gene.",
        "contexts": "spine subclass of bone | fracture subclass of bone | hip bone subclass of bone | bone subclass of tissues | bone damage subclass of bone | osteoporosis subclass of bone loss | osteoblasts subclass of bone-forming cells, Physis subclass of cartilage, bone has part Epiphysis | Bone scan subclass of X-ray | fibrous subclass of connective tissue | Metastatic cancer subclass of bone cancer, primary bone cancer subclass of bone cancer, Osteosarcoma subclass of Bone sarcomas, Osteosarcoma subclass of bone cancer, Sarcomas subclass of Sarcomas, chondrosarcoma subclass of bone cancer | arthritis subclass of bone damage | Bone x-ray subclass of X-ray, body has parts of the class bones | Metastatic cancer subclass of bone cancer, Ewing sarcoma subclass of bone cancer, Bone sarcomas subclass of Sarcomas, Soft tissue sarcomas subclass of Sarcomas, malignant subclass of cancerous | bone cancer subclass of tumors | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | cartilage subclass of tissues | wisdom teeth subclass of teeth",
        "metrics": {
          "rouge_score": 0.5217391304347826,
          "answer_correctness": 0.23586598156685812
        }
      },
      {
        "id": "Medical-b6f1658b",
        "question": "What is the relationship between HPV status and the recommended biomarker testing in oropharyngeal cancer?",
        "ground_truth": "HPV status is assessed by p16 (HPV) testing, which is recommended for all oropharyngeal cancer patients.",
        "generated_answer": "HPV testing is a facet of throat (oropharyngeal) cancer, which suggests that HPV status is relevant to biomarker testing in this type of cancer.",
        "contexts": "HPV testing facet of throat (oropharyngeal) cancer | biomarkers facet of cervical cancer | test facet of Liver cancer | tumor profiling subclass of biomarker testing, case-by-case subclass of biomarker testing | Surveillance Follow-up testing facet of cancer, surveillance testing facet of cancer survivors | Further testing facet of kidney cancer | Germline testing facet of cancer | molecular tumor testing subclass of biomarker testing | Testing for AML facet of AML | Urine test for tumor markers facet of urine | diagnosis facet of cancer | cervical biopsy facet of cervical cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Tumor markers facet of Breast cancer | Treatment facet of prostate cancer, prostate cancer location prostate, test listed here facet of prostate cancer, Common prostate test subclass of prostate cancer screening test, Diagnosed facet of prostate cancer, PSA instance of Proteins, prostate cancer screening test subclass of diagnostic test, PSA test instance of blood test, PSA level instance of warning sign | biomarker testing subclass of Molecular | tumor, node, metastasis facet of Throat cancer | spread facet of cancer, Testing for AML facet of AML",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.5391770682604308
        }
      },
      {
        "id": "Medical-ed26b623",
        "question": "Which laboratory tests are essential for initial workup of primary CNS lymphoma, particularly in patients with suspected immunodeficiency?",
        "ground_truth": "Blood tests including CBC, CMP, LDH, and HIV blood test are essential for initial workup.",
        "generated_answer": "Essential laboratory tests for initial workup of primary CNS lymphoma in patients with suspected immunodeficiency include complete blood count, metabolic panel, HIV testing, and cerebrospinal fluid analysis.",
        "contexts": "primary CNS lymphoma has cause impaired immune system | CNS lymphoma has cause reduced immune system, reduced immune system has effect CNS lymphoma | What causes primary CNS lymphoma? facet of cancer | primary CNS lymphoma instance of disease, CNS lymphoma has part primary CNS lymphoma | primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of brain tumor, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of Treatment | primary CNS lymphoma subclass of Lymphoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma | primary CNS lymphoma location central nervous system | brain has effect CNS lymphoma | central nervous system has effect CNS lymphoma | primary CNS lymphoma has cause Enrolling in a clinical trial | primary CNS lymphoma instance of Treatment | chemotherapy medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment chemotherapy | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma",
        "metrics": {
          "rouge_score": 0.19047619047619047,
          "answer_correctness": 0.7340006032513822
        }
      },
      {
        "id": "Medical-311d66d6",
        "question": "Which risk factors should be evaluated in a patient with a new breast lump to assess their likelihood of breast cancer?",
        "ground_truth": "Family history, BRCA1/2 mutations, and assigned female at birth should be evaluated as risk factors for breast cancer.",
        "generated_answer": "Risk factors to evaluate include family history of breast cancer, age, hormonal factors, and personal health history related to breast conditions.",
        "contexts": "breast has effect Breast cancer, Breast cancer has cause breast | Breast cancer has effect Breast cancer, Breast cancer has cause Breast cancer | Breast cancer has cause breast milk | cells of the breast has effect Breast cancer, Breast cancer has cause cells of the breast | cancer has cause tumor, tumor has effect cancer | Breast cancer has part breast, carcinoma has effect Breast cancer, Ductal carcinoma subclass of Breast cancer | cancer has effect cancer, cancer has cause cancer | estrogen has effect Breast cancer, Breast cancer has cause estrogen | Breast cancer has cause Hormones | Breast cancer has cause estrogen | health problems has effect cancer, cancer has cause health problems | hereditary has effect Breast cancer, Breast cancer has cause hereditary | cancer type has effect cancer | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | Breast cancer location breast",
        "metrics": {
          "rouge_score": 0.2,
          "answer_correctness": 0.4544770729597576
        }
      },
      {
        "id": "Medical-417cbcfd",
        "question": "What is the connection between the assessment of biomarkers/genetic changes and the selection of diagnostic methods in CBCL?",
        "ground_truth": "Assessment of biomarkers and genetic changes in CBCL requires diagnostic methods like biopsy and immunophenotyping.",
        "generated_answer": "The assessment of biomarkers and genetic changes informs the selection of diagnostic methods in CBCL by identifying specific molecular features that guide targeted testing and treatment strategies.",
        "contexts": "biomarker subclass of genetic | biomarker subclass of genetic testing | tumor mutation testing subclass of biomarker | biomarker subclass of biomarker | Genetic risk testing subclass of Genetic and biomarker testing | Biomarkers subclass of biomarker | testing for AML biomarker and genetic changes subclass of biomarker | biomarker subclass of test, biomarker test subclass of biomarker | molecular subclass of biomarker | biomarker test subclass of test | genetic testing subclass of test | biomarker testing subclass of Molecular | testing for AML biomarker and genetic changes subclass of biomarker, tumor profiling subclass of molecular testing, biopsy subclass of tissue sample, genetic cancer risk testing subclass of genetic testing | genetic testing subclass of diagnostic test | following biomarkers subclass of biomarker | RNA subclass of genetic information, DNA subclass of genetic information | germline mutations subclass of genetic testing, DNA subclass of genetic information | biomarker subclass of features | molecular tumor testing subclass of biomarker testing",
        "metrics": {
          "rouge_score": 0.42857142857142855,
          "answer_correctness": 0.7444245790937524
        }
      },
      {
        "id": "Medical-2782702e",
        "question": "What symptoms would prompt a clinician to perform a skin biopsy for suspected CSCC?",
        "ground_truth": "Scaly patches, solid or misshapen lesions, or lesions in areas of chronic damage would prompt a skin biopsy.",
        "generated_answer": "Symptoms that would prompt a clinician to perform a skin biopsy for suspected cutaneous squamous cell carcinoma (CSCC) include the presence of a suspicious skin lesion, changes in an existing mole, non-healing sores, or any skin growth that appears abnormal or has characteristics of cancer.",
        "contexts": "skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | biopsied part of pathologist, histology part of pathologist | histology part of pathologist, biopsied part of pathologist | biopsy studied by pathologist, pathologist studies biopsy | Biopsy studied by pathologist, biopsied part of pathology report | biopsy part of surgery | cytology part of pathologist | biopsy uses sample | Biopsy uses sample, sample use Biopsy | Biopsy use biopsy | Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist | biopsy uses needle | Biopsy uses tissue sample | endoscope use biopsy | biopsy subclass of diagnosis | needle biopsy studied by interventional radiologist, interventional radiologist studies needle biopsy",
        "metrics": {
          "rouge_score": 0.15625,
          "answer_correctness": 0.23010455197118312
        }
      },
      {
        "id": "Medical-ac781c3a",
        "question": "If a patient with stage 4 primary biliary cholangitis develops liver cancer, what is the likely sequence of risk events?",
        "ground_truth": "Stage 4 primary biliary cholangitis increases risk of cirrhosis, which then raises the risk for liver cancer.",
        "generated_answer": "Stage 4 primary biliary cholangitis leads to liver damage, increasing the risk of developing liver cancer.",
        "contexts": "Liver cancer has cause liver | spread of cancer has effect liver damage | Liver cancer has cause increased risk, increased risk has effect Liver cancer | spread to the liver has effect cancer, cancer has cause spread to the liver, kidney connects with liver | primary liver cancer subclass of cancer | pancreas has effect Pancreatic cancer | primary liver cancer subclass of Liver cancer, intrahepatic cholangiocarcinoma subclass of Liver cancer | Hepatitis B has effect cirrhosis, cirrhosis has cause Hepatitis B | cancer type has effect cancer | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | lymph nodes has effect cancer | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | cancer has effect cancer | Hepatitis Hepatitis has cause hepatitis C, cirrhosis has cause cirrhosis, Hepatitis B has effect Hepatitis Hepatitis, Hepatitis Hepatitis has cause Hepatitis B, hepatitis C has effect Hepatitis Hepatitis | neuroendocrine tumor has effect Pancreatic cancer, Pancreatic cancer has cause Cancer cells, Cancer cells has effect Pancreatic cancer | cancer type has effect stage",
        "metrics": {
          "rouge_score": 0.6060606060606061,
          "answer_correctness": 0.8485359893764937
        }
      },
      {
        "id": "Medical-68e55e0e",
        "question": "If a patient has papules under the skin and is diagnosed with a lymphoma subtype originating from B lymphocytes, which subtypes should be considered?",
        "ground_truth": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
        "generated_answer": "Burkitt lymphoma, B-cell lymphoblastic lymphoma, non-Hodgkin lymphoma.",
        "contexts": "Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell | T lymphocyte has effect B-cell lymphoblastic lymphoma | Lymphoblast has cause lymphocyte, B cell subclass of lymphocyte, lymphocyte has effect Lymphoblast, T-cell subclass of lymphocyte, Burkitt lymphoma subclass of non-Hodgkin lymphoma | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Lymphoma has effect lymph nodes | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | B cell subclass of lymphocyte, B cell subclass of lymphocyte | Cancer cells has effect tumor, tumor has cause Cancer cells, cancer has cause Cancer cells | brain has effect CNS lymphoma | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | B cell subclass of white blood cell, B cell subclass of lymphocyte, white blood cell has part B cell | platelet subclass of Red blood cell, Red blood cell has part Red blood cell, B cell subclass of lymphocyte, Red blood cell has part white blood cell, white blood cell part of Blood, white blood cell subclass of Red blood cell, lymph tissue has part lymph nodes, white blood cell followed by platelet, Red blood cell has part platelet, B lymphocyte subclass of lymphocyte, progenitor cells followed by lymphocyte, B cell part of immune system | CLL has cause bone marrow, bone marrow has effect CLL | central nervous system has effect CNS lymphoma | Cancer cells has effect tumors, tumors has cause Cancer cells | B lymphocyte subclass of lymphocyte | cancer has cause Cancer cells",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.2257279821087383
        }
      },
      {
        "id": "Medical-c09d2bcb",
        "question": "Which populations are at increased risk for nasopharyngeal carcinoma and what risk factors contribute to this increased incidence?",
        "ground_truth": "People from Asia, Native America, and North Africa are at increased risk due to geographic origin and EBV infection.",
        "generated_answer": "Populations at increased risk for nasopharyngeal carcinoma include those with a family history of the disease, individuals exposed to the Epstein-Barr virus (EBV), and those with a history of smoking or alcohol use. Other contributing risk factors include radiation exposure and certain genetic mutations.",
        "contexts": "cancer has cause risk factors, risk factors has effect cancer | Nasopharyngeal cancer has cause EBV | cervical cancer has cause risk factors, risk factors has effect cervical cancer | Radiation exposure has effect thyroid cancer, risk factors has effect thyroid cancer, thyroid cancer has cause risk factors, thyroid cancer has cause Radiation exposure, risk factors for thyroid cancer instance of risk factors | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | risk factors facet of cancer | Epstein-Barr virus has effect mononucleosis, Nasopharyngeal cancer has cause EBV | bladder cancer has cause risk factors for bladder cancer, Smoking has effect bladder cancer, risk factors for bladder cancer has effect bladder cancer, secondhand smoke has effect bladder cancer, Family history has effect bladder cancer, bladder cancer has cause secondhand smoke, bladder cancer has cause Family history, bladder cancer subclass of cancer in the urinary tract, mutations in certain genes has effect bladder cancer, bladder has part urothelial layer | lung cancer has effect preventing, tobacco smoke has effect cancer, Coal smoke has cause Air pollution, Air pollution has parts of the class nitrogen oxides, tobacco smoke has cause smoking tobacco, lung cancer has cause smoking, Risk factors for lung cancer facet of lung cancer, Air pollution has cause diesel fumes, Air pollution has effect Coal smoke, secondhand smoke has effect lung cancer, diesel fumes has cause Air pollution, soot has effect Air pollution, smoking tobacco has effect tobacco smoke, ozone has Air pollution, lung cancer has cause secondhand smoke | Throat cancer has cause squamous cell carcinoma | Nasopharyngeal cancer subclass of tumor, EBV has effect Nasopharyngeal cancer | Head and neck cancer has cause lymph nodes | Head and neck cancer has cause Tobacco and alcohol use history Tobacco | Liver cancer has cause increased risk, increased risk has effect Liver cancer | cancer has cause cancer type | cancer has cause cancer | squamous cell carcinoma has cause Squamous cell",
        "metrics": {
          "rouge_score": 0.15625,
          "answer_correctness": 0.3818287358825703
        }
      },
      {
        "id": "Medical-6d12f4ff",
        "question": "How does immunosuppression influence both the risk and clinical management of CSCC?",
        "ground_truth": "Immunosuppression increases CSCC risk and is a factor in risk assessment, requiring intensified surveillance and potentially altered treatment.",
        "generated_answer": "Immunosuppression increases the risk of cutaneous squamous cell carcinoma (CSCC) by weakening the immune system's ability to detect and eliminate cancer cells. In clinical management, it necessitates careful monitoring and may require adjustments in treatment strategies to balance cancer control and immune function.",
        "contexts": "Immunotherapy part of systemic therapy, systemic therapy has part Immunotherapy | Immunotherapy part of immune system | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | surgery part of Treatment | chemotherapy part of Treatment, radiation therapy part of Treatment, Treatment has part chemotherapy, Treatment has part radiation therapy, Treatment has part surgery, surgery part of Treatment | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | white blood cell has part B lymphocyte, Lymphatic system has part Lymphocytes, liver has part blood vessel, Lymphocytes part of Lymphatic system, lymph nodes part of Lymphatic system, B lymphocyte subclass of white blood cell, Lymphatic system has part lymph nodes, organs has part tissues, Lymphatic system part of immune system, immune system has part Lymphatic system, lymphatic part of Lymphatic system, lymphocyte part of lymph tissue, Lymphatic system has part lymphatic, lymph nodes has part lymphatic vessel | pre-treatment part of Clinical | nucleus part of lymphocyte, immune system has part Lymphatic system, Lymphatic system part of immune system, Lymphatic system has effect Hodgkin lymphoma, white blood cell has part lymphocyte, lymph nodes part of Lymphatic system, Lymphatic system has part lymph nodes, lymphocyte subclass of white blood cell, lymphocyte has part nucleus, Lymphatic system part of immune system | Immunotherapy facet of immune system, Immunotherapy subclass of systemic therapy | Immunotherapy facet of immune system | systemic therapy part of Oncology | Treatment part of plan, prognosis has part more than one treatment option, Treatment practiced by surgeon, surgeon field of this occupation Treatment, more than one treatment option part of prognosis | stage part of Treatment | body has part immune system",
        "metrics": {
          "rouge_score": 0.22580645161290322,
          "answer_correctness": 0.7380112688015645
        }
      },
      {
        "id": "Medical-1e7500e4",
        "question": "What combination of tests would be used to assess both disease burden and prognosis in CLL?",
        "ground_truth": "CBC, beta-2 microglobulin, biomarker testing (FISH, DNA sequencing, karyotype), and diagnostic CT scan assess disease burden and prognosis.",
        "generated_answer": "A combination of cancer staging, risk factors assessment, and overall health evaluation would be used to assess both disease burden and prognosis in CLL.",
        "contexts": "prognosis facet of disease | prognosis facet of course the cancer will take, prognosis facet of more than one treatment option | cancer staging facet of prognosis | risk factors facet of disease | Treatment facet of disease | symptom facet of disease | prognosis facet of cancer, breast cancer is staged facet of Breast cancer | CLL has effect prognosis, prognosis facet of Cancer treatment, prognosis facet of CLL | overall health facet of health conditions | supportive care facet of cancer, end of life facet of disease, quality of life facet of cancer | Signs and symptoms facet of disease | Treatment decisions facet of cancer | Treatment facet of cancer, Cancer treatment facet of cancer | Treatment facet of Treatment | Treatment facet of cancer | Cancer treatment facet of cancer | staging facet of Treatment decisions | plan treatment facet of Treatment, plan treatment facet of disease",
        "metrics": {
          "rouge_score": 0.27906976744186046,
          "answer_correctness": 0.22939508352008398
        }
      },
      {
        "id": "Medical-37f18801",
        "question": "What features distinguish grade 3A from grade 3B follicular lymphoma in terms of treatment?",
        "ground_truth": "Grade 3A FL may be treated as classic FL or as DLBCL, while grade 3B FL is always treated as DLBCL.",
        "generated_answer": "The information provided does not specify features that distinguish grade 3A from grade 3B follicular lymphoma in terms of treatment.",
        "contexts": "Treatment medical condition treated CNS lymphoma | Methotrexate medical condition treated Lymphoma, Lymphoma drug used for treatment Methotrexate | treatments medical condition treated cancer, cancer drug used for treatment treatments | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Chronic lymphocytic leukemia drug used for treatment Treatment | cancer drug used for treatment Treatment | Treatment medical condition treated cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment treatments, treatments medical condition treated cancer | effective treatment medical condition treated CLL | Bone marrow biopsy medical condition treated Lymphoma, Treatment facet of Lymphoma, Bone marrow biopsy studies marrow | Treatment medical condition treated primary CNS lymphoma | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | cancer drug used for treatment Cancer treatment | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment | CNS lymphoma drug used for treatment standard treatments | cancer drug used for treatment Treatment, best treatment facet of cancer",
        "metrics": {
          "rouge_score": 0.1951219512195122,
          "answer_correctness": 0.2342917274152035
        }
      },
      {
        "id": "Medical-f7300f3c",
        "question": "Which diagnostic methods are shared between classic Hodgkin lymphoma and NLPHL, and what does this suggest about their diagnostic process?",
        "ground_truth": "Both use excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests, indicating a similar diagnostic process.",
        "generated_answer": "Classic Hodgkin lymphoma and NLPHL share similar diagnostic methods, suggesting that they may have overlapping characteristics in their diagnostic processes. This similarity could indicate a need for careful differentiation during diagnosis.",
        "contexts": "diffuse large B-cell lymphoma different from Burkitt lymphoma | non-Hodgkin PMBL subclass of Hodgkin lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma, SLL different from CLL, CLL different from SLL | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Nasopharyngeal cancer different from laryngeal cancer, laryngeal cancer different from Nasopharyngeal cancer, esophageal cancer different from Nasopharyngeal cancer, Nasopharyngeal cancer different from esophageal cancer | tumors different from cancer, cancer different from tumors | Hodgkin lymphoma subclass of Lymphoma | Locally advanced cancer different from metastatic | cancer type different from cancer, cancer different from cancer type | Chemotherapy different from Chemotherapy | Hodgkin lymphoma instance of rare | diffuse large B-cell lymphoma subclass of classic FL | Burkitt lymphoma subclass of non-Hodgkin lymphoma",
        "metrics": {
          "rouge_score": 0.14814814814814814,
          "answer_correctness": 0.572543077033679
        }
      },
      {
        "id": "Medical-f57e3ab2",
        "question": "What combination of clinical and pathological features would support a diagnosis of mediastinal gray zone lymphoma (MGZL) in a young male patient?",
        "ground_truth": "A large mediastinal mass, Reed-Sternberg cells, and an age of 20-40 years assigned male at birth support MGZL diagnosis.",
        "generated_answer": "A combination of imaging findings, histological analysis, and clinical presentation consistent with lymphoma, along with specific pathology report details indicating gray zone characteristics, would support a diagnosis of mediastinal gray zone lymphoma (MGZL) in a young male patient.",
        "contexts": "pathologic subclass of Clinical, initial diagnosis part of Clinical | pathology has part histology, histology part of pathology | pathology has part Imaging, Pathologic stage part of initial diagnosis | pathologic studied by surgeon | histology part of pathologist, biopsied part of pathologist | tumor part of cancer, pathology has part Imaging, cancer has part tumor | biopsied part of pathologist, histology part of pathologist, pathologist has part histology | pathologic subclass of stage | biopsied part of pathology report | Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging | pathology subclass of blood test, Imaging part of pathology | pre-treatment part of Clinical | tumor has part tumor(s), tumor(s) part of tumor | tumor has part tissues | tissues part of tumor, tumor has part tissues",
        "metrics": {
          "rouge_score": 0.13559322033898305,
          "answer_correctness": 0.2325430937438735
        }
      },
      {
        "id": "Medical-2a5688d0",
        "question": "What are the main imaging modalities used in the diagnosis and surveillance of bladder cancer?",
        "ground_truth": "CT scan, MRI, PET/CT, ultrasound, pyelogram, and urogram are main imaging modalities used.",
        "generated_answer": "The main imaging modalities used in the diagnosis and surveillance of bladder cancer include Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, and X-rays.",
        "contexts": "Magnetic resonance imaging studied by radiologist, Imaging studied by radiologist, Imaging has cause scan, radiologist studies Magnetic resonance imaging, Magnetic resonance imaging uses scanning machine, Magnetic resonance imaging subclass of MRI test, CT scan studied by radiologist, CT scan uses X-ray, scanning machine use Magnetic resonance imaging, radiologist studies CT scan, CT subclass of computed tomography, Magnetic resonance imaging uses magnetic field | Imaging practiced by radiologist, imaging test studies cancer, cancer has effect Treatment, cancer studied by imaging test | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer, Imaging practiced by radiologist, After \u2013 Imaging follows During \u2013 Imaging | Imaging part of pathology, Imaging facet of cancer | radiologist studies Imaging, Imaging studied by radiologist | imaging test use Imaging | pathology has part Imaging | Imaging used by doctor | Imaging practiced by radiologist | physical exam subclass of Surveillance | Magnetic resonance imaging uses Magnetic resonance imaging | Imaging facet of cancer, Imaging subclass of test results | imaging test used by doctor | biomarker testing use diagnosis | Surveillance facet of cancer | radiology subclass of Imaging | scan has effect Imaging | Imaging Imaging facet of cancer",
        "metrics": {
          "rouge_score": 0.20512820512820512,
          "answer_correctness": 0.6671808409706739
        }
      },
      {
        "id": "Medical-6d56985a",
        "question": "How does the diagnosis of gray zone lymphoma change if there is extra-mediastinal disease?",
        "ground_truth": "If extra-mediastinal disease is present, the diagnosis changes to DLBCL, not otherwise specified (DLBCL-NOS).",
        "generated_answer": "The diagnosis of gray zone lymphoma may be classified as non-mediastinal gray zone lymphoma if there is extra-mediastinal disease present. This indicates a different staging and potential treatment approach compared to mediastinal gray zone lymphoma.",
        "contexts": "Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Gray zone lymphoma subclass of mediastinal, MGZL subclass of Primary mediastinal B-cell lymphoma | extranodal (outside of the lymph node) disease subclass of FL, Follicular lymphoma subclass of non-Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of cancer | Non-Hodgkin lymphoma subclass of Lymphoma | Mediastinal gray zone lymphoma opposite of Non-mediastinal gray zone lymphoma, non-Hodgkin PMBL subclass of Hodgkin lymphoma, Non-mediastinal gray zone lymphoma opposite of Mediastinal gray zone lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | extranodal extension subclass of Lymph nodes with cancer | Classic Hodgkin lymphoma subclass of Hodgkin lymphoma | Hodgkin lymphoma subclass of Lymphoma | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | diffuse large B-cell lymphoma subclass of classic FL, classic FL subclass of Follicular lymphoma | diffuse large B-cell lymphoma subclass of Hodgkin lymphoma | Regional lymph node subclass of lymph nodes, Acute myeloid leukemia subclass of blood cancer, distant metastasis subclass of lymph node metastasis, lymph nodes has effect Head and neck cancer, lymph nodes part of cancer",
        "metrics": {
          "rouge_score": 0.22641509433962265,
          "answer_correctness": 0.23155336403722138
        }
      },
      {
        "id": "Medical-18be1c24",
        "question": "Which diagnostic and biomarker tests are indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma?",
        "ground_truth": "TSH test, neck ultrasound, fine-needle aspiration, pathology review, molecular tests, and biomarker analysis for BRAF, NTRK, and ALK gene mutations are indicated.",
        "generated_answer": "Biomarker tests indicated include tumor markers and molecular tumor testing. Diagnostic tests may involve genetic testing and biopsy.",
        "contexts": "biomarker subclass of biomarker | Biomarkers subclass of biomarker | biomarker subclass of test, biomarker test subclass of biomarker | molecular subclass of biomarker | biomarker test subclass of test | biomarker subclass of genetic | biomarker subclass of genetic testing | following biomarkers subclass of biomarker | biomarker testing subclass of Molecular | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor profiling subclass of biomarker testing | Testing for this biomarker subclass of biomarker | genetic testing subclass of diagnostic test | tumor mutation testing subclass of biomarker | molecular tumor testing subclass of biomarker testing | Diagnosis by blood test subclass of blood test",
        "metrics": {
          "rouge_score": 0.1951219512195122,
          "answer_correctness": 0.5035269201033071
        }
      },
      {
        "id": "Medical-2f70ddcb",
        "question": "What follow-up tests are recommended after total thyroidectomy for thyroid cancer, and how can recurrence be detected?",
        "ground_truth": "Physical exam, TSH, thyroglobulin, anti-thyroglobulin antibodies blood tests, and neck ultrasound are recommended; recurrence may be detected by rising thyroglobulin or imaging.",
        "generated_answer": "Follow-up tests after total thyroidectomy for thyroid cancer typically include neck ultrasound and serum thyroglobulin tests. Recurrence can be detected through these imaging tests and monitoring thyroglobulin levels.",
        "contexts": "Total thyroidectomy medical condition treated thyroid cancer | Total thyroidectomy medical condition treated papillary cancer, papillary cancer drug used for treatment Total thyroidectomy | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer, thyroid cancer drug used for treatment Surgery Surgery | Total thyroidectomy medical condition treated thyroid cancer, Total thyroidectomy different from RAI therapy | Levothyroxine medical condition treated thyroid cancer | External beam radiation therapy medical condition treated thyroid cancer, thyroid cancer drug used for treatment External beam radiation therapy, radiation therapy medical condition treated Anaplastic thyroid cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | surgery medical condition treated cancer | Treatment medical condition treated cancer | Ultrasound Ultrasound medical condition treated thyroid cancer | treatments medical condition treated cancer | Neck ultrasound medical condition treated thyroid cancer | Chemoradiation medical condition treated cancer | radical trachelectomy medical condition treated cancer | bladder cancer surgery medical condition treated bladder cancer | surgery medical condition treated Skin cancer | surgery medical condition treated cancer, cancer drug used for treatment surgery",
        "metrics": {
          "rouge_score": 0.2692307692307692,
          "answer_correctness": 0.740369776618947
        }
      },
      {
        "id": "Medical-831bb1e6",
        "question": "Which combination of risk factors should prompt earlier and more frequent skin exams for BCC?",
        "ground_truth": "A combination of older age, fair skin, and family history of skin cancer should prompt more frequent skin exams.",
        "generated_answer": "A combination of fair skin, a history of sunburns, excessive sun exposure, and a family history of skin cancer should prompt earlier and more frequent skin exams for basal cell carcinoma (BCC).",
        "contexts": "tests you might receive medical condition treated IBC | basal cell skin cancer treated medical condition treated Basal cell skin cancer | Skin exams by your doctor subclass of skin examined | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Photodynamic therapy medical condition treated keratoses, Cryotherapy medical condition treated keratoses, topical therapy medical condition treated keratoses, keratoses drug used for treatment topical therapy | Skin exams by your doctor subclass of skin exams | radiation therapy medical condition treated Skin cancer, Skin cancer drug used for treatment surgery, skin biopsy use test it for cancer, surgery medical condition treated Skin cancer, systemic therapy medical condition treated Skin cancer, Skin cancer drug used for treatment systemic therapy, Skin cancer drug used for treatment radiation therapy | skin check subclass of physical exam | Skin cancer has cause radiation therapy, skin cancer drug used for treatment surgery, skin cancer drug used for treatment radiation therapy, skin cancer drug used for treatment systemic therapy | Skin cancer drug used for treatment early | skin exams subclass of general health test | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Cisplatin medical condition treated squamous cell skin cancer, squamous cell skin cancer drug used for treatment Cisplatin | Treatment for SISCCA medical condition treated SISCCA | Immunotherapy medical condition treated cancer anywhere in the body, treatments medical condition treated bladder cancer, cancer anywhere in the body drug used for treatment Immunotherapy, bladder cancer drug used for treatment treatments, Can bladder cancer be cured? facet of Bladder cancer, cancer anywhere in the body drug used for treatment chemotherapy, bladder cancer drug used for treatment Treatment",
        "metrics": {
          "rouge_score": 0.6666666666666666,
          "answer_correctness": 0.24050269710082006
        }
      },
      {
        "id": "Medical-6e464eb2",
        "question": "In a patient with symptoms of hormone excess and an adrenal mass found incidentally on CT, what further tests are indicated to determine tumor type?",
        "ground_truth": "Biochemical tests to assess hormone secretion and further imaging such as MRI or PET scan are indicated.",
        "generated_answer": "Further tests indicated include hormonal assays to evaluate hormone levels, imaging studies for tumor characterization, and possibly a biopsy to determine the tumor type.",
        "contexts": "Benign (not cancer) adrenal tumor subclass of adrenal tumor, Malignant adrenal tumor subclass of cancerous tumor | systemic Hormone therapy subclass of hormone replacement therapy, Androgen deprivation therapy subclass of hormone replacement therapy, Male hormone has part androgen, androgen subclass of Male hormone, testosterone subclass of Male hormone, testosterone subclass of androgen | androgen subclass of Hormones, testosterone subclass of gonadotropin-releasing hormone, Ovarian ablation subclass of endocrine therapy, testosterone subclass of androgen | adrenal tumor subclass of tumor | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer, Adrenocortical carcinoma location adrenal cortex, aldosteronoma subclass of adenoma | Neuroblastoma subclass of adrenal tumor, Adrenocortical carcinoma subclass of Adrenal cancer | Adrenocortical carcinoma subclass of adrenal tumor, Adrenal gland product or material produced hormones, endocrine system has part Adrenal gland, Adrenal gland has part Adrenal medulla | tumor subclass of abnormal areas | Adrenal cancer subclass of cancer | multiple endocrine neoplasia subclass of syndromes | overactive thyroid subclass of hyperthyroidism | early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | enlarged prostate subclass of benign prostatic hyperplasia | abnormal tissue growth subclass of cancer | aldosterone instance of hormones, dopamine instance of hormones, hormones part of immune system, Hormone subclass of chemical substance",
        "metrics": {
          "rouge_score": 0.19512195121951217,
          "answer_correctness": 0.8360744356358503
        }
      },
      {
        "id": "Medical-781a9787",
        "question": "What diagnostic tests are used for both initial evaluation and staging of colon cancer, and what unique information does each provide?",
        "ground_truth": "Blood tests (CBC, chemistry profile, CEA) are used for initial evaluation, while CT with contrast is the main imaging test for staging and surveillance; CEA is also a biomarker for monitoring.",
        "generated_answer": "Imaging tests provide visual assessment of the cancer's location and spread, while genetic testing offers insights into the tumor's genetic makeup. Biopsy confirms the presence of cancer cells and helps determine the specific type of cancer.",
        "contexts": "staging subclass of Imaging | testing subclass of diagnosis | Clinical subclass of cancer staging, pathologic subclass of cancer staging | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | genetic testing subclass of diagnostic test | Clinical staging of lymph nodes subclass of staging | Staging after surgery subclass of Clinical stage | pathologic subclass of stage | minimally invasive procedure subclass of Surgical staging | staging part of grading | Diagnosis by blood test subclass of blood test | biomarker subclass of test, biomarker test subclass of biomarker | testing Biopsy subclass of biopsy | Biopsy subclass of test | biopsy subclass of test | genetic testing subclass of test | imaging test subclass of diagnostic test, diagnostic test facet of cancer | test subclass of Biopsy, CT subclass of computed tomography",
        "metrics": {
          "rouge_score": 0.11594202898550723,
          "answer_correctness": 0.22996382532592516
        }
      },
      {
        "id": "Medical-27edd702",
        "question": "What systemic therapies are available for bladder cancer patients with advanced or metastatic disease?",
        "ground_truth": "Systemic therapies include chemotherapy (cisplatin-based regimens), immunotherapy (checkpoint inhibitors), and targeted therapies.",
        "generated_answer": "Systemic therapies for bladder cancer patients with advanced or metastatic disease include chemotherapy, immunotherapy, and targeted therapy.",
        "contexts": "early-stage prostate cancer subclass of prostate cancer, Early vs. advanced prostate cancer facet of prostate cancer, advanced-stage prostate cancer subclass of localized prostate cancer, regional prostate cancer subclass of prostate cancer, localized prostate cancer subclass of prostate cancer, localized subclass of cancer, metastatic prostate cancer subclass of cancer, metastatic prostate cancer subclass of metastasis, Advanced stage subclass of cancer, early-stage subclass of cancer | metastatic disease subclass of cancer | metastatic subclass of cancer | Stage III facet of Pancreatic cancer, Stage 1 pancreatic cancer subclass of Pancreatic cancer, stage II facet of Pancreatic cancer, Metastatic pancreatic cancer subclass of Pancreatic cancer, Stage 0 pancreatic cancer subclass of pancreatic tumor, Pancreatic cancer has part Stage 1 pancreatic cancer, Stage 4 pancreatic cancer subclass of Metastatic cancer, metastatic subclass of cancer | very advanced disease subclass of disease, metastatic subclass of cancer | metastasized subclass of cancer | Metastatic cancer subclass of Breast cancer | metastatic subclass of prostate cancer | de novo subclass of Metastatic cancer | nonmetastatic subclass of cancer, metastatic subclass of cancer | Metastatic cancer subclass of Metastasis Cancer | metastasis subclass of cancer | advanced subclass of prostate cancer | metastasized subclass of bone cancer, nodal disease subclass of Cancer in the lymph nodes, metastatic subclass of cancer | metastatic subclass of cancer, Head and neck cancer subclass of tumor | metastatic prostate cancer subclass of prostate cancer | Progressive disease subclass of cancer, locally progressive subclass of metastatic disease, non-metastatic anal cancer subclass of metastatic anal cancer | Stage 4 cancer subclass of Metastatic cancer | localized prostate cancer subclass of cancer, metastatic prostate cancer subclass of prostate cancer, early-stage prostate cancer subclass of prostate cancer, metastasis subclass of spread, regional prostate cancer subclass of cancer | metastasis subclass of metastasized",
        "metrics": {
          "rouge_score": 0.5333333333333333,
          "answer_correctness": 0.9869165186576956
        }
      },
      {
        "id": "Medical-3a5fb7b0",
        "question": "Why are high-grade gliomas treated differently than low-grade gliomas following surgery?",
        "ground_truth": "High-grade gliomas require additional therapy after surgery due to their aggressive nature, unlike low-grade gliomas.",
        "generated_answer": "High-grade gliomas are treated differently than low-grade gliomas following surgery due to their aggressive nature and higher risk of recurrence, necessitating more intensive treatment strategies. Low-grade gliomas typically have a better prognosis and may require less aggressive management.",
        "contexts": "high-grade glioma opposite of low-grade glioma, low-grade glioma opposite of high-grade glioma | Normal cell opposite of Cancer cells, high-grade glioma opposite of low-grade glioma, oligodendroglioma subclass of Glioblastoma | oligodendrocyte subclass of brain tumor, Grade 3 tumor cells subclass of Glioblastoma, high-grade glioma opposite of low-grade glioma | low-grade glioma opposite of high-grade glioma, molecular part of Glioblastoma, oligodendrocyte subclass of glial cell, Glioblastoma subclass of glioma tumor | High-grade cancer opposite of lower-grade cancer, lower-grade cancer opposite of High-grade cancer | lower-grade cancer opposite of High-grade cancer, High-grade cancer opposite of lower-grade cancer | early-stage prostate cancer opposite of more advanced cancers, more advanced cancers opposite of early-stage prostate cancer | Can glioma be cured? subclass of treatable | low-risk disease opposite of high-risk disease, high-risk disease opposite of low-risk disease | Glioblastoma subclass of Glioblastoma, Glioblastoma has cause glial cell, oligodendroglioma subclass of Glioblastoma, treat medical condition treated Glioblastoma, abnormality has effect Glioblastoma, astrocytoma subclass of Glioblastoma, glial cell has effect Glioblastoma, Glioblastoma subclass of brain tumor | tumors different from cancer | Glioblastoma subclass of brain tumor | Metastatic bladder cancer subclass of cancer, High-grade cancer opposite of Low grade bladder cancer | Glioblastoma subclass of tumor | primary tumor opposite of metastasis",
        "metrics": {
          "rouge_score": 0.41379310344827586,
          "answer_correctness": 0.5424658076930455
        }
      },
      {
        "id": "Medical-e851fe04",
        "question": "What factors determine the use of fertility-sparing surgery in ovarian cancer patients?",
        "ground_truth": "Fertility-sparing surgery is considered for select early-stage cases, depending on stage and patient fertility desires.",
        "generated_answer": "Factors include the stage of cancer, the patient's desire for future pregnancy, and the extent of the disease.",
        "contexts": "Treatment medical condition treated ovarian cancer | ovary medical condition treated ovarian cancer, ovarian cancer medical condition treated ovary | Fertility-sparing surgery facet of cancer | initial surgery medical condition treated ovarian cancer | Treatment medical condition treated ovarian cancer, ovarian cancer drug used for treatment Treatment | surgery medical condition treated cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | Fertility-sparing surgery different from hysterectomy, surgery medical condition treated cancer, cancer drug used for treatment surgery, hysterectomy different from Fertility-sparing surgery | treatments medical condition treated cancer | Fertility-sparing surgery facet of pregnancy, Fertility-sparing surgery subclass of difficult for those wishing to get pregnant in the future | abdominal surgery subclass of Fertility-sparing surgery | its treatment medical condition treated prostate cancer | surgery medical condition treated Skin cancer | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer | bladder cancer surgery medical condition treated bladder cancer",
        "metrics": {
          "rouge_score": 0.16666666666666669,
          "answer_correctness": 0.8280684447473969
        }
      },
      {
        "id": "Medical-e0c754c6",
        "question": "How does the histopathology of MGZL relate to its clinical presentation?",
        "ground_truth": "MGZL presents with a large mediastinal mass and Reed-Sternberg cells as histopathological features.",
        "generated_answer": "The histopathology of MGZL is part of the clinical presentation, as it provides essential insights into the tumor's characteristics and behavior, aiding in diagnosis and treatment planning.",
        "contexts": "histology part of pathology, pathology has part histology | histology part of pathologist, pathologist has part histology, biopsied part of pathologist | histology part of pathologist, biopsied part of pathologist | pathologic subclass of Clinical | pathologic examination studies tumor, Pathologic examination studied by pathologist | pathology has part Imaging, Pathologic stage part of initial diagnosis | tumor(s) studied by histology, biopsy subclass of Imaging, histology studies tumor(s) | biopsied part of pathology report | tumor histology studies cancer | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | Pathology review practiced by pathologist | Pathologist studies disease, pathologist studies Biopsy, pathologist studies cancer, cancer studied by pathologist | pathology practiced by pathologist, pathologist field of this occupation pathology | tissues studied by pathologist, pathologist studies tissues | Pathologic stage part of initial diagnosis, pathologic subclass of cancer staging | pathology subclass of blood test, Imaging part of pathology",
        "metrics": {
          "rouge_score": 0.14285714285714285,
          "answer_correctness": 0.23333454073438661
        }
      },
      {
        "id": "Medical-4a4eaab8",
        "question": "How does the presence or absence of the t(14;18) translocation affect the classification of follicular lymphoma?",
        "ground_truth": "FL cases lacking t(14;18) or with uncommon pathologic features are classified as uncommon FL (uFL) but are treated as classic FL.",
        "generated_answer": "The presence of the t(14;18) translocation is a key factor in the classification of follicular lymphoma, as it is commonly associated with this type of non-Hodgkin lymphoma. Its absence may indicate a different subtype or classification of lymphoma.",
        "contexts": "Follicular lymphoma subclass of non-Hodgkin lymphoma | enlarged spleen has effect Follicular lymphoma | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | Follicular lymphoma subclass of Lymphoma | classic FL subclass of Follicular lymphoma | lymphocyte part of immune system, lymph nodes part of lymphatic fluid, lymph nodes has part lymphatic vessel, white blood cell has part lymphatic fluid, Lymphatic system has effect Lymphatic system Lymphoma, lymphatic vessel part of lymph nodes, lymphatic fluid has part lymph nodes, lymphatic vessel connects with lymphatic fluid, organs has part tissues, lymphatic fluid connects with lymphatic vessel, immune system has part lymphocyte, lymphocyte part of Lymphatic system, Lymphatic system Lymphoma has cause Lymphatic system, Lymphatic system has part spleen, Lymphatic system has part lymph nodes, lymph tissue has part lymphatic vessel, lymphatic vessel part of lymph tissue, Lymphatic system has part lymphatic vessel, spleen part of Lymphatic system | CLL has cause bone marrow | Lymphoma has cause lymphocyte, T-cell has effect Cutaneous T-cell lymphoma, lymphocyte has effect Lymphoma, Cutaneous T-cell lymphoma has cause T-cell | cancer has cause lymph nodes | Lymphoma has effect lymph nodes | FL grade 3B subclass of follicular large B cell lymphoma | papillary\u2011like nuclear features subclass of follicular thyroid neoplasm, follicular subclass of thyroid cancer, follicular tumor different from Papillary, Papillary thyroid cancer subclass of thyroid tumor, oncocytic subclass of thyroid cancer, Follicular thyroid carcinoma subclass of thyroid cancer, H\u00fcrthle cell carcinoma subclass of Oncocytic carcinoma, Papillary different from follicular tumor | Germinal centers Follicular lymphoma subclass of Lymphoma | CML has effect CML, chromosome 22 has effect Philadelphia chromosome Chronic myeloid leukemia, Philadelphia chromosome Chronic myeloid leukemia has cause chromosome 9, CML has cause CML, chromosome 9 shares border with chromosome 22 | cancer has cause cell changes | Head and neck cancer has cause lymph nodes | Non-Hodgkin lymphoma subclass of cancer | Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma | CML has cause CML",
        "metrics": {
          "rouge_score": 0.12500000000000003,
          "answer_correctness": 0.7305409464952608
        }
      },
      {
        "id": "Medical-884a8392",
        "question": "Which cancers are managed similarly to ovarian cancer and why might their management overlap?",
        "ground_truth": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer due to shared origin and treatment protocols.",
        "generated_answer": "Cancers managed similarly to ovarian cancer include breast cancer, cervical cancer, and pancreatic cancer. Their management may overlap due to shared treatment protocols, genetic factors, and similar staging systems.",
        "contexts": "hereditary ovarian cancer subclass of ovarian cancer | ovarian subclass of cancer | Breast cancer subclass of cancer | Esophageal cancer subclass of cancer | lung cancer subclass of cancer | Adrenal cancer subclass of cancer | thyroid cancer subclass of cancer | ovarian subclass of cancer, breast subclass of cancer | Nasopharyngeal cancer subclass of cancer | Metastatic cancer subclass of cancer | Pancreatic cancer subclass of cancer | Less common ovarian cancers subclass of ovarian cancer | ovarian cancer subclass of less common | bladder cancer subclass of cancer | colon cancer subclass of cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | cervical cancer subclass of cancer | vaginal subclass of cancer, warts subclass of abnormal skin growths, vulvar subclass of cancer, anal subclass of cancer, penile subclass of cancer, cervical cancer subclass of cancer | Platinum-resistant cancer subclass of ovarian cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.4489795918367347,
          "answer_correctness": 0.23465166270716603
        }
      },
      {
        "id": "Medical-6e3e48fa",
        "question": "Which diagnostic procedures are essential for confirming a case of cutaneous B-cell lymphoma presenting with skin nodules?",
        "ground_truth": "Skin exam, blood tests, imaging tests, biopsy, and immunophenotyping are essential for confirming CBCL with nodules.",
        "generated_answer": "Skin biopsy is essential for confirming a case of cutaneous B-cell lymphoma presenting with skin nodules.",
        "contexts": "Cutaneous T-cell lymphoma subclass of Lymphoma, primary cutaneous T-cell lymphoproliferative disorders subclass of mycosis fungoides | papule subclass of nodule, Primary cutaneous marginal zone lymphoma subclass of Primary cutaneous B-cell lymphoma, Primary cutaneous follicle center lymphoma subclass of Primary cutaneous B-cell lymphoma | Basal cell skin cancer subclass of Skin lesion | basal cell subclass of skin cancer, Basal cell skin cancer subclass of lesion | papule subclass of nodule | skin subclass of cancer | Squamous cell subclass of skin cancer, lesion subclass of scaly spots, Marjolin\u2019s ulcer subclass of CSCC, Actinic keratosis on top of head subclass of Actinic keratoses, scar subclass of wound, Actinic keratosis on the hand subclass of Actinic keratoses, CSCC subclass of genetic syndromes | Local cutaneous squamous cell carcinoma subclass of squamous cell skin cancer | basal cell subclass of skin cancer | squamous cell skin cancer subclass of skin cancer, squamous cell carcinoma subclass of squamous cell skin cancer, nonmelanoma skin cancer different from melanoma, basal cell carcinoma subclass of skin cancer, squamous cell carcinoma subclass of cancer | Squamous cell subclass of skin cancer | melanoma subclass of skin cancer | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma | skin biopsy studied by pathologist, skin biopsy subclass of Biopsy, pathologist studies skin biopsy, biopsy practiced by doctor, scar subclass of biopsy, doctor field of this occupation biopsy, scarring subclass of biopsy, remove as much of the suspected area subclass of biopsy, Squamous cell subclass of skin cancer | diffuse large B-cell lymphoma subclass of Lymphoma | Follicular lymphoma subclass of non-Hodgkin lymphoma | Burkitt lymphoma subclass of non-Hodgkin lymphoma | Non-Hodgkin lymphoma subclass of cancer",
        "metrics": {
          "rouge_score": 0.42424242424242425,
          "answer_correctness": 0.6076781827590596
        }
      },
      {
        "id": "Medical-59ea36ca",
        "question": "What follow-up procedures are recommended after achieving remission in primary CNS lymphoma?",
        "ground_truth": "Repeat MRI, eye exam, blood tests, and performance status assessment are recommended for surveillance.",
        "generated_answer": "Regular follow-up eye exams and brain imaging are recommended to monitor for any recurrence of primary CNS lymphoma. Additionally, ongoing assessments of neurological function and overall health are important.",
        "contexts": "primary CNS lymphoma subclass of Treatment, primary CNS lymphoma subclass of cancer, primary CNS lymphoma subclass of CNS lymphoma, primary CNS lymphoma subclass of brain tumor | primary CNS lymphoma subclass of Lymphoma, Can primary CNS lymphoma be cured? medical condition treated CNS lymphoma | primary CNS lymphoma subclass of brain lymphoma | primary CNS lymphoma subclass of tumor, vitreoretinal lymphoma subclass of CNS lymphoma | CNS lymphoma subclass of Lymphoma | primary CNS lymphoma instance of Treatment | more than one treatment option facet of primary CNS lymphoma | lymphoma in the eyes subclass of CNS lymphoma | primary CNS lymphoma subclass of eye exam | plan treatment facet of primary CNS lymphoma | CNS lymphoma has part primary CNS lymphoma, primary CNS lymphoma instance of disease | Treatment medical condition treated primary CNS lymphoma, primary CNS lymphoma drug used for treatment Treatment | primary CNS lymphoma has effect Helping a person with primary CNS lymphoma | Mediastinal gray zone lymphoma different from Primary mediastinal B-cell lymphoma, Primary mediastinal B-cell lymphoma different from Mediastinal gray zone lymphoma, Hodgkin lymphoma subclass of Mediastinal gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Gray zone lymphoma, Hodgkin lymphoma subclass of Gray zone lymphoma, Primary mediastinal B-cell lymphoma subclass of Mediastinal gray zone lymphoma",
        "metrics": {
          "rouge_score": 0.27272727272727276,
          "answer_correctness": 0.5666783939968619
        }
      },
      {
        "id": "Medical-95bdfdba",
        "question": "Which symptoms should prompt consideration of throat cancer and subsequent diagnostic evaluation?",
        "ground_truth": "Difficulty swallowing, sore throat, and voice changes should prompt evaluation for throat cancer.",
        "generated_answer": "Symptoms that should prompt consideration of throat cancer include persistent sore throat, difficulty swallowing, unexplained weight loss, and a lump in the neck.",
        "contexts": "Symptoms used by diagnosis, Symptoms has cause medical problem, medical problem has effect Symptoms | diagnosis uses test, test used by diagnosis | test use diagnosis | pathologic examination studies tumor, Pathologic examination studied by pathologist | radiologist studies Imaging, Imaging studied by radiologist | diagnosis studies brain tumor, brain tumor studied by diagnosis | Symptoms has effect Symptoms, Symptoms has cause Symptoms | Magnetic resonance imaging studied by radiologist, Imaging studied by radiologist, Imaging has cause scan | Symptoms different from symptom | Symptoms has cause Treatment | plan treatment uses diagnostic test | illness has effect Symptoms, Symptoms has cause illness | illness has effect Symptoms, Symptoms has cause illness | Symptoms different from Symptoms | signs different from Symptoms, Symptoms different from signs | symptom facet of disease | disease studied by Pathologist",
        "metrics": {
          "rouge_score": 0.2222222222222222,
          "answer_correctness": 0.6664078230737198
        }
      },
      {
        "id": "Medical-640a315c",
        "question": "Which supportive care interventions are necessary for an AML patient presenting with severe anemia and infection risk?",
        "ground_truth": "Transfusions and infection prevention measures are necessary supportive care interventions.",
        "generated_answer": "Supportive care interventions for an AML patient with severe anemia and infection risk include blood transfusions, antibiotics for infection prevention, and nutritional support.",
        "contexts": "supportive care subclass of health care | supportive care subclass of Treatment | Symptoms subclass of supportive care | Hospice subclass of supportive care, Palliative care subclass of supportive care | Clinical trial subclass of health research, supportive care subclass of Treatment | supportive care subclass of supportive care | Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | supportive care part of cancer care | supportive care facet of cancer | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | platelet subclass of Red blood cell, Blood Acute lymphoblastic leukemia subclass of blood cancer, Red blood cell subclass of Red blood cell, platelet subclass of blood stem cell, Granulocyte subclass of white blood cell, white blood cell subclass of Red blood cell, Red blood cell has part cells, white blood cell subclass of Red blood cell, platelet subclass of Red blood cell, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, progenitor cells subclass of precursor cell | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | cancer care subclass of Treatment | cancer survivors subclass of care | recommendations subclass of care recommendations | sustained subclass of nutrition | Palliative care subclass of cancer care | Acupuncture subclass of Complementary and alternative therapies, Homeopathy subclass of Complementary and alternative therapies, Integrative oncology subclass of cancer care, Integrative oncology subclass of cancer center, Treatment decisions subclass of options",
        "metrics": {
          "rouge_score": 0.24242424242424243,
          "answer_correctness": 0.7338277709919474
        }
      },
      {
        "id": "Medical-8ac49b5b",
        "question": "Which biomarker must be tested in all patients diagnosed with oropharyngeal cancer, and what is its clinical significance?",
        "ground_truth": "p16 (HPV) testing must be performed in all oropharyngeal cancer patients as it serves as a surrogate biomarker for HPV-mediated disease.",
        "generated_answer": "The biomarker that must be tested in all patients diagnosed with oropharyngeal cancer is HPV (Human Papillomavirus). Its clinical significance lies in its association with the prognosis and treatment response in oropharyngeal cancer patients.",
        "contexts": "biomarker subclass of biomarker | Biomarkers subclass of biomarker | biomarker test subclass of biomarker, biomarker subclass of test | molecular subclass of biomarker | following biomarkers subclass of biomarker | biomarker subclass of genetic | biomarker test subclass of test | biomarker subclass of genetic testing | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | biomarker testing subclass of Molecular | Testing for this biomarker subclass of biomarker | tumor profiling subclass of biomarker testing | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor mutation testing subclass of biomarker | biomarker subclass of biomarker, colorectal cancer subclass of colon cancer | Imaging subclass of test results, biomarker test subclass of biopsy | molecular tumor testing subclass of biomarker testing",
        "metrics": {
          "rouge_score": 0.25,
          "answer_correctness": 0.7390587981887269
        }
      },
      {
        "id": "Medical-5fdb115b",
        "question": "What imaging modalities are used for both staging and surveillance of nasopharyngeal carcinoma?",
        "ground_truth": "CT scan, MRI, PET/CT, and ultrasound are used for both staging and surveillance of NPC.",
        "generated_answer": "CT, MRI, and PET scans are used for both staging and surveillance of nasopharyngeal carcinoma.",
        "contexts": "staging subclass of Imaging | radiology subclass of Imaging | CT subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging, metastasized subclass of cancer, PET subclass of scanning, tumor subclass of irregular, PET/MRI said to be the same as PET/CT | Clinical subclass of cancer staging, pathologic subclass of cancer staging | computed tomography subclass of Imaging | Magnetic resonance imaging subclass of Imaging, CT subclass of Imaging | contrast subclass of Imaging | Imaging subclass of Imaging, CT subclass of Imaging | CT subclass of Magnetic resonance imaging | SSTRPET subclass of PET scan, FDG-PET subclass of PET scan, PET/MRI subclass of PET, FDG-PET uses tracer, PET/CT subclass of CT, PET subclass of scan, PET scan uses positron emission tomography, PET/CT subclass of PET, PET/MRI subclass of Magnetic resonance imaging | Ultrasound subclass of Imaging, Magnetic resonance imaging subclass of Imaging | biopsy subclass of Imaging | Biopsy subclass of Imaging | minimally invasive procedure subclass of Surgical staging | PET subclass of Imaging methods for detecting prostate cancer, Magnetic resonance imaging subclass of Imaging methods for detecting prostate cancer, Before \u2013 Imaging subclass of Imaging, Magnetic resonance imaging uses Magnetic resonance imaging, bone scan subclass of Imaging methods for detecting prostate cancer, early-stage subclass of prostate cancer, CT subclass of Imaging methods for detecting prostate cancer | Imaging subclass of biopsy | Staging after surgery subclass of Clinical stage, Clinical subclass of cancer staging | CT scan subclass of Imaging",
        "metrics": {
          "rouge_score": 0.7096774193548386,
          "answer_correctness": 0.6698676962894349
        }
      },
      {
        "id": "Medical-5f54bb84",
        "question": "What symptoms and diagnostic findings would prompt a clinician to test for biomarkers and genetic changes in a suspected case of CBCL?",
        "ground_truth": "The presence of skin nodules or papules and findings from biopsy or immunophenotyping would prompt biomarker and genetic testing in suspected CBCL.",
        "generated_answer": "Symptoms such as persistent skin lesions, lymphadenopathy, or systemic symptoms like fever and weight loss, along with diagnostic findings indicating atypical lymphoid proliferation, would prompt testing for biomarkers and genetic changes in suspected cases of CBCL.",
        "contexts": "biomarker subclass of biomarker | Biomarkers subclass of biomarker | biomarker subclass of test, biomarker test subclass of biomarker | molecular subclass of biomarker | biomarker test subclass of test | biomarker subclass of genetic | biomarker subclass of genetic testing | following biomarkers subclass of biomarker | biomarker testing subclass of Molecular | biomarker subclass of features, Fluorescence in situ hybridization subclass of biomarker | biomarker testing subclass of biopsy, biopsy subclass of test results | Tumor markers subclass of biomarker, tumor profiling subclass of molecular testing | tumor profiling subclass of biomarker testing | Testing for this biomarker subclass of biomarker | genetic testing subclass of diagnostic test | tumor mutation testing subclass of biomarker | molecular tumor testing subclass of biomarker testing | Diagnosis by blood test subclass of blood test",
        "metrics": {
          "rouge_score": 0.41379310344827586,
          "answer_correctness": 0.9855646146242171
        }
      },
      {
        "id": "Medical-5422875d",
        "question": "What risk factors should be evaluated in a patient suspected of having ALL and why are these important?",
        "ground_truth": "Genetic syndromes and family history should be evaluated as they increase the risk of developing ALL.",
        "generated_answer": "Risk factors to evaluate in a patient suspected of having acute lymphoblastic leukemia (ALL) include family health history, age, and previous exposure to certain chemicals or radiation. These factors are important as they help assess the patient's risk level and guide appropriate screening and treatment options.",
        "contexts": "lung cancer studied by risk factors, risk factors studied by Risk assessment, risk factors studies lung cancer, risk factors part of family health history, Risk assessment studies risk factors, family health history has part risk factors, risk factors facet of lung cancer, Lung cancer screening instance of risk factors, Lung cancer screening facet of lung cancer | Risk assessment studies problem, problem studied by Risk assessment, assessment of their risks facet of Treatment | risk factors has effect cancer, cancer has cause risk factors | age instance of risk factors, risk factors facet of cancer | risk factors facet of disease | age instance of risk factors, prostate cancer has cause risk factors, cancer subclass of risk factors | risk factors has effect cervical cancer, cervical cancer has cause risk factors | side effects studied by controlled, side effects subclass of risks, controlled studies side effects | Clinical trial studied by Clinical trial | risk level subclass of factors, Risk assessment facet of skin cancer | outcomes studied by researchers, researchers studies outcomes | cancer studied by health history",
        "metrics": {
          "rouge_score": 0.1904761904761905,
          "answer_correctness": 0.4466245696595697
        }
      },
      {
        "id": "Medical-890965f6",
        "question": "What laboratory findings and symptoms together would strongly suggest a diagnosis of AML?",
        "ground_truth": "The presence of \u226520% myeloblasts in bone marrow or blood along with symptoms such as fatigue, infections, bleeding, and bruising suggest AML.",
        "generated_answer": "Laboratory findings such as elevated white blood cell count and symptoms like fatigue and easy bruising would strongly suggest a diagnosis of AML.",
        "contexts": "Symptoms has effect Symptoms, Symptoms has cause Symptoms | illness has effect Symptoms, Symptoms has cause illness | diagnosis has effect Treatment, Treatment has cause diagnosis | illness has effect Symptoms, Symptoms has cause illness | Diagnosed has effect treated, treated has cause Diagnosed | Symptoms used by diagnosis, Symptoms has cause medical problem, medical problem has effect Symptoms | diagnosis has effect Treatment, Treatment has cause diagnosis | Treatment has cause diagnosis, diagnosis has effect Treatment | diagnosis has effect plan treatment | Treatment has effect Symptoms, Symptoms has cause Treatment | diseases has effect conditions | Symptoms different from Symptoms | diagnosis uses test, test used by diagnosis | signs different from Symptoms, Symptoms different from signs",
        "metrics": {
          "rouge_score": 0.31111111111111117,
          "answer_correctness": 0.8379833322473295
        }
      },
      {
        "id": "Medical-98bb0bbc",
        "question": "How does the classification of uncommon FL (uFL) differ from classic FL (cFL), and how does this affect treatment?",
        "ground_truth": "Uncommon FL is t(14;18)-negative or has unusual features, but is treated as classic FL.",
        "generated_answer": "Uncommon FL (uFL) is not classified as classic FL (cFL) and is considered a different category, which may influence treatment approaches. Pediatric-type FL is a subclass of classic FL, indicating that treatment strategies may vary based on the specific classification.",
        "contexts": "Uncommon FL said to be the same as Uncommon FL, Pediatric-type FL subclass of classic FL, classic FL instance of ICC classification system | lengthens opposite of widens, widens opposite of lengthens | low risk opposite of high risk | lower risk opposite of higher risk, higher risk opposite of lower risk | fusiform opposite of circle | benign opposite of cancerous | dormant opposite of active | p16-negative opposite of p16-positive, p16-positive opposite of p16-negative | Unresectable opposite of Resectable, Resectable opposite of Unresectable | Moderately differentiated different from Poorly differentiated, Well differentiated different from Moderately differentiated, Moderately differentiated different from Well differentiated | female opposite of male | speak different from see | male opposite of female | T-ALL different from B-ALL",
        "metrics": {
          "rouge_score": 0.20689655172413793,
          "answer_correctness": 0.5316386052151512
        }
      },
      {
        "id": "Medical-836e7db0",
        "question": "Which symptoms, when present together, would most strongly suggest CLL as a diagnosis requiring further blood and immunophenotyping tests?",
        "ground_truth": "Swollen glands, fatigue, and recurrent infections together should prompt CLL workup with blood test and flow cytometry.",
        "generated_answer": "Lymphocytosis, splenomegaly, and lymphadenopathy.",
        "contexts": "Blood has part B cell, Blood has part white blood cell, Blood part of immune system, platelet part of Blood, B cell part of Blood, Blood has part Red blood cell, Blood has part white blood cell, immune system has part Blood, Blood has part T cells, Blood has part platelet, antibodies has cause lymphocyte, white blood cell part of Blood, lymphocyte has effect antibodies, T cells part of Blood, plasma part of Blood, white blood cell part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, Red blood cell subclass of Red blood cell, white blood cell subclass of Red blood cell, platelet part of Blood, white blood cell has part lymphocyte, lymphocyte subclass of white blood cell, platelet subclass of Red blood cell, blood stem cell part of Red blood cell | cells part of Blood, Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, Blood has part cells, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | Red blood cell part of Blood, Red blood cell subclass of Red blood cell, Neutrophil subclass of white blood cell, Blood has part blood stem cell, differentiation product or material produced Red blood cell, Blood part of immune system, bone marrow product or material produced Blood, platelet part of Blood, white blood cell has part lymphocyte, immune system has part Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, blood stem cell part of Blood, white blood cell has part Granulocyte, white blood cell part of Blood, plasma part of Blood, plasma has part water, white blood cell has part monocyte, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, platelet follows white blood cell, Granulocyte subclass of white blood cell | immunophenotyping facet of immune system | tissues part of organs, Red blood cell part of Blood, kidney instance of organs, liver instance of organs, Blood has part white blood cell, white blood cell part of Blood, white blood cell follows Red blood cell, Blood has part platelet, liver connects with stomach, platelet part of Blood, Blood has part platelet, Blood tests subclass of blood test | Immunophenotyping subclass of Biopsy | HLA typing instance of blood test | Blood test uses sample | immune system has part Blood | white blood cell has part lymphocyte, Red blood cell part of Blood, Blood has part Red blood cell, cells part of Red blood cell, Blood part of immune system, Red blood cell subclass of blood stem cell, blood stem cell subclass of stem cell | white blood cell part of Blood, Granulocyte subclass of white blood cell, erythrocyte subclass of Red blood cell, Red blood cell has part blood stem cell, plasma part of Blood, Red blood cell part of Blood, plasma has part water, Blood has part plasma, lymphocyte subclass of white blood cell, monocyte subclass of white blood cell, bone marrow has part bone marrow, platelet follows white blood cell | Bone marrow test uses bone marrow | Blood studied by hematopathologist | Blood has part WBC, WBC part of Blood | Blood has part bone marrow | Blood subclass of test | blood sample part of bone marrow, Blood has part cells | white blood cell subclass of blood stem cell, Red blood cell subclass of blood stem cell, Red blood cell part of Blood, platelet subclass of blood stem cell, Red blood cell has part blood stem cell, Lymphoid progenitor cell followed by lymphocyte, white blood cell part of Blood, platelet part of Blood, lymphocyte follows Lymphoid progenitor cell, Red blood cell has part Red blood cell, Red blood cell subclass of Red blood cell, blood stem cell part of Red blood cell, bone marrow has part bone marrow, lymph tissue has part lymphatic vessel | Blood has part cells | Blood has part white blood cell",
        "metrics": {
          "rouge_score": 0.09523809523809523,
          "answer_correctness": 0.22793585340590675
        }
      },
      {
        "id": "Medical-e1deaedc",
        "question": "Which molecular biomarkers should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy, and why?",
        "ground_truth": "ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, and TMB-H should be tested to guide targeted therapy.",
        "generated_answer": "Molecular biomarkers such as BRAF, RAS, and RET should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy to identify potential targeted therapies and inform treatment decisions.",
        "contexts": "RAI therapy medical condition treated cancer cells left in the body, cancer cells left in the body drug used for treatment RAI therapy | RAI therapy uses iodine | Total thyroidectomy medical condition treated thyroid cancer, Total thyroidectomy different from RAI therapy, Total thyroidectomy followed by After total thyroidectomy, RAI therapy different from Total thyroidectomy | Total thyroidectomy medical condition treated thyroid cancer | Levothyroxine medical condition treated thyroid cancer | Surgery Surgery medical condition treated thyroid cancer, Lobectomy medical condition treated thyroid cancer | Ultrasound Ultrasound medical condition treated thyroid cancer | External beam radiation therapy medical condition treated thyroid cancer, Anaplastic thyroid cancer drug used for treatment radiation therapy, radiation therapy medical condition treated thyroid cancer, iodine- Radiation therapy has part iodine-131, iodine-131 part of iodine- Radiation therapy, thyroid cancer drug used for treatment External beam radiation therapy, radiation therapy medical condition treated Anaplastic thyroid cancer, RAI therapy uses wholebody scan | Neck ultrasound medical condition treated thyroid cancer | Total thyroidectomy medical condition treated papillary cancer | Metastatic bladder cancer subclass of treatable, bladder cancer drug used for treatment detect and treat, treatments medical condition treated bladder cancer, treated medical condition treated bladder cancer, cancer drug used for treatment treated, bladder cancer drug used for treatment treatments, treated medical condition treated cancer, bladder cancer drug used for treatment treated, cured facet of bladder cancer | Treatment medical condition treated cancer | treatments medical condition treated cancer | Ultrasound medical condition treated Thyroid nodules | Chemoradiation medical condition treated cancer",
        "metrics": {
          "rouge_score": 0.30769230769230765,
          "answer_correctness": 0.6346942186137992
        }
      },
      {
        "id": "Medical-413d4c7e",
        "question": "What are the main symptoms prompting diagnostic evaluation for cervical cancer, and which diagnostic methods confirm the diagnosis?",
        "ground_truth": "Symptoms like watery vaginal discharge, pelvic pain, and abnormal vaginal bleeding prompt evaluation, confirmed by cervical biopsy.",
        "generated_answer": "Main symptoms include abnormal vaginal bleeding, pelvic pain, and unusual discharge. Diagnostic methods include cervical biopsy and HPV testing.",
        "contexts": "cervical biopsy facet of cervical cancer | biomarkers facet of cervical cancer | side effects facet of cancer | ectocervix has effect cervical cancer, Other risk factors facet of cervical cancer, cervical cancer has cause ectocervix | symptom facet of disease | Signs and symptoms facet of disease | symptoms of SCLC subclass of Symptoms, symptoms of SCLC facet of cancer | cervical cancer has cause Cervical changes Cervical cancer, cervical cancer has cause ectocervix, ectocervix has effect cervical cancer | cervical cancer has cause risk factors, risk factors has effect cervical cancer | Stage 1 subclass of cervical cancer, Stage IB3 Cervical Cancer subclass of cervical cancer, Stage IB2 Cervical Cancer subclass of cervical cancer, Stage 1B2 and 1B3 cervical cancer subclass of cervical cancer, Stage 2A1 cancers follows Stage 2A1 cancers, stage facet of cancer, Cancer 3 mm or smaller subclass of cervical cancer, Stage 2A1 cancers followed by Stage 2A1 cancers, cervical cancer subclass of cervical cancer | breast exams facet of Breast cancer | HPV testing facet of throat (oropharyngeal) cancer | spread subclass of cancer, tumor part of cancer, stage facet of cancer, prostate cancer screening test facet of cancer, tumor, node, metastasis facet of Breast cancer, cancer has part tumor | Lung cancer screening facet of lung cancer, Risk for lung cancer facet of lung cancer | cervical cancer has cause Cervical changes Cervical cancer | Lung cancer screening facet of lung cancer | side effects facet of chemotherapy | FIGO system facet of cervical cancer",
        "metrics": {
          "rouge_score": 0.3888888888888889,
          "answer_correctness": 0.9081443463568504
        }
      }
    ]
  }
}